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PHENOTYPIC AND FUNCTIONAL CHARACTERIZATION OF la+ AND la- SUBUNES OF THE 
HUMAN MONOCYTE-LIKE CELL LINE,  U937 
Abstract 
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College of Virg in ia ,  Virg in ia  Commonwealth Un iversity. 
Coles Meredith Squire 
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Advisor :  Dr. T. Mohanakumar 
Subl ines were derived from the U937 human monocyt ic ce l l  l i ne  by l im it ing 
d i lut ion  techniques. Several of the sub l ines derived i n  th is  manner were fou nd to 
constitu itive ly express la ,  u n l ike most U937 cel l  l ines previous ly examined.  Thus  the 
l a+ and l a- subl ines were exam ined and characterized phenotypical ly and functiona l ly .  
Morpholog ical ly the sub l ines ,  both l a+ and la - ,  were fou nd to be s im i l a r  to the 
orig inal ly described U937 parent ce l l  l i ne .  They were positive for production of non­
specific esterase and expressed the HLA phenotype A(3,X), 8(51,18), DA(2,X). The 
subl ines were examined by immunofluorescence techn iques with a large n u m ber  of 
antibodies specific for ce l l  surface structures and found to express M H C  class I ,  M H C  
class " the major type being H LA- DR and perhaps H LA- DQ i n  smal l  amou nts ,  Fc 
recepto r, TA- 1 structure typical of monocytes and T cel l s ,  endothe l ia l  a ntigens  and 
CD4.  The subl ines and parent U937 cel l  l i ne  were found to express few cel l  surface 
antigens typical of mature monocyteslmacrophages; however ,  they expressed myeloid 
antigens typical of early monocytic or  promonocytic l ineage . Expression of M H C  class " 
by the subl ines was confirmed by immunoprecipitat ion with monoclona l  ant ibody to a 
framework determinant of human l a  and SOS-PAG E autoradiography which gave bands 
at p29 :34 for l a+ subl ines but not for l a- parent  U937 cel l  l i nes .  Ce l l  s u rface 
expression of la was i ncreased to a s ign ificant deg ree by treatment with g a m m a  
interferon which peaked a t  24-48 hours o f  treatment. 
Functional ly the parent U937 ce l l  l ine and several l a+ subl ines were examined 
in  several assays. The la- and l a+ U937 cel ls were fou nd to stimulate the generation of 
specific CTLs in CML assays to approximately the same degree. The l a+ subl ines were 
fou nd to stimulate i n  M LR assay, although variable resu lts were obtained and indicated 
that the U937 parent and subl i ne  cel ls produced factors wh ich were fou n d  to be 
inherently immunosuppressive . The subl ines were able to substitute for monocytes by 
reconstituting the C03 mediated T ce l l  m itogenic response. The la+ subl ines and the 
parent U937 cell l ine (also weakly la+) were found to present tetanus toxoid antige n  to 
ny lon -woo l pur i fi ed T ce l l s  fol lowing an overn ight  pu lse with ant ig e n ,  a n d  th i s  
response was found to  be  s ig n ificantly abrogated by  addition o f  antibody specific for 
C 04 and M HC class I I ,  but not M HC class I .  Pre l im inary characte rizat ion of  the 
immunosuppressive factor produced by the U937 ce l l  l i ne and the subl ines revealed 
that it was strongly antiprol iferative and affected lymphoid cel ls somewhat more than 
non- lymphoid cel l s ;  that its probable molecular weight  was approx imately 90 ,000 ,  i t  
was not i nactivated by treatment with trypsi n  or chymotryps in ,  was not i m m ed iately 
i nactivated by freezing although dialysis and long term storage d iminished its activity , 
and was partial ly inactivated by heat treatment at both 56°C and 80°C. Clear indication 
of so lub le I L- 1  product ion by the U937 parent  ce l l  l i n e  and  the sub l i nes  was 
problematic due to the strong i n h ibit ion of pro l iferative assays by supernatants ; 
however,  part ia l  inactivat ion  of i nh ibitory activity by heat treatment as wel l  as part ia l  
removal of the i nh ibitor fraction by ge l  f i l trat ion ind icated that I L- 1  o r  a cytokin e  
with I L- 1  act ivity was const itu it ively produced by t h e  ce l l s .  Membrane  I L- 1  was 
detected in  very low amounts in  unst imulated cel ls and was sign ificantly increased by 
treatment  with phorbo l esters but not other  i m m u no modu lators . P re l i m i n ary 
examination of Northern blots of HLA-OR alpha and HLA-OQ alpha mRNA production by 
the parent U937 cel ls and the subl ines revealed that both H LA-OR alpha and H LA-OQ 
alpha mRNA were detectable for la+ subl ines E1 1 ,  G4 and G 1 1 ,  that on ly trace amounts 
were detectable for relatively l a- subl ine E9 and that surpris ingly,  H LA-OQ alpha was 
detectable for the 2-1 parent ce l l  l ine but no H LA-OR alpha mRNA was detectable . The 
resu lts of m RNA analysis fol lowing gamma interferon treatment,  as wel l  as treatment 
with LPS and phorbol esters , were variable for the different subl ines and indicate that 
in  some sublines gamma interferon treatment appears to augment la  specific m R NA and 
in  others the levels are decreased indicating that the expression of MHC class I I  specific 
m R NA may be d ifferential ly regu lated in the different subl ines.  
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Immunity and the role of monocytes and macrophages in competent immune 
function. Maintenance of the integrity of the organ ism in the face of hordes of i nvaders 
is dependent on both i nnate relatively non-specific mechanisms and adaptive specific 
mechanisms. 
Innate. non-specific. non-adaptive mechanisms of immune function .  I n nate 
mechan isms include the presence of healthy i n tact sk in and m ucous m embranes ,  
phagocyt ic cel ls present in  a wide variety o f  t issues and  organs and  the  enzymes and 
secreted substances such as lysozyme and reactive oxygen intermediates wh ich are 
products of phagocytic ce l ls once invaders have been encountered . I nnate mechan isms 
of immune function shou ld not be u nderemphasized in  the protection of the ind iv idua l .  
Ma in tenance of in tact i nnate mechan isms protects the i ndivid ua l  fro m  a l l  of the 
i nvaders except those which have developed mechan isms fo r pe n etration .  The 
importance of innate immune function becomes obvious in  the overwhelm ing infections  
com mon to  patients with severe burns and exfo l iative d iseases, t he  cu rrent f ind i ng that 
the smal l  skin and mucous membrane lesions produced by i nfection with Herpes v i rus 
or syphilis predisposes i ndividuals to human immunodeficiency v irus (HIV) infection 
( 1 ) and the  i n fect ions ,  especia l ly  opport u n ist ic bacte r ia l  and funga l  i n fect ion s ,  
com mon i n  chron ic granu lomatous d isease (2, 3,  4) . Although these are merely a few 
examples, they point to the severity and l ife-th reaten ing nature of a compromised host. 
Specific, adaptive immune function . Specific mechanisms of immune function 
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are ch aracterized by two features : they are anamnestic, i . e .  they h ave in t ri n s ic  
memory ; and they are exquis itely specific.  Both specificity and the i nform at ion 
req u i red for memory are encoded by members of the i m m u noglobu l i n  supergene  
fami ly, so  named because the genes and gene products share a battery o f  characteristics 
wh ich a l low for the product ion of vast n u m bers of different, m u lt icha i n  receptors 
having domain structu re from a fin ite number of encoded genes. 
The specific arm of the i m m u ne response is  characte rized by i nteract io n s  
between several types of cel ls, t h e  most common o f  wh ich are T lymphocytes, B 
lymphocytes, monocytes, macrophages and dendritic cel ls .  I t  is now general ly accepted 
that the production of a specific response necessitates the production of a termolecular 
complex between an ant igen in a presentable form, a major h istocompatibi l ity com plex 
(M HC) encoded class I or  class I I  receptor on an appropriate ant igen present ing cel l, 
and a specific T ce l l  receptor capable of recogniz ing the antigen bound to a part icu lar  
M HC .  This interact ion is capable of  i n it iat ing a specific response to an almost inf in i te 
n umber of antige n ic determ inants engendering a level of complexity pecu l iar  to the 
immune  system.  Several  complex processes are requ i red for the production of each 
component of the termolecu lar complex wh ich is fo l lowed by signa l  transduction leading 
to T cel l  activation, clonal expansion of he lper and effector cel ls, and expression of 
e ither a humoral or  cel lu lar response to an antigen .  Production of an immune response 
is, therefore, dependent on  successfu l accomplishment of a ser ies of steps:  expression 
of M HC class I o r  class I I  receptor, ant igen process ing and presentat ion by an 
appropriate antigen presenting cel l  (APC) ,  expression of a specific T cel l  receptor on a 
T lymphocyte wh ich  necess itates t he  pr ior  e l i m i n at ion  of se l f- react iv i ty and  
concomitant preservation o f  a d iverse T cel l  repertoire, and  T ce l l  activation invo lv ing 
transduction  of s ignals across the cel l  membrane to the n uclear compartment  for the 
induction  of secretory products and in it iat ion of ce l l u la r  prol ife ration .  
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The T cell receptor. The en igmatic T ce l l  receptor, various ly postu lated to be 
e i ther a s ingle receptor with dual  recogn ition propert ies or  two separate receptors, 
was fi nal ly caught and extens ively investigated using the development of monoclona l  
ant ibodies to T cel l  hybridomas and clonal ly expanded T cel l  poplu lations  (5,  6 ,  7) i n  
1 983. A single receptor was found to convey both antigen and MHC specificity and has 
convinced most investigators of the correctness of the s ing le receptor-dual  recogn it ion 
model (8, 9, 1 0) .  The receptor was found to be a d isu lphide- l i nked heterod imer  
having a combined molecu lar we ight o f  80-90 kd  composed of  an  acid ic g lycoprotein 
a lpha chain with a molecu lar weight of 39-49 kd and a second, but more basic, 38-44 
kd beta chain which is  a lso g lycosylated. (There is sti l l  d isag reement in the l ite ratu re 
on the characteristic size of each chain . )  (Reviewed in 1 1 ,  1 2, 1 3, 1 4, 1 5) The two 
polypeptides were found to be encoded by separate genes but shared several features 
inc lud ing al le l ic excl usion, domain structu re and featu res of gene arrangement  wh ich 
were also very simi lar to the genetic arrangement of immunog lobu l i n  genes ( 1 6 ,  1 7 , 
1 8) .  The alpha chain is located on  chromosome 1 4  in both m ice and h u mans ( 1 9, 20 ,  
2 1 ) ,  and the beta cha in  is located on chromosome 6 i n  m ice and chromosom e  7 i n  
h u mans (22, 23, 24); therefo re, as  with immunoglobu l i ns, a m u lticha in product is  
constructed from the products of  separate chromosomes. Structurally the a lpha cha in  
gene is composed of th ree types of e lements i n  addit ion to a leader  sequence :  
approx i mately 50- 1 00 var iable (V) genes, 20-50 J reg ion genes, a n d  a s i ng le  
constant (Ca) reg ion gene. The  beta gene o f  humans is composed o f  approx imately 50 
Va genes, 2 Da genes, 1 3  Ja genes, and 2 Ca genes. The mouse beta chain genes are 
som ewhat more l im ited and consist of 2 1 -30 variab le (Va) genes and on ly 1 2  J 13 
genes. The beta genes are also arranged such that the variable genes are fol lowed by two 
c lusters of DJ C genes as fo l lows ( 1 3 , 1 5) :  
[ Da1 . . .  Ja( 1 - 7) . . .  Ca1 ]  & [Da2 . .  ·Ja( 7- 1 2) . . . Ca21· 
The generation of specifici ty and diversity is accompl ished by the arrangement of 
4 
al l  the possible combinations of VDJ for alpha and beta chain genes with the added 
measure of d iversity conveyed by the possib i l i ty of us ing the D B genes in e ither  
orientation and by the  addition of  random nucleotides a t  N reg ions.  The total n umber of 
postu lated combinations (T ce l l  receptors) is g reater than 1 X 1 07 (25 , 26) . Th is  
n umber of  poss ible T ce l l  receptors is  more than sufficient to  recogn ize the ant igens  
avai lable to  the  an imal, bu t  the  reperto ire is  se lected such  that far fewer clo na l ly  
d istributed specificit ies are present. 
T cell repertoire selection. Selection of a cion al ly d istributed reperto ire of T 
ce l l  receptors, i l lustrated schematical ly i n  Figure 1 ,  is a complex process which seems  
to  take place i n  the thymus o f  the developing an imal and resu lts i n  t he  product ion of 
suffic ient diversity of T cel l  receptors to recogn ize a l l  i nvading fore ign antigens  in the 
context of self-MHC whi le at the same t ime insuri ng tolerance to self. Production of 
both immune capabi l i ty and self tolerance requ ires the se lection and clonal de let ion or  
suppression of  a l l  clones wh ich have h igh  affin i ty for i nteract ion with e i th e r  [se lf­
M H C] a lone or  with [se lf- M HC+self-prod ucts] . T h i s  n ecessar i l y  req u i res  t h e  
se lect ion and death o f  a large n u mber o f  possible clones .  I t  is known that of the  
lymphocyte precursor ce l ls  which enter the thymus ,  very few, perhaps 1 % , rema in  
a l ive to leave (27) . There must ,  however, be a s imu ltaneous selection of  clones h aving 
receptors wh ich wi l l  recogn ize nonself products in  the context of self-MHC.  The widely 
accepted view that the mechan isms i nvolved in  reperto i re selection m ust be poised to 
e l im inate clones having h igh affin ity receptors whi le at the same t ime selecting clones 
wh ich have weak affin ity receptors for the same molecular structu res, self- M H C  (25, 
28, 29), e l im inat ing in the process recepto rs fo r nominal ant ig e n ,  appear  to be 
mediated through processes of both positive and negative selection (30) . Although the 
mechan isms invo lved i n  reperto i re selection have been di fficu lt to invest ig ate, it is  
cu rrently an area of  active investigation, and a coherent pictu re is beg inn ing to emerge .  
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F IGURE 1 .  Selection of the T cel l  repertoire. 
The thymus is the s ite for both se lection· of (antigen+self) -MHC specific T ce l l  
rece pto rs (TcR's )  and  e l i m i nat ion  of  c l o n e s  b e a r i n g  (se l f- M H C )  o r  ( s e l f­
prote i n+self-MHC) specific TcR's.  Selection is made from TcR bearing lymphocytes 
wh ich express both CD4 and CD8 ;  therefore , if a TcR reacts with self-MHC of class I 
and interacts with CD8 on a T cel l, that clone wi l l  be e l im inated and that T cel l  receptor 
w i l l  not appear on e i ther CD4+ or CD8+ T cel ls i n  the se lected reperto i re (32 . 33, 
3 4 )  . 
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7 
During the gestat ional development of the mouse,  popu lation s  of lymphocyte 
precursors appear in the thymus at about day 1 2 ; by day 1 7  T cell receptors are 
rearranged and expressed on thymocytes positive for both CD4 and CD8, and by day 1 8 , 
C D 4+ ( L3T4+) T ce l l  recepto r posit ive function al he lper T ce l ls  are present (31 ) .  
Recent evidence from several laboratories , notably von Boehmer e t  a l .  and S h a  e t  a l .  
(32, 33 , 34) , us ing transgen ic m ice i n  wh ich the rearranged T ce l l  receptor (TcR) 
genes for the male-specific m inor h istocompatibi l i ty ant igen H-Y were expressed only 
o n  C D 8+ ce l ls  and on ly if the orig ina l  M HC ( H-2Db ) was present  supports the 
occurence of positive selection in the thymus.  The find ings indicate that the double 
pos itive CD4+8+ immature thymocytes are the precursor popu lation from wh ich both 
C D4+8- and CD4-8+ cel ls develop and that the development of the mature TcR-bearing 
single positive cel l  is dependent on  the presence of thym ic MHC,  either class I or  class 
II, and the presence of heterod imeric TcA. They postu late that the se lect ion of 
perm itted TcR's is mediated by interaction of M H C  with TcR in  the absence of nomina l  
ant igen ,  i n  th is case H -Y, probably by receptor cross l i nking strong ly aug m e nted by 
cointeract ion with CD4 or C D8 (33) .  
Both e l im ination of self reactivity and generation of self-MHC restrict io n a re 
dependent on the presence of self-MHC in  the thymus ;  however, th is is apparently not 
a" that is requ i red (25 , 28,  29,  3 1 ) .  Kappler a n d  Marrick e t  a l .  have s hown that 
there is a corre lation between the use of the T ce l l  receptor variable gene,  VB 1 7a ,  and 
the presence of the la  gene products for any haplotype of I -E. Some stra ins of mice do 
not express I -E, ( H-2b , s , f ,q ) (35) and these m ice were fou nd to make use of the 
V B 1 7a variable gene i n  approximately 1 0% of the T cel l reperto i re. Stra ins  which do 
express I -E were found to have very few T cel l  receptors ut i l iz ing th is  variable gene 
and those wh ich were present d id not recogn ize  I - E .  Moreover ,  I - E+ a n i m a l s  
reconstituted with I -E- ce l ls  after lethal i rradiation were found to be repopulated with 
VB 1 7 a+ cel ls leading to the conclus ion  that the presence of I -E  on  the rema in i ng  
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endothel ia l  and stromal  cel l s  of the thymus was insufficient for the self  to lerance 
inducing deletion of ce l ls bearing the Va 1 7a variable reg ion gene product (25) . Von 
Boehmer et a I . ,  from experiments using deoxyguanosine  treated m ice,  postu late that 
induction of tolerance to self-MHC is dependent on MHC+ thymic epithel ia l  t issue ,  but 
development of self-MHC restrict ion is dependent on  bone marrow derived ce l ls  in  the 
thymus (29) . Other  recent work from Kappler and Marrick (36) and others (37, 
38) in  the Mis system may beg in  to shed some l ight  on  the selection aga inst se lf 
reactive clones. As in  the Va 1 7a experiments ,  it was noted that mice having an M lsa 
genotype expressed few if any T ce l l  receptors us ing the variable gene ,  Va 8 . 1  . 
MacDonald et al . noted that these individuals also did not express T cel l  receptors u sing 
the Va6 variable gene (37) .  M lsa (m ixed lymphocyte st im u latory) i s  a non M H C  
ant igen wh ich i n  M H C  matched but Mis d isparate m ice wi l l  cause the generat ion o f  a 
very strong mixed lymphocyte reaction .  A human analogue has been postu lated but has 
not been identified . Both Va8 . 1  and Va 6 variable genes used in  T ce l l  receptors 
confered strong Mlsa reactivity in  spite of MHC haplotype and also i nspite of the J 
reg io n gene used, a lthough Mlsa is  recogn ized i n  conjunction with M H C .  Matu re 
thymocytes bearing the Va8 . 1  and Va6 gene products in m ice expressing Mlsa were not 
fou nd indicating that there had been clonal deletion of the Va8. 1  and Va6 expressi ng 
c lones.  I t  is suggested that Mlsa may be an MHC binding prote in  wh ich b inds to a 
possib le groove in  the M HC mo lecu le  in  the thymus  thereby producing a broadly 
reactive selection receptor for e l im inat ion of certa in  self- M HC reactive clones and 
thus retention of usefu l T ce l l  clones (36,  37,  38) . Based on the ir  fi nding that normal  
percentages of these receptor bearing ce l ls  (Va 1 7a and Va8 . 1 ) are present  i n  ear ly 
thymocytes (double posit ive o r  CD4+ 8+ cel ls ) , Kappler and Marrack et a l .  have 
proposed that there is a developmenta"y regu lated "abortion"  of any  ce l l s  hav ing 
reactivity to  se l f  such that both mature thymocytes and periphera l  blood T ce l ls  have 
been selected and no longer contain the offending receptor bearing popu lat ions .  The 
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detai ls of th is negative selective mechanism are in agreement with several g roups of 
i nvestigators (28 ,  29) and not with others (33) . 
The sequence of events during thymic selection of permitted clones is not known ; 
however, pos itive se lection mechanisms have been thought to occur before n eg ative 
selection events based on the f inding that MHC expressed on thym ic cortical epithe l ia l  
cel ls appears to interact with TcR on double positive ce l ls wh ich are found primari ly in 
the thymic cortex (29,  39) and negative selection requ i res the bone marrow derived 
cel ls  found in  the medul lary reg ion (29, 40) . The proposed mechan isms for posit ive 
and negative selection in the thymus remain somewhat contradictory , and the spatia l  
and temporal relationsh ips are not ent irely understood. In  negative selective processes 
engagement of the TcR is a signal  for death in  immature thymocytes, and in  posit ive 
se lective processes it is  the means for preservat ion  and perm itted m at u rat ion .  
Presumably the same type of TcR interact ion i n  the periphery has the more posit ive 
effect, i .e. causing I L-2 production and clonal expansion . 
Ramarl i  et a l .  (4 1 )  postulate that the CD2 (T1 1 )  receptor plays a pivotal ro le  in  
the  thymus in  that it is the fi rst observable T ce l l  ant igen wh ich is expressed and the i r  
finding that engagement of  T1 1 causes an alternative pathway of  T ce l l  activat ion .  I f  the 
Tc R's on  T1 1 + thymocytes a re subsequent ly  cross l i nked ,  T 1 1 m ed iated I L-2 
production ceases, although I L-2 receptor and TcR production are not affected .  They 
contend that I L-2 is  requ i red for g rowth and maintenance of these c lones and i ts 
absence causes them to die,  again making engagement of the TcR in  the thym us a s ignal  
for clonal  death (28, 29, 4 1 ) .  Saito and Germain (8)  and Ashwel l  et a l .  (42) report 
that TcR i n teract ion with antigen+M H C  causes g rowth i nh ibit io n, i . e .  cessat ion of 
Iymphokin e  product ion, u n l ess fu rthe r  s igna ls  are de l ivered . P art icu la r  variab le 
reg ion genes, e i ther Va or Va , may predispose a T cel l  receptor to recogn ize a 
particular M H C ;  however, evidence currently indicates that the total specificity of the 
receptor is dependent on contributions made by both alpha and beta chains.  Rather than 
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selection  by h igh and low affin ity , se lection by mod ified self avai lable o n ly i n  the 
thymus is favored ,  supported by evidence that VB 1 7a recogn izes an a l logene ic M LR­
stim u lating determ inant on ly on I -E+ B ce l ls and peritoneal macrophages and not o n  1-
E+ macrophage cel l  l ines and transfected fibroblasts , suggesting that a self  product 
binds with the I -E  molecule to produce the I -E  a l logeneic l igand and that th is product is 
not avai lable in  the macrophage cel l  l i ne or  the transfected fibroblast (3 1 ) .  The effect 
is not re lated to density of express ion of I -E  on the cel l  surface (43) . Th is find ing in  
combination wi th  the recent advances i n  the u nderstanding of Ag process ing and 
presentation to be discussed below (44 , 45,  46) wou ld seem to lend weight to the idea 
that al logeneic responses are polyclonal responses to fore ign MHC complexed to self 
peptides (47) . The large n umber of self peptides,  which in combination with self M H C  
are not recog n ized,  wou ld ,  i n  combination with fore ign MHC ,  b e  recog n ized b y  larg e  
numbers of clones. 
Thus it is obvious from the brief ment ion of work from several g roups that 
progress i s  be ing made i n  determin ing  m echan isms for reperto i re se lect ion and  
to lerance induction ; however,  t he  picture is  far from clear and  there is  cu rrent ly no  
consensus on the detai ls. There is growing agreement, however, that selection of the T 
ce l l  repertoire is dependent on thymic MHC,  both class I and class I I ,  and interactions  
between M HC and TcR's expressed on immature T cel l s  wh ich are double posit ive 
C D4+8+ thymocytes ; and that th is  selection process works i n  negative ways for the 
e l im ination of  auto reactive clones and in  positive ways for the selection of TcR's wh ich 
can i nteract with se lf-MHC for the product ion of a TcR-beari n g ,  s i ng le  posit ive 
reperto i re sufficiently diverse to offer induction of immune  fu nction to a l l  potent ia l ly 
harmfu l foreign antigens. The growing body of knowledge of the mechanisms of a l le l ic 
exclus ion  and express ion of the alpha and beta chains  of the T cel l  receptor  i n  
coniunction with the several constant chains o f  the C D3 complex,  however, has been 
more c learly shown and has contr ibuted d i rect ly to i nvest igat ion of  repe rto i re 
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se lection .  
The clonotypic T cell receptor and the monomorphic CP3 complex. The T cel l  
receptor is fou nd as an integ ra l  membrane prote in i n  close association  with the  
polypeptide chains o f  the  CP3 complex . The  CP3 complex in  h umans i s  composed of a 
gamma chain (25-28 kd g lycoprotein) ; a delta chain ,  the orig inal ly detected l igand for 
OKT3 monoclonal antibody , (20 kd g lycoprote in); and a n  epsi lon chain (20 kd non­
g lycosylated prote in )  ( 1 5) .  The murine CP3 equ iva lent was found (48) and u pon  
analysis was found to be  composed o f  several additional chains .  The N-g lycosylated 28  
kd delta-equ ivalent, 21  kd N-g lycosylated gamma, and  25  kd non-g lycosylated epSi lon 
were present ;  however, an additional 34 kd non-g lycosylated homodimer des ig n ated 
zeta was found as was a 21 kd non-g lycosylated chain (p21 ) disu lphide l inked in  some 
instances to zeta (49) . Zeta was subsequently identif ied i n  hu mans but  d id not  
comodulate or coprecipitate with either  T cel l  receptor o r  antibody to the C P3 com plex 
( 1 5) .  The components of the CP3-T cel l  receptor complex apparently are produced in  
excess quantity by T cel l s, the various  cha ins  are  g lycosylated and the complex i s  
assembled prior to  expression on the  cel l  surface , the  excess chains  be ing  rapidly 
degraded intrace l lu larly (50, 5 1 ) .  Production of components, g lycosylation ,  assembly 
and fina l  processing were found to be very rapid events as shown by p u lse-chase 
exper iments in which i ntrace l lu lar components were evident i n  less than 1 0  m i nutes;  
however, membrane expression requ i red a m in imum of 90  m in utes (51 ) and  the 
presence of the zeta chain was found to be a l im it ing factor i n  the m urine system (50) . 
The gamma and delta genes of the CP3 complex are very sim ilar and are bel ieved to have 
arisen by gene dupl ication prior to the divergence of m ice and h umans .  The epsi lon 
gene is also re lated to the gamma and delta genes but diverged somewhat earl ier (52) . 
Functionally the CP3 complex appears to be centra l  to the transmission of signals from 
the engaged T cel l  receptor, probably v ia both TcR alpha and beta cha ins (51 ), to the 
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C D3 complex into the cel l  by second messengers. The gamma chain of the CD3 complex 
is a substrate for prote in  k inase C mediated phosphory lation during T ce l l  activation 
( 1 5 ,  53) . 
A second type of clonally distributed T cell receptor has been isolated. When 
or ig ina l ly isolated the gamma cha in  of th is second type of receptor was m istaken ly  
thought to be the  TcR alpha chain .  Although i t  had immunoglobu l in- l ike variab le  and 
constant regions , i ts apparent lack of N-g lycosylation s i tes made it suspect ( 1 7) .  The 
gamma chain has been more completely described and fou nd to be composed of variable ,  
jo in ing ,  and constant reg ions which are rearranged early in  thymocyte development 
(54 , 55, 56) . The delta gene has a lso been isolated and sequenced and found to be 
located next to the components of  the TcR alpha chain genes.  Th is  chain is composed of 
variable ,  jo in ing , diversity and constant reg ions (57, 58) . The gam ma and de lta 
chains are both g lycosylated , contrary to orig inal f indi ngs ,  and have molecu lar weights 
of 35 kd (m ice) -55 kd ( humans)  and 40-45 kd, respective ly .  The receptor i s  
expressed a s  a disulphide l inked CD3 associated heterodimer on CD4-C D8- thymocytes 
and a smal l  number of peripheral  blood lymphocytes and appears ear l ier in  thymocyte 
development than the alpha :beta heterodimer (54 , 55, 59, 60) . I t  is postu lated that 
gene  rearrangements for chains  of both types of TcR beg i n  ear ly i n  thymocyte 
deve lopment  and p rod uctive rearrange ment  of g am m a :de l ta  preve nts  fu rt h e r  
rearrangement  o f  a lpha :beta . I f  o n  the other  hand ,  the gamma :de l ta does not 
productively rearrange ,  the alpha :beta genes continue ,  g iv ing r ise to popu lat ions of 
ce l l s  wh ich express e ither  receptor ,  but not both . The thymocytes express ing 
gamma :delta and those expressing alpha :beta are ,  therefore ,  separate T cel l  l i neages 
which have com mon progen itors.  There has been extensive specu lation about  the 
possible roles played by th is second T cel l  receptor (54 ,  55) . There cont inues to be 
controversy as to the level of  d ivers ity expressed with in  the popu lation of ce l l s  wh ich 
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express this type of TcR and whether the CD3 complex expressed with it is  identical to 
that expressed with a lpha :beta express ing ce l ls ( 6 1 , 62) . Ce l l s  beari n g  t he  
gamma:delta receptor can be  stimu lated to  produce I l-2 ,  I l-4 and  gamma interferon  
(54 ,  62) , have been  reported to be  cytolytic i n  both  MHC specific and non-specific 
ways (54 , 55,  63 , 64) . I t  i s  proposed by some that they may represent both an 
ontolog ical ly and phylogenetically earl ier form of T ce l l  receptor which may represent 
a fu nctional  defense aga inst deve lopment of i nfect ions and neoplasms  th rough  
recogn ition o f  non-po lymorphic M HC class I molecu les (55) by  gamma:delta bear ing 
epithel ia l  dendritic cel ls (65) present i n  skin .  Gamma:delta T cel l  receptors have been 
fo und on  a wide assortment of T cel l  hybridomas,  natural  k i l ler- l ike c lones  and 
responding ce l ls  in m ixed lymphocyte reactions  (62 , 66,  67) . I t  i s  apparent that the 
funct ion al re levance of th is  type of receptor express ion is  cu rrent ly a top ic of  
extens ive research ; however, at  present very l itt le is known with certainty. 
T cell activation. T cel l  activation invo lves a complex series of in teractions  
leading eventual ly to  clonal expansion. The  e lucidation o f  the  structure of the  T ce l l  
receptor complex i n  both the murine and human systems a s  the products o f  a gene  
fami ly s imi lar to that o f  immunog lobu l in  has opened up aven ues for disclosu re o f  how 
the three necessary components-T ce l l  receptor, antigen in presentable form and M H C  
molecules-come together for T cel l  activation wh ich is  necessary for the production of 
specific immune effector function . The series of interactions  is in it iated by contact 
and binding of the clonotypic antigen-specific T cel l  receptor to its l igand wh ich i s  an 
MHC molecu le ,  e i ther MHC class I or  c lass I I ,  which probably has a presentable 
fragment of ant igen already attached (44 , 45) . T ce l l  activat ion leads to modu lation or 
internal ization of the T cel l  receptor and i ts associated CD3 complex,  production of I l-
2 ,  expression of I l-2 receptors and DNA synthesis lead ing fi na l ly to clona l  expansion .  
T h e  series of i nteractions i s  not completely u nderstood ; however major strides  have 
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been made in characterizing some of the early signals and second messengers involved. 
Signal transduction mechanisms. Signals are carried from the T cel l  receptor 
interactions at the cel l  surface into the interior to in i t iate the events characteristic of 
T ce l l  activation . Fol lowing receptor- l igand interaction on the external surface of the T 
ce l l ,  a sig na l  is transduced in to the in te rior of the  ce l l  perhaps mediated by a 
conformational change due to interfacial receptor b ind ing ,  i .e .  binding by two receptors 
wh ich are integral membrane g lycoproteins constrained by their  anchoring i n  two l ipid 
by layers in close apposition ,  and crossl inking by accessory molecules such as C D4 ,  
C D 8  o r  LFA-1 . This signal may b e  propagated by way o f  both alpha and beta chains 
interacti ng with the closely ,  but noncovalent ly, expressed chains of the C D3 complex 
( 1 4 , 1 5) .  Although the complete detai ls of activation are unknown,  there is  evidence 
that th is  s ignal  in it iates phosphol ipid m etabol ism and a r ise i n  i ntrace l l u lar  [Ca+ + ] 
(68) presu mably by fi rst interact ing with a GTP binding prote in  (G prote in )  which is  
pertussis toxin insensitive (69) and cholera toxin sensitive and seems to have some  Gs  
character, but i s  not Gs, and has not been identified (70, 71 ) .  The  G protein activates 
a phosphod iesterase,  phosphol ipase G, which hydrolyzes a d iphosphory l ated 
phos phat idy l i nos i to l  presen t  in the m e m bra n e ,  P I P2 [ p h o s p h a t i d y l i n o s i to l 
bisphosphate] , into two second messengers: I P3 and diacylg lycerol ,  thus g iv ing r ise to 
a "bifurcat ing signal transduction system"  described by Berridge (72) . I P3 [ inos ito l  
1 ,4 ,5  tr iphosphate] wh ich is so lub le i n  the cytosol is responsib le for m ed iat ing  a 
calci u m  (Ca++ )  f lux wh ich characteristical ly has two phases (72) .  Phase I i nvolves 
Ca+ +  re lease from intracel lu lar  stores i n  the endoplasmic reticu l um g iv ing r ise to an 
i n i t ia l  spike i n  i ntrace l l u lar Ca+ +  concentration [Ca+ + ] seen i n  studies us ing  the 
C a+ +  indicators Qu in  2 and more recently I ndo 1 (73, 74) .  Cu rrent  evidence using 
excised patches from Jurkat ce l ls and extracel l u lar  patch c lamp techniques indicate 
that the second phase of the calcium response is mediated by activation of a vo ltage 
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i nsensit ive Ca+ +  channel  by I P3 (75) caus ing an i nf lux of extrace l l u la r  C a+ +  thus  
g iv ing rise to the  second Ca+ +  spike .  The  biphasic Ca+ +  response is n ecessary for 
product io n of I L-2 ,  a l t hough  express ion  of I L-2  receptor i s  i n se n s it i ve  to 
in t race l l u lar  [Ca+ + ] (69,  76) .  Che lation of extrace l l u lar Ca+ +  prevents ce l l s  from 
d iv id ing afte r T3-Ti sti m u lat ion (69) probably due  to i nh ibit ion of I L-2  i nduct ion .  
The second second-messenger formed after P I P2 hydrolysis is d iacy lg lycero l wh ich 
activates prote in kinase C (77) and mediates its translocation from the cytoplasm to 
the p lasma membrane  (78 ,  79) . There i n  co ncert with phosphat idy l se ri n e ,  
d iacy lg lycerol act ivates prote in  k inase C to phosphory late a n um ber  of  recepto r 
molecules including the gamma chain of CD3 and the CD4 and CD8 receptors (53 , 79,  
80) . T ce l l  activat ion is  a lso accompan ied by an increase i n  in t race l l u la r  p H  by 
activation of the Na+/H+ antiporter ;  however, th is ce l l u lar a lkal in ization has not been  
shown to  be  critical t o  other events leaving its role  in  question (69, 76) . The s igna l  
transduction mechan isms so far  described are very rapid ly and trans ient ly  active 
(72) . I P3 is subsequently metabolized or further phosphory lated to I P4 wh ich m ay 
a l so have reg u l ato ry fu nct ion .  D iacy lg lycero l i s  e i t he r  reconst i tuted to fo rm 
phosphatidic acid o r  fu rther  deg raded re leas ing  arach idonate fo r p roduct ion of  
prostag landins and leukotrienes (72, 8 1 ) .  The activated protein k inase C ,  wh ich i s  
auto-phosphorylating , is inactivated or down regu lated, perhaps by  dephosphorylation 
by a phosphodiesterase or by interaction with cAMP dependent mechanisms (77) . Thus 
the early events of signa l  transduction take p lace i n  the cytoplasm ,  and though the 
signals are transient they lead to profound changes i n  T cel l  behavior over severa l  days. 
The events fo l lowing i n it ia l  signa l  t ransduction are not u nderstood and ne i the r  the 
messengers nor the messages conveyed to the n ucleus are known (70 , 72,  77) . I n  
publ ications contain ing figu res describing the events of T ce l l  activation ,  th is  area of 
the d iag ram is generally labeled THE F INAL EVENT-CELL DIVISION. 
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Cellular proto-oncogenes. Fol lowing T cel l  activation ,  it has been  noted that a 
series of identified ce l l u lar proto-oncogenes are temporal ly expressed in  pro l i fe rat ing 
ce l ls  g iv ing rise to the hypothesis that these genetic e lements may code for g rowth or  
"prog ression" factors necessary for D NA repl ication wh ich either turn o n  genes  for 
DNA binding protei ns or are DNA binding prote ins themse lves (82, 83 , 84) . Seve ra l  
of these proto-oncogenes code for prote ins which are found exclusively i n  the  n uc leus .  
Among these genes, one of the fi rst expressed is the c-fos gene which appears with in  5-
1 0  m inutes of  ce l lu lar  activation and has been postu lated to be a "master switch" for 
the triggering of an assortment of other genes which lead to DNA repl ication ( 85) . 
Other  proto-oncogenes wh ich code for n uclear bind ing prote ins ,  thus  appare nt ly 
involved in DNA repl ication , wh ich have a lso been examined re lative to T cel l  activation 
are the c-myc gene and the c-myb gene.  As an isolated event ,  stim u lat ion th rough  
interaction with the  T cel l receptor in the  absence of  I L-2 is not mitogenic but appears 
to induce the express ion of c-fos very early and c-myc m RNA s l ig htly l ater .  Us ing 
severa l  systems derived from h u man per iphera l  b lood mononuc lear  ce l l s ,  the 
expression of  these oncogenes has been found to  be associated with a change i n  the status 
of the T cel ls  wh ich may be a change from the rest ing GO state to the sti l l  rest ing but  
"competent" state of G 1 (86,  87,  88) . The expression of these genes has a lso been 
fou nd to take place i n  spite of che lation of extracel lu lar Ca++ , a l though expression was 
subopt imal (88) . The addit ion of I L-2 to ce l ls  g iven an incomplete activation s igna l ,  
i .e .  st imu lat ion wh ich was insufficient  to lead to a m itogen ic response (87) , or  
del ivery of a complete m itogen ic s igna l  (86,  88)  caused a post- I L-2 l ate expression 
of c-myb and a seco nd induction of c-myc expression ,  both of which requ i red 
extrace l l u la r  Ca+ +  and interaction of I L-2 with its receptor.  Although the specific 
effects mediated by the products of these oncogenes are sti l l  unknown , both the i r  
spat ia l  and temporal expression relative to  T ce l l  activat ion is  suggestive of intimate 
i nvolvement .  I f  there is any analogy to the f inding that more that 70 m R NAs were 
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induced by N I H  3T3 cel l  interaction with g rowth factors in  seru m  (89) , there m ay be 
m any other gene products i nvolved i n  T ce l l  act ivat ion wh ich h ave  not  been  
i nvestigated . 
Expression of proto-oncogenes has also been  examined i n  myelomonocytic cel l  
l i nes in a n  attempt to determ ine the relationsh ips between proto-oncogene expression 
and diffe rentiat ion i n  normal macrophages ( 9 0 ,  9 1 , 92, 93) .  D i ffe ren tiat ion is  
frequently equated to phorbol ester treatment of  ce l ls  to produce adherent cel ls having 
characteristics of mature macrophages. F indings indicate that during the cou rse of 
differentiation ,  the c-myc and the c-myb gene expression is  decreased and c-fos and c­
fms gene expression is i ncreased. As indicated by M itche l l  et a l .  (94) ,  proto-oncogene 
expression ,  the kinetics of i ts  transcription and the duration of avai labi l ity of i ts  gene 
product are dependent on the cel l type being examined ,  i .e .  lymphoid ce l ls are qu ite 
different from monocytic ce l ls  wh ich are in turn different from fibroblasts . A quest ion 
raised frequently i n  the l ite rature is whether the appearance of a proto-oncog ene  
transcript or gene product has  any  causative relationship in  mediation o f  events leading 
to differentiation and the answer, when causation  can be examined, frequent ly is no 
(94) . As with the c-fos gene examined i n  the U937 monocyte- l ike ce l l  l ine (95) , the 
expression of the c-fos gene occurs but can not be shown to be sufficient nor  even 
necessary for d i ffe rentiation (94) . 
Alternatiye methods for T cell activation. T cel ls  can be activated i n  more than a 
s ingle way . Although activation by engagement of the antigen specific T ce l l  receptor 
(T3-Ti )  by a membrane bou nd ,  ant igen bear i ng  M HC mo lec u l e  i s  t h e  m ost 
immunolog ical ly relevent form of activation ,  T cel ls  can be activated by a n umber of 
other  paths, many of wh ich evoke a polyclonal T cel l  activation or m itogen ic response.  
The features of a polyclonal response are the same as an antigen  specific response 
except that more cel ls  are capable of responding . Much of the seminal  work o n  T ce l l  
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activation has been dependent on activation mediated by monoclonal ant ibodies to the 
clonotypic T cel l  receptor or  monoclonal antibodies to the C D3 complex (70 , 96, 97) . 
Soluble monoclonal antibodies to the TcR and to CD3 were found to be unable to activate 
pu rif ied popu lat ions of rest ing T cel l s  without comb inat ions of add itiona l  s i gna l  
co mpou nds such as phorbol esters , calci u m  ionophores ,  i n te rl euk i n  2 ( I L-2 ) , 
in ter leuk in 1 ( I L- 1 ) o r  cross l ink ing of antibod ies by i m mobi l ization o n  s ubstrates 
such as sepharose beads (69, 70, 76) . The responses of purified truly resting T ce l ls  
were found to be different from responses of  previously stimu lated T cel l  clones and 
hybridomas eve n though rested fo r long periods (70) , thus the picture,  thoug h sti l l  
unclear, seems to indicate that in unprimed T ce l ls there i s  an absolute requ i rement  for 
I L-2 and probably a requ i rement for I L- 1  for the  production of a p ro l ife rat ive 
response.  Autocrine production of I L-2 may be sufficient  fo r activat io n ;  howeve r, 
macrophages or other cel ls  are required to supply I L- 1 . The membrane form of I L- 1  
may b e  a necessary add it ional s ignal  i n  i n it iat ion o f  T ce l l  c lonal  expansion (98 ) .  
Whether there i s  an absolute necessity for accessory ce l ls or some un identified product 
of accessory cel ls  is sti l l  controversial (69 , 70 , 76) . The monoclonal ant ibody OKT3 
was found to be h igh ly m itogenic for T cel ls in the presence of Fc receptor (FcR) 
bearing accessory cells (99) . Other antibodies to CD3 such as UCHT1 were found to be 
non mitogenic for a substantial portion of  the population and the defect was traced to an 
i nabi l i ty of their  monocyte- FcR to i nteract with the particu lar  ant ibody i sotype ( 1 00 ,  
1 0 1 ) . There is ,  however,  conti nu ing controversy as to whether accessory ce l l s  o r  
t he i r  so l uble products are requ i red i n  CD3 med iated m itogenesis ( 1 02 ,  1 03 ,  1 04 ) .  
P lan t  lect ins such as  phytohemagglut in in  (PHA) and  concanaval i n  A (Con  A)  wh ich 
seem to adhere to the T ce l l  receptor g lycoprote i ns  as we l l  as other m embrane 
g lycoprote ins ( 1 05 , 1 06) cause a polyclonal  T ce l l  response.  These m itogen ic p lant 
lect ins may also mediate other effects by their  abi l i ty to cross l ink receptors to wh ich 
they bind and to stick ce l ls  together. The mRNAs expressed and the k inetics of the i r  
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expression for oncogenes c-fos,  c-myc and c-myb induced by PHA stimu lat ion of 
human peripheral blood mononuclear cel ls is the same as that seen with other modes of 
T ce l l  activation .  There is also evidence that they may activate additiona l  m echan isms 
for causing Ca+ +  infl ux  (69) . 
Other means for T ce l l  activation involve i nteract ion of membran e  receptors 
oth er  than the TcR with appropriate l igands.  The C 02 (T1 1 )  receptor ,  the sheep 
erythrocyte receptor on T ce l ls ,  is expressed early i n  T ce l l  ontogeny and is  capable of 
transm itti ng a mitogen ic sig nal when stimu lated with a combination of monoclona l  
antibodies ( 1 07, 1 08) .  A natural l igand for T1 1 i s  the  lymphocyte function associated 
ant igen (LFA-3) g lycoprote i n  fou nd widely distr ibuted on both hematopoiet ic and 
non  hematopo ietic ce l ls  ( 1 09 ) .  Althoug h fu l l y  m itogen ic T ce l l  act ivat ion  is  not  
stimu lated by  the  binding of  sheep eryth rocytes or a monoclonal antibody specific for 
the epitope on T1 1 to wh ich SRBCs bind (anti-T 1 1 1 ) (76 , 1 1 0) ,  T cel l  activat ion by 
b ind ing  of monoclona l  ant ibodies to two other epitopes is very effect ive . The  
monoclonal antibodies have been designated anti-T1 1 2 and anti- T1 1 3 ( 1 07) .  B inding 
of ant i -T1 1 2 induces the expression of the epitope recognized by anti-T1 1 3 wh ich is  
on ly  avai lable to be bound on activated T ce l ls . Cel lu lar prol iferation resu lts o n ly from 
a co mbination of the ant ibod ies, and the mechanisms invo lved in  induction of ce l l  
d iv is ion are s imi lar to those seen in TcR (T3-Ti )  mediated T ce l l  activat io n ,  a l though 
the kinetics appear to be sl ightly slower. Reinherz et al. postu late that T ce l l  activation 
by way of the T1 1 receptor is  important in selection of the T cel l  reperto i re in the 
thymus,  and, in  the periphery because binding the TcR causes i nduction of the T1 1 3 
epitope , subsequent activating signals leading to I L-2 production are transmitted by the 
T1 1 receptor rather that the TcR-C03 complex (76) ; however th is  remains somewhat 
co nt rovers ia l  (70 ,  1 08) . 
Accessory molecules: C04. C08 and LFA. Other receptors including C 04 ,  C 08 
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and lymphocyte functio n-associated ant igens  ( LFA's) a re i m portant  accesso ry 
mo lecules i n  T ce l l  act ivation . I nteraction of T3-Ti with ant igen and M HC is  not 
sufficient for ful ly m itogenic T cel l  activation except perhaps when the T cel l  receptor 
is of extremely h igh affin ity . Other i nteractions are requ i red.  Two such membran e  
receptors are CD4 and CD8. Both the CD4 and CD8 receptors have been iso lated and 
their  genes have been cloned ( 1 1 1 ) . Because of the i r  homology to immunog lobu l i n  
l igh t  cha in  variable reg ions and domain structures, they  have been  inc l uded i n  the 
g rowing l i s t  of members of the immu nog lobu l in  supergene fam i ly ( 1 1 2 , 1 1 3) .  C D4 
(ca l led T4 or  Leu 3 i n  humans,  L3T4 i n  m ice) is a nonpo lymorphic 55 kd in tegral  
membrane g lycoprote in  characterized by f ive exte rna l  domains ,  a hydrophob ic  
transmembrane segment and a h igh ly conserved cytoplasmic ta i l  ( 1 1 4 , 1 1 5) .  C D8 
(cal led T8 or Leu 2 i n  h umans,  Lyt 2 and Lyt 3 i n  m ice) is apparently d iffe rent i n  
humans and m ice i n  that the  h uman 34 kd CD8 is  expressed as a d isu lf ide- l inked 
ho modimer  (or mu lt imer) on the su rface of cytolytic/suppressor T ce l ls  ( 1 1 6) and 
the murine CD8 is expressed as  a heterodimer composed of  a 34-38 kd Lyt 2 cha in  
d isu lf ide l inked to  a 30 kd Lyt 3 cha in  ( 1 1 7) .  The general structure of t he  C D8 
mo lecu le is a s ingle external domain , h i nge region ,  transmembrane reg ion and h igh ly  
conserved cytoplasm ic tai l ( 1 1 1 ) . Some early thymocytes express both C D4 and C D8 ,  
some express neither CD4 nor  CD8 ; however,  shortly after express ion of functiona l  
TcR ,  the majority of  thymocytes express e ither C D4 or  CD8  but  not  both . There i s  
cu rrently strong evidence that these cel ls  develop from a double pos itive precurso r  
popu lation found in t he  cortical reg ion o f  t he  thymu s  (29 , 33 ,  1 1 8) .  I n  genera l ,  T 
ce l l s  wh ich fit the  he lper induce r  phenotype are C D4+ , and T ce l ls  wh ich a re 
phe notypica l ly cytolyt ic are CD8+ ; however a few C D4+ cytolytic ce l l s  and a few 
C D 8 + he lper ce l ls  have been fou nd.  C D4+ cel ls  are restricted by M H C  class 1 \  
molecules whether  they are helper ce l ls  or  cyto lyt ic ce l ls ,  a n d  COS+ cells are 
restricted by MHC class I molecules ( 1 1 9) .  C D4+ helper o r  i nducer ce l l s  m ed iate B 
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cel l  activation fo r ant ibody production and interact i n  al logene ic m ixed lymphocyte 
reactions  and delayed type hyper-sensit iv ity .  CD8+ T cel ls are  specific cyto lytic T 
ce l l s  for v i ra l ly in fected cel ls  and tumor ce l l s  and m ay also contain the  e l usive 
suppressor T cel ls.  Both membrane g lycoproteins have been postu lated to be focusing 
receptors which cou ld bind to a monomorphic l igand on accessory cel ls to stabi l ize the 
binding of the TcR ,  ant igen and M HC molecu les which were characterized as a loose 
confederation ready to d issociate u n less cemented together by oth er  in te ract ions .  
Current u nderstanding of  the re latively stable i nteraction of MHC molecu les wi th  
presentable antigen prior to interaction with the TcR has necessitated a change in  view 
(44 , 45) . The C D4 and C D8 receptors are now thought to bind to monomorph ic 
determinants on the MHC molecu les themselves and serve as both enhancers of binding 
av idity and as functiona l  receptor cross l inkers capable of aiding i n  the de l ivery of a 
t ra n s m itted act ivat ion  s i gna l  across t he  m e mbrane ( 1 2 0 ,  1 2 1 , 1 22 ,  1 23 ) . 
Evo l utionary conservation of the transmembrane and cytoplasmic tai l  reg ions of both 
genes is postulated to be related to an important but not yet clearly u nderstood function 
of these receptors in  signal transduction ( 1 1 1 ,  1 24) .  CD4 and C D8 molecu les are both 
phosphory lated during T ce l l  activation of their respective types of T ce l ls  and are 
comodulated from the cel l  surface with the TcR-CD3 molecules after TcR i nteraction 
(80, 1 25 ,  1 27) . There is ev idence that althoug h approx imately 5% of the C D4 
molecu les on the surface of a resting lymphocyte are associated with the TcR-CD3 
complex,  TcR interaction causes a rapid redistribution of the CD4 molecu les  to the 
TcR-C D3 complex ( 1 27, 1 28) . C D4 is  found primari ly on  T lymphocytes but is  a lso 
found on monocytes at lower concentration ( 1 29 ,  1 30) . The C D4 molecu l e  has been 
identified as the cel lu lar  receptor for human immunodeficiency v i rus ( H IV) and C D4+ 
lymphocytes are selectively e l iminated i n  active A IDS patients leading to profound fatal 
immunodeficiency ( 1 3 1 ) .  The presence of the CD4 receptor on  monocytes is also the 
means by which HIV gain entry i nto monocytes where the v i rus is  protected fro m  
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immune survei l lance . With in  th is safe haven ,  H IV  appears to be able to evade the 
cel lu lar degradative machinery and instead causes the macrophages to cease to function 
effectively against opportu n istic i nvaders ( 1 32 ,  1 33 ) .  
The  lymphocyte function associated antigens (LFA's) have been shown to  be  
important i n  ce l lu lar adhesion and  aggregation ( 1 34) . A fami ly  o f  cel l u la r  adhesion 
molecules has been identified which are composed of heterodimers and which share the 
expression of one chain .  The LFA- 1 , Mac- 1 , p 1 50,95 fami ly  shares express ion of 
beta chains but have different alpha chains and have been shown to be immunological ly 
very important largely through the identification of the l ife-threaten ing bacter ia l  and 
fungal infections charactistic of individuals with a severe deficiency of these membrane 
adhes ion mo lecu les ( 1 35) . LFA- 1 i s  present  on hematopoiet ic ce l l s  i nc lud ing  
l ymphocytes ,  g ra n u locytes and most  mo nocyte s .  I t  i s  not  expressed  on  
nonhematopo ietic ce l l s ,  e ryth ro id and myelo id precu rsors and res ide n t  m u ri n e  
m acrophages ( 1 34 ) .  LFA-1  i s  important i n  adhes ion  o f  specif ic Tc R bear ing 
lymphocytes with antigen presenting ce l ls  or with ce l ls bearing al logeneic M H C  class I I  
ant igens i n  mixed lymphocyte reaction , adhesion of CTL's to specific target ce l l s  and 
natu ral k i l ler  ce l ls to NK targets. Although T cel l  activat ion is postu lated to be the 
trigger for inducing adhes iveness, adhesion by LFA- 1 is re lative ly antigen i ndependent ;  
however, stable aggregation of T effector ce l ls  with targets or antige n  presenters 
faci l itates the specific interactions . The natural l igand for LFA-1 is cu rrently bel ieved 
to be ICAM- 1 ( interce l lu lar adhesion molecu le- 1 ) wh ich is  a heavi ly g lycosylated 90-
1 1 4 kd g lycoprote in  widely distributed on lymphoid ce l l s ,  vascular  endothe l ia l  ce l l s ,  
t i ssue  macrophages , dendri t ic ce l l s ,  and epithe l ia l  ce l l s  i n  the  thym u s  ( 1 36) . 
Expression of I CAM-1  is g reatly i ncreased i n  i nflammation and is positive ly regu lated 
by I L- 1 , gamma interferon and tumor necrosis factor ( 1 34,  1 36) . LFA-2 i s  a nother 
name for C02, the human sheep e rythrocyte receptor, wh ich has been described. The 
rat and mouse homologues have also recently been identified and cloned and appear to be 
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s imi lar  to human CD2 ( 1 37, 1 38) .  The natural l igand for C D2 appears to be LFA-3 
wh ich i s  a 55-70 kd g lycoprote i n  widely d i str ibuted on e ndothe l i a l ,  ep it he l i a l ,  
connective and hematopoietic ce l ls  ( 1 09 ,  1 39) . 
Soluble medjators. Immune function is regu lated in  part by signals conveyed by 
soluble mediators . Cel lu lar interactions transmitted by membrane receptors serve to 
i n it iate ce l lu lar changes wh ich u lt imately lead to deve lopment of effecto r function .  
I n i t iat io n ,  however ,  m u st b e  closely fo l lowed both tempora l ly  and spat ia l l y  by 
propagation of those s ignals by cytokines.  Although the l ist of important cytok ines ,  
Iymphokines and interleukins grows longer and more complex, a few soluble mediators 
have been chosen fo r mention because they have been shown to be of part icu lar  
importance in T ce l l  activation ,  antigen proceSSing and presentation or  modu lat ion of  
macrophage function .  
Interleukjn 2 lIL-21. Orig ina l ly ca l led T ce l l  g rowth facto r, I L-2 has  been 
shown to be an integral component of  the development of  T ce l l  effector function capable 
of st imu lat ing the progress ion fro m  G1 in the cel l  cycle  th rough S->G2-> M ( 1 40 ) .  
I L-2 is  a 1 5 ,500 dalton  g lycoprote in  ( 1 4 1 ) encoded o n  chromosome 4 i n  h u mans  
( 1 42) wh ich is producted by  T cel ls  u pon  stimu lat ion by  presented ant igen+M HC ,  
m itog e n s  and comb inat ions  o f  phorbo l e sters a n d  calc i u m  ionophore s .  T h e  
subpopulation of T cel ls producing I L-2 has been designated TH1  by Mosmann e t  a l .  who 
noted that T helper  clones could be shown to produce either I L-2 and gamma inte rferon 
(TH 1 )  o r  I L-4 (TH2) ( 1 43) . I nvestigation of the I L-2 receptor h as been g reat ly 
fac i l itated by development of the ant i -Tac monoclonal  ant ibody by Uchiyam a  et a l . 
( 1 44) lead ing to the f inding that two types of receptors are expressed , the majority of 
which are of low affi n i ty ( 1 45 ,  1 46) . H ig h  affi n ity receptors for J L -2 must be 
expressed for the prol iferative response by T cel ls ,  as it is the inte ract ion of I L-2 
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with the I L-2 receptor wh ich apprears to convey the message for DNA replication and 
clonal expansion . As an in itiat ing signal the stable interaction of the TcR-CD3 complex 
with antigen-MHC confers specificity , and the s ignal  transduction emanat ing from that 
interaction is the trigger which activates the autocr ine production of I L-2 .  The n atu re 
of that s ignal  is not known at present;  however, transcription of messenger RNA i s  
rapidly apparent with in  1 -2 hours and  peaks from 5 - 1 0 hours after  st im u l at io n ,  
depending on the cel ls or  cel l  l i ne  used ( 1 47, 1 48 ,  1 49 ,  1 50) . I L-2 m RNA i s  a lso 
short l ived and qu ickly beg ins  to d isappear, return i ng to near basal levels i n  from 1 0  
to 24 hours, again depending on  whether  Jurkat ce l ls ,  EL4 .E1  cel ls ,  periphera l  b lood 
mononuclear cel ls o r  h u man tons i l  ce l ls  a re exam ined ( 1 47,  1 48 ,  1 49 ,  1 50 ) . 
Although there is some disagreement among investigators, it is probable that as soon as 
the st im u lus  for activation is  no longer present ,  there is  an increased rate of I L-2 
deg radation or repression wh ich can be blocked by cyclohexamide treatment,  indicating 
that prote in synthesis is  requ i red for the repressor, i n  spite of continued transcription 
of m RNA ( 1 48,  1 49 ,  1 50) .  Th is constitutes a negative feedback control to l im it the 
continuation  of  activation beyond i ts  ant igen specific in it iat ion ( 1 47) . Expression of 
gamma interferon mRNA appears at the same t ime as I L-2 mRNA ( 1 47) indicating the 
poss ibi l ity of coordinate regu lation .  Although gamma interferon production is  induced 
by I L-2 ,  i n it ia l ly they are probably regu lated by a series of overlapping and non­
overlapping signals ( 1 5 1 ) .  Expression o f  proto-oncogenes c-fos and c-myc preceed 
I L-2 gene  expression (88, 1 52 ,  1 53 ,  1 54 ) ; however ,  t he i r  re l at i onsh ip  to I L-2  
expression or repression is  not known . Expression of functiona l  prote ins for both I L-
2 and I L-2 receptor do not peak unt i l  24-48 hours ,  and I L-2 receptor preceeds I L-2 
( 1 53) . Because rest ing T cel ls express neither I L-2 nor I L-2 receptor ,  the period of 
time when a cel l  is primed by activation through the TcR ,  producing I L-2 and receptive 
to its i nteract ion th rough  the I L-2 receptor is  of re lat ive ly short du ration .  I f  the  
activat ion sequence is  not  completed during th is  period , the ce l l  en ters a refractory 
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period during wh ich it is impervious to further stimu lat ion ( 1 45,  1 47) . 
Although the primary function noted for I L-2 is  in  T cel l  p ro l iferation ,  I L-2  is  
functional ly pleomorphic having been shown to  cause B cel l  pro l iferation and activation 
of macrophages when used at high concentrat ion ( 1 40 ,  1 45) . I L-2 receptors h ave 
been found on roughly 5% of T ce l ls i n  the periphera l  c i rcu lation and 20% of the T 
cel ls i n  lymph nodes probably indicat ing transient activation .  I L-2 receptors at low 
density have also been found on some B cel l  l ines and on  monocytes, macrophages ,  
Kupffer ce l ls and sk in  Langerhan's ce l l s  ( 1 45) . U n l ike I L-2 receptor expression ,  I L-
2 production is sens itive to Ca+ +  b lockade, the effects of g l ucocorticoids such as  
dexamethasone ( 1 55)  and cyclospori n A wh ich i n h ib its I L-2 at t he  leve l  of  
transcription ( 1 50) , has Ca+ +  channel  blocking character and a lso appears to block 
the interaction of I L-2 and the I L-2 receptor ( 1 56) . 
Interleukjn 4 (IL-4) . I n te rleukin  4 ,  cal led B-ce l l  st imu lat ing factor ( BS F- 1 ) 
prior to renaming as an interleukin ,  is the product of activated T ce l ls ,  the TH2 type of 
lymphocyte ( 1 43) . I L-4 is a 20,000 dalton g lycoprote i n  found to costim u late rest ing 
B ce l ls  when treated with anti- immunog lobu l i n ,  stimu late resting B ce l ls  to increase 
M HC class I I  expression ,  and LPS-activated B cells to increase production of IgG 1 and 
IgE ( 1 57) . Although characterized as a B cel l  specific mediator, I L-4 has been found to 
have effects on many other  ce l l  types inc lud ing T cel ls , macrophages ,  e ryth ro id 
precursors and granu locytes ( 1 57) . A high aff in i ty receptor shown to bind purified 
I L-4 has been found, widely distributed , on both hematopoietic and non hematopoietic 
ce l ls  ( 1 58) . Recombinant I L-4 has been found to increase B cel l  antigen  presentation 
at least part ia l ly by i ncreasing M H C  class I I  expression ( 1 57) . More recent ly I L-4 
has been shown to increase monocyte/macrophage antigen  presentat ion in a bone 
marrow derived murine macrophage ce l l  l ine but  not  in  several macrophage tumor ce l l  
l i nes  ( 1 59) . I n  another  study us i ng  centrifugal ly e lutriated h u man monocytes ,  I L-4 
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caused an increase in  MHC class I I  expression ,  receptor for C3bi (CR3) and p1 50 ,95 
adhesion molecu les and concomitant decrease in cytostatic factor production ,  I L- 1  
product ion a n d  morpho log ical changes pu rpo rted t o  i nd icate s t im u l at io n of  
different iation ( 1 60) . Thus I L-4, l ike many other  interleuk ins ,  appears to possess 
mu ltiple reactivities which at present are not clearly defi ned. 
Interleukjn 1 .  I nter leukin 1 ( I L- 1 ) ,  which has been refe rred to by many  
function-re lated names and  is produced by  a wide range of different ce l l  types ,  is a 
polypeptide cytokine having diverse biolog ical activit ies including production of fever,  
cost imu lat ion of thymocytes , st imu lat ion of  acute phase reactants,  resorption  of 
cart i lage and wasting of muscle ( 1 61 , 1 62) .  Some of these effects have been attributed 
more recently to tumor necrosis factor (TN Fa)  which is induced by the same stimu l i as 
I L- 1  ( 1 63) . I mmu nolog ical ly ,  I L- 1  was shown to be a product of monocytes and 
referred to as lymphocyte activating factor (LAF) because i t  was shown to costim u late 
murine thymocytes when combined with submitogen ic doses of phytohemagg lut i n i n  
( 1 64) . Although I L- 1  is characterized as  a monocyte product, i t  has been shown to  be 
produced by a vast array of ce l ls  throughout the body i nc luding endothe l ial cell s ,  
hepatocytes ,  chondrocytes ,  synovial  ce l ls  and v irtual ly every type o f  ce l l  examined 
( 1 65) .  Of particular importance i n  the immune system ,  I L- 1  has been shown to be 
produced by dendritic ce l ls  ( 1 66) , B lymphocytes ( 1 67) and also has been reported to 
be made by some T cel l  leukemia cel l  l ines ( 1 68) in addition to the orig ina l ly identified 
producer, the monocyte .  
Characterization of  I L- 1 has been hindered by a scarcity of ce l l  l i nes producing 
large quantities ;  however, the murine P388 .D1  macrophage cel l  l ine ( 1 69) and h uman 
ce l l  l ines THP- 1  ( 1 70) and a sub l ine  of the  monocytic ce l l  l ine U 937 ( U 937 . 1 ) 
( 1 7 1 )  have been found to produce I L- 1  u nder appropriate stim u latio n .  lL- l has 
rece nt ly been ch aracte rized at  the molecu lar  leve l  by severa l g ro ups ( 1 72 ,  1 73 ,  
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1 74) . The consensus has been that there are two forms in  both m ice and humans.  They 
are referred to as I L- 1  a and I L- 1  B and have isoe lectric points of approx imately 5 .0  
and  7 .0 ,  respective ly ( 1 72 , 1 75) . Although there is agreement o n  t he  ex istence of 
these two types of I L- 1 , there are a lso reports of  other I L- 1  ' s  h av ing  d ifferent  
isoe lectric po i nts ,  part icu lar ly a p i  6 fo rm wh ich is s im i lar  to I L- 1  a ( 1 7 4 ) ; 
therefore, there may be a whole fami ly of interleukin 1 molecu les perhaps produced by 
different cells ( 1 62) . The genes for both I L- 1  a and I L- 1  B are tightly l inked and fou nd 
on ch romosome 2 in  both m ice and hu mans ( 1 76 ,  1 77) . Although  i n  m ice the 
interleukin 1 genes are in  close prox imity to  beta-2 microg lobu l in  ( 1 76) , i n  h u m ans  
beta-2 microglobul in  i s  on a separate chromosome .  The  amino acid sequences for I L-
1 a and I L- 1  B are very dissimi lar showing on ly 22% and 26% homology to each other  
in  m ice and humans, respectively; however, the homology of  each type of I L- 1  across 
species is fa irly h ig h ,  shown to be 62% for I L- 1  a and 67% for I L- 1  B ( 1 78) . The 
functional activity resides i n  the carboxy terminal  1 40- 1 50 amino acids of the gene  
products wh ich are trans lated as  33 kd  polypeptide precu rsors ( 1 79) . The  I L- 1 a 
precursor appears to have I L- 1  activ ity ; however, the precursor I L- 1  B appears to be 
i nact ive ,  although trypsin treatment causes activation ( 1 78,  1 80) .  I nterleuk in  1 was 
orig ina l ly characterized as a soluble product ; however, more recently it has been fou nd 
that a far greater proportion of I L- 1  remains intracel lu lar and a large part of that pool 
is in  the precursor form ( 1 74) . I L- 1  B is approximately 1 0  t imes more abundant that 
I L- 1 a ,  although I L- 1  a has been found to have considerably h igher  specific activ ity 
( 1 78 , 1 8 1 ) . Upon stimu lation ,  a membrane I L- 1  is expressed , wh ich has been found 
to  be I L- 1  a ,  prior to  appearance of the  secreted form (98 ,  1 82) . The f i nd ing  that 
most I L- 1  is i ntrace l lu lar corre lates wel l  with the addit ional fi nd ing that ne ither  form 
of I L- 1  has a competent signal peptide ( 1 78, 1 80) . Explanation of a means by which it 
m ig ht be excreted have been problematic and it has been suggested that it is only 
present extrace l l u larly when cel ls  are ruptu red ( 1 78) . I L- 1  does however  h ave 
2 8  
h igh ly conserved eOOH terminal  hydrophobic amino acids and is  clearly present  on  
membranes apparent ly as  an i ntegral membrane prote i n ;  the refore ,  i t  has  been  
suggested that i t  is possibly attached by  a g lycosyl phosphatidyl i nos itol m e m bran e  
anchor ( 1 80)  wh ich has been fou nd t o  be an i mportant  m embrane attac h m e nt 
mechan ism for a number of immunolog ical ly relevant molecules including LFA-3 and 
Thy 1 ( 1 83) . Although l itt le is currently known about th is  type of attachment ,  the 
actual site of attachment and subsequent transport to the membrane, it has been studied 
in Trypanosoma brucei ( 1 83) . Attachment is postu lated to occur  i n  the endoplasmic 
ret icu l um and appears to occur  very rapidly , with in  one  m i nute of the  end  of 
translation for the variant surface g lycoprote in  (VSG) protein  of Trypanosoma brucei. 
This type of attachment appears to al low for rapid expression ,  extremely h igh  receptor 
moti l i ty al lowing for rapid redistribution after stimu lation and expression of an  active 
receptor wh ich can be easily cleaved, perhaps by extracel lu lar elastases, to g ive a fu l ly 
funct ional hydrophi l l ic soluble moiety ( 1 74) . This suggestion may in part expla in the 
controversial finding of 23 kd membrane I L- 1  and a 1 7  kd so luble I L- 1 . Membrane 
I L- 1  has been characterized on  both macrophages and B ce l ls (98 ,  1 84) . Althoug h I L-
1 a and I L- 1  B are very d ifferent i n  amino acid sequence, they appear to mediate the 
same d iverse functions and a lso interact with the same high aff inity receptor present in  
smal l  numbers on T ce l ls  and other  ce l ls  ( 1 85, 1 86) . The EL4 ce l l  l i ne  has been 
beneficial  i n  investigat ion of the I L- 1  receptor because i t  appears to express  a 
relat ively large number  of receptors , un l ike normal T cel ls ( 1 85 , 1 87) . Receptor 
l igand in teract ion has bee n  shown to down reg u late receptor expressio n ,  and 
internal ized I L- 1  has been visual ized by immunofluorescent techn iques to  co l lect i n  the 
n ucleus .  The sign ificance of  th is  finding is not known at  present; however, i t  may have 
re levance in the i nteraction of I L- 1  with T cel ls  in T ce l l  activat ion v ia  the T ce l l  
receptor ( 1 85 ,  1 87) . 
Many of the effects of I L- 1  on  macrophage activation and on  T ce l l  activation 
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remain controversial ( 1 62, 1 88) . Tumor necrosis factor (TN F) in teract ion with I L-
1 has been a fu rther compl ication ,  as both I L- 1  and TN F are i nduced by the same 
st imu l i  ( 1 63) , TNF is  induced by I L- 1  ( 1 89) and they apparently synerg ize i n  some 
systems and antagon ize in  others ( 1 89 ,  1 90) . I nter leukin 1 i s  strong ly i nh ibited by 
prostag landin and also stimu lates the production of PGE2 which may act as a negative 
feedback mechanism ( 1 91 ) .  Prostaglandins have also been shown to down regu late the 
expression of MHC class I I  molecules ( 1 92) . By suppression of both I L- 1  production 
and MHC class I I  expression , the ce l l  may curtai l  the immune response by prevent ing T 
ce l l  act ivation shown to be dependent on the levels of expression of both membrane I L-
1 and MHC class I I  ( 1 93) . I L- 1  production is a lso i n h ibited by g l ucocort ico id  
hormones which suppress a t  the  level o f  mRNA transcription but  also increase the rate 
of m RNA degradation ( 1 94) .  I n ter leuk in 1 transcriptio n has been shown to be 
reg u lated by DNA methylation in the U937 monocytic ce l l  l i ne  in which I L- 1  is not 
norma l l y  detected even  afte r  treatment  wi th  l i popo lysacchar ide (LPS)  ( 1 7 1 ) .  
Treatment with 5-azacytid ine induced express ion of both I L- 1  m RNA and sol uble I L- 1  
in  U937. 1 , a subl ine o f  the U937 monocytic ce l l  l ine and vastly increased expression 
of I L- 1  i n  the THP-1 ce l l  l i ne  afte r LPS stimu lat ion ( 1 7 1 ) .  Bacter ia l  LPS is  the 
inducing agent used most frequently for I L- 1  production .  A l though E. coli LPS is  
typica l ly employed, Salmonella LPS has been fou nd to  be sign ificantly more potent  in  
h uman monocytes ( 1 95) . Monocytes isolated and g rown In endotoxin free  cu ltu re 
express l ittle detectable I L- 1  o r  I L- 1  mRNA. There i s  a trans ient express ion at 3-6 
hours of intrace l lu lar I L- 1  presumably due to adherence wh ich has been shown to be a 
fai rly weak i nducer of I L- 1  ( 1 95) . Salmonella LPS causes a rapid expression of 
i n trace l lu lar  I L- 1  with in 2-3 hours which decl i nes at about  20  hours .  Secreted I L- 1  
appears somewhat later and cont inues to rise after 24 hours .  Fuh lbrigge e t  al . ( 1 96) 
found that adherence of peritoneal macrophages caused sign ificant  I L- 1  production in  
the absence of  endotoxin and that in trace l lu lar and membrane I L- 1  were expressed 
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trans ient ly and early, peaking with in  4 hours,  but that secreted I L- 1  cont inued for 
more that 24 hours and suggested that monocytes wh ich are isolated by adherence are 
not rest ing ce l l s .  LPS st imu lates a trans ient  but s ig n ificant ly h i ghe r  leve l  of 
expression .  Phorbo l  esters are potent inducers of  I L- 1  and synerg ize with LPS,  
apparently by activat ing somewhat different induction pathway ( 1 97) . The trans ient  
nature of LPS- induced I L- 1  production has been attr ibuted to the coinduction of a 
cyclohexamide inh ib itable repressor ,  s im i lar to what is seen with I L-2 ( 1 98) . M any 
other  signals are capable of inducing I L- 1  production by monocytes including m u ramyl 
peptides wh ich have adjuvant activity ( 1 99) ,  PPD (200) , immunog lobu l i n  Fc (201 ) ,  
CSa as we l l  as CSa des arg ,  inactive CSa lacking a terminal arg in ine residue (202) and 
heat k i l led Listeria monocytogenes (98) . .  Weaver and Unanue (203) have repo rted 
that I L- 1  induction by bacterial products is  a d irect effect and does not requ ire other  
ce l l u lar in teract ions ; however ,  st imu lation by so l ub le  ant ig ens requ i re i nteract ion 
with T ce l ls  or  with a T ce l l  product wh ich they have fou nd is  not I L-2 , g a m m a  
i nterferon ,  I L-4 or colony stimu lating factor- 1 (CSF-1 ) .  Th is  interact ion appea rs to 
be necessary to get macrophages ready to present antigen .  The capacity to produce I L- 1  
may a lso be related to  the maturity of  the macrophage. Kurt-Jones et a l .  (98)  fou nd 
that macrophages which had been stimu lated to produce both secreted I L- 1 and 
membrane I L- 1  were capable of  producing on ly membrane I L- 1  when restim u l ated . 
Also when human alveolar macrophages are compared to peripheral blood monocytes ,  
monocytes were found to  be s ign ificantly more capable of stimu lation to  produce I L- 1  
and with in  both popu lations  there was a corre lation between I L- 1  product ion and 
mature phenotype measured by morphology and ce l l u lar density (204) .  Because I L- 1  
is a potent m ed iato r i n  inflammation ,  a down regu lat ion of  product ion may b e  a 
mechanism for t issue protection .  
I L- 1 has been shown to be  necessary in the  induction of  T ce l l  activat ion in  naive 
or rest ing T cel ls .  Lowenthal and MacDonald have reported that CD4+ cel ls ,  but not 
3 1 
C D 8+ cel ls ,  show an absolute requ i rement for accessory cel ls  for activation and that 
th is  requ i rement  is fo r membrane I L- 1  (205 ) .  S im i larly , Ku rt-Jones et a l .  (98)  
have fou nd that macrophages can present ant igen on ly if both MHC c lass I I  and 
membrane I L- 1  are expressed. The f inding that many T cel l  clones and hybridomas 
have no requ i rement for I L- 1  has been attributed to the i r  being in  a primed state 
rather than in a truly resting Go state (70) . Thus the i nvestigation of the role  of I L- 1  
i n  immune function i s  actively being pursued and many areas remain controvers ia l .  
I L- 1 , perhaps more than any other i nterleukin , has been shown from early studies to 
be extreme ly pleomorphic in both its molecu lar  structu re and i n  its fu nct ion a l  
capabi l i t ies leading t o  questions o f  its true identity .  T h e  ro le o f  I L- 1  i n  i m m une  
functions i s  clearly a m inute portion o f  its overal l  function in  t he  whole body. 
Gamma interferon. Gamma interferon (G- I FN) ,  also cal led Type I I  o r  i m m une  
i nterferon ,  is  a non-viral ly induced Iymphokine  produced by  C D3+ T ce l ls ,  the  TH1  
ce l ls  wh ich also produce I L-2,  I L-3 and  GM-CSF, in  response to  antigen presentation ,  
PHA, Con A, I L-2 and antibodies capable o f  inducing T ce l l  activation ( 1 43) . Gamma 
i nterferon is also produced by  C D3+ -C D 1 6+ and C D3- -C D 1 6 - lymphocytes hav ing 
characteristics of  natural ki l ler  ce l ls  (206) I nterferon gamma,  l ike interferons  a lpha 
and beta, interferes with v iral infection ,  thus ,  the name.  One manner in  wh ich G - I FN 
conti n ues to be quantitated is in terms of its ant iv iral specific activity, measured as 
the abi l ity to inh ibit the v i ral ly produced cytopathic effect on cel l s  in cu l ture .  Gamma 
interferon i s  produced on ly  in  activated cel ls and  then  in  m inute quantit ies making its 
co l l ect ion  and ch aracter izat ion d i ff icu l t  (207) ; t he refo re , t h e  p rod uct i o n  of 
recombinant G- I FN has faci l itated many more studies. Gamma i nterferon is the product 
of a s ing le  gene on ch romosome 1 2  in h u mans (208) , and three d i fferent  s ize 
g lycoproteins  have been isolated : 1 5- 1 7 kD,  20 kD and 25 kD g lycoprote i ns  (209,  
2 1 0 ) .  The d i fferences i n  s ize are apparent ly  due to m icro -heterog e n e i ty in 
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g lycosolation and differential ly processed COOH termina l  forms but are functiona l ly  
very s im i lar and are not  homologous to  interferons a lpha and beta (2 1 1 ) . There is  
ev idence that G- I FN se l f  associates and may exert i ts  effects as a homod imer  or  
tetramer (207) . It is a basic protein having a pi of 8.5 and is extremely acid labi le 
being , rapidly destroyed by treatment at pH 2 (2 1 0) .  Natural G- IFN and recombinant 
G- I FN produced in eukaryotic cel ls are 5-1 0 t imes more active than the u ng lycosylated 
recombinant G - IFN  produced in E. coli (207) . G lycosylat ion appears to be the 
explanation for th is difference ; however, g lycosylation does not affect i ts abi l ity to bind 
to its receptor (21 0) . The G- I FN receptor is expressed on many cel l  types and is  coded 
for by a gene on the long arm of human chromosome 6 (2 1 2) .  There is  controversy as 
to whether the receptors on all ce l l  types are identica l ;  however, there is apparently a 
s ing le type of h igh affin ity receptor on  particu lar cel l  types (2 1 3) .  There are as few 
as 500 receptors on rest ing T cel ls but 1 3 ,000 on monocytes and a very sma l l  
proport ion of t he  avai lable receptors need to  be  occupied i n  o rder to  st i m u l ate a 
response (2 1 4) .  As few as 40-60 molecules of G- IFN per ce l l  produces maximal  M H C  
class I I  induction and anti v i ral effects in monocytes (21 0) . The orig ina l  fi nd ing  of 
receptors having mu lt iple affin it ies on popu lations of ce l ls apparently was due to the 
fair ly h igh  degree of  nonspecific binding of  G- IFN to ce l ls  (21 0) .  Once G- I FN interacts 
with its specific receptor ,  it is ve ry rapidly endocytosed in clath r in  coated pi ts 
faci l itat ing down regu lation of the receptor on the su rface ; however, the e ndocytosed 
receptor separates from the bound l igand in the acidic endosome and is recycled to the 
surface (2 1 0) .  The G- IFN present in the endosome has variously been  found  to be 
degraded after endosomal fusion with enzyme- laden Iysosomes or to be transported to 
the n ucleus (21 0 ,  2 1 5) .  Mediation of G- I FN effects requ i res both the i nteract ion of 
G- I FN with i ts receptor and a gene product coded for on chromosom e  21 which h as not 
been identif ied (207) . 
I nduction of G- I FN production in activated T cel ls may be biphasic with an  early 
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peak seen concomitant with the appearance of I L-2 and a later larger  peak wh ich is  
possibly induced by the endogenous production of  I L-2 (21 6) .  Gene regu lat ion of  G­
I FN has been shown to be coordinately regu lated with I L-2 ; however ,  G- I FN i s  a lso 
induced by I L-2 (206) .  The fi nding of a cis-act ing consensus sequence i n  t he  5' 
f lanking reg ion of the G- IFN gene which is  83% homologous to a sequence in  the I L-2 
gene has led to specu lation that both genes may be regulated by the same DNA binding 
prote in (2 1 7) . When the human G- I FN gene was transfected into mur ine Iymphoblasts 
and fibroblasts , expression was seen on ly in the lymphoblast ce l ls  leading to the 
conclusion that regu latory factors are present on ly  in  lymphoid cel ls .  Thus l ike other  
cytokines,  the  regu lat ion of  expression of  G- I FN is  i nt imately con nected with that of 
other cytokines and is confined to particu lar cel l  types (21 8) . Gamma interferon 
production is suppressed by treatment with g lucocort icoids (2 1 9) and cyclospo rin 
( 1 50) wh ich may or may not be secondary to the effects of those compounds o n  I L-2 
express ion .  
Gamma interferon has a variety of effects o n  immune  fu nction .  The best  
characterized effects are the induction of  MHC class I and class I I  molecu les o n  the 
su rface of monocytes and other t issue ce l ls ,  the antiviral effects which it i nduces and 
de l ivery of the prim ing signal i n  macrophage  activat ion (207, 220,  221 ) .  Gamma 
i nte rferon i s  considered to  be  the  T cel l  product h av ing the g reatest inf luence on 
m acrophage fu nct ion and differentiation .  Gamma interferon causes a s ign ificant 
increase in  Fc receptor expression  and a concomitant increase in phagocytic activity 
and antibody dependent cel l  cytotx icity mediated by th is  receptor (222) ; however ,  i n  
contrast to  the  Fc  receptor, both C3b receptor (C R 1 ) and mannosyl-fucosy l receptor 
expression are down regu lated and phagocytos is mediated by these receptors is  
decreased (223) .  Gamma interferon induces increased MHC class I I  expression of  a l l  
types, H LA-DR, DQ, and DP and also i nvariant cha in  (220 , 225 ,  226). The marked 
increase in monocyte/ macrophage mediated accessory function is probably d i rectly 
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re lated to th is i ncreased MHC class I I  expression and perhaps also to the i nc reased 
expression of I L- 1  st i m ulated by G- I FN (220) . Gamma interfe ron i ncreases the  
transcription of  TN F and u rokinase m RNA (227) , i ncreases expression of  complement 
components C2 and factor B (207, 228) , and has been found to induce the expression of 
I L-2 receptors on monocytes (229) . Gamma interferon activation of  macrophages 
i ncreases the abi l ity of these cel ls  to  k i l l  i ntrace l l u la r  parasites i n  both m ice and 
h u mans (22 1 ) ,  i ncreases the respi ratory bu rst and  re lease of react ive oxyg e n  
compounds (221 ) and i ncreases macrophage mediated tumor cel l  cytotox icity (221 ) .  
I nduction o f  the 2' ,5'-0 I igoadenylate synthetase , endoribonuclease , phosphodiesterase 
system of enzymes occurs after addition of G- IFN (207) ; however,  its sig n if icance in 
the functiona l  activation remains a mystery .  Gamma i nterferon interact ion with its 
specific receptor apparent ly induces act ivation of a prote in  kinase C and a s low 
increase in intracel lu lar calcium concentration and may induce a cascade s im i lar to the 
s ignal  transduction seen in  T ce l l  activation (22 1 ) .  In non-macrophage cel l s ,  G - I FN 
a lso h as marked effects o n  cyto lytic funct ion includ ing generat ion of cytolyt ic T 
lymphocytes and activation of n atura l  k i l ler  cel ls (207) . Gamma i nte rferon i nduces 
the expression of both M HC class I and class I I  ant igens ,  beta-2 m icrog lobu l i n  and 
i nvariant chain on  t issue ce l l s  (220 , 225 , 226 , 230,  23 1 ) .  Gamma interferon  does 
not induce i ncreased MHC class I I  expression on B ce l ls  (232) ; however, it has been 
shown to modu late antibody isotypes expressed by B cel l s  (233) . Gamma i nterferon  
st imu lates the production of IgG2a and inh ibits the production o f  IgG 1 and Ig E which are 
stimu lated by I L-4.  
Thus it is apparent that G- I FN is  s imi lar  to othe r  cytok ines i n  that  i t  has 
hormone- l ike capacity to interact with a specific receptor to mediate the expression of 
a complex array of functions ,  that it is transient ly expressed, u nder strong regu latory 
control and its m R NA has a relat ive ly short half- l ife , and that it acts in  conjunction 
with a large number of other regu latory molecules to induce and modu late an i m m u ne 
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response. 
Antigen processing and presentation. 
Antigen must be processed before it can be productively presented to T cells. 
The puzzle afforded by the apparent d ifference between the recogn ition of antigen by B 
ce l ls and by T cel ls is beg inn ing to yie ld some clues to its i ntr icasies.  B cel ls  were 
found to recogn ize and bind antigen in  its native form without  any modificat ion and 
indeed were found to cease to recognize antigens if they were sufficient ly denatu red 
(234) . When binding sites were analyzed, B ce l l  recognit ion was found to i nvolve 
conformational epitopes on antigen molecules (235) . The B cel l  receptor for ant igen  
was also found to be  a membrane anchored form of  antibody which had previously been 
fou nd to be the med iator of h u moral immune function (236) . Analysis of ant ibody 
structu re and immunog lobu l in  genes has revealed the extremely complex nature of the 
generation of the exquisite specificity exh ibited by the i nteraction of ant ibody with 
ant igen (237) . Analysis of the interaction of T cel ls with ant igen proved to be more 
difficu lt, largely because there was no soluble product produced in  large quantity wh ich 
co u ld u ndergo biochemical characterization and a lso be used as an ant igen  for the 
production of antibody with wh ich to f ish out the e lucive receptor. And because the T 
cel l  recepto r is clonal ly d istributed , a s ing le T ce l l  receptor is present i n  van ish ing  
sma l l  quantity with i n  the  avai lable ce l ls  i n  the T ce l l  reperto i re .  The advent  of  
monoc lona l  ant ibody production and col l ateral tech n iques fo r T ce l l  hybr idom a  
formation ,  T ce l l  clon ing procedures and techn iques for molecu lar genetic ana lYSis 
made isolation and characterization of the T ce l l  receptor complex possib le .  The  
explosion of fi nd ings led  to  i nclus ion o f  the  T ce l l  receptor i n  the  i m m unog lobu l i n  
supergene fam i ly because of its genetic o rgan ization (26) . The ant igen  specificity 
exhibited by T cells us ing a mu ltichain receptor is s imi lar in many respects to that of 
B ce l l s ;  however, the m anner  in  which antigen is  recogn ized appears to be  very 
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d ifferent. T cel ls recogn ize epitopes dependent on  the primary sequence of ant igens  
rather  than conformat ional  dete rm inants (234 ) ,  and  that recog n it ion of  a nt ige n  i s  
strictly dependent on t h e  presence o f  accessory cel ls (238) . T h e  requ i rement  for 
accessory cel ls has been shown to involve the presence of molecules encoded by the 
major h istocompatibi l ity complex (MHC) and the necessity for recogn it ion of ant igen  
by  the  T cel l  receptor on ly  in  association with MHC (239,  240) . 
Several ce l l  types can se rve  as accessory ce l l s ,  pr inc ipa l l y  i nc l ud i ng  
monocyte/macrophages, B cel ls and dendritic ce l ls  (24 1 , 242) . The  abi l ity of  these 
ce l ls to act as accessory cel ls is dependent on their capacity to express M H C  class " 
mo lecules (243) . Although macrophages were vehemently defended as the archetypica l  
antigen presenting ce l l ,  Chestnut and Grey (244) clearly showed the competence of B 
ce l ls to present antigen to T cel ls .  B cel ls have also been shown to be able to process 
ant ig en  fo r presentat ion (245) . Lanzavecch ia  (246) e luc idated t h e  poss ib le  
mechanisms for a d irect ro le of B cel ls in  t he  med iation of T ce l l  he lp  wh ich seeks to 
expla in the manner in  wh ich a s igna l  from an antigen  specific T ce l l  receptor can 
mediate activation of B cel ls to produce vast quantities of an antigen receptor, antibody, 
specific fo r total ly  diffe rent epitopes on the ant igen  molecu le .  B ce l ls  have the  
advantage of  possession of  a specific membrane receptor which can recogn ize antigen in  
i ts  native fo rm , bind it ,  internal ize i t ,  process it and reexpress fragm ents of i t  in  
association with MHC class " molecu les to T cel ls  with specific receptors wh ich can 
then stim i late the present ing B cel l  to prol ife rate and d i fferent iate i nto a n  ant ibody 
factory cel l ,  a p lasma cel l ,  and in  the process generate memory B cel ls .  Dendritic cel l s  
are morpholog ical ly complex ce l ls  found int imately associated with T and  B cel ls i n  
organs of t h e  i m m u n e  system where they may serve a s  repositor ies of  ant igen ic  
competence for extremely long  periods of t ime (247) . There a re several d i fferent 
types of dendritic cel ls  wh ich appear to differ i n  at least some of their funct ional  
capacit ies;  however, there is agreement that dendritic cel ls express large  quantit ies of 
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M H C  class I I  on  the i r  su rface , are extre mely  potent st imu lators of the  m ixed 
lymphocyte response to fore ig n  M HC class I I  antigens and are also very potent antigen 
present ing cel ls  (247, 248,  249) . Although B cel ls  and dendrit ic ce l l s  h ave been 
s h own to p resen t  an t ig e n  v e ry e ff ic i e n t l y ,  accessory ce l l  f u n c t i o n  by  
monocyte/macrophages wi l l  be  emphasized ch iefly for two reasons :  first because that 
is the cel l  in which the largest body of work has been done and second , because th is  
project involved us ing  the U937 ce l l  l i ne wh ich i s  der ived from a h ist iocyt ic 
lymphoma and has monocytic characterist ics (95) . 
The interaction of monocytes or  macrophages (M0) with ant igen ,  i l l ustrated 
sch ematical ly  in  Fig u re 2, stim u lates endocytos is  which may be p inocytos is  o r  
phagocytosis.  The process o f  phagocytosis requ i res an in it ial interact ion with som e  
type o f  membrane receptor on  t h e  M 0 ,  pr imari ly receptors fo r immunoglobu l i n  Fc, 
complement recepto rs and mannosyl/fucosyl receptors , although  there are p robably 
many other M0 receptors which are capable of receptor mediated endocytos is (250 ,  
25 1 ) .  Particu late antigens ,  opson ized by antibody or  free ,  adhere t o  an appropr iate 
receptor and are engulfed by the M0 by receptor mediated endocytosis.  The events 
which fo l low endocytosis leading final ly to i nteraction of fragmented ant igen  with the 
MHC molecules on the su rface of the cel l  remain one of the most active areas of current 
research in  immunology. I t  is postu lated that after antigen is endocytosed it is d igested 
partia l ly and somehow is reexpressed on the surface of the M0 where it is presented to 
a specific T cell in conjunction with an MHC molecu le (252 , 253) . Although the re is 
sti l l  controversy over the fate of antigen in the endosome,  its trafficking through  the 
interior of the cel l  and the location of its fi na l  i nteract ion wi th MHC, i nformation on 
the cel l biology of  intrace l lu lar proteolysis, acid ic compartments and mediat ion of bu lk  
and di rected flow of intrace l l u lar  vesicles is relevant to the events taking  p lace in  
antigen processing . Antigen attached to specific receptors appears to have two paths for 
deg radation (252 , 253 , 254) .  Once i nterna l ized , the endosome is acidif ied probably 
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F IGURE 2 .  A schematic view of antigen processing . 
Antigen must first be recognized by a macrophage by interaction with a receptor 
( 1 ) fo l lowed by engu lfment by receptor med iated endocytosis (2) .  Fol lowing th i s  
phagocytic function , the  endocytosed antigen is contained with in a phagosome (3) which 
may fuse with a primary g ranule (4) wh ich contains proteolytic enzymes to form the 
acidic compartment (5) where the ant igen  is s uccessively d igested i nto sma l l e r  
fragments (6-7) . Two paths are avai lable according to  two proposed mechan isms for 
ant igen fragment reexpression on the surface of the cel l .  Pathway (8 )  (44) requ i res 
that MHC class I I  antigens present on the i nternal surface of the phagosome salvage 
ant igen ic peptide fragments from the digestive environ ment of the endosome and 
reexpress these fragments on the surface of  the cel l  ( 1  O) . Pathway (9 )  i l lustrates the 
ant igen ic pept ide fragments adhe ring d i rectly to the l ip id b i layer by means of the 
hydrophobic face of the amphipath ic and probably a lpha he l ical fragment config u rat ion 
leading to reexpression d i rectly on the surface of the cel l  ( 1 1 )  where i nteraction with 
MHC class I I takes place by some unspecified mechanism (254) . 
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changing the binding affin i ty of the receptor and releasing the antigen .  The receptor 
may be shuttled back to the ce l l  surface and reexpressed or  may accompany the antigen 
as the endosome fuses with Iysosomes wh ich release the i r  store of  proteolytic e nzymes 
into the l umen of  the  phagolysosome.  There are also enzymatic reactions  of l im ited 
proteolysis with in  the endosome which are potentiated by decreased pH (255, 256,  
257) . These enzymes may cleave antigen into peptide fragments of vary ing lengths .  
Another  s i te proposed for l im ited proteo lysis i s  the cel l  membrane i tse l f  whe re a 
ser ine protease which i s  g l u taraldehyde insensit ive have been ide nt i f ied (258 ) .  
Altho ugh this s ite for process ing has not been widely accepted, its possible ro l e  i n  
experiments us ing g l utaraldehyde fixed antigen presenting ce l ls is  open to specu lation .  
Treatment o f  ce l ls with Iysomotroph ic agents, such as  ch loroqu ine which raises the pH 
of  Iysosomes, effect ively e l im inates the  abi l ity o f  the M0 to  present antige n  (259) . 
Although not generally accepted because of the large body of research which supports a 
fa i r ly specific type of act ion for Iysomotrophic agents ,  it h as bee n  a rg u ed t hat 
ch loroqu ine may have other effects on cel l  physiology that are un re lated to ant igen 
process ing but that  can i nh ibit  ce l l  funct ion thereby caus ing  decreased ant ig e n  
process ing or  presentat ion b y  ind i rect pathways (254) . There ' is  ev idence t hat 
chloroquine does inhibit the dissociation of invariant chain from MHC class I I  molecules 
and decreases the expression of MHC class I I  molecu les on  the ce l l  s u rface (260) . 
These effects wou ld certain ly be expected to influence antigen presentation .  The findings 
of G ruenberg and Howe l l  (261 ) that a transme mbrane prote i n ,  i n  th is  case the G 
prote in of vesicu lar stomatitus v i rus (VSV-G) , o nce i nterna l ized by endocytos is ,  
spends a very short t ime ,  less  than 5 minutes,  in  an endosome wh ich is competent  to 
fuse with a lysosome probably has relevance. The internal ized VSV-G takes one of two 
possible paths :  it is reshuttled to the cel l  surface or it remains i n  the portion  of the 
endosome which fuses with a lysosome and is degraded. I f  the concentration of VSV-G in  
the ce l l  membrane is increased or  i f  the VSV-G is coupled to antibody, the proportion of 
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membrane prote in which takes the lysosomal fusion path is markedly increased . I ndeed 
it has been shown that if antigen to be endocytosed is opsonized by antibody,  phagocytic 
activity is markedly enhanced and the rate of Fc receptor expression is increased 
(224) .  Macrophages then uti l ize Fc mediated endocytosis of antigen a lmost exclusively 
and down regulate mannosyl-fucosyl receptors . 
The findings by Rothman et a l .  (262 , 263) and others that organe l le specific 
retention and vesicle trafficking are dependent on  the presence and/or absence of 
specif ic amino acid sequences may also have relevance for the processing of som e  
antigens for presentation rather than complete catalysis.  Cytoskeletal e lements appear 
to have an important ro le in receptor mediated endocytosis and endosome traffic a lso 
(264) . The organ ized network of m icrotubules or ig i nat ing from the centrio les  i n  the 
Golg i  reg ion are important pathways fo r sh utt l i ng  ce l l u la r  ves ic les wi th i n  the 
cytoplasm in  un id i rect ional  fashion prope l led by so cal led moti l i ty motors such  as  
k inesin remin iscent o f  actin -myosin interaction in  muscle (265) . Although co ntro l  o f  
the i r  function and the concerted interplay of  the  whole array of ce l lu lar mach inery for 
engulf ing , degrading and expel l ing as wel l  as the integration with biosynthesis is not at 
al l  clear, one looks forward to rapidly advancing knowledge on  many fronts . 
Processing requ i res that most antigens be cleaved into fragments ;  however ,  a 
m in imum size requirement for presentation appears to be approximately 7- 1 0 amino 
acids and for many peptide fragments studied a longer peptide is more antigen ic  (266) . 
This wou ld seem to indicate that enzyme digestion must be l imited because deg radation 
to ind ividual amino acids wou ld obviate presentation ; therefore, the fragments m ade 
ava i lable to the T ce l l  during presentation must be derived from the e ndosome or 
retained and somehow rescued from proteolysis i n  the phagolysosom e  (267) . This led 
to the suggestion that the M HC molecu les fu l fi l l ed the ro le  of rescu i n g  b indable 
frag me nts from the enzyme soup with in  the phagolysosome .  This idea has been 
discounted by several g roups because it is felt  that if the receptor MHC molecules are 
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present in the phag lolysosome, they too would be degraded rather than shutt led back to 
the surface (254 , 268) .  I nteraction of antigen ic fragments with intrace l l u lar  M H C  
molecu les , however, remains a major requ i rement i n  the genera l ly accepted scheme 
for antigen presentation .  There are also several antigens  wh ich have been described 
wh ich do not requ i re processing for presentatio n .  Al len et a l .  (269) fou n d  that 
fibri nogen A alpha chain can be presented without proteo lytic c leavage o r  mod ification . 
Previously Al len et a l .  (253) had shown that proteolytic fragmentation was requ i red 
for presentation to some but not al l  avai lable HEL specific T ce l ls  as clone  3A9 was 
capable of reacting with carboxymethy lated H EL. Zieg ler et al. (270) also found that 
particu late antigens (Listeria monocytogenes) requ i red processing ; however ,  some 
bacterial products could be presented by paraformaldehye treated ant igen present ing 
ce l ls  without addit iona l  mod ification .  Berzofsky et a l .  (254) fou nd that  s i mp ly  
denaturing sperm whale myog lobin was sufficient to  a l low for antigen presentation to  T 
ce l ls .  The antigens which can be presented without fragmentation are so lub le  and 
probably adopt a random coi l  configu ration i n  solut ion (269 ,  270) . Th is is  apparently 
true for the port ion of the fibrinogen A alpha chain wh ich binds d i rectly to the I - Ek 
molecule .  T ce l l  antigen epitopes have begun to be characterized and, although there is 
sti l l  d isagreement, these epitopes appear to be composed of segments of amino acids in 
random co i l  o r  hav ing  h ig h  seg mental  mobi l ity wh ich can , under  appropr iate 
condit ions ,  adopt an a lpha he l ical configuration (254) .  Adoption of the a lpha he l ical 
configu ration may be dependent on the interaction with the binding g roove of the M H C  
molecules wh ich may cause the al ignment o f  the hydophobic amino acids to o n e  face and 
the hydrophi l ic residues to the opposing face thereby producing an amphipath ic he l ical 
structu re h av ing two th i rds of its su rface re lat ive ly  hydrophobic and  o n e  th i rd 
hydroph i l ic. I ndeed the primary structure of presentable T cel l  ep itopes has been 
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postu lated to be composed of the fol lowing general structure : 
N H4--G LY (or charged a. a.)-hydrophobic a.a.-(hyd rophobic a .a. ) 1 -2-hyd rophi l ic  a. a. -COOH 
wh ich wou ld generate an amph ipathic a lpha he l ix (254 , 269) . Although th is  view i s  
championed by  several g roups, there is no t  complete agreement and othe r  T ce l l  
epitopes may prove to  be  very different. Using H E L  peptide fragments hav ing known 
amino acid sequence and defined length , Al len et al . (266) were able to determ ine a 
m in imum peptide length of 7- 1 0 amino acids for presentation .  A peptide fragment of 
th is size al lows for at least two and probably three polar residues on  its hydroph i l ic 
face i f  it assumes an alpha hel ical configu ration .  Th is wou ld appear to provide a T cel l  
receptor interact ion s i te to wh ich the antigen contr ibutes three to fou r  res idues  
protruding from the  MHC binding g roove . The  geometry o f  th is face o f  t he  ant igen ic  
pept ide is  necessar i ly governed by several parameters,  two of wh ich are the  
periodicity o f  alpha he l ices and the  interaction o f  t he  opposite face of t he  a lpha he l ical 
frag ment with the binding site on the MHC receptor. Periodicity of peptide a lpha he l i x  
is 3 .6  residues wh ich affords a staggerred array of polar res idues if the genera l  amino 
acid configu ration of ant igen ic peptides holds t rue (254) .  Thus the f irst and seventh 
residue wou ld fal l  in  phase with each other to a g reater degree than the first and th i rd 
or  fourth .  The interaction of the opposite face of the alpha he l ical fragment imposes 
constra in ts both by hydrophobic i nteraction s  and by the fracta l n atu re , i . e .  the 
bumpiness, of the peptide fragment and the MHC molecu le with which it is inte ract ing 
wh ich wi l l  tend to induce bending or  eversion of the residues on the hydroph i l ic face . 
The finding that the s ignal  sequence for membrane protei n  i nsert ion adopts an  alpha 
hel ix if successfu l ly inserted i nto the membrane but adopts a beta p leated sheet 
co nf ig u ration  atop the membrane if i nsert ion is frustrated (254) i l l ustrates the 
p leomorphic nature of particu lar  amino acid sequences and the i r  dependence on  
environmental constraints for secondary structure.  
The requ irement for antigen processing became apparent from the seminal  work 
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on antigen  presentation by a number  of g roups using fragments isolated from e nzym e  
cleavage of protein  antigens notably h e n  egg lysozyme (H EL) (44) ,  ch icken oval bu m in 
(OVA) (45) , pigeon cytochrome c (271 ) and lambda repressor (272) . Zieg le r  and 
Unanue  (273) showed that if accessory ce l l s  were i ncubated wi th a nt ige n  and 
subsequently gently f ixed with paraformaldehye, they were capable of present ing  
antigen to  T cel ls just as  u nfixed cel ls were ; however, if the antigen was added after 
fixation ,  no presentation was ach ieved. This finding seemed to clearly ind icate that the 
antigen must be altered in  some way by the macrophage to mold or process i t  i nto a 
recog n izable form . To take this type of study one step further, Sh imonkevitz et a l .  
(274) determined that a peptide fragment of  antigen added di rectly to  f ixed cel ls cou ld 
substitute for the processing events and be presented; and indeed Watts et a l .  and others 
(275) showed that peptide fragment could be presented by MHC class I I  molecu les 
anchored in  synthetic membranes. Thus the requ irement for "processing" seem s  to 
ho ld  true for most antigens examined. The findings of  Walden et  a l .  (276) that whole 
hen egg lysozyme chemical ly cross l inked to l a  conta in i ng  I iposomes wou ld a lso 
stimu late specific T cel l  activation has been cited as evidence to counter the claim for a 
processing requ i rement ;  however, there is a strong possibi l ity that eithe r  there was 
denaturation of the HEL during cross l inking or less l ikely that there was very s l ight  
contam ination of the or ig ina l  preparation with peptide framents (277) . Identificat ion 
of naturally processed peptide fragments on the surfaces of ant igen presenting ce l ls  has 
not been deemed to have been successfu l .  Although recent studies by Berzovsky and 
De lovitch et a l .  (278) have purported to show the i ntrace l l u la r  route traversed by 
antigen i n  the process of being  "processed , "  the major crit icism conti nues  to be 
questions of whether the label be ing fol lowed remains associated with any part of the 
antigen , much less any relevent epitope. 
Antigen processing discussed thus far applies to soluble proteins  and particu late 
matter wh ich enter the antigen  presenting cel l  most commonly by receptor mediated 
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endocytosis and fol low the endocytic pathway to presentation on  the ce l l  s u rface.  
whatever that actua l ly involves . 
The pathway is considerably more complex when the part icu late m atte r is 
bacterial . vira l  or parasitic and has mechan isms of i ts own to evade deg radat ion or to 
stifle the abi l ity of the macrophage to k i l l  and degrade the ant igen for presentation .  
Although vast numbers of examples of evasion mechan isms of various organisms have 
been  demonstrated . the f i nd ings  of C l u ff and Zieg l e r  (279) us i ng  L is te ria 
monocytogenes demonstrate anew that investigations  using k i l led or avi ru len t  
organ isms. wh i le important in a mechanistic sense . a re  not  strictly re levent  to  an 
an ima l 's immune response to  that  o rgan ism under  env i ron me ntal cond it io n s .  I n  
studying hemolys in  negative and hemolys in  positive Listeria. Cluff and Zieg ler  found 
that mice were capable of  processing and presenting hemo lysin negative bacteria with 
g reat faci l i ty ; however, hemolys in  positive bacteria even  in  smal l  numbers were not 
processed and presented, resu lt ing in v i ru lence i ncreased by a factor of 1 03 as 
measured by LDso values.  I ncreased viru lence was also not attributable to e i ther  
decreased la  expression or d i rect ki l l i ng of  the macrophages after bacterial ingestion . 
Viruses poses problems which are more complex than most other  infectious  agents.  
The i r  routes of entry and escape from membrane compartments and th e i r  evasion 
mechanisms which make use of the cel ls  own resources make presentat ion of v i ra l  
ant igens a d ifferent process. Viral prote ins are produced by the ce l l  once infected and 
these prote ins may be formed large ly on  the free ribosomes i n  the cytosol  wh ich  in 
u n i nfected ce l l s  are respons ib le for the production of prote i ns  i nvolved i n  the 
intermediary metabol ic functions of the cel l  (280. 281 ) .  Although these prote ins  may 
be transported to membrane bound vesicles and cycled to the surface of the cel l ,  the fate 
of v i ral  prote ins produced in th is manner is not wel l  u nderstood and the prob lem of 
i n sert ing m ater ia l  fro m the hyd roph i l i c  env i ro n ment  of the  cytoso l  t h ro u g h a 
hydrophobic membrane i nto a compartment contai n i ng M HC class I mo lecu les  is  
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unexpla ined (282) . The very fact that v i ra l ly infected cel ls and perhaps tumor  ce l l s  
are usual ly recogn ized and  e l iminated by  a different system of  MHC molecu les,  M HC 
class I ,  and T cel ls ,  CD8+ rather  than C D4+ , i ndicates that the processes involved i n  
what Braciale e t  al . (283) refer to  as the  "endogenous presentation pathway" are very 
different from those employed for the processing and presentation of exogenous antigen .  
The requirement for processing of  endogenous viral ant igen is favored but  has not been 
clearly demonstrated ; however,  v i ral  prote ins may be subject to various degradative 
processes while i n  the cytosol i ncluding ubiqu it in dependent degradation (284 ) ,  P EST 
sequence mediated degradation (285) and Ca++ dependent proteases (286) . Although 
the most common ly found cyto lytic T cel l  is a CD8+ ce l l  which recognizes v i ra l  ant igen 
in association with MHC class I molecu les,  Braciale et a l .  (283 , 287) compared the 
cyto lyt ic T cel ls  specific for inf luenza hemagg lut in in  wh ich were C D8+ with those 
which were CD4+ . Morphological ly CD4+ CTL's were indistingu ishable from CD4+ 
he lper cel ls and the  " lethal hit" del ivered by  both CD4+ and C D8+ CTL's was ident ica l .  
C D 4  + CTL's recog n ized ce l l s  treated wi th  ant igen  from both in fectious  and  non­
i n fectious  v i rus and presentat ion was i n h i bited by t he  Iysomotroph ic  ag e n t ,  
ch loroqu ine ;  however, CD8+ cel ls recognized antigen o n l y  from infectious  v i rus and 
recognition required de novo prote in  synthesis and was not i nhibitable by chloroqu ine .  
Thus  processing and presentation of  viral antigen to CD4+ T ce l ls probably fol lowed the  
typical exogenous pathway through endosome-lysosome degradation and reexpression 
prior to recognition i n  conjunction with MHC class I I  molecu les . CD8+ cel ls were able 
to recogn ize antigen in conjunction with M HC class I molecu les on ly if the virus had 
successfu l ly infected the target cel l  and i nit iated production of its v iral prote ins by the 
ce l l .  These findi ngs have s ign ificant impl icat ions for the induction of v i ral  i m m u n ity 
by immun ization using ki l led versus attenuated v i rus in  terms of the type of response 
generated. 
Thus processing of antigens proceeds probably by al l  the degradative routes 
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available with in the cel l  and runs the gamut between no degradation  to fragmentation 
into short peptides. I t  remains difficu lt to reconci le the need for an i ntact peptide of 
seven or more residues with progression of ingested material through the lysosom e  
where i t  i s  subject to t h e  effects o f  40 or  more enzymes, t h e  products o f  which wou ld 
appear to be too smal l  to interact with MHC molecules to be presented to T cel ls .  I t  is  
a lso apparent that antigen processed by different compartments, i .e .  with in  endosomes 
or  with in  the cytoso l ,  is presented by different MHC mo lecu les primari ly to different 
subsets of T cel l s ;  however, l ike other systems encountered in immune function ,  the 
systems are not total ly exclusive and in  fact are overlapping.  
Once processed. antigen is presented in recognizable form to T cells in 
association with MHC molecules. Zinkernagel and Doherty in 1 974 (240) showed that 
response to antigen requ ired that the MHC haplotype of the antigen presenting cel l  be 
the same as that of the T cell being asked to respond. The response was, therefore, M HC 
" restricted ;"  however ,  the  manner  by wh ich th is  rest riction was i m posed was 
unknown . Restriction proved to res ide in  a portion of the M HC which was separate 
from the transplantation antigens and was designated as the I reg ion . Questions  relating 
to M HC restrict ion led to intense debate ove r  the natu re of the T cel l  recepto r 
interaction with antigen and the concomitant but incongruous necessity for recogn it ion 
of MHC I - region gene products on accessory cel ls.  A second important aspect of immune 
function concerned the finding that in g uinea pigs and in mice when antigens of l im ited 
epitope heterogene ity were admin istered, some stra ins  of an ima ls  made a strong  
response and other  strains made little if any  response (288 ) .  Thus  arose the  problem 
of responder and non-responder stra ins which when further  examined a l so was 
dependent on the haplotype of the MHC region immune response genes ( IR genes) . The 
nature of both restriction and response/non-response remained a topic of i nvest igation 
and conjecture ,  clarified somewhat by the find ing that the serolog ica l ly defi ned l a  
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ant igens on accessory cel l s  were the products of I R  genes .  Identif icat io n  of the 
clontotypic T cel l  receptor as the s ing le recogn ition structure for both antigen and M H C  
dispel led the problem o f  dual receptors but did not indicate how polymorph ic but non­
clonotypic structures, the MHC molecu les, cou ld  bind to al l  the different ant igens  for 
wh ich the T ce l l  reperto ire was selected. I nstead a loose association of ant ig en  
stabi l ized by T ce l l  receptor i nteraction was postu lated to  account for t he  M H C  lack o f  
specificity . Recent findings indicate qu ite clearly that M H C  molecu les a re  ant igen 
b inding structures i n  the absence of T ce l l  receptors (289)  and further that ant igen  
remains tightly associated with the M HC molecu les for relatively long periods of  t ime 
(253) . Babbitt et a l .  (44) and Buus e t  a l .  (45) demonstrated that MHC class I I  
molecu les bound free antigenic peptides and their propensity to bind peptide fragments 
corre lated with the abi l ity of ce l ls  with that haplotype to respond to the particu lar  
antigen ic fragments used (252 , 253) .  Thus M HC class I I  molecu les are d i rect b inding 
structures which se lect determinants wh ich wi l l  be avai lable to T ce l ls  in  conjunct ion 
with M H C  (290, 291 ) .  Moreover ,  the antigen ic fragments of several ant igens  were 
found to compete for association with MHC in a haplotype restricted manner i ndicating 
that there is a s ingle antigen bind ing site on MHC molecu les which serves a l l  ant igen 
in te ract ions .  Other recent studies ut i l iz ing photoaffin ity labe l i ng  and f luore scent  
photobleaching have supported the f inding that MHC di rect ly b inds peptide fragments 
(292) , althoug h findings of Delovitch et al. (289) using beef insulin indicated that all 
MHC molecu les bound antigen but to different degrees.  Experimental evaluation of M H C  
binding affin ity using equ i l ibrium d ialysis has confi rmed a dissociation constant o f  1 0-
5 -2 X 1 0-6 M/sec- 1 for antigen ic peptides tested (45 , 253).  The react ion has been 
shown by Buus et a l .  (45) to be very temperatu re dependent and stable requ i ring 
fai rly long t imes for d issociation of the complexed antigen g iv ing a t 1 /2 of 30 hours at 
room temperature and 5-1 0 hours at 37°C.  Further evidence for d i rect M H C  binding 
of peptide was afforded by the crystal lographic data obta ined for the structure of the 
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human H LA-A2 molecule ,  an MHC class I molecule,  which indicates that MHC molecules 
may seldom be devoid of ant igen (293 , 294) . Recent structural information derived 
from amino acid sequence data indicate that MHC class I I  structure is s imi lar to that of 
M HC class I molecu les and may i nvolve the same type of antigen g roove (295) .  Thus  
the  concept o f  MHC restriction and responders and  non-responders is now clearly seen 
as a di rect capacity of the MHC molecu les  to d i rect ly  b i nd to frag men ts or 
conformational ly permiss ive seg ments of ant ig e n .  D ifferent haplotypes of  M H C  
molecu les al low interaction with different peptide fragments.  I n  g lobular prote ins ,  a 
heterogeneous array of peptide frag ments can be released by l im ited proteo lys is .  
With in  a g iven haplotype, the probabi l ity i s  g reat that there wi l l  be one  o r  more 
epitopes with wh ich the MHC molecu les can interact. For antigens with l im ited epitope 
heterogene ity such as the random terpolymers of g l utamic acid, a lan i n e ,  tyros ine  
(GAT) or g lutam ic acid, lysine ,  phenylalan ine (GL0) , the MHC molecules expressed by 
some haplotypes do not bind to the  one or two epitopes avai lable and thus  do not  respond. 
M H C  restriction ,  therefore, i s  governed by the determinant se lectivity of the M H C  
molecules wh ich are the structures requ i red for in teract ion with ant ig en-specif ic T 
ce l l  recepto r (253 , 29 1 ) .  MHC i n te ract ion is  n ecessary fo r i m m u n e  respo n s e ;  
however, i t  does not insure that a corresponding T cel l  receptor has been selected with 
which this complex can interact . T cel l  repertoire selection appears to clona l ly de lete 
or markedly diminish T cells which interact with unbound self-MHC molecules or self­
M H C  molecu les bound to self peptides but selects for self-M HC molecu les  bound  to 
foreign epitopes.  For th is reason ,  the T cel l  reperto ire recogn izes on ly ce l ls  wh ich 
have the same MHC molecules which were present during the selection process i n  the 
thymus.  Fore ig n  M HC may be recogn ized as analogous to self-MHC bound to fore ign 
ant igen or self-MHC bou nd to self ant igen , a l though there is  conf l ict i ng  evidence 
concerning any requ irement that fore ign M HC antigen be processed prior to recogn it ion 
( 2 9 6 ,  297) . 
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The s ite of i nteraction of MHC molecules with antigen  to be presented remains 
controversial .  Two primary hypotheses have been postulated to explain the interaction :  
fi rst , that the antigen and M H C  bind wh i le  i n  the endosome (or phagolysosome)  o r  i n  
t h e  t rans-Go lg i where newly synthesized M H C  mo lecu les are avai lab le a n d  a re 
reexpressed on the surface of the cel l  together (24 1 , 297) ; and second that the antigen 
fragments which , as previous ly stated may have a hydrophobic face, are attached 
di rectly to the phosphol ipid of the endosomal membrane and reexpressed on the surface 
of the ce l l  sti l l  attached to the membrane with MHC i nteraction occurri ng  o n  the  
extrace l lu lar surface (254) .  The  fi rst hypothesis is  more general ly accepted a t  l east 
partial ly due to the problem of retention of antigen after processing ,  its reexpression 
and subsequent disengagement from the cel l  surface and interaction with M HC .  There is  
ev idence from Cresswel l  (298)  that MHC has access to ant igen i n  an  i ntrace l l u lar  
compartment.  Berzofsky et a l .  (254) champion the second hypothesis and expla i n 
ant igen retention by hydrophobic interact ions ,  a l though M H C  i nteract ion re ma ins  
u nclear.  F indings of Falo et a l .  (299) that treatment  of ant igen pu lsed cel ls with 
phosphol ipase prevents antigen presentation of sol uble ant igen but not a l logeneic M H C  
tends t o  support t h e  second hypothes is  s i nce i t  i s  the i r  content ion t h at t h e  
phosphol ipase is  removing ant igen  o r  ant igen ic fragm e nts which are i n te racti ng  
d i rectly with phosphol ipids o f  t he  ce l l  membrane.  Al logene ic M H C  is no t  affected 
because it is an integral membrane protein. 
I t  is apparent that recent developments have clarified the role of M H C  molecu les 
with respect to restrict ion phenomena and T cel l  activation by antigen ; however ,  the 
ce l l  biology of ant igen processing and MHC interaction remains to be fu l ly explained . 
As shown i n  F igu re 3 wh ich is a cartoon representation of ant igen  presentation ,  the 
components necessary for transmission of antigen  specific signals to T cel ls  to i n it iate 
clonal expansion and production of efferent immune function are macrophages, antigen 
in  presentable form i n  association with MHC class I I  molecules and appropriate T cel ls 
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FIGURE 3. Antigen presentation .  
As shown in  cartoon form , t he  components requi red for successful presentation 
of antigen  ( 1 ) are macrophages with appropr iate receptors for med iat ion of  
endocytosis of antigens ,  antigen  and a T cel l  with the appropriate T cel l  receptor 
previously clonally selected by MHC interaction in  the thymus.  Antigen is processed by 
the macrophage (2) and reexpressed on the cel l  surface in  association with M H C  class 
I I  through either association of ant igen fragment with M H C  class I I  intrace l l u larly (3) 
or  extrace l lu larly (4) , fol lowed by interaction with the T cell bearing the appropriate 
receptor (5) leading to conveyance of activation signals across the T ce l l  membrane.  
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present i n  the clonally selected repertoire. As d iscussed i n  previous sections  but  not 
ind icated in the drawing ,  there are other  important in te ractions wh ich take place in 
ant igen presentation and T cell activat ion involv ing ce l l  su rface receptors inc lud ing 
CD4 and LFA and soluble products present in the microenvironment produced by both T 
cells and macrophages. 
Major histocompatibility complex (MHC)' The molecules of the  m ajor  
h istocompatibi l ity complex are a lso members of the immunog lobu l in  supergene fami ly  
(26) .  More than fifty years ago,  Peter Gorer proposed that the mouse H-2 complex 
was the major determinant of  g raft acceptance i n  mouse transplantation (300 , 30 1 ) .  
Since that t ime the genes for the mouse H-2 and the analogous human H LA  have been 
examined at length and the genetic map has been drawn and redrawn many t imes. The 
mouse H-2 was identified on chromosome 1 7  (302) and the human HLA was fou nd on  
the  short arm o f  chromosome 6 (303) . Although the  genes encoded are very s im i lar ,  
the genetic organ ization of the murine H-2 u nderwent a major change at a point  in 
evo lut ion after speciat ion est imated to be approximately 75 mi l l ion years ago (304) . 
The murine type of MHC having a split class I reg ion is apparently anomalous and fou nd 
to occur on ly in mice and rats . The human MHC gene arrangement has been found to be 
common to other species, predicted even for the molerat cousin of mice, making i t  the 
more ancient form (304 ) .  Because m ice have been  the a rchetypical i m m unolog ical 
beast, the murine MHC has been the most extensively examined and sequenced ; and 
although the gene arrangement proved to be different, the major features of the m u rine  
MHC have also appl ied to  the  human MHC. Figure 4 shows a compi lation of  the  g enes of 
the murine and human major h istocompatibi l ity complexes. Fou r  types of genes are 
found in both m ice and h u mans,  as wel l  as a l l  other  an ima ls  wh ich h ave been 
investigated : ( 1 ) class I ,  (2 )  class I I ,  (3 )  class I I I  and (4)  other  genes. 
C lass I genes encode the classical transplantation antigens wh ich exh ibit an  
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F IGURE 4 .  Major Histocompatibi l ity Complex . 
The murine MHC,  found on chromosome 1 7, is composed of split class I ,  class I I ,  
class I I I  and unclassified genes.  Not a "  haplotypes have been shown to have al l  genes 
i l lustrated . Two class I MHC K genes (K and K2) have been  demonstrated as we" as fou r  
D genes ( D ,  D2, D3, D4) and a single L gene. The I region contains alpha and beta chains 
for I -A (Aa ,  Aa2 ,Aa)  and I -E (Ea ,  E a2 , Ea and postu lated E a3) .  The class I I I  genes 
present i n  the  murine MHC include C2 ,  C4 ,  Bf, and Sip. U nclassified genes fou nd to  be 
present i nclude 21 -hydroxylase A and B (2 1 OH-A & 21 OH-B) ,  TNFa and TN F a  and 
LM P (304 , 305) .  
Human HLA, located on chromosome 6 in  the  center of  6p ,  is composed of non­
split class I ,  class I I ,  class I I I  and unclassified genes. The class I genes include H LA-A, 
B ,  C & E. Class I I  genes include the alpha and beta benes of DR (a and B1 , B2 , B3) ,  DO 
(a and B) , DX (a and B) , DO ( B) ,  DZ ( a )  and DP (a 1 , B1 , a2,  B2) . Gene order for DO 
and DX is not clearly known . Class I I I  genes present are C2,  C4-A and C4-B and Bf. 
Unclassified genes include 21 -hydroxylase A & B (21 OH-A & 21  OH-B) and TNFa and 
T N F a  (306, 307) . 
5 5  
M AJ OR H I S TOC OMP A T I B I L I TY C OM P L E X  
Class I 
() (  
K 
(H-2 1 MOUSE CHROMOSOME 1 7  
Class " Class ' "  
'\ ( '\ 
s 
��, �I ----------� 
lMP 
IHL A I HUMAN CHROMOSOME 6 
6p 6Q 
( 1 
L,J 
HLA 
Clus I I  
Class I 
( '\ 
D Qa T1 8 
r-----',llrt 
I 
Clus I 
( 
5 6  
extremely h igh degree of polymorphism with in  popu lations and encode a 44-45 k D  
membrane bound g lycoprotein which i s  found o n  nearly a l l  ce l ls o f  t h e  body and wh ich 
is expressed in conjunction with beta-2 m icrog lobu l i n ,  a 1 2  kD prote in  encoded on a 
separate ch romosome (308) . The class I molecu le i l lustrated in  Figu re 5 is composed 
of three extracel lu lar  domains each comprised of approximately 1 00 amino acids, a 
transmembrane segment and an intracel lu lar tai l .  The external domains,  a 1 and a 2  at 
the N terminal are extremely polymorphic and associate to form the ant igen  b ind ing 
s i te .  The a 3 domain which is d isu lfide l inked and shows sequence homology to 
immunoglobu l in constant domains is non polymorphic and l ies close to the membrane.  
Th is  domain shows structu ral homo logy to beta-2 m icrog lobu l i n  wi th  wh ich i t  is  
c lose ly  associated to form the scaffo ld ing for the ant igen b ind ing structu re (293,  
294) . Polymorphic c lass I M HC molecu les are important i n  recog n it ion of  v i ra l ly 
infected cel ls and tumor cel ls and their  e l im inat ion by specific cyto lytic T cel ls .  The 
class I MHC genes of  the  mouse are the K and D (L) genes and the  human genes are H LA­
A,  B ,  C and newly described E (306 ,  308) .  With i n  the human  H LA,  the  best 
characterized genes are the A and B loci  which have been found to be extens ive ly 
polymorphic, especial ly the B locus (309) .  There are a lso large n u mbers of non­
polymorph ic class I genes found i n  the Oa and Tla reg ions (308) . These genes are 
s imi lar in structure to polymorphic class I genes and may have served as repositories 
for genetic information for recombination or  gene conversion with polymorphic class I 
genes ; however, they have not been found to have a ro le  in  T cel l  activat io n ,  and 
althoug h they are cu rrently the subject of in tense i nvestigation ,  wi l l  not be tre ated 
fu r t h e r .  
C lass I I  genes i n  the mouse have been investigated successfu l ly  due  to the 
development  of inbred and congenic stra ins of m ice wh ich d i ffe r on ly at specif ic 
segments of the MHC.  Findings that t he  l a  antigens expressed on  accessory ce l l  
membranes were, as  suspected , synonymous with t he  I R  gene products (305) was 
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FIG U R E  5 .  MHC class I and class I I  molecules�protein structure . 
MHC class I molecu les are composed of a heavy chain of 44-45 kD comprised of 
two h ig h ly polymorph ic external domains ( a  1 and a 2) ,  a non-polymorphic doma in  
(a  3)  i n  close prox im ity to  t he  ce l l  membran e ,  a transmembran e  segm e nt and 
cytoplasmic tai l .  The heavy chain is associated with beta-2 m icrog lobu l in  wh ich a lso 
has domain structure. Each domain contains approximately 1 00 amino acids and the a 2  
and a3 domains and beta-2 m icroglobul in domains are disulfide bonded. The ant igen 
ginding structure is formed by the configu ration of the a 1 and a2 domains supported by 
the scaffolding structu res of the a 3  and beta-2 m icrog lobu l in  ( 82m) (293 , 294) . 
MHC class I I  molecu les are composed of two chains wh ich are closely ,  but non­
covalently associated. The alpha heavy chain has a molecular weight of 34 kD  and is  
composed of  two domains of  approximately 1 00 amino acids each . The beta l igh t  chain 
has a molecu lar weight of 29 kD and is also composed of two domains.  The external  
domains (a 1 and 8 1 ) are h ig h ly polymorph ic, whereas the membrane p rox ima l  
domains (a2  and 82) are non-polymorphic. The  a 1 domain ,  l ike t he  class I heavy 
chain a 1 domain ,  is not disu lfide bonded ; however,  al l other  domains do contai n a 
disu lfide bond. Both chains have a transmembrane region and a cytoplasmic tai l  (295) . 
The configurations of both class I and class I I  molecu les are s imi lar in  that they provide 
h igh ly polymorphic binding g rooves composed of two domains,  one of wh ich contains  a 
disu lfide bond and one which does not. I t  is proposed that this groove constitutes the 
ant ig en b inding s i te (293, 294,  295) . 
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fol lowed by the use of molecular genetics techniques to examine the MHC region genes at 
the molecular level for large segments of the genome causing major redrawing  of the 
m uri ne MHC, e l iminat ing several postu lated immune response genes and ide nt ify ing 
"hot spots" of  recombination wh ich had caused the MHC to falsely appear to  be large r  
because o f  increased recombinatorial frequency (3 1 0 ,  3 1 1 ) . When t he  dus t  sett led , 
the m ur ine class " reg ion consisted of genes which encoded membrane bo u nd 
g lycoprote ins of on ly two types,  I -A and I -E  (305) . The investigation of the h uman 
MHC class " genes did not have the benefit o f  congenic strains and has necessarily been 
more problematic. I t  has also been found to contain more than two types of  genes.  The 
hu man equivalent of I -A and I -E  have been found to be DQ and DR, respective ly ; 
however, several other class " genes, specifical ly DP,  DO, DX, DZ, have also been fou nd 
wh ich appear to be less polymorph ic than DR but compl icate assessment of c lass I I  
molecular function (306 ,  3 1 2 ,  3 1 3 ,  3 1 4) .  Sequence analysis of murine  and h uman 
loci h as i ndicated that several m u rine genes  located in  the  I -A or I -E  reg ions may 
actual ly be  analogous to the  additional human class I I  genes,  e .g .  murine A B3 = h u man 
D P B , murine AB2 = human DOB (3 1 3) .  Each type of  class " gene encodes a s ing le  
alpha chain and one or more beta chains.  The MHC as cu rrently drawn is certain ly not 
the final picture and as new genes are fou nd ,  both evolutionary and functional questions  
may be  answerable . Class " molecu les are membrane bound  heterodimers com posed of 
a 34-35 kD g lycoprote in heavy chain encoded by the alpha chain loci and a 28-29 kD 
g lycoprote in l ight chain encoded by the beta chain loci (3 1 3 , 3 1 4) . As a genera l  ru le 
combinations of mismatched class I I  molecu les are not expressed ; however, m ismatched 
pairs , i .e .  combinations of A alpha + E beta or E a lpha + A beta chains ,  have been 
observed u nder certain condit ions  and the i r  abi l ity to pair may reside in  haplotype 
specific inherent conformational constraints on juxtaposition , i . e .  some of the chains of 
different haplotypes may just not fit together no matter how hard they try .  M H C  class 
II polypeptides have a characteristic disu lfide l inked domain structure shown in  F ig u re 
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5 .  The alpha chain contains an N-termina l  polymorph ic non-disu lfide l inked domain  
(a 1 ) , fo l lowed by a d isu lf ide l i nked rel at ively non-polymorph ic domain  ( a 2 ) ,  a 
transme mbrane anchor and a short cytoplasmic seg ment (3 1 3) .  The beta cha in  is  
composed of  an N-terminal  polymorph ic disu lfide l i nked domain  (13 1 ) ,  fol lowed by a 
second d isu lf ide l i nked domain which is a lso relat ive ly non -po lymorph ic ( 132 ) ,  a 
transmembrane anchor and a short cytoplasmic seg ment (3 1 3) .  Each dom ain  consists 
of approximately 1 00 amino acids. Both alpha and beta chains are g lycosylated at 
asparagine residues (N- l inked) , the alpha chain at two s ites and the beta chain at one .  
Further modifications of  the chains include O-l i nked g lycosylation of  the a lpha chai n ,  
addit ion o f  palmit ic acid and  phosphory lation o f  t he  cytoplasmic tai l  (31 7) . The a lpha 
and beta chains are non-covalently l inked but  are tightly he ld together. Like the T cel l 
receptor heterodimers ,  s ing le chains are apparent ly not expressed (305) . I nvar iant 
chain ,  a 3 1  kD basic glycoprotei n ,  may have a role i n  MHC class I I  gene expression , 
although it is encoded on a separate chromosome (31 8) .  Evidence has indicated that 
invariant chain is necessary for assembly of the heterodimer, for transport to the  ce l l  
su rface o r  for membrane insertion (31 7) ; however, a l l  o f  these events have been noted 
to take place in  the absence of invariant cha in  (3 1 9) making i t  u nc lear whethe r  
invariant chain has a ro le in causation or simply appears as  a resu lt o f  these events.  
I nvariant chain wh ich has a protein  core is large ly composed of a g lycophori n structure 
wh ich binds to class I I molecu les i ntrace l l u la rly and d isengages genera l l y  before 
su rface expression (320) . The fu nction of i nvariant chain is  not fu l l y  u nderstood ; 
however,  C resswe l l  (3 1 7) suggests that attached i nvariant cha in  h as a ro le i n  the 
intrace l lu lar binding of  antigenic fragments to M HC molecules in  vesicles and that once 
bound,  the invariant chain is d issociated from the complex probably by acidificat ion .  
C lass I I I  genes found with in  t he  mur ine and  h uman M H C  encode complement 
components : C2,  C4 and factor B (Bf) . These are apparently h igh ly conserved as is  
the i r  genet ic arrangement (307) . 
6 1  
The fourth group of genes encoded by the MHC is the group of a l l  other  gene 
products which have ove r  the years been mapped to  the M HC but  wh ich defy 
class ification into one of the classes of molecules (306, 321 , 322) . These include the 
recently d iscovered genes for tumor necrosis factors a lpha and beta (322) , genes for 
2 1  hydoxylase (322) , neuram i n idase (304) and low mo lecu lar  weig h t  p rote i n s  
(LM P) (323) . Whether  these g enes are int imately associated with the transcription ,  
trans lation or functions o f  t he  class I ,  I I ,  o r  I I I  genes in t he  MHC is not known . The i r  
genetic material and gene order are h igh ly conserved and there are probably more of  
them present in  the uncharted reg ions of the genome both between and with in  the  
classes (324) . Although MHC disease associations may be primari ly attributable to 
some inherent characteristic of class I or class I I  mediated antigen presenting function ,  
i t  i s  also possible that there are some MHC disease associations wh ich are actual ly due  
to closely l inked genes. 
The M H C  genes of particu lar i nterest i n  ant igen presentat ion and T ce l l  
activation are the class I and class I I  genes and the i r  products . Recent  structura l  
analysis o f  H LA-A2 molecu les by  x- ray crystal lography (293 , 294) and  comparison 
of these structura l  revelat ions with sequence data for class I I  molecules (295) has 
clarified the nature of the antigen binding s ite , its existence as a s ingle s ite rather than 
mu lt iple sites and i ts structure composed of a groove formed by alpha he l ical segments 
and floored by B-pleated sheet. The structu ral inte raction of the non-po lymorph ic 
domains clearly analogous to immunog lobul in domains has been revealed to stabi l ize 
the antigen binding structure and the polymorph ic portions of the molecu les h ave been 
shown to play the major ro le in ant igen binding . Thus we beg in  to know what M H C  
molecu les look l ike and perhaps where and how i n  t h e  molecular sense they interact 
with antigen .  
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MHC class II antigen (la) is constituitively expressed on relatively few types of 
cells in the unstimulated host unlike MHC class I molecules. MHC class " molecu les are 
constitu it ively expressed on monocytes ,  macrophages, B ce l ls  and dendrit ic ce l l s  i n  
h umans (31 2) . I n  m ice, l a  is  constitu it ively expressed on  B cel ls  and dendritic ce l ls  
but  m ust be induced on macrophages (24 1 ) .  Express ion of M HC class I I  molecu les on 
murine and h uman macrophages is subject to reg u lat ion by cytok ines,  part icu lar ly 
gamma interferon (220) . Gamma interferon wil l  also induce express ion on  endothel ia l  
ce l l s  and other t issue ce l l s  (207) . Macrophages are very sensi t ive to g a m m a  
interfe ron and the ir  abi l ity t o  present  ant igen to T cel ls i s  m arkedly e n hanced by 
gamma interferon treatment because of the increased level of MHC class I I  expressed on 
the ce l l  su rface (220 ,  225 , 226 ) .  I n it ia l  expression of MHC class " mo lecu les  
appears to  requ i re demethy lation of  the MHC class I I  genes (325) ,  a l though exactly 
oppos ite resu lts have also been noted (325, 326) and subsequent cycles of expression 
and loss of expression may not requ i re further  demethy lat ion  (327) . Conse nsus  
sequences referred to as  X and Y boxes (or A and B boxes) contain ing typical CCAAT box 
sequences (328) and W sequences (329) have been identified in  the  5' f lanking region 
of the MHC class I I  genes which appear to be sites for regu latory DNA binding prote ins.  
Several g roups have noted that one or more of these s i tes is reg u lated by gamma 
interferon (329,  330) . Evidence from M HC class I I  nonexpress ing severe combined 
i m m u nodeficiency indicates that other non-gamma interferon trans-acting factors a lso 
regu late class I I  expression i n  a l l  types of cel ls  (33 1 ) .  B ce l l s  are sti m u l ated to 
express class I I  by I L-4 rather than gamma interferon ( 1 57) and have been s hown to 
be regulated by products of a gene locus wh ich does not affect M0 la expression (332) . 
Other regulatory sequences which have been identified in  the 5' flanking reg ion of MHC 
class I I  genes  appear to  confer t issue specificity (333) .  Thus the expression o f  M HC 
class " gene products on macrophages as well as B cel ls is a closely regu lated event.  
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Macrophage differentiation. 
Macrophages arise from pluripotent stem cells in the bone marrow. 
Experimental evidence obta ined by T i l l  and McCu l loch (334) in the ear ly 1 960 's  
bolstered the position of  those whose contention i t  was that a l l  of the cel lu lar e lements 
of the hematopoietic system were derived from single p lu ripotent stem cel ls  present in  
the bone marrow. Us ing radiation depletion of hemopoietic progen itors fo l lowed by 
reconst i tut ion with syngene ic  bone  m a rrow stem ce l l s ,  they i nvest igated t h e  
popu lations of ce l ls  i n  resu ltant progen itor co lon ies formed in  t h e  sp lee n .  T h e i r  
f ind ings i nd icated that co lon ies contained a m ixtu re of c e l l  types and that t h e  
reconst i tut ing bone marrow ce l ls  were capable o f  m ainta in ing stab i l ity with i n  t he  
peripheral blood under varied physio log ical states . Although the  monocyte was not one  
o f  t he  ce l ls  orig inal ly ascribed to  the  plu ropotent l ineage ,  i t  was added a short t ime 
later (335) . Since that t ime the p lu ripotent stem cel l  has been firm ly establ ished,  
although i ts  identification is  sti l l  problematic and i ts  presence can o n ly be proved 
retrospective ly by the progeny it produces (336) . More recent  find ings seem to 
ind icate that the p luripotent or totipotent stem cel l  population is  i ndeed present in the 
bone marrow ; however, i t  may remain in  a somewhat dormant state u n less extreme 
condit ions deve lop. The  requ i rements for rout ine mainta inance o f  hematopo iet ic 
e lements resides with the popu lation of m u lt ipotent stem ce l ls  which are capable  of 
rap id pro liferation into functional  cel ls of more than a single phenotype (336) . The 
sig nals for induction of prol iferation and designation of selected phenotype appear  to be 
reg u lated by a battery of colony st imu lat ing factors (CSF) , synerg ist ic factors and 
in teraction wi th the bone  marrow stromal ce l ls  (337) . The progen ito r popu lations of  
monocytes arise from m u lt ipotent stem cel ls  wh ich , depending on  the type of CSF 
avai lab le ,  can be pushed to different iate into e i ther  monocyte or  g ranu locyte l ineage 
(336 , 337) . Seve ral CSF's have been identif ied and characte rized ; however  the i r  
fu nct ions  in  v ivo are  not  clearly known,  althoug h the i r  cont i nuous prese nce d u ring  
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maturation and differentiation of hemopoietic progen itors is  abso lu te ly  requ i red to 
sustain ce l l u lar  v iabi l ity (337) . Of these i nter leukin 3 ( I L-3) ,  which was n am ed as 
an interleukin when it was characterized as a lymphocyte product having lymphocyte 
modu lating activity in addition to i nduction of 2 1 -hydroxylase activ ity , has s ince been 
ch aracte rized as a broadly act ive colony sti m u lat ing  factor hav ing specif icity fo r 
mu lt iple l i neage stimu lation wh ich seems to be quite active on early progen itor ce l ls ,  
possibly the p lu ripotent s tem ce l l s  (338) . Granu locyte monocyte CSF (GM-C S F) 
st im u lates mu lt ipotent  monocytic-granu locytic d i ffe rent iat ion causing progress ion of 
the mu ltipotent stem cel ls without selection of f inal l ineage. Terminal  l i neage selection 
appears to be dependent on monocyte CSF (M-CSF) or  g ranu locyte CSF (G-CS F) to 
dr ive the  immat u re ce l l s  to d i ffe rent iate i nto fu l ly funct iona l  and  ident i f iab le  
monocytic and g ranu locytic phenotypes (337, 339) . The whole scheme is  compl icated 
by the f indings that hemopoietin I and perhaps several other  factors have synerg istic 
effects with colony stim u lat ing factors and whi le i nsufficient to susta in  l ife or i nduce 
differentiation on their  own clearly modu late the pathways taken by progress ing ce l ls  
(337) . The network of i n  v ivo effects of both st imu lato ry factors and i n h ib i to ry 
factors i n  conjunction with the effects mediated by stromal  ce l l  i nteraction produce a 
f ine ly reg u lated se lf-renewing hemopoietic system which has been o n ly part ia l ly  
dissected. 
The deyelopment of circulating monocytes is similar to that of other hemopoietic 
.ce.ll.s.. Pluripotent stem cel ls g ive rise to m u ltipotent stem cel ls ,  as shown in  F ig u re 6 ,  
having more l i m ited d ifferent iat ive capacity (335 , 336 , 340) . P l u r ipoten t  s tem 
ce l l s ,  a lso refered to  as colony form ing u n its-sp leen (C FU-S) , are  probably sma l l  
mononuclear cel ls resembling lymphocytes.  These cel ls have been  found to  express M HC 
class I and class I I  as we l l  as theta antigens.  Mu lt ipotent, or bipotent, stem cel ls  g ive 
rise to monoblasts which are identif ied as having f ine chromat in structu re ,  v is ib le  
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FIG URE 6. Macrophage Differentiation .  
P lu ripotent stem cel ls  reside in  the bone marrow where they may remain  i n  a 
do rmant state whi le the normal requ irements fo r ce l l u lar p ro l ife rat ion a re met  by 
bipotent ce l ls which are driven to differentiate a long e ither  a granu locyt ic pathway o r  a 
monocyt ic pathway dependent on the colony st imu lat i ng and progression facto rs 
present .  The promonocyte is  the first clearly ident if iab le monocyt ic ce l l .  Afte r 
several ce l l  divisions the mature monocytes enter the periphera l  ci rcu lat ion whe re 
they remain unt i l  they are attracted i nto the t issues where they may res ide for long 
periods of t ime as tissue macrophages or  where they become activated by inf lammatory 
processes. Signals for macrophage movement into t issues are not we l l  u nderstood 
except for several we l l  characterized chemotactic factors. 
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n uc leo l i  and pos it ive react ions for non-specific esterase .  The i r  m o rpho log ica l  
ident ification is based sole ly on the i r  proxim ity to  identif iable monocytes rather  than 
any in t r ins ic character wh ich they possess , and they h ave been  fou n d  to be  
morphologically synonymous to  myeloblasts wh ich are identified in  close prox im ity to 
g ranu locytes .  Monoblasts apparently u ndergo a s ing le  ce l l  d iv is ion to produce 
promonocytes which are the fi rst clearly recogn izable ce l ls  in the monocytic l i neage 
and contain a large i ndented nucleus and azuroph i l ic g ranu les.  Promonocytes are 
weakly phagocytic, adhere to g lass , contain non-specific esterases and peroxidases 
including acid phosphatase and arylsu lfatase ,  and remain in the bone marrow where 
they probably undergo at least three divisions before g iv ing rise to monocytes wh ich 
are extruded into the c ircu lation ,  where as a rule they no longer pro l i fe rate (335 , 
336) . Few mature monocytes remain in the bone marrow un l ike po lymorphonuclear 
leukocytes, thus an increased number of monocytes i n  c ircu lation is  due to de  novo 
produced monocytes rather  than release of a seq u estered poo l (336) . Mature 
monocytes constitute 1 -9% of the ci rcu lating leukocytes and average approx imately 
400 monocytes/Il' b lood i n  adults ,  s l ight ly more than 1 000 monocytes/Il' blood i n  
i n fants (336) . Monocytes remain i n  c i rcu lat ion an  average o f  2 - 5  days  before 
m igrating into t issues to become tissue macrophages. Throughout the prog ression from 
p l u ripotent stem ce l l  to term ina l l y  d i ffe rent iated t issue macrophag e ,  the ce l l s  
successively lose differentiative plasticity as  well as  prol i ferative capacity and in  turn 
acqu i re more special ized functiona l  capacit ies many of wh ich can be modu lated by 
environmental factors . 
Circulating monocytes are large cells measuring 1 2- 1 5  11m in diameter. When 
exam ined in stained blood smears they are characte rized by a l arge ,  ren ifo rm ,  
eccentrical ly placed n ucleus (336,  340) .  The cytoplasm of monocytes conta ins  a 
variety of granules and vacuoles .  Monocytes contain relatively l i tt le  e ndoplasmic  
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reticu lum but contain a wel l  developed golg i region ,  and the centrosome located i n  close 
prox im ity to the nuclear c left serves as the m icrotubu le  organiz ing center for the 
extensive array of  m icrotubules and m icrofi laments wh ich are involved i n  movement  of 
ce l l u lar  organel les and movement and attachment of the cel ls to substrata. The  
propensity of monocytes to adhere to  plastic and g lass surfaces, indeed to  a lmost any  
su rface , i s  very characteristic and  has  been employed as  a primary means of isolation .  
Monocytes adhere as  circu lar cel ls and  exh ibit marked membrane ruffl ing or  ve i l s  on  
the  leading edge toward wh ich the  ce l l  is moving.  Un l ike dendritic ce l l s ,  monocytes 
remain f irmly attached to surfaces and in genera l  mainta in a rounded morphology 
without the formation of extended processes (247, 336) . 
Monocytes deyelop into macrophages and multinucleated giant cells. These cel ls 
are larger  and more amorphous  i n  shape,  contain large qu ant i t ies of lysosoma l  
enzymes,  have i ncreased metabol ic activity ind icated by  the increase i n  s i ze  and  
complexity o f  the  Golg i and  i ncreased nu mbers of larger  m itochondr ia and show 
increased phagocytic and pinocytic activity (336, 341 ) .  Monocytes i n  c ircu lation  are 
considered to be immatu re macrophages because the i r  sojourn in the c i rcu latory 
system takes them to al l parts of the body where they are able to respond to chemotactic 
inf lam matory products which cause them to m arg inate and leave the c i rcu lat ion by 
d iapedesis (342) . Once out  of the c i rcu lat io n ,  monocytes m igrate to s i tes of 
i n fl ammation . There are other homing m echanisms probably involv ing  adhesion 
mo lecu les such as f ibronect in- Iam in i n  (34 1 ) and LFA- 1 - ICAM- 1  in teractions  (343) 
for local ization of monocytes in t issues under normal ce l lu lar renewal conditions.  Once 
local ized, the monocytes take on morphology and functional capabi l ity characteristic of 
the h ist iocytes of the particular tissue in wh ich they are embedded.  
Macrophages are found in nearly all tissues where their specific functions as 
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mononuclear phagocytes serve as an important means for removing foreign invaders as 
well as effete autologous particulate matter. Phagocytosis (and endocytosis) by 
m acrophages is probably mediated by an extremely  d iverse a rray of recepto rs 
inc lud ing hormone receptors , man nosyl -fucosyl receptors , a lpha-2 m acrog lobu l i n ,  
i ron-b ind ing prote in  receptors for lactoferrin a n d  transferrin ,  f ibri n a n d  f ibr i nog e n  
specific receptors, extrace l lu lar matrix prote in  receptors for fibronectin a n d  l a m i n i n ,  
receptors for l ipoprote ins ,  a s  wel l  a s  receptors for opson ized materia ls ,  F c  receptors 
for I gG and IgE  and complement receptors (341 ) .  Monocytes treated with gamma 
interferon have also been shown to  express receptors for I L-2 i n  addit ion to increased 
l a  expression (220,  344 ) .  E l ie  Metchn ikoff noted the ab i l i ty to e ng u lf fore ign  
part ic les by ce l ls  of  the starfish larvae i n  1 882 (345 ) .  He  cal led th ese ce l l s  
phagocytes and noted that they actively "ate" (from the  Greek phage in ,  t o  eat or  digest) 
as opposed to being entered by an invader as previoulsy bel ieved . I n  1 884 he extended 
his observations to the leukocytes of humans and rabbits and noted that these cel ls  were 
also phagocyt ic and would active ly remove bacter ia from the i r  surround ings (346) .  
Metchn ikoff subsequently left  Russia to  work a t  the  Pasteu r  I nstitute in  1 888 and went 
fu rther to study inflammation and the ro le of the phagocytic ce l l  i n  the inflammatory 
response. He is  credited with be ing the founder of the theory of ce l l u lar  i m m u n ity ; 
howeve r, he and h is  fo l lowers were embattled for most of the early years of the 
twentieth century by the proponents of h umoral immunity, including J ules Bordet who 
discovered complement mediated lysis wh i le  working in  Metchn ikoff's laboratory .  As 
an indication of the inabi l ity to resolve the issue ,  Metchn ikoff was awarded the Nobel  
Pr ize i n  1 908 along with Pau l Ehrl ich , the fou nder of the theory of h umoral  immun ity 
(347) . 
Monocytes ,  primari ly as more h igh ly differentiated macrophages ,  p lay a major 
role i n  host immun ity due  to the i r  abi l ity to engu lf fore ign matter and the body's 
obselete ce l lu lar products and subject them to proteo lytic breakdown and d i sposal .  
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I nvasive organisms which have developed methods for evasion of phagocytosis ,  o r  o nce 
engu �fed evade the effects of the vast array of proteolytic digestive machine ry in the 
acidified vesicles of the macrophage ,  tend to have profound effects on  the host (34 1 ) .  
Mycobacterial infections are an example o f  bacteria l  escape o f  macrophage defense 
mechanisms.  Althoug h they may be phagocytosed , they remain i ntact with i n  the 
macrophage because the i r  waxy coats provide protect ion from digestion . Another  
organism which appears to  enter macrophages but  does not  u ndergo degradation is the  
hu man immu nodeficiency v i rus ( H IV-1 ) wh ich enters macrophages and monocytes 
presumably by attachment to the CD4 receptor on the surface which is then taken i n  by 
recepto r mediated endocytosis ( 1 32,  1 33) .  The v i rus however ,  cont i nues to l ive 
with in  the monocyte and indeed the monocyte may serve as a v i ra l  reposi to ry for 
subsequent infection of T ce l ls at distant s ites ( 1 32 , 348) . Phagocytosis of particu late 
matter  is int imately associated in free macrophages with stimu lation of the respiratory 
bu rst and release of reactive oxygen intermediates and othe r b ioact ive secretory 
p roducts (341 , 349) . 
Monocytes and tissue macrophages also serve as secretory cells. as antigen 
presenting cells and as directly cytotoxic cells for elimination of tumor cells . The 
ant ig en present ing capacity of  monocytes and macrophages has been  p rev ious ly 
discussed. Monocytes and macrophages secrete more than 1 00 different products, most 
of wh ich have profound effects on their  m icroenvironment and its cel lu lar  i n habitants 
(350 ) .  Among the products secreted are a variety of hormone- l ike substances 
inc lud ing  i nter leuk in  1 ,  tumor necros is factor-a lpha ,  a lpha in terferons ,  p late let  
derived g rowth facto r, transforming g rowth factor- B and othe r  f ibroblast g rowth and 
act ivating factors , and colony stimu lat ing and hemopoietic modu lating factors . Many of 
the complement components and coagu lation factors are produced by m acrophages. A 
wide variety of enzymes including neutral proteases such as plasminogen activator and 
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e lastase , l ipases, lysozyme, lysosomal enzymes as wel l  as enzyme inh ibitors are a lso 
produced. Extrace l lu lar matrix proteins such as fibronect in and binding proteins  such 
as transferrin and apolipoprote in  E are other polypeptide products . Smal ler  molecular 
weight products include h igh ly active cyclooxygenase and l ipoxygenase products such as 
prostag land ins E2 and F2 a , leukotrienes and mono- and di-hydroxyeicosatetranoic 
acids;  platelet activat ing factor ;  neopteri n ;  pur ine and pyri m id ine  sa lvage pathway 
products ; and reactive oxygen intermediates, superoxide and hydrogen peroxide (350) . 
This is an abbreviated l isting of macrophage secretory products and in no way claims to 
be comprehensive ; however, it is apparent that macrophages secrete a vast a rray of 
products most of which are very active in mediat ing significant chemical react ions o r  
in inducing receptor mediated cel lu lar  modulation .  I t  is a lso apparent that among the  
products are many wh ich have overlapping capacities and  also many wh ich have clearly 
antagonistic capacities. The modulation of secretory function ,  therefore, must be u nder 
stringent control to insure that a particular effect can be e l icited (350) . M acrophage 
secretory function is  modu lated by the state of activat ion and by the site of t issue  
local ization (241 ) .  The  concept o f  macrophage activation is  most clearly de l ineated in  
the murine system in wh ich peritoneal  macrophages can be described as res ident ,  
e l icited or  activated depending on the st imu lus used (35 1 ) .  In  studying h um an 
macrophages and monocytes, the desig nations are less clearly defined and with in  a 
populat ion taken from a no rm al  ind ividual ,  m u lt ip le stages of act ivation m ay be 
represented (352) . In the murine system,  activated macrophages are characterized by 
a respiratory burst i nvolving the secretion of both proteolytic enzymes and reactive 
oxygen intermediates which arm the macrophage for tumoricidal activity and cause the 
macrophage to express MHC class I I  antigens in  a transient manner  (349) . H uman 
macrophages are also capable of  exhibit ing a respiratory bu rst but express MHC class 
I I  molecules constitu itively,  albeit at a re latively low level  compared to dendrit ic ce l ls  
and B ce l ls .  The expression of M HC class \ I  molecules is increased upon activation 
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probably as a resu lt of transcript ional  reg u lat ion by gamma in terferon p roduced 
primari ly by T cel ls (3 1 2) .  Fu l ly differentiated t issue macrophages such as alveolar  
macrophages and Kuppfer ce l ls in the l iver display a reduced abi lty to secrete reactive 
oxygen  intermediates and inflammatory products u n less stimu lated over  a period of 
severa l  days (353) . Th is  characteristic i s  postu lated to reduce the probl e m  of 
bystander t issue damage by cel ls wh ich are con stant ly in contact with nox io u s  
substances ,  i . e .  ant igens .  C i rculat ing monocytes wh ich are attracted t o  s i tes of 
i nflammation are more readi ly activated to produce h igh ly damaging reactive oxygen  
compounds;  however, they would not be  activated to  risk destruction o f  normal t issues 
along with destruct ion of t reaten ing i nvaders u nt i l  the developm ent  of the i n i t ia l  
inflammatory lesion attracted them to marginate and d iapedese (34 1 ) .  Therefore there 
are probably large differences in the capacit ies of t issue macrophages depending on the 
receptors wh ich were ut i l ized to attract them to the i r  sites of local ization .  
The  relationship between macrophages and dendritic cel ls is not ent i re ly clear.  
Both types of cel ls may be derived from a common progen itor wh ich arises with in  4-5 
weeks fol lowing fert i l ization in the human fetus and develops i n  the yo lk sac and 
mesenchyme prior to the development of either  the thymus or  the bone marrow (336) . 
The finding that dendritic ce l ls express large quantities of MHC class I I  molecu les,  are 
very effective antigen present ing cells and stimu lators of m ixed lymphocyte react ion 
makes them very important in  immune funct ion (354) and ce l ls  previous ly identif ied 
as tissue macrophages such as Langerhans ce l ls  of skin have more recent ly been 
identified as dendritic cel ls  (355) . Efforts to d ismiss the macrophage as an ant igen  
presenting cel l  have not been entirely successful i f  on ly because synthetic membranes 
which contain MHC class I I  molecu les i n  a proper or ientation have been shown to 
competently present antigen (275) .  One can not escape the in t imate re lat ionsh ip  
between macrophages and antigen and their capacity to  endocytose, degrade and disgorge 
processed ant igen . Macrophages ,  therefore, have a vital ro le to play i n  i m m une  
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function through their capacit ies to phagocytose materia l ,  secrete bioactive products 
and present fragments of antigenic matter in conjunction with MHC class I I  molecules 
to T ce l ls .  
The necessity of isolation of monocytes and macrophages constitutes a problem 
for their study. The elucidation of the central role p layed by the macrophage i n  the 
maintenance of competent immune function begun  by Metchn ikoff has been extended in  
numerous species, particu larly m ice and humans,  and the morpholog ical and functional  
characteristics of th is cel l  type have been  reported i n  vo lumes of reports.  F ind ing 
sou rces of  large numbers of unperturbed monocytes and macrophages for study has 
been  a conti nu ing problem . The ce l l s  studied i n  the m u rine  system are genera l ly  
isolated as peritoneal exudate ce l ls ,  e l icited with ster i le inflammatory agents such as 
proteose peptone or th iog lycolate or activated macrophages stimu lated prior to removal 
from the animal by injection of bacterial extracts such as E. coli LPS . Alternative ly 
macrophages are isolated as a portion of the popu lation of ce l ls  in the spleen ,  lymph 
nodes, or  bone marrow (349) . In  the hu man system the cel l  sou rce is gene ra l ly  
peripheral blood monocytes,  occasional ly alveolar macrophages isolated by lavage and 
even less frequently macrophages from tissues excised as a result of  medical treatment 
or  autopsy such as spleen ,  lymph nodes, l iver, bone marrow or ce l ls  from peritonea l  
dialysis. Although in  a l l  cases the cel ls being examined are of macrophage  l i neage ,  it is  
u n l ike ly that they are iso lated at the same stage of different iation ;  t herefore ,  the 
resu lts found in a g iven species may not necessarily be comparable to another species. 
I so lation of human monocyteslmacrophages involves m u ltiple step separations and has 
been plagued by the necessity of removing th is cel l  type from a m i xtu re of ce l ls  of 
which they are a m inor component using iso lation procedures  which frequently are 
dependent on the propensity of the monocyte to adhere to g lass or p lastic. This step 
m u st i nvariably be fo l lowed by removal of adhered cel ls  by enzyme treatment  or 
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scraping wh ich frequently changes functional  capabi l ity or  decreases the n umber of 
v iable ce l ls  recovered . Other  procedures make use of counter flow elutr iat ion (356) 
or density g radient centrifugation on perco l l  g rad ients (357) . These procedu re s  
requ ire large volumes o f  blood from donors (who are relatively scarce) i f  one  is  to 
recover  working numbers of monocytes .  There have been ind ications that these 
methods are not innocuous to monocytes and with Percol l  separations the monocytes 
may phagocytose the col loidal s i l ica (358) .  The problem is further compounded in  the 
h uman system by the lack of constant sources of M HC identical ce l l s  necessitating 
complex screening and match ing of cel ls from donors. There are in the l i teratu re m any 
reports of methods for isolation of  monocyteslmacrophages and each method y ie lds a 
product wh ich is s l ig htly d ifferent from every other. 
Stable murine macrophage cell lines haye been deyeloped. I n  o rder  to 
circumvent the difficul ty of macrophage isolation ,  i nvestigators have sought to develop 
macrophage cel l  l i nes wh ich can be grown using standard tissue cu lture techn iques. I n  
t he  murine system ,  t h i s  has  been re latively successfu l ,  and there are numerous  cel l  
l ines avai lable for study o f  which P388D1 , J774 , WEH I-3 and RAW264 (359 , 360 ,  
3 6 1 , 362) represent  a few of the  ava i l ab le  ce l l  l i n e s  derived from m u ri n e  
m acrophages.  Other strateg ies for establ ish ment  o f  cel l l i nes  h ave re l ied o n  
transfect ion o f  muri ne  macrophages with an  or ig i n  o f  repl icat ion deficien t  ( O R n 
SV40 DNA construct developed by Sambrook (363) . 
The deyelopment of monocyte or macrophage-like cell lines in the human has 
been less successful. although there are now seyeral cell lines which haye been 
successfully used. Early attempts to derive cel l  l i nes from cultu red human monocytes 
have met with l i t t le long term success (364 , 365, 366 ) .  More successfu l recent 
developments have yie lded cel l  ines which are stable for long periods of t ime and which 
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retain major monocytic charateristics especial ly expression of MHC class I I  ant igens ,  
H LA D R  and DQ.  Th is  has been ach ieved by us ing  techn iques such as som atic ce l l  
hybridization of  human monocytes with mouse myeloma cel ls (367) and transfect ion of 
h u man monocytes with the aforementioned OR 1- SV40 construct (368) .  I m mo rtal ized 
ce l l  l i nes produced by these methods are st i l l  being evaluated and may prove usefu l ;  
however, i n  the study of the effects o f  expression of M H C  class I I  antigens, the addtional  
expression of either mouse derived g lycoproteins or  v i ral T antigens on these cel ls  may 
compl icate interpretation of any resu lts. Attempts to isolate cel l  l ines having monocyte 
characteristics from tumor t issues or from natural ly transfo rmed ce l ls  has m et w ith 
l im ited success ; however, in recent years severa l  ce l l  l ines have been isolated from 
various leukem ias which have monocyte/macrophage- l ike characteristics or  can be 
induced to have those characterist ics , are stable over a long period of t ime,  and can be 
propagated under normal tissue culture conditions.  Among these are U937 (95 ) ,  H L60 
(369) , KG-1 (430 ) ,  and T H P - 1  (371 ) ,  of wh ich H L-60 and KG- 1 are m o re 
typical ly of the granulocyt ic l ineage than monocytic l ineage. These ce l l  l i nes h ave a l l  
been used for the study of  human monocyte/macrophage function in  the last  several 
years. H L60 cel l  l ine has been used extensively because it can be i nduced to 
d i fferent iate along either the monocytic or  g ranu locytic pathways. KG-1 and T H P- 1  
have been more recently developed . THP-1  has been  especial ly usefu l i n  investigation 
of I L- 1  induction (372) . 
The human monocytic cell line. U937. The U937 monocyt ic ce l l  l i ne  was 
iso lated from the pleura l  effusion of a 37 year old m ale  d iag nosed with d iffuse 
h ist iocytic lymphoma (95) . The ce l ls isolated by Sundstrom and N i lsson i n  1 976 by 
ut i l iz ing organ culture techniques and fibroblast or g l ia l  ce l l  feeder l ayers retained the 
characteristics of the tumor ce l ls found in the pleural effus ion .  The cel ls  were iso lated 
fol lowing both radiation and chemotherapy ; however, the tumor was rapidly fatal to the 
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patient and cont inued to g row vigorously in  culture i n  rich t issue culture m edia.  
The cel ls  were characterized as typical of monocyte-precursors . By l igh t  
m icroscopy they appeared to  be morphological ly heterogeneous in that they ranged in  
shape from round to  polygonal with frequent cytoplasmic projections which o n  scann ing 
e lectron m icroscopic examination appeared main ly as blebs and occass iona l  lamel lar  
projections ,  somet imes sharp barbs . The ce l ls  were fou nd to be 1 2 .5 ± 4 .4  11 in  
d iameter with moderate amounts of  cytoplasm contain i ng n umerous acidic g ranu les ,  
wel l developed Golg i apparatus, many polyribosomes, wel l  developed m itochondria and 
l itt le endoplasmic reticu lum .  The s ingle n ucleus was found to be variab le i n  shape 
although frequently lobu lated and contained at least one large n ucleolus. The cel ls  g rew 
as s ing le ce l ls  in suspens ion cu ltu re . Although in the fi rst years of g rowth the cel ls  
were maintained on feeder layers of g l ial cel ls ,  the U937 ce l ls d id not strongly adhere 
to the feeder layer. Cytochemical ly U937 cel ls were fou nd to be strongly positive for 
nonspecific esterase and exh ibited NaF i nh ibitable naphtho l AS-O esterase activity 
wh ich has been described as very characteristic of h uman monocytes (95) . The cel l s  
we re fou nd to  have ce l l  su rface receptors for immu nog lobu l in  Fc  and complement  
component C3 .  They produced no immunog lobu l in ,  either intracel lu larly or  on  the cel l  
surface, and no EBV genome or viral proteins were detected. The U937 cel ls  were typed 
for H LA  by microcytotoxicity and found to be H LA-A 3 ,w1 9 ;  B 5 , 1 8 ;  Cw1 ,w3 . No M H C  
class I I  antigen profi le was reported . A s  further evidence for the monocytic l ineag e  of 
these ce l l s  they were fou nd to produce and secrete lysozyme  at fa i r ly  h ig h  
concentration ; but u n l ike monocytic cel ls ,  on ly a smal l  percentage of the U937 ce l l s  
were found to be actively phagocytic and they were negative for acid phosphatase and 
peroxidase (95) . Chromosomal ly they exhibited aneuploidy but were characterized as 
ar is ing from a monoclonal l i neage .  A recent  karyotypic analys i s  of  th ree U937 
cu l tures (373) obtained from geograph ical ly d ispersed sites inc lud ing ce l ls  obta ined 
from the laboratory of orig in  found that there was g reat diversity i n  ch romosomal  
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makeup of the three cultu res and at fi rst it was bel ieved that the cel ls must be different 
cell l i nes ;  however, changes in  four  ch romosomes were constant for al l th ree U937 
ce l l  l ines tested . These changes were 3q- , 1 1  q - , 1 6p+ , and 1 7p- . De let ion in 
ch romosome 1 1  has been found to correlate with deletions characteristic of monocytic 
and myelomonocyt ic mal ignancies.  Although the g enes i nvolved h ave not been  
determ ined, this deletion is  probably re lated to t he  orig ina l  tumor. The  s ign ificance of 
the other consistent abnormal it ies is not known (373) .  
The U937 cel l  l i ne has been extensively ut i l ized as a tool for study s ince its 
development. I t  is variously characterized as h istiocytic, monocytic and monoblastic, 
although the distinctions are not clear. Harris and Ralph (374) reviewed the explosion 
of information available for both HL60 and U937 cel l  l ines i n  1 985. Since that t ime ,  
the  U937 cel l  l ine-related l iterature has continued to expand a t  an accelerated rate. It 
was fe lt that a detai led comprehens ive review of that l i teratu re ,  both the new 
in formation and the many redu ndancies,  was beyond the scope of th is  project .  
Therefore a brief overview of selected i l l ustrative citations  was employed to ind icate 
the major areas of endeavor in uti l ization of the U937 monocytic cel l  l ine .  In  addit ion 
to the characteristics of the U937 cel l  l ine orig ina l ly reported , the ce l l  l ine has been 
found to secrete a large n umber of bioact ive products such as elastase (375) and 
g lycosidases and acid and a lkal ine phosphatases (376) , catheps in  G (377,  378 ) ,  
choleste ry l  esters (379 , 380) , to express ce l l  surface receptors for I g E  F c  (381 ) ,  
i nsu l in  receptor (382,  383) , gamma interferon receptor (384 , 385) , h i sta m i n e  H 2  
receptors (386) ,  CD4 cel l  surface antigen (387, 388) , and to produce a n  array of 
complement components (C1 - INA, C1  r, C8, Factor H, Factor 0, and smal l  amounts of 
C3 (389 ,  390,  391 , 392) ,  and factors h aving suppressive activity (393 ,  394 , 395 ) .  
The  constitu itive production o f  i nterleukin 1 has  been controvers ia l  (396 ,  397) . The  
cells can be  activated by gamma interferon (398) , phorbol esters (399) ,  vitam in  0 
metabolites (400) ,  retinoic acid (40 1 ) and a n umber of other  agents and combinations 
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of agents to become more differentiated concomitantly express ing more macrophage 
character ist ics and perfo rm ing  m acrophage funct io n s  such as i n h ib i t io n of 
i nt race l l u la r  parasites (402) , tumor ce l l  ki l l i ng  (403) , ant ibody dependent  ce l l  
cytoxicity of ch icken erythrocytes (404) ,  phagocytosis and stimu lated production  of 
reactive oxygen compounds (405) , chemotaxis (406) , adherence to g lass and p lastic 
surfaces and cessation of pro l iferat ion (407) , expression of I L-2R (408) , I -CAM 1 
(409) and p1 50,95 (4 1 0) adhesion related structures , re lease of e icosonoids , PGE2 
and thromboxane (4 1 1 ,  4 1 2) ,  and release of plasminogen  activator i nh ibitor-2 (4 1 3 , 
4 1 4) .  Although al l  agents l isted affect the cel ls i n  different ways and none are able to 
mediate a l l  of the changes described , they al l  tend to push the U937 cel l  l i ne toward a 
more activated and termina l ly differentiated state , except gamma i nterferon wh ich 
merely activates in a reversible manner .  A major portion of the l iteratu re concern ing 
the U937 cel l  l ine involves i ts  use in d iffe rentiation studies, both for assessment of the 
effects of  the agents used to induce differentiation and for the information gained about 
progression through monocytopoiesis. 
I n  more cl inica l ly relevant research,  the U937 cel l l ine has also been  usefu l in 
investigating the effects of chemotherapeutic agents on tumor ce l ls .  Although the true 
h ist iocytic mal ignancies are relatively rare , the U937 ce l l  l i ne  serves as a ready 
source of tumor ce l ls for testing to determine effects of new combinations of treatment 
modal it ies (41 5 ,  4 1 6 ) .  In add it ion the find ing t hat the - U937 ce l l  l i ne  can be 
ch ro n ical ly  i n fected with H IV- 1 (4 1 7 , 4 1 8 ,  4 1 9) m akes it a potent ia l ly  va l u ab le  
adjunct to A IDS research . 
A th i rd area in  which U937 cel ls have been useful is in  the rea lm of immune  
fu nctio n  and  gene  regu lation . Th i s  area overlaps with the area o f  d i ffere nt iat ion 
especial ly with regard to investigations into the expression and the role of oncogenes in  
the  differentiation process (420 , 421 ) and i n  the alte red functiona l  state fo l lowing 
term ina l  d i ffe rent iat ion (398-4 1 4) .  A second area of i nvest igat ion i nto g e n e  
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regu lation concerns the expression of MHC class I I  molecules.  Several g roups h ave 
reported induction ,  or  lack of induction ,  of MHC class I I  expression on U937 us ing 
e i ther  gamma i nterferon (422)  o r  phorbol esters (423) o r  g am m a  i nterfe ron 
fo l lowing treatment with demethylat ing agent ,  5-azacytid ine  (424 ) .  There i s  no 
explanation for the disparity seen between the U937 ce l l  l ines in different laboratories 
wh ich apparently behave in  different ways. There are a lso reports of const i tu i t ive 
expression of MHC class II molecules from a number of laboratories including ou r  own. 
The la+ 1937 ce l l  l ine derived by cel l  sorting from an l a+ U937 cel l l i ne by G itter et 
a l .  (425) has been i nvest igated and appears to con st i tu it ive ly e xpress a h i g h  
concentration of surface M H C  class I I  and also has been shown to stimu late a m ixed 
lymphocyte reaction .  This is  one of the on ly reports of immune function requ i ri ng  
interaction between T ce l ls and accessory cel ls in  which the  re levant accessory function 
was mediated by the U937 cel l  l ine.  
Rationale for pursujt of thjs project. At the time that th is  project was begun ,  
the U937 was one  of only two human monocytic cel l  l ines,  U937 and H L60,  wh ich had 
been fairly wel l  characterized. Neither  standard ce l l  l i ne  had been found to express 
M HC class I I  antigens and HL60 was used to investigate granu locyte differentiat ion to a 
larger  degree than monocytic differentiation .  Although the U937 ce l l  l i ne  had been 
extensively investigated for macrophage characteristics and capacit ies, i ts  lack of MHC 
class I I  molecu les and its inabi l ity to be  induced to express M H C  class \ I  prevented the 
ce l l  l ine from serving as a macrophage analog in  immune function in  which M H C  class 
I I  molecules were thought to be intimately i nvolved,  i . e .  a nt igen  presentation  and 
stimu lation of mixed lymphocyte reaction .  One of the U937 ce l l  l ines avai lable i n  the 
laboratory had been fou nd to express MHC class I I  molecu les constitu itive ly.  I t  was felt 
that the avai labi l ity of a wel l  characterized , easi ly propagated h uman monocytic ce l l  
l i ne  constituitively expressing known M H C  class I I  molecules wou ld b e  of g reat value  i n  
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the dissection of antigen presentation and the role of M HC class " molecules. I n  spite of 
the obvious questions raised by the use of a tumor cel l  l ine for the extrapolation  of 
normal macrophage function ,  the potential of this cel l  l i ne  for e lucidation of h uman 
macrophage function in antigen presentation ,  m ixed lymphocyte reaction ,  generation of 
specific cytolytic T cel ls ,  production of monokines, antigen endocytosis and process ing ,  
presentation of  antigen fragments to ant igen specific T cel l s ,  macrophage secretory 
capacity , and regu lation of expression of M HC class " molecu les and other cel l  su rface 
receptors continues to be apparent. The phenotypic and functional characterizat ion of 
th is ce l l  l i ne is by no means complete , and on many occasions more questions arose 
from experiments than answers ; however ,  the MHC class " positive U937 cel l  l i nes  
offer a means for dissecting re lationsh ips in a ce l l  type of exqu isite complexity. 
MATERIALS AND METHODS 
Media . Cel ls were g rown and assays were conducted i n  RPMI  1 640 t issue 
culture medium which was obtained in powdered form from G IBCO, Grand Is land,  NY, or 
from Hazelton Laboratories, Denver, PA. Packets of powdered media were reconstituted 
us ing  u l t ra-pu re deion ized water (M i l l ipore Corp . ,  Bedfo rd , MA) and ster i l ized by 
fi l t rat ion through M i l l ipo re (M i l l ipak) 0 .22J..l fi l ters i n to steri le  bottles .  Med ia was 
s u pp l e m e nted with 1 00 u n i ts  of  pen ic i l l i n/m l .  a n d  1 00 m icrog r a m s  of 
streptomycin/ml .  (G I BCO, Grand Is land, NY) .  Media was also supplemented with 2 m M  
L-g l u tam ine  (G I BCO , G rand I s land,  NY) du ring ear ly experi ments b u t  addit iona l  
g l utam ine was found to be  unnecessary for the  routine g rowth o f  the U937 cel l  l i ne .  
s.eI.a. Fetal bovine serum (FBS) was obtained from several suppl iers .  Prior to 
pu rchase , seru m was screened in  the laboratory to ascerta in  which lots wou ld 
satisfactor i ly support the g rowth of the cel l  l i nes carried in  the laboratory. Du ring the 
period of this project , fetal bovine serum used for growth of U937 ce l ls  was obtai ned 
primarily from Sterile Systems (Logan , UT) and from Haze lton Laboratories (Denver.  
PA) . Standard tissue culture media used for g rowth of the U937 cel l  l ine was R P M I  
1 640 supplemented with pen ici l l i n ,  streptomycin and 1 0% FBS. 
Normal h u man seru m (N HS)  was obtai n ed by poo l i ng serum d rawn by 
ven ipunctu re from approximately 20 healthy donors. Parous women and ind ividuals on 
medications other than bi rth contro l  pi l ls were excluded from the donor pool .  Fast ing 
(prefe rred but not a lways avai lab le)  samples of 200 m l .  we re d rawn u s i ng a l l  
necessary precautions after informed consent was obtained from each donor. B lood was 
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al lowed to clot and serum was removed after centrifugation . When al l cel ls had been 
removed,  the serum samples were combined, heat inactivated at 56°C for 30 m i nutes, 
ce ntr ifuged at 1 5 ,000 x g fo r 60 m in utes ,  fi l tered t h rough a 0 .45Jl ster i l e  f i l ter  
(M i l l ipore Corp. , Bedford , MA) , a l iquoted into steri le  tubes and frozen at -20° C .  
Samples of each batch were tested for steri l ity by addition to media and i ncubation at 
3 r C  for several days. RPM I  1 640 (pen ici l l i n  and streptomycin added) contai n i ng 
1 5% normal hu man serum was used i n  m ixed lymphocyte cu l tures ( M LC) , ce l l  
mediated Iympholysis assays (CML) and for antigen presentation assays. 
Tissue culture. U937 ce l ls  were maintained in suspension cu ltu re in R P M I  
1 640 contain ing 1 0% fetal bov ine seru m ,  2 mM g l utam ine ,  1 00 U/m l .  penici l l i n  and 
1 00 Ilg/m l .  streptomyci n in  25 cm2 or  75 cm2 t issue cu l ture f lasks ( Costar ,  
Cambridge ,  MA) at  37°C,  i n  5% C02 in an incubator with h u midified atmosphere .  L­
g l utamine (extra 2 mM) was occasional ly added to the cu lture media;  however,  th is  
addit ion was found to be unnecessary . These cel ls are very metabol ical ly active and 
g row rapidly causing the pH of  the media to become very acidic. Although they h ave 
been found to g row opt imal ly  i n  a moderately acid ic m ediu m  (pH 6 .8-7 .0 ) , the  
cul tures rapidly lost viabi l ity after s ix  days u n less divided.  For th is  reason adherence 
to a maintenance schedu le  was impo rtant and cel l s  were rout inely propagated by 
spl itt ing cultures at a 1 :8 d i l ution every fourth day . U937 cultu res grew poorly in the 
presence of HEPES buffer. Periodica l ly samples of the ce l l  l ine and isolated c lones 
were frozen in  l iq u id n itrogen for future retrieval . Cel ls  to be frozen were removed 
from cul ture ,  centrifuged to concentrate the ce l ls  in a loose pel let. The supernatant 
was decanted or  pipetted off of the pel let and the cel ls were resuspended in  cold 1 0% 
DMSO/40% FBS and subjected to control rate freezing .  These samples were mainta ined 
in either l iqu id n itrogen or n itrogen vapor phase storage . . 
Tissue culture techniques and a l l  ce l lu lar  assays requ ir ing steri le  preparations  
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were performed in laminar flow tissue culture hoods.  
Isolation of clones of U937 by limiting dilution techniQues. Both la  positive and 
l a  negative parent l ines of U937 were plated i n  96 we l l  f lat bottom t issue cu ltu re 
plates (Costar, Cambridge ,  MA) at cel l u lar concentrations of 0 .5 ,  1 ,  2, 5, 1 0  and 1 00 
ce l l s/we l l  in  200 ,.1.1 .  (426) to iso late clones by l im it ing d i l ut ion tech n iq u es fo r 
furt he r  study . Twenty-fou r  o r  forty-e ight  we l l s  were p lated fo r each of t he  
concentrations ,  except 1 00 ce l ls/we l l  which was plated i n  twelve we l l s  o n ly as a 
control that l iv ing ce l ls  were plated . Plates were maintained i n  5% C02 for severa l  
weeks and were scanned 2-3 t imes each week for ce l l  g rowth . Growth was slow in  
we l ls at  low ce l l  doses. After g rowth was wel l  establ ished i n  the wel ls of ind iv idua l  
d i l utions, half of  the o ld media was removed by pipet and an equal amount of fresh m edia 
was added unti l  the g rowth in the wel l  was confl uent at which t ime the cel ls were 
pipetted into we l ls in a 24 wel l  plate to which 2 m l .  of medium was added. These ce l ls  
were fed by removal of  spent media and addition  of fresh media as gauged by p H  and ce l l  
concentration .  When the ce l l  concentration became confluent in  the 24 we l l  p lates,  the 
ce l ls were transfered to 25 cm2 tissue flasks. When g rowth was stable ,  a l iquots were 
tested for membrane la and samples of each clone were frozen .  Cel ls plated at each 
concentration were not considered to be clonal ly derived u n less no growth occurred in 
at least 37% of the wel ls (426,  427, 428) . 
phenotypic analysis of U937 clones and parent line by fluorescent antibody 
staining and flow cytometry. Both d irect and i nd irect immunofluorescence assays were 
performed . Ce l ls ,  5 X 1 05 - 1 X 1 06 ce l ls  per assay , we re washed three t imes with 
cold phosphate buffered sal ine (PBS) conta in ing 1 % FBS and 0 .02% sod ium azide 
(wash buffer) by centrifug ing at 400 x g, decant ing , resuspension of the pel l et by 
gentle ag itation and addition of fresh wash buffer. Assays were performed in disposable 
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g lass tubes ( 1 2 x 75 mm) . For d i rect assays appropriate d i l ut ions of each of the 
antibodies to be tested were added to the washed pel let of ce l ls ,  m ixed gently by finger 
tapping and incubated on ice fo r 30 m inutes.  The ant ibodies used were d i rectly 
conjugated with fluorescein isoth iocyanate (F ITC) and intended for use on h uman blood 
cel l  samples. These antibodies were used according to the manufacturer's instruction s  
a s  direct reagents.  I n  most cases these reagents were added to ce l ls after the cel ls  were 
incubated with a non-specific isotype matched antibody i n  the form of a hybridoma 
supernatant or normal human serum for 30 minutes on ice fo l lowed by  three washes 
with wash buffer. I ndirect immuno-fluorescence assays were performed i n  m uch the 
same fash ion ; however, the un labeled first antibody was added to the ce l ls  eithe r  after 
non-specific antibody or normal hu man serum treatment or  d i luted with PBS i n  the 
presence of  non-specific antibody or normal human serum.  After an incubation period 
of 30 minutes on ice , the ce l ls were washed 3 t imes with co ld wash buffer at 400 x g 
and an al iquot of FITC labeled second antibody was added . The second antibodies most 
common ly used were F(ab')2 goat anti-mouse IgG or  F (ab')2 sheep ant i -mouse IgG 
(Organon Tekn ika-Cappel ,  Malvern , PA) . FITC labe led ant ibodies were tite red with 
known positive antisera to obtain an appropriate di l ution of antibody to g ive the h ig hest 
percentage of staining without g iv ing an i ncrease in background stain ing . Contro ls for 
immunofl uorescence consisted of unstained cel ls for d irect assays and ce l ls  pretreated 
with isotype matched non-specific antibody or normal human serum and sta ined with 
the second antibody alone for i ndirect assays. Normal human mononuclear cel l s  were 
also examined and part icu lar cel l  popu lations were gated for analysis in  some assays. 
Capping was prevented by the presence of sodium azide i n  the wash buffer and by 
keeping the ce l ls  in  the cold at all t imes. 
Ce l l s  we re exam ined us i ng the Ortho Spectru m I I I  laser activated f low 
cytometer equipped with an argon-ion laser with 488 nm wavelength em ission .  The 
trigger reg ion was set to include the entire v iable popu lation ,  and gain settings were set 
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such that the whole popu lation was evenly dispersed with in the gated field. Forward and 
rig ht angle scatter and green fluorescence were m easured for each sample and  
h istograms were recorded . 
If a large n umber of samples were to be read at one t ime,  the samples were 
centrifuged at 400 x g ,  decanted and the cel ls were resuspended in PBS contain ing 1 % 
paraformaldehyde and kept on ice . Prior to examination ,  cel l s  were further d i luted in  
PBS + 1 % FBS + 0.02% sodium azide. 
Isolation of human mononuclear cells for mjcrocytotoxicity assay and cellular 
proliferation assays. Peripheral b lood mononuclear cel ls  ( PBMC) were iso lated from 
blood samples drawn from normal volunteers after informed consent was obtained.  
Standard separation techniques developed by Boyum (429) were used . B lood samples 
were heparin ized with preservative free heparin (O'Ne i l ,  Feldman & Jones,  St.  Lou is ,  
MO), mixed gently, d i luted with RPMI  1 640 1 :2- 1 :3 and layered onto tubes contain i ng 
approximately an i nch depth of fico l l -hypaque separation m edi u m  (specific g ravity 
1 . 077- 1 .079) , i . e .  4 m l .l 1 7 x 1 00 mm tube or 1 5  m l .l50 m l .  tube . D i l u ted b lood 
was carefu l ly  pipeted or poured onto the fico l l -hypaque  cush ion .  Tubes were 
centrifuged at 400 x 9 for 20-30 minutes . Mononuclear ce l ls  were removed from the 
i nterface between media and separation medium carefu l ly with a pipet.  These ce l l s  
were washed 3-4 times with media by centrifuging at  400 x g and decanti ng . Ce l l s  to 
be used for microcytotoxicity assay for H LA  phenotype were treated with Tris N H4C I  to 
remove erythrocytes by adding the solut ion to the ce l l  pel let ,  incubating at 37°C.  for 5 
m inutes fol lowed by washing .  
Isolation of plastic adherent cells. The mononuclear ce l ls  isolated by 
fico l l  hypaque density centrifugation were d i luted to a concentrat ion of 2 X 1 0B/m l .  and 
plated into 1 00 mm petri dishes (Falcon ,  Oxnard ,  CA) and i ncubated for 60 m inutes at 
3rC in the C02 incubator. After incubation ,  the dishes were swi rled and the non-
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adherent cel ls were removed by gently wash ing the dishes with media. The plates were 
addit ional ly washed with more vigor using a pipet to remove any stubborn lymphocytes 
wh ich were discarded .  Adherent ce l ls  were removed by scraping  with a rubber 
po l iceman or  with d isposable plast ic pol icem e n  (Costar ,  Cambridge ,  MA)  and  
transfered to  a polypropylene tube on ice , to  m in im ize sticking ,  u nt i l  further  use .  
Isolation of nylon wool non-adherent cells. Nylon wool co l u m ns were 
prepared by addition of 1 .0 g ram of nylon wool  (Fenwal l Laboratories ,  Deerfie ld ,  I L) to 
a d isposable 1 0  m l .  plastic syringe .  The nylon wool was manual ly  fl uffed befo re 
packing loosely into the syringe. The columns prepared in this manner were autoclaved 
with vacutainer stoppers contain ing a blunt 1 8  gauge needle in paper bags to ster i l ize. 
To prepare columns for use ,  they were assembled and attached to a r ing stand in a t issue 
cu ltu re hood where they were connected to a 50 ml .  plastic syringe reservoir .  Columns  
were washed with 1 00 m l .  of warm RPM I 1 640 fol lowed by  add it ion of  the non­
adherent fract ion of  mononuclear cel ls removed from plastic petri d ishes in  a vo l u me of 
1 -3 m l .  Cel ls were s lowly run into the column and incubated at 37°C for 45 m i n utes. 
During the i ncubation period media was added and carefu l ly run into the col umn  twice 
at 1 5  m inute i ntervals .  After incubation ,  the co l u m n  was aga in  attached to the 
reservoir and the non-adherent ce l ls were eluted with 50 m l .  of warmed (37°C)  R P M I  
1 640.  These ce l ls  were col lected , concentrated by centrifug ing  a t  4 0 0  x g for 1 0  
minutes, counted and resuspended in RPMI 1 640 + 1 5% NHS. 
Isolation of T and B cells for microcytotoxicjty assay. Blood samples 
(30 m l . )  for microcytotoxicity assay were depleted of monocytes by add it ion of  
approx imate ly 2 g.  carbonyl  i ro n  partic les (GAF Corp, N ew York ,  NY) . After  
incubation at  3rC for 1 0  m i nutes,  tubes were centrifug ed and the part ic les and 
phagocytic cel ls wh ich had ingested them were removed by passing the blood over a 
strong magnet whi le decanting i nto a second tube . The mononuclear cel ls  were iso lated 
from th is  blood by standard fico l l- hypaque de nsity g radient centrifugation  prev ious ly 
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described . The lymphocyte population isolated in  th is manner was used for H LA  class I 
ant igen determ ination by m icrocytotox icity .  For H LA  class I I  antigen determ ination ,  B 
ce l ls were isolated . Lymphocytes were adjusted to a concentration of 1 x 1 07 ce l l s/m l .  
and added to a nylon wool (0 . 1  g ram) contain ing sealed plastic dr inking straw. The 
straw was incubated for 30 minutes at  37°C and the non-adherent ce l ls  were washed 
out with a syringe contain i ng 20 ml .  of McCoy's media + 1 0% FBS (G IBCO,  G rand 
I s land,  NY) .  The adherent cel ls were then dis lodged from the ny lon wool  by manua l  
man ipu lation (squeezing and squish ing with the  fingers) and e luted from the  nylon wool 
by addition of 20 ml of McCoy's + 1 0% FBS. These B ce l ls were used for H LA- D R  & DQ 
dete rm inat ion by m icrocytotoxicity .  
Determination of  HLA phenotype by microcytotoxicity assay. U937 parent  
l ines,  clones and cel ls from normal donors were tested for HLA phenotype by the Tissue 
Typing Laboratory at MCV using m icrocytotoxicity tech n iques em ploy ing a pane l  of 
specif ic ant isera and low cytotox icity , pretite red com plement  (430) . Monon uclear 
cel ls were isolated by ficol l -hypaque density centrifugation ,  washed and eryth rocytes 
we re re moved by treatment with Tris- N H4CI  treatment.  Cel ls were adjusted to 2 X 
1 0 6 cel ls/m l .  in RPMI  1 640 and plated into m icrowel ls  ( 1  �l/we l l) of Terasaki t issue 
typing plates (One Lambda,  Los Angeles,  CA) with a Hami lton repeati ng syringe 
(Hamilton Co . ,  Reno , NV) . Plates were incubated for 30 minutes at  room temperature. 
Barbital buffer was added to each well to wash ,  the plates were emptied (fl icked) and 5 
Ill .  of pretitered rabbit complement (Cedarlane Laboratories, Hornby, Ontario , Canada) 
was added to each wel l .  Plates were again incubated fo l lowed by another wash and fl ick 
and addition of a t iny drop of trypan blue.  Percent cytotoxicity based on  incorporation 
of trypan b lue by dead ce l ls  in  each wel l  was assessed by reading the plates on  an 
inverted m icroscope . Wel ls conta in ing greater than 20% dead cel ls were considered to 
be posit ive . Negative controls consisted of wel ls  contain ing buffer a lone.  For typ ing 
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H LA class I ant igens ,  total lymphocyte populat ion was used and pos it ive contro l s  
cons isted o f  wel ls  contain ing anti-thymocyte g lobu l i n  (ATG) .  For typ ing H LA class I I  
ant ige n s ,  ny lon woo l pu r if ied B ce l l s  were p lated i n  typi ng t rays conta i n i ng  
heterologous antisera o f  known H LA-OR specificity (One Lambda, Los Angeles,  CA) and 
m icrocytotoxic ity assays were performed as fo r dete rm inat ion of H LA-A and B 
phenotype. In H LA-OR determinations pos itive controls cons isted of wel ls  conta in ing 
anti -B ce l l  antibody . 
Non-specific esterase determination. Non-specific esterase as a lpha n aphthol 
acetate esterase activity was dete rmined on U937 ce l l s  using the reag ents and 
procedure provided in  a kit  pu rchased from Sigma Chemical Co. ,  S1 . Lou is ,  MO.  Ce l ls  
were smeared on s l ides or  cytocentrifuged onto m icroscope s l ides us ing a Shandon 
Cytospin (Shandon Southern I nstruments, Sewickly,  PA) , a i r  d ried, f ixed i n  c i trate­
acetone-methanol fixative fo r 30 seconds,  washed with deion ized water ,  sta ined i n  
tr is-alpha naphthol acetate-Fast B l ue  RR stain for 30 m i n utes, washed in  tap water 
and exam ined microscopica l ly for the inc l us ion of black g ranu lat ion i n  the  ce l l  
cytoplasm . 
Immunoprecjpjtatjon of HLA-OR and SOS-pAGE analysjs. U937 parent ce l l  l i ne 
and cloned cel ls (3 X 1 07 ce l ls  of each type) were washed three t imes with PBS to 
rem ove serum protei ns  and soluble products fro m  t issue  cu l ture m ed ia .  I f  ce l l  
v iabi l ity was less than  90% by trypan b lue  exclusion ,  non-v iable ce l l s  were removed 
by f ico l l - hypaque dens i ty g rad ient centr i fugation .  Ce l l  su rface prote i n s  were 
radio iod i nated by lactoperox idase-catalyzed add it io n of 1 2 5 1 as sod i u m  iodide 
(Amersham,  Arl i ngton He ights ,  I L) to tyros i ne  res idues of the e xposed i nteg ral 
membrane prote ins.  Cel ls remained i ntact. The procedure used is a modification of 
several publ ished methods (431 , 432 , 433) . U sing a m icropipettor ,  sod i u m  iodide 
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(300-500 IlCi in  3-5 Ill .) was carefu l ly added to each sample , fol lowed by the add it ion 
of lactoperoxidase ( 1 0 Ill . of 1 66 I U/m l .  so lut ion) (Worth ington Biochemical Corp. , 
Freehold, NJ) . The reaction was in itiated by quickly adding hydrogen peroxide ( 1 5 Il l .  
of 0 .03% solution) . Tubes were m ixed continual ly and addition of lactoperoxidase and 
hydrogen peroxide was repeated twice more at  one minute intervals .  The reaction was 
stopped by addit ion of the reaction mixture to R PM I  1 640 contain i ng 1 0% FBS ( 1 0 
m I . ) .  The cel ls were centrifuged at 500 x g for 1 0  m inutes,  decanted and resuspended 
in 1 ml. media fol lowed by incubation for 1 hour at 37°C .  To remove u nbou nd 1 25 1 , the 
cel l  suspension was layered onto a FBS cushion and centrifuged at 700 x g for 4 
m inutes . The cel ls were washed once with PBS prior to addit ion of 1 m l .  of 0 .5% N P-
40 i n  PBS and 1 0  Ill . 1 00 m M  pheny l- methy l -su lfony l -f l uoride ( P M S F )  ( S ig m a  
Chemical Co. , St. Lou is, MO) to solubl ize the ce l ls and prevent enzymatic degradation of 
the l iberated ce l l u lar prote ins ,  respectively. After i ncubation at 4°C .  for 30 m i n utes 
and centrifugation to sediment i nsoluble ce l lu lar com ponents,  the supern atant was 
removed and precleared with an i rrelevant monoclona l  antibody pr ior to specif ic 
immunoprecipitat ion (434) . This was accompl ished by adding 50 III of  antibody 
(usual ly anti-LETS wh ich is  a monoclonal antibody specific for fibronectin )  to 0.5 m l .  
o f  cel l  extract and i ncubating the m ixtu re a t  room temperature for 30-60 m in utes 
fo l lowed by addition of 0 .5 m l .  Staphylococcus aureus Cowan stra in (heat k i l led and 
kept frozen) previously treated with rabbit anti-mouse IgG (SAC) . After incubation of 
th is mixture for 1 hour at 37°C. and centrifugation ,  the supernatant was removed and 
30 Ill . Monoclonal  antibody to a framework determinant of human H LA- O R ,  K u l a  2 
ascites ,  was added to 0 .5 m l .  of supernatant. Fol lowing an overnight i ncubation at 
4 ° C . ,  SAC was added to inso lubl ize the immunoprecipitated prote i ns  which were 
retrieved by ce ntrifugation .  The pe l let was washed several t imes ,  e lectrophoresis 
buffer was added and the sample was boi led for 5 m inutes. The l iqu id was removed, 
cleared by quickly centrifug ing at 1 0 ,000 x g, and an al iquot was counted in a gamma 
9 0  
counter to gauge the amount of labe l led material being loaded on the gel .  Bromophenol  
b lue tracking dye was added to the sample wh ich was then loaded o nto a 1 0- 1 6% 
g radient SDS-po lyacrylamide ge l  and e lectrophoresed at 60 V for several hours i n  a 
vertical s lab ge l  e lectrophoresis apparatus (Hoefer ,  San Francisco, CA) . Fol lowing 
e lectrophores is ,  gels were sta i ned with 0 .5% Coom ass ie  B l u e  in 25% 2-
propanol/1 0% acetic acid and desta ined with 1 0% acetic acid. Once gels were 
sufficiently destained to visual ize molecu lar weight standards, gels were soaked i n  1 0% 
acetic acid- 1 % glycerol for 30 m inutes .  After desta in ing , ge ls were dried for 3 hours 
on  a vacuum gel  dr ier after wh ich they were placed i n  X-ray cassettes contain i ng 
i ntensif ier screens with XR5 X-ray f i lm (Kodak, Rochester, N .Y.)  and placed i n  a -
70°C freezer for autoradiography (436) . F i lm was exposed for various t imes gauged 
by tr ial  and error .  Fi lm was developed in automatic deve lopers provided in the 
Radiology Department of MCV Hospital .  
Cellular inactivation procedures for cells to be used as stimulators. 
Inactivation of stimulator populations by irradiatio n .  Per iphe ra l  b lood 
mononuclear ce l ls to be used as stimu lator ce l ls  i n  m ixed lymphocyte assays o r  ce l l  
mediated Iympholysis were i nactivated by exposure t o  3000 rads o f  i rradiat ion b y  
placing ce l ls  in  1 2  X 75 mm plastic tubes in  a cesiu m  source gamma i rradiator.  The 
dose rate for the i rradiator was calculated by the Radiat ion and Envi ronmental  Safety 
Department to be 2 1 1 6  rads/m inute. Cel ls treated with th is dosage remained i ntact and 
viable ; however, they did not i ncorporate 3 H-thymid ine when pu lsed after i ncubation 
for 72-96 hours .  
Inactivation of stimulator populations by mitomycin C .  I rrad iat ion was 
found to be ineffective for inactivat ion of U937 cel ls and m itomycin C inactivation was 
used as an alternative . Cells were removed from tissue cu ltu re flasks and washed one 
t ime with RPMI 1 640.  Cel ls were adjusted to 2 X 1 06 cel ls/m l .  M itomycin C (Sigma 
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Chemical Co . ,  St. Lou is ,  MO) was made up fresh or a l iquoted and kept frozen for not 
more than 30 days . When possible , fresh m itomycin C was always used. M itomycin C 
was d i l uted to 250 �g .lm l .  with R P M I  and protected from l igh t  by wrapp ing  i n  
a luminum foi l .  Cel ls were treated by addition o f  25-50�g Jml .  of ce l ls .  T h e  ce l ls  were 
mixed gently and incubated at 37°C.  for 30 minutes , washed 5 times with R P M I  1 640 
to remove residual m itomycin C and resuspended in  RPMI + 1 5% N HS for use in  m ixed 
lymphocyte assays, cel l  mediated Iympholysis,  antigen presentation and T3 m itogenesis 
assays. 
Mixed lymphocyte reaction .  Periphera l  b lood monon uc lear  ce l l s  from 
hepari n ized blood from normal vo lunteers isolated by fico l l -hypaque dens ity g radient  
ce ntr i fugat ion were plated i n  the we l l s  of 96 we l l  f lat  bottom o r  round  bottom 
m icrotiter plates (Costar, Cambridge ,  MA) at  a concentration of 1 -2 X 1 05 cel l s/we l l  
i n  R P M I  1 640 + 1 5% NHS (responder cel ls) . Stimu lator cel ls were added to  these 
wel l s .  Normal mononuclear ce l ls  used as stimu lator cel ls were i rradiated with 3000 
rads us ing a 1 37Cs i rradiator.  These ce l ls  were also plated at  concentrat ions of 1 -2 X 
1 0 5 cel ls/we l l .  Because i rradiat ion was fou nd to be i neffective for i nactivat ion of 
U937 cel ls , U937 cel ls  used as stimu lator ce l ls  were pretreated with m itomycin C 
(Sigma Chemical Co . ,  St. Lou is ,  MO) prior to plating . Concentrations  of U937 ce l ls  
varied and were dependent on the assay being done. Total volu me in each wel l  was 200 
�1 . Plates were incubated at 37°C .  in 5% C02 for 5 days, pu lsed with 1 �C i 3 H ­
thymidine ( ICN Biomedica ls ,  Cambridge ,  MA) , i ncubated for an addit iona l  1 6  hours ,  
harvested onto g lass f iber fi l ter d isks us ing  a ce l l  harvester (PHD H a rvester ,  
Cambridge ,  MA. ) ,  transfe red to scint i l lat ion count ing v ia ls to wh ich cou nt ing cocktai l  
( R P I , Mt .  P rospect, I L) was added and cou nted in a l iq u id scinti l l at ion  cou nte r 
(Beckman I nstruments , Fu l lerton ,  CAl . Assays were set up i n  tripl icate and assay 
resu lts were expressed as the mean and standard deviat ion of these tr ipl icate we l ls .  
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Controls i ncluded responder cel ls without added stimu lator ce l ls  and stim u lator ce l ls  
without added responder cel ls .  As a control when us ing U937 cel ls ,  at  least one normal 
one-way mixed lymphocyte response between a normal responder and a normal H LA­
D R  m ismatched stimulator was set up. 
Cell mediated Iympholysis assay. Responder ce l ls ,  stimu lator ce l ls  and U937 
cel ls  were treated and plated as for the mixed lymphocyte reaction except that on ly 96 
wel l round bottom wel ls were used .  Cells were i ncubated for a total of 6 days at 37°C 
in 5% C02 ; however on day 3 ,  1 00 ,.tI. of media was removed from a l l  wel ls and 1 00 
Jll .  of fresh media was added. For normal stimu lators , 1 x 1 07 mononuclear ce l l s  
orig inal ly isolated were added to  a 25 cm2 tissue culture flask in  1 0  m l .  of media to  be 
prepared as PHA blast target ce l ls .  On day 2 after isolation ,  a m itogen ic  dose of 
phytohemagglut in in (PHA)(Difco Labs , Detroit ,  M I )  was added to the flask and it was 
replaced in  the incubator. On day 6 of the assay, the P HA targets and a l iquots of the 
U937 cel ls  to be used as targets (4 X 1 06 ce l l s  each) were removed from cu l ture ,  
washed wi th RPMI and labeled wi th 200 JlCi 51  chro m i u m  as sod iu m c h ro m ate 
(Amersham , Arl i ngton Heights, I L)for 30-60 m inutes at  37°C .  Cel ls were thorough ly  
washed, counted , resuspended at  5 X 1 04 cel ls/ml .  and 50 Jl l .  o f  ce l l  suspension was 
added to the appropriate wel ls .  P lates were incubated for an additional 6 hours at 37°C .  
Supernatants were harvested by  Skatron apparatus (Skatron ,  Sterl i ng ,  VA) or  p lates 
were centrifuged at 400 x g for 1 0  m inutes and supernatants were re moved by 
m icropipettor ( 1 00 Jll .lwel l )  and put into d isposable tubes .  Samples were counted in 
a fou r  channel gamma counter (LKB I nstruments ,  Gaithersburg ,  MD) .  Control samples 
cons i sted of responder ce l l s  + targets without st i m u lato r ce l l s  (backg ro u nd) , 
st imu lator ce l l s  + target cel ls (just to make sure the stimu lato rs weren't  do ing the 
k i l l i ng ) ,  target ce l l s  + media (spo ntaneo us release) and target ce l ls  + lys i ng buffer 
( m ax i m u m  re lease) . Tr ipl icate we l l s  of a l l  test comb inat ions were set u p  and 
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calcu lations were done using the mean of tripl icate wel ls .  Percent specific cytotox icity 
was calcu lated using the fo l lowing formula :  
% Cytotoxicity = Experimental cpm-Background cpm X 1 00 
Maximun cpm-Spontaneous cpm 
CP3 mediated I cell proliferation. Ihe capabi l ity of U937 clones and parent 
l ine to reconstitute the m itogen ic response of normal I cel ls to monoclonal  antibody to 
the I-ce l l  receptor associated 13 cel l  su rface structure (437) was assessed by 
addit ion of m itomycin C treated U937 cel ls to nylon wool-pu rified non-adherent  ce l ls  
from normal  human donors i n  the presence to a monoclonal antibody to C D3 ,  O KI3, 
(Ortho Diagnostic Systems,  Raritan ,  N .J . ) . Peripheral blood mononuclear ce l l s  were 
isolated from normal donors and nylon wool pu rified non-adherent ce l ls  were prepared 
as previously described . Cel ls were plated in 96 wel l  flat bottom m icrotiter plates at a 
ce l l  concentrat ion of 1 X 1 05 ce l ls/wel l .  U937 cel ls  or  peripheral blood adherent ce l l s  
( iso lated and treated as  previously described) were added to  the  wel l s  at vary ing  
concentrations o f  from 2 X 1 03-5 X 1 04 ce l ls/wel l .  Monoclonal  anti-13 ant ibody (0 . 1  
�g ./m l . )  was added to  the experimental wel ls .  P lates were incubated a t  37°C i n  5% 
C 02 for 72  hours, pu lsed with 1 �Ci 3 H-thymid ine for t he  last 1 6  hours of incubat ion 
and harvested onto g lass fiber fi lters us ing a cel l  harvester. Samples were set up  in 
tr ipl icate and counted i n  a l iquid scint i l lat ion counter. Contro ls i ncluded nylon wool 
non-adherent cel ls (I ce l ls + contaminants) alone ±OKI3 (to assess background OKI3 
st im u l at io n )  and non-adherent  ce l l s  + U937 ce l l s  without  O KT3 (to assess the  
stimulation of  a mixed lymphocyte reaction ) .  Results are expressed as  mean ± standard 
deviation of tripl icate wel ls .  
Antigen presentation of tetanus toxoid. Ihe capabi l i ty of U937 parent l i ne  and 
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subl ines to process and present soluble antigen to nylon wool  purified peripheral blood 
mononuclear ce l ls was assessed us ing a modification of methods described by (438) . 
Selection of normal donors for testing . Normal donors with specif ic 
H LA-DR phenotypes were selected from the MCV Tissue Typing Laboratory cel l  pane l  
and pretested for cel lu lar response to  tetanus toxoid (Massachusetts Department  of 
Health , Jamaica Plain , MA) . Th is was necessitated by the f inding that althoug h a l l  
individuals on the  cel l  panel  had been immun ized a t  some time against tetanus ,  two 
ind iv iduals made no ce l lu lar response u nt i l  re immun ized. Th is test ing was don e  by 
isolation of peripheral blood mononuclear cel ls as described and plating these ce l ls  at 2 
X 1 05 ce l ls/wel l  in 96 wel l  round bottom microtiter plates.  Tetanus toxoid was added 
at final d i l ut ions of 1 : 1 0 , 1 :20 ;  1 :50 ; 1 : 1 00 ;  1 :200 ;  1 :400 ; and 1 : 1 000 .  P lates were 
i ncubated for 96 hours ,  pu lsed for the f inal 1 6  hours with 3 H -thym id i n e ,  h a rvested 
and counted as previously described . Control wel ls  contained on ly ce l ls  and media .  
We l ls  we re set  up i n  tr ipl icate and resu lts were expressed as mean ± standard 
deviation .  A sign ificant cel lu lar response was judged to be any response which exceeded 
the control response by three standard deviations .  
presentation of tetanus toxoid by U937. Tetanus  responde rs were 
se lected from whom nylon wool  non-adherent ce l l s  were prepared as prev iou s ly 
described.  U937 cel ls  were i ncubated with tetanus toxoid for 1 hour and washed 
extensively before being treated with m itomyc in C.  A tetan u s  toxoid concentratio n of 
1 :200 was used because that concentrat ion cons istent ly gave optimal  pro l i fe rative 
responses in  normal tetanus toxoid assays. Responding cel l s  were plated in round 
bottom 96 wel l  plates a t  2 X 1 05 cel ls/wel l  in  RPM I  1 640 + 1 5% NHS.  U937 cel ls  
were added to respo nder cel ls  at concentrations of 2 X 1 02 - 1  X 1 05 ce l ls/we l l .  
Autologous adherent ce l ls isolated as  previously described were also added to  responder 
ce l ls and tetanus toxoid. The higher concentrations  of U937 were used to assess the 
effects of the addition of antigen to a m ixed lymphocyte reaction .  Because of h igh  
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background tetanus response i n  some individuals, tetanus toxoid was not added di rectly 
to the assay wel ls contain i ng U937 cel l s  i n  most exper iments ; therefo re the o n ly 
tetanus toxoid present was added e ither stuck to the U937 cel ls added or  processed and 
expressed by U937. P lates were i ncubated fo r 96 hours ,  pu lsed with 1 J.1.C i 3 H ­
thym id ine  for the f ina l  1 6  hours ,  harvested and cou nted i n  a l iqu id  sci n t i l l at ion 
counter. Tests were set  up in  tripl icate and resu lts are expressed as mean ± standard 
dev iat ion of tripl icate wel ls .  Contro ls consisted of responder ce l ls  alone ;  responder 
ce l ls  + tetan us toxoid ; responder ce l ls  + U937; U937 ce l l s  a lon e ;  U937 cel ls  + 
tetanus  toxoid ;  and responder ce l ls  + U937 at h igh  concentrat ion + tetanus  toxoid 
(M LR co ntro l ) . 
Inhibition of proliferative response by addition of antibody. To assess 
the ro le of several ce l l  surface proteins in the presentation of tetanus toxoid antigen  to 
normal  ny lon woo l  pu rif ied monon uclear ce l l s ,  ant ibod ies to seve ral m e mbrane 
proteins were added to the antigen presentation assay described above. Antibodies used 
were as fol lows : heteroant ibodies to specific H LA-DR haplotypes (anti -DR2 ,  a nt i ­
D R3 ,  and anti-DR7) wh ich were obtained from the MCV Tissue Typing Laboratory and 
the Washington Un ivers ity Tissue Typing Laboratory (S1. Lou is ,  MO) ; monoclona l  
ant ibody to  beta-2 m icrog lobu l i n  (439 ) ;  monoclonal  ant ibody specific for an  epitope 
on  the human CD4 molecule ,  KT69-7 (440) ; monoclonal  antibody specific for h uman 
Fc receptor ,  Ku Fc79 (43 1 ) ;  monoclo n a l  ant ibody specif ic fo r a fra m e wo rk 
determ inant of human H LA-DR,  Ku la2 ;  and an i rrelevant monoclonal antibody MOPC 
1 1 ,  IgG2b isotype . Antibodies were added to g ive a final d i lut ion o f  1 :1 0 . Assays were 
set up, harvested and counted as described above. 
Mitogen stimulation of peripheral blood mononuclear cells. Periphera l  blood 
mononuclear ce l ls  were isolated by fico l l -hypaque density g radient  centr ifug ation as 
prev iou s ly described.  M i togens  added were phytohe magg lu t i n i n  ( P HA) ( D i fco 
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Laborator ies,  Detroit ,  M I ,  o r  B urroughs-We l lcome Laborator ies,  Research T riang le ,  
NC)  a t  a f inal d i l ut ion of  1 :200 or 1 :400 and concanaval i n  A (Calbiochem-Behri ng ,  
San  Diego , CA or Sigma Chemical Co. ,  St. Lou is,  MO) at a concentration o f  50 J.l.g .lwel l .  
M itogens were p i  petted into m icrotiter wel ls  i n  10  J.l.1 . prior to  addit ion o f  cel l s .  Ce l l s  
(2  X 1 05 cel ls/wel l )  were pi petted i nto steri le 96 we l l  m icrotiter plates .  M edia u sed 
for m itogen stimulat ions was R PM I  1 640 + 1 5% NHS.  Volumes in  wel ls was adjusted 
to 200 J.l.1. with additional media when necessary. Plates were i ncubated for 96 hours ,  
pu lsed with 1 J.l.Ci 3 H-thym id ine for the  final  1 6- 1 8 hours of  incubation , harvested by  
ce l l  harveste r and counted i n  a l iqu id scint i l lat ion cou nter as  previous ly described . 
Tests were set up in tripl icate and resu lts were analyzed as mean ± standard deviation 
of tr ipl icate we l ls .  
Collection of supernatant from U937 cells. In general , supernatants to be tested 
were col lected from t issue flasks on day 2-3 after spl i tt ing .  At that t ime ,  the  cel l s  
usua l ly were in  opt imal  condit ion and  the pH of  the  t issue  cu lture med ia  was  st i l l  
approximately 7.2. Cel ls were centrifuged for 1 0  m inutes at 500 x g to sed iment ce l ls .  
Supernatants were decanted into d isposable syringes and fi lter steri l ized th roug h a 
0 .22J.l. M i l l ipak fi lte r (M i l l ipore Corporation , Bedford , MA) and used immed iately o r  
stored frozen at  -35°C .  On two occasions,  supernatant samples from the parent l i ne  
and from clones were col lected and d ivided into equal parts : half o f  the  supe rnatant was 
stored in the refrigerator overn ight,  the second half was d ia lyzed against R P M  I 1 640 
conta in ing 25  mM Hepes buffer (Sigma Chemical Co . ,  S t .  Lou is ,  MO) to  maintain a 
neutra l pH u nder atmospheric condit ions .  The dialysis tubing (American Scientif ic 
Products , McGaw Park, I L) wh ich was previously boi led in 1 mM E DTA-2% sod ium 
bicarbonate solut ion ,  washed with deion ized water and autoclaved before use ,  was 
sti rred on a magnetic stirrer overn ight in the coldroom with two changes of dialysate . 
Although the dialysis was done under ster i le condit ions ,  the samples were refi l tered 
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after removal from the i r  respective bags .  Non-dialyzed and d ialyzed supernatant 
samples were al iquotted into tubes and frozen .  As a contro l  an equal vol u me of R P M I  
1 640 + 1 0% FBS was subjected to the same treatments a s  the supernatant samples .  I n  
several experiments, supernatants from U937 parent l i n e  a n d  clones were pooled and 
were subjected to further treatments prior to addition to testing assays.  Supernatants 
were treated i n  the fo l lowing ways : (a) repeated freezing and thawing through  th ree 
cycles of  freez ing for 30 minutes, thawing for 1 5  m inutes ; (b) i ncubation at  56°C . i n  
a water bath for 30  minutes ;  (c) i ncubation at 80°C .  i n  a water bath for 1 0  m i n utes ; 
(d) i ncubation at 1 00° C .  i n  a boi l i ng  water bath fo r 1 0  m inutes ;  (e) t ryps i n  o r  
chymotrypsin treatment us ing trypsin and chymotrypsin coated beads (Sigma Chemical 
Co . ,  St. Lou is ,  Mo. ) .  Beads were resuspended and washed several t imes in m edia 
acco rd ing  to i n st ruct ions  s uppl i ed from the m a n u facturer .  One m i l l i l i t e r  of  
supernatant was added to  each type of  bead and incubated at  37°C. for 30 m inutes after 
which the tubes were centrifuged to sediment the beads. The supernatant was col lected 
by pipet and filter steri l ized as described. All treated supernatants were assayed for 
suppressive activ ity immediately after treatment .  
Supernatant from U937 cel ls  general ly contained 1 0% FBS. In  order  to lower 
the FBS concentration to a l low for concentration ,  U937 parent l i ne and sub l ines were 
g rown up in 1 00 ml .  cu ltu res of normal media for 3 days, 90 m l .  of media was removed 
from each flask and replaced with RPM I  1 640 without serum for an addit iona l  24 
hours .  Cu ltu re media from these cel ls was harvested by centrifuging the ce l ls  at 500 x 
g for 1 0  m inutes , decanting the supernatant and pool ing it . A sample of th is  pooled 
supernatant were stored in  the refrigerator and a second sample was d ialyzed overnight 
against RPM I  1 640 + 25 mM HEPES with two additional  changes of dia lysate . The 
remain ing supernatant was concentrated 50-fold by vacu u m  dia lys is u si ng  1 /4 inch 
dialysis tubing and a vacuum flask at 4°C.  The concentrat ion requ i red several  days.  
Concentrated supernatant was final ly removed from the dialysis tubing in  a vo l ume of 
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3.2 m l .  and dialyzed against PBS. 
Assessment of supernatant effects on cell lines . Supernatants and treated 
supernatants from U937 were added to the cu ltu re m edia of other  ce l l  l i nes  to 
determine how it m ight affect the v iabi l ity or 3 H-thymidi ne  i ncorporat ion of the  ce l l  
l i ne .  Ce l l  l ines used for these studies were as fo l lows : ( 1 ) REH (human lymphoid cel l  
l i n e ,  n u l l  ce l l  leuke m ia ) (44 1 ) and (2)  K562 ( h u m a n  erythroleukemia )  (44 2 ,  
443) . Cel ls from conti nuously maintained cu ltures o f  these ce l l  l ines were spl it  i n  the 
normal manner which y ie lds a cel l  concentration of 2-3 X 1 05 ce l ls/m l .  in normal  
culture media, RPMI  1 640 + 1 0% FBS. One hundred micro l iter samples of ce l ls  were 
added to 96 wel l  flat bottom m icrotiter plates .  D i lut ions of U937 supern atants were 
added to plates also i n  1 00 ,.d . I n  general ,  the h ighest concentration of s upernatant 
tested was 1 :4 . Supernatant was di luted in  RPMI  1 640 + 1 0% FBS and contro l  wel ls  
contained ce l ls and media alone.  Cel ls  were incubated at 37°C. i n  5% C02 for 72 hours .  
P lates to  be  assessed for 3 H-thymidine incorporation were pu lsed with 1 J.lC i  for t he  
last 1 6  hours o f  incubation , harvested and counted as described. Plates to be assessed 
for viabi l ity were examined m icroscopica l ly .  Cell viabi l ity and counts were assessed 
on a hemocytometer us ing trypan blue exclusion as an indicator of viabil ity. 
Assessment of supernatant effects on cellular assays. Di lutions of supern atants 
and treated supernatants were added to m ixed lymphocyte assays between H LA- D R  
mismatched donors and t o  mitogen proliferation assays o n  norm al donor cells . Mixed 
lymphocyte assays and mitogen stimu lat ions were performed as previously described 
us ing peripheral blood mononuclear ce l ls  from normal i nd iv iduals . Contro l samples 
cons isted of wel ls  without addit ion of supernatant .  Resu lts are presented as % 
I n h ibit ion according to the fol lowing formu la :  
% I nh ibit ion = (cpm without sup) - (cpm + sup) X 1 00 
(cpm w ithout sup) 
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Column chromatography of supernatant from cells grown at reduced FBS 
concentration . An 85 m l .  Sephacryl  S-200 ( Pharmacia ,  Piscataway, NJ)  g lass column  
( 1  cm2 x 85  cm) was poured in  PBS, pH  7.2 , and charged with a 2 .7 m l .  sample of 
concentrated pooled supernatant previously described. The flow rate was 9 .2 m l ./hou r 
and 1 m l .  fractions were col lected and mon ito red by spectrophotometer ( Beckman 
I nstruments, Fu l lerton ,  CA) at  280nm.  Column fractions were pooled based on  O .D .  
280 readings, filter steri l ized and tested in assays described above as  wel l  as for I L- 1 
act iv i t y .  
Interleukin 1 assay, soluble and membrane bound. I nterleukin 1 activity was 
assayed using the I L- 1  dependent indicator cel l  l i ne ,  D1 0 .G4 . 1 , provided by Dr. Brian 
Susski nd. The D1 0.G4 . 1  orig inal ly described by Janeway et a l .  (444) was maintained 
and rout ine ly antigen sti m u lated . Pr ior to use for I L- 1  measurement ,  ce l ls  were 
rested for a min imum of 8 days;  however, longer rest ing of the cel ls generally resu lted 
in more sensitivity to I L- 1 . (The genera l  ru le  wh ich stated that the worse the ce l ls  
looked, the better they responded, he ld true . )  For so lub le I L- 1  assays ,  supernatants 
and d i lut ions to be tested were pi petted i nto 96 wel l  round bottom m icrotiter p lates. 
For membrane I L- 1  assays, paraformaldehyde-fixed cel ls at concentrations of 2 X 1 04 
or 1 X 1 05 cel ls/ wel l  were added to 96 wel l  p lates (98) . I ndicator D 1 0 .G4 . 1  ce l ls  
suspended in RPMI 1 640 + 1 0% FBS containing a submitogen ic dose of concanaval in  A 
(Con A) , 2 X 1 04 cel ls/wel l , were added to g ive a total volume of 200 ,.tI.lwel l and a 
f ina l  Con A concentration of 2 .5 J.1g .lm l .  Contro l  wel ls i ncl uded D1 0 .G4 . 1  ce l ls  with 
media + Con A as a negative control and D1 0.G4 . 1  ce l ls + Con A + purified I L- 1  (0 . 1 , 
0 .5 ,  o r  1 Un iVwel l )  (Genzyme Corp . ,  Boston ,  MA) . Plates were incubated at 37°C .  in  
5% C02 for  72 hours ,  pu lsed for the fi na l  1 6- 1 8 hours wi th  1 J.1Ci  3 H - t h y m i d i n e ,  
harvested and counted as described. 
paraformaldehyde fixation of cells . U937 ce l ls  were removed from 2-3 day 
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cu ltu res of ce l ls which had received no additions, added gamma interferon for 24 hours 
or phorbol ester (as PMA or as PDBu) for 72 hours.  Cel ls  were washed three  t imes 
wi th  R P M I  1 640 to remove any residua l  t issue cu l ture media,  serum or  i m m u ne 
modu lators. Cel ls were gently resuspended after the last wash i n  fresh ly prepared 
ster i le  fi lte red 1 %  paraformaldehyde i n  PBS and ce l l s  were incubated at roo m  
temperature for 1 5  minutes. Cel ls were washed with steri le PBS twice , a n d  once with 
RPM I  1 640 and resuspended in RPMI  1 640 + 1 0% FBS in  the refrigerator overn ight 
to al low residual paraformaldehyde to diffuse out of the cel ls .  The fo l lowing day f ixed 
cel ls  were washed an additional  1 -2 t imes with R P M I  1 640 + 1 0% FBS pr ior to 
cou nt ing with a hemocytometer and plat ing i n  96 we" p lates fo r membrane I L- 1  
dete rm inatio n .  
Addition of exogenous immune modulators to cells: 
Gamma- I nterfe ro n .  P u rif ied h u m a n  gamma in terfero n ( M e loy  
Laboratories ,  Springfie ld,  VA and Sigma Chemical Co . ,  S I .  Lou is ,  MO) was a l iquoted 
after purchase and stored frozen at -20°C unt i l  use to avoid repeated freez ing  and 
thawing . Gamma interferon was added to U937 cel ls in cu lture at  a fina l  concentration 
of 1 00 u n its!m l .  and i ncubat ions other  that k inetic studies were 24 hours u n less 
otherwise stated. 
,LES. U937 cel ls in cu ltu re were treated with E. coli l i popolysaccharide 
(LPS) ( Difco Laborator ies, Detroit ,  M I )  at a concentration of 2 or 1 0  Ilg .lm l .  for 24 
hou rs .  
phorbol esters: PMA and PDBu. Phorbol 1 2-myristate 1 3-acetate 
(PMA) (Sigma  Chem ical Co. , SI. Lou is ,  MO) was d isso lved in 95% ethano l  at a 
concentration of 1 0-2M and di lutions were made with RPMI  1 640 .  PMA was added to 
ce l ls  at concentrations of 1 0-8 M or below in most assays and cel ls  were incubated for 
72 hours at 37°C in  5% C02 . An equal concentration of ethanol served as a contro l .  
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Phorbo l 1 2 , 1 3-dibutyrate ( P DBu)  was obta ined f ro m  Dr .  Car l  McCrady at a 
concentration of 1 0-2M dissolved i n  dimethylsu lfoxide (DMSO) and kept frozen prior 
to use.  Further d i lut ions were made us ing either DMSO or RPMI  1 640 .  PDBu  was 
added to cel ls at 1 0-7M and ce l ls were incubated as with PMA. After i ncubation with 
either  PMA or PDBu, cel ls were extensively washed prior to use in assays. Cel ls  were 
treated with an equal amount of DMSO as a control in experiments with PDBu ; however, 
DMSO was found to i nduce U937 cel ls to become markedly adherent to plastic t issue 
cu ltu re flasks . To min im ize th is effect, PDBu obtained in DMSO was fresh ly d i l uted in 
RPMI 1 640 prior to use. Contro l  cel ls were treated with an equal amount of DMSO and 
did not adhere to the flasks. 
Indomethacin . Release of prostaglandins was inh ibited by addit ion of 
indomethacin (Sigma Chemical Co . ,  St. Louis ,  MO) to assay media at a concentration of 
1 0 -5 , 1 0- 6 and 1 0- 7 M .  I ndomethaci n was d isso lved in 95% ethano l  at a 
concentration of 1 0-4 M and was prepared fresh before use.  
Transformation of E. coli HB1 01 by plasmid DNA. Competent bacter ia l  ce l ls  
were prepared by inocu lation of L broth with a loopfu l of  recently tested E. coli H B 1 0 1  
and g rowth at 37°C .  to a nephelometer reading of 2 .0 at 0.0.  600 n m .  At that t ime,  7 
m l .  of bacterial cu lture was removed and centrifuged to obtain a pe l let of ce l l s  wh ich 
were treated with 75 mM CaCI2 fol lowed by centrifugation and addition of ice cold 1 0  
m M  CaCI2 and 0 . 1  Jlg DNA (T-33 unpubl ished ,  HLA-DR alpha probe ; obtained from Dr. 
Jack Strominger) to be i ncorporated. After i ncubation on ice for 60 m inutes, the ce l ls  
were heat shocked at  42°C for 2 minutes, L broth was added and cel ls were added to an 
ampici l l i n  contain ing L-agar petri plate . Cel ls were spread on the plate us ing a bent 
g lass rod and the plate was incubated at 37°C .  When colon ies had g rown , twelve 
colonies were picked and a fresh ampici l l in  plate divided into sectors was streaked with 
each colony. When these selected colonies had g rown up, each colony was picked and a 7 
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ml .  a l iquot of L Broth was inocu lated . These cultures were g rown for 1 6  hours with 
rapid shaking at 37°C after wh ich bacteria were sed imented by centrifugation .  DNA 
was isolated by a modification of  the min i-prep procedure as described by Man iatis et 
al. (445) and M. Pucci (personal communication ) .  Bacteria were lysed by addit ion of 
lysozyme (1 mg .lm l .  in Tris-sucrose buffer) (Sigm a  Chemical Co . ,  St . Lou i s ,  MO)  
fol lowed by addition of  1 0% sodium dodecyl su lfate (SDS) and 5 M potass ium acetate 
incubated on ice for 30 m inutes . Liberated DNA was iso lated by centr ifugation at 
1 2 ,000 X g for 1 5  minutes and phenol  extraction and ethanol precipitation . Samples 
were d igested with appropriate restr ict ion endon uc lease ( Eco R 1 )  (Boe h ri n g e r  
Mannhe im ,  I ndianapol is ,  I N) for 3 0  m inutes a t  37°C after  wh ich each sample was 
e lectrophoresed in  1 % agarose in  the presence of ethid ium brom ide to make sure that 
the pUC plasmid contain ing 1 .3 kb of probe insert was present. Bacteria contain i ng  the 
T-33 probe were grown up i n  L Broth + ampici l l i n , centr i fuged to concentrate ,  
g lycerol was added and the suspension was aliquoted and frozen  as 50% g lycerol stocks 
at -40°C .  
Plasmid preparation and isolation. I nvestigation of the mRNA produced by U937 
ce l ls which was specific for MHC class I I  alpha chains was facil itated by obtai n ing DNA 
probes in  the form of plasm ids from Dr .  Jack Strominger,  Harvard Un iversity, Boston ,  
MA.  Dr .  Strominger sent ou r  laboratory a probe for HLA-DR alpha (T  -33) and gave 
h is permission for use of a probe for H LA-DQ alpha which was avai lable in Dr. L .  B .  
Schook's laboratory . Another probe which was used for hybrid ization ,  a lbeit  re latively 
u nsuccessfu l ly ,  was a probe for h uman 28S rRNA wh ich was obtained from Dr .  E ric 
Westi n .  Thus the fol lowing probes were isolated and used for hybridizat ion with RNA 
on  Northern blots : 
1 0 3 
probe name probe specificity plasmid Type & Size Reference 
T - 3 3 HLA-DR alpha pUC1 3 cDNA 1 .3kb unpubl ished 
pDCH1 HLA-DQ alpha pBR322 cDNA 0.8 kb (446) 
pAD-1 9 . l Ia 28S rRNA pBR322 cDNA 6.2 kb (447) 
The rRNA probe was obtained from Dr. J .  Pu l len as purified plasmid at s ufficient ly 
h igh concentration that it could be used d i rectly without reintroduct ion in to bacteria 
and isolation . 
Large scale plasmid isolation was accomplished using a high salt/SDS iso lation 
procedure from Dr. F.  Macrina and modif ied by Dr .  J. Pu l len .  Fifty m i " i l i ter starter 
cu ltu res of L-broth contain ing the appropriate antibiotic (either ampici l l i n  for pUC or  
tetracyc l ine  for pBR322) were inoculated from 2-3 day L-agar + ant ibiot ic plates 
previo us ly  streaked from part ia l ly  thawed g lycero l  stocks of probe tran sfo rmed 
bacteria (HLA-DR a lpha probe or  H LA-DQ alpha probe) . Starter cu ltu res were g rown 
with vigorous shaking at 3rC for 6-8 hours. One l iter cultures divided between  fou r  
one- l i ter flasks ( 4  X 250 m J . )  were i nocu lated with starter cu lture and g rown o n  a 
shaker platform vigorously rotated at 37°C overn ight .  Bacteria were harvested by 
centr ifugation at 6000 x g for 1 0  m in utes,  washed and lysed after th ree cycles  of 
freezing and thawing and lysozyme (1 mg/ml)  treatment  by addit ion of S D S  (fin al 
co ncentrat ion 1 %  SDS) (Sig ma Chemical Co . ,  S1 . Lou is ,  MO) and NaC I  (f i na l  
concentration 0 .5  M) .  Bacterial lysate was cleared by  centrifugation a t  20 ,000 x g i n  
a 70 .2  Ti  rotor i n  a Beckman u lt racentrifuge (Beckman I nstruments , Fu l l erto n ,  CA) . 
Cesium ch loride (Cabot Chemical Co . ,  Ch icago,  I L) was added to the lysate (9 . 1 2 g 
CsCI/9.33 ml lysate + ethidium bromide) and dispensed into 1 5  m l  Beckman Quik Seal 
tubes which were balanced and centrifuged at 41 ,000 x g for 48 hours .  P lasmid band 
was local ized by u ltraviolet i l l umination of eth idi u m  bromide (Sigm a  Chemical Co . ,  S1 . 
Lou is ,  MO) and removed by punctur ing the tube with a 23 gauge needle and 3 m l  
disposable syringe .  The isolated plasmid was again added to ces ium ch loride and 
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rebanded by centrifug ing at 41 ,000 x g for 48 hours. After subsequent removal of the 
plasmid band, eth id ium brom ide was extracted by several cycles of CsCI  satu rated 
isopropanol and the plasmid preparation was dialyzed against TE buffer overnight with 
4-5 dia lysate changes. Plasmid preparations were then ethanol precipitated and 
resuspended in TE buffer for restriction endonuclease evaluation .  DNA was quantitated 
spectrophotometrical ly at 260 n m .  us ing a Beckman spectrophotometer and quartz 
m icrocuvettes . 
Restriction endonuclease digestion and DNA probe isolation by agarose 
electrophoresis and electroelutjon. I n  order to determine whether the plasmid isolated 
contained the probe required , 1 Jll. of the plasmid preparations were digested with the 
appropriate restriction endonuclease (Eco R1  for plasm ids T33 and rRNA and Pst 1 for 
p lasm id pDC H 1 ) by carefu l addit ion of e nzym e  to DNA sample co nta i n i n g  the  
appropriate buffer .  Restrict ion endonucleases and matched cleavage buffers were 
obta i ned from e ither Bethesda Research Labs (Gaithersburg , M D) or  Boe h ri nger  
Mannheim Corp. ( I ndianapol is ,  IN ) .  Reaction m ixtures were incubated for 1 hour  at 
37°C and electrophoresed in a 1 % agarose gel with bromophenol blue tracking dye in a 
submarine  e lectrophoresis chamber ( I B I ,  New Haven ,  CN) . Control lanes contained 
commercial ly prepared DNA gel markers of known size. For most gels the contro l lanes 
contained either Lambda ladder (H ind I I I  fragments of lambda DNA) or a 1 kb l adder 
(Bethesda Research Labs. , Gaithersburg ,  MD) .  Gels were run at 1 00 volts for 1 -2 
hours, sta ined with ethid ium bromide and photographed on an u ltrav iolet l ight  sou rce 
us ing a Polaro id M P-4 camera and T-55 b lack and wh ite f i lm ( Po laro id Corp . ,  
Cambridg e ,  MA) . If insert and plasmid DNA were fou nd which m atched probe and 
plasmid size, the preparat ion was judged to contain the des ired probe . The T -33 
plasmid specific for H LA-DR alpha was cut with restrict ion endonuclease ( Eco R 1 ) in 
bulk by overnight d igestion ,  e lectrophoresed in a preparative slab gel of 1 % agarose at 
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1 00 volts . When the insert band was clearly separated from the plasmid band, the 
insert band was cut  from the gel ,  inserted into a dialysis bag and e lectroeluted from the 
agarose by continu ing to  electrophorese the ge l  ins ide the bag for 3 hours fo l lowed by 
reversing the polarity of electrophoresis for 3 minutes .  I solated insert was removed 
from the dialysis bag by Pasteur pipet, precipitated with ethanol and phenol extracted. 
This pu rified insert was quantitated by runn ing on another 1 % agarose gel  (445) .  
Labeling of DNA probes with by nick translation and random priming 
techniQues. Two types of labe l ing procedures were used for Northern blot analys is .  
I n i t ia l ly the H LA- D R  a lpha T -33 probe was labeled by n ick trans lation us i ng  a 
commercial ly avai lable kit (Amersham Corp. ,  Arl ington He ights, I L) because the insert 
DNA had been cleanly iso lated . Label ing by random priming techn iques also us ing  a 
com mercial ly avai lable kit (Boehringer Man nhe im , I nd ianapol is ,  I N) was used for a l l  
probes fo r the  remainder of  the  Northern blot analys is .  The rationa le  for use  of  
random priming was the fact that insert DNA need not be isolated prior to  labe l ing and 
subsequent hybridizat ion .  G iven the constra ints of t ime  and equ ipment ,  random 
priming appeared to provide a short cut  to the information sought.  
T-33 (HLA- DR alpha probe) DNA was labeled with 32 p by n ick trans lat ion by 
addit ion of 20 III nucleotide buffer + 1 III H20 + 22 III dCTP (Sigma Chemical Co. ,  St. 
Louis, MO) + 43 III [alpha 32 Pl-dCTP ( ICN Biomedicals , Inc., Cambridge ,  MA) + 1 0 
III DNA polymerase/DNAse to 4 III ( 1  Ilg) T -33 DNA. After incubation for 2 hou rs at 
1 5°C, un incorporated nucleotide was removed by Elutip column (Sch leicher & Schue l l ,  
I nc. , Keene,  NH)  and labeled probe was eluted with h igh salt buffer. An al iquot was 
cou nted in a l iquid scinti l lation counter to determine the degree to which the DNA was 
labeled. 
Random primed labe l ing of DNA probes was carried out as out l i ned in the 
product bu l letin .  Briefly ,  1 Ilg DNA to be labeled in  a total of 9 III was pipetted into a 
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plastic tube . Sequential ly the fol lowing additions were made with the enzyme (K lenow 
fragment) added last : 1 J.11 each dGTP, dTTP, dATP;  2 J.11 reaction m ixture in  1 0X buffer 
(hexanucleotide pr imers) ; 5 J.11 [alpha-32 p] dCTP ( ICN Biomedicals ,  I nc . ,  Cambridge ,  
MA) ; and  1 J.1 1  Klenow fragment.  Tubes were incubated a t  37°C for 30 m inutes,  the 
reaction was stopped by the addition of EDTA and u n inco rporated n ucleotide was 
re moved by pass ing the labeled DNA over 1 m l .  Sephadex G-50 ( P h armacia ,  
P iscataway, NJ) spun columns i n  TE buffer (445) . An a l iquot of labeled probe was 
counted in a l iquid scinti l lation counter to determine the degree of label ing . 
Isolation of total cellular RNA. Total cel lu lar RNA was isolated from cel ls us ing 
a modification of publ ished procedures (445, 448) . G lassware used in RNA extraction 
procedu res was scrupu lously c leaned,  autoclaved and baked at 1 80°C overn ight .  
Whenever possible, v i rg in  p lasticware items were used instead of g lass and reagents 
used for RNA were handled on ly with disposable rubber g loves and were not avai lable 
for uses other than RNA extraction .  Cel ls from which RNA were to be extracted were 
removed from cu ltu re after a variety of treatment protocols and washed with PBS to 
remove serum proteins.  Cel ls were centrifuged at 400 x g and decanted to g ive a d ry 
pe l let  of 1 -2 X 1 07 ce l l s .  Ce l l s  were lysed by the addit ion of 4 M  g u an id i ne  
isothiocyanate (F luka Chemical Corp. , Ronkonkoma,  NY)  accompanied by v igo rous  
pipetting fo l lowed by  addition o f  sodium sarkosyl detergent (Sigma Chemical Co . ,  St. 
Louis ,  MO) .  Complete disruption of the cel ls was accomplished by repeated expuls ion of 
the l iqu id through a syringe fitted first with an 1 8  gauge needle fol lowed by a 23 gauge 
needle .  The l iqu id was pipetted carefu l ly onto a cush ion of u ltrapu re CsCI (Bethesda 
Research Labs . ,  Gaithersburg ,  M D) i n  a 1 5  ml Beckman Qu ik Seal tube (Beckman 
Instruments ,  Fu l lerton ,  CA) , sealed and centrifuged at  4 1 ,000 x g i n  a Beckman 70.2 
Ti rotor for 1 8  hours . The RNA pel let obtained after centrifugation was washed with 
ethano l ,  dissolved in  water and reprecipitated from sodium acetate with cold ethano l .  
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The thorough ly dried precipitated RNA was resuspended in  300 J.11 water and quantitated 
spectrophotometrical ly  at 260 n m .  The prote i n  contam inat ion of the R N A  was 
ascertained by the 0.0.  260/0.0 .  280 ratio. I n  general the ratios were between 1 .6 and 
2 . 0 .  
preparation of RNA blots by electrophoretic transfer from agarose gels. R NA 
samples were transfered to membranes by a mod ification of several procedu res (445, 
449 , 450) . RNA samples (5, 8 or 1 0  J.1g) to be probed were added to wel ls i n  1 .3-
1 .5% horizontal agarose gels. The gel size general ly used was 1 4  X 20 cm contain ing 
1 00 ml and either 1 0  (60 J.11) or  1 6  (30 J.11) lane combs were used.  The gels contained 
2 . 2  M fo rma ldehyde  ( F i s h e r  Scie nt i f ic , P i tts b u rg h ,  PA) i n  M O P S  ( 3 - [ N ­
morpho l i no]propane-su l fon ic acid) buffer (S ig m a  Chem ical Co . ,  S1. Lou is ,  M O) .  
Samples were loaded i n  loading buffer contain ing bromophenol blue and electrophoresed 
in MOPS buffer at 1 5  volts for 24 hours in an I B I  (New Haven ,  CN)  horizonta l  
e lectrophoresis chamber with B io Rad Labs (Anaheim,  CA) power supply . To maintain 
even buffering capacity, the chamber was reci rcu lated with a sma l l  pump  ( LKB 
I nstruments ,  Gaithersbu rg ,  MO) .  Ge l s  were sta ined after e lectrophoresis with 30  J.11 
eth id ium bromide ( 1 0 J.1g/ml ) ,  washed twice with phosphate buffer and photog raphed 
o n  an u l traviolet trans i l l um inator us ing a Kodak M P-4 camera and T -55 f i lm as 
previously described. Positions of  the obvious ribosomal R N A  bands were local ized in 
the photographs by including a ru ler  i n  each picture .  Gels were washed i n  0 . 025M 
phosphate buffer, pH 6.5 on a rotary shaker for 60 minutes wi th two buffer changes.  
The blott ing medium used was Genatran 45 (P lasco , I nc. , Woburn , MA) which i s  a 
nylon membrane with h igh  binding capacity . Gel-s ize pieces of blotting  membrane 
were cut and prewet with buffer before being carefu l ly placed on  top of the ge l  us ing 
g reat care to e l iminate any air bubbles .  The gel  and membrane were placed between 
two sheets of Whatman 3mm fi lter paper (Whatman I nternationa l ,  Ltd . ,  Ma idstone ,  
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Eng land) and placed in the ge l  holders of the transblotting apparatus (Hoefer Scient ific 
Instruments, San Francisco, CA) with the membrane at the anode . Transfer of the RNA 
to  the membrane was accompl ished by e lectrophoresing at  1 .5 Amps , 40 volts for 1 
hour.  The system was cooled by runn ing tap water through an ice bath and then through 
cool ing tubes i n  the transblotter chamber. Once transfered , the RNA blot was washed 
twice in  2XSSC, placed between sheets of filter paper and clamped between g lass plates,  
and then dried in a vacuum oven at 80°C for 4 hours.  B lots were stored i n  a vacuu m  
dess icator after dry ing .  
Northern blot hybridization and autoradiography. RNA blots were hybridized by 
a mod if icat ion of pub l i shed procedu res (445 , 449 451 ) .  R NA b lots  we re 
pre hybrid ized to prevent non-specific binding of l abe led probe by i ncubat ion in a 
prehybrid ization m ixtu re cons isti ng of 1 00 m M  Tr is ,  6XSSC , 2 m M  E DTA, 1 0X 
Denhardt's solut ion ,  1 % SDS,  200 J.1g/m l Salmon sperm DNA, and 50% satu rated 
formamide (Aldrich Chemical Co . ,  M i lwaukee , WI ) .  Mu lt iple blots were ei the r  p laced 
in covered plastic containers contain ing pre hybridization so lut ion and rapidly ag itated 
on a rotat ing platfo rm in a 42°C incubator or  they were sealed in i ndividual  plastic 
bags contain ing pre hybridization solution and plased in  a 42°C water bath .  B lots were 
pre hybridized for at least 24 hours after which the prehybridizat ion m i xtu re was 
pou red off and 3 2 p labe led probe (1 X 1 07 cpm/b lot) was added in fre sh  
pre hybrid ization so lution .  Both labeled probe and salmon sperm DNA were boi led for 5 
m i nutes prior to addit ion to the hybridization .  Hybridizat ions of m u lt ip le b lots were 
carried out in  plastic containers and also in individual sealed bags .  I ncubation s  were 
carr ied out  at 42°C overn ig ht .  B lots were removed fro m hybr id izat ion m i xtu re,  
washed with 3 X 500 ml .  h igh  salt  wash buffer (2XSSC; 0 . 1 % SDS) for 20  m inutes per 
wash on a shaker platform at room temperatu re , fol lowed by washes with 2 X 500 m l .  
low salt wash buffer (0 . 1 XSSC ; 0 . 1  % SDS) for 30 m inutes per wash a t  62°C .  After 
1 0 9 
the fina l  wash ,  blots were blotted , placed on fi lter paper cut s l ig htly larger  than the 
b lot ,  wrapped in  p lastic wrap and placed i n  X- ray cassettes conta in ing  i n tens if ier  
screens (Dupont Cronex,  Du Pont  Co. ,  Wi lm ington , D E) for autorad iography (436) .  
Type XAR-S X-ray fi lm (Kodak, Rochester, NY) was placed on each blot. B lots were 
identified by 35S- ink markings.  Cassettes were placed i n  a -70°C freezer for 72 
ho urs to 3 weeks after wh ich fi lm was deve loped i n  X-ray f i lm deve lopers i n  the 
Radiology Department. 
Eyaluation of autoradiograms by scanning densjtometry. After hybridizing R NA 
blots with probes for H LA-DR alpha,  H LA-DQ alpha and 28S rRNA, qu ant itative 
in te rpretation of auto rad iograms was deemed necessary ,  especia l ly in l i gh t  of two 
problems.  The first problem arose when it begame apparent that on most b lots , the 
probe for 28S rRNA had given a bubbly , splotchy pattern as though hybridization had 
been uneven.  Photographs of the RNA gels indicated that there was i ndeed 28S rRNA 
present on these gels and although the quantities in  each wel l varied to some degree, 
they did not vary to the degree indicated by the rRNA probe hybridization .  The blots had 
a lso been checked after transblotting and found to have eth id ium bromide sta ined 28S 
rRNA bands d i rectly comparable to the bands pictured i n  the correspond ing  g e l  
photographs. The rRNA probe had been used a s  a positive control but more importantly 
as a means to determine relative quantity of RNA on the blot . The second proble m  arose 
from the faintness of most of the autoradiograms and the very messy background fou nd 
particularly with the H LA-DQ alpha probe. I t  was decided that for pu rposes of relative 
quantitation ,  readings from a scann ing densitomete r would suffice . Dr. Guy  Cabral 
made his Hoefer dens itometer (Hoefer Scientif ic I nstru ments ,  San Francisco , CA) 
avai lable for examination of al l  autoradiograms. Three scans were taken of each band 
by removing the fi lm  after each scan and reposition ing it for optimal  exposure to the 
l ight source . Background readings were taken near the poSition of the bands but not 
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i ncluding any of the bands for messy blots.  In order to have a way of determi n ing 
relative 288 rRNA on  each blot, the Kodak T-55 f i lm n egatives of the or ig i na l  g e l  
photographs were scanned, three times each.  Background scans were necessary on the 
photographs because there was a consistent, regu lar darkening of the negative toward 
the center. I n  general the background corresponded to the arc of a circle wh ich cou ld be 
fitted to the rRNA readings.  Because the RNA quantit ies had been determined by 
spectrophotometer prior to runn ing of the gels ,  the quantit ies of RNA loaded i nto each 
wel l  were usual ly  very s im i lar with in  a s ing le  ge l .  A re lative nu mber has  been 
calcu lated fo r the m RNA specific for the probes with i n  a s ing le ge l  by us ing  the 
fo l lowing fo rmu la :  
Relative specific m RNA = probe dens. reading - probe bkgd. dens. reading 
rRNA (photo negative) - photo background* 
*Photo background determined in most cases by arc fitting 
RESULTS 
The U937 cel l  l ine ,  isolated from the pleural effusion of a h istiocytic lymphoma 
pat i en t  i n  1 975-76 , was we l l  character ized by Sundstrom and N i l sson  both 
morpho log ical ly and biochemical ly when first reported (95) . The ce l l  l i ne  was found  
to  exh ibit many characteristics o f  human monocytes and  macrophages and thus became 
the pr imary and, for a t ime, the only monocyte-l ike ce l l  l i ne avai lable i n  h umans.  The 
U937 cel l  l i ne was made available to our laboratory where the ce l ls were m aintained in  
cu l ture and further characterized. An antibody specific for U937 cel ls  was shown to 
react in an analogous manner with ce l l  surface antigens on ly on h uman monocytes 
(452) , thus strengthening the l i nk  between U937 cells and the monocytic l ineage.  An 
important functional aspect of U937 cel lu lar capabi l ity was the find ing that they were 
able to mediate ant ibody dependent ce l l  cytotoxicity (ADCC) fo l lowi ng ove rn igh t  
activat i on  with Iymphok ines (404 ) .  U937 ce l l s  d i ffered i n  one very i m po rtant  
respect from human monocytes, however. Although they clearly expressed M HC c lass I 
molecu les, there was no expression of MHC class I I  molecu les and thus they were not 
seen as capable of mediat ing the immune  functions  dependent on in teractio n of 
monocytes with T cel ls through  interaction between MHC class I I  and T ce l l  receptor .  Of 
cou rse, at that point  in time these i nteractions were also not wel l  u nderstood ; however 
the requ irement for MHC class I I  had been clearly shown by Zinkernagel  and Doherty 
(239) . In 1 98 1 , the U937 ce l l  l i ne ,  wh ich had previously been  cons istently negative 
when tested for express ion of ce l l  surface la, was used as a negative control in an 
exper iment i n  our laboratory in  wh ich the effects of phorbol  este r ( PMA) on the 
expresson of ce l l  su rface la  were being invest igated. At  that t ime one  of the U937 
I I I  
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parent ce l l  l i nes  su rpri s i ng ly exh ibited two bands h av i ng mo lecu lar  we igh ts of  
approximately 29K and 34K on an autoradiograph of  cel l  surface prote ins wh ich were 
iod inated and i m m u noprecip itated us i ng  a monoclona l  ant ibody to f ramework 
determ inants of  human la  (mAb Ku l a2) .  When th is parent l i ne  was then  examined by 
immunofluorescence using th is  antibody, approximately 20% of the ce l ls  present were 
positive for ce l l  surface la. A second parent l ine of U937 used at th is time rema ined 
ent ire ly negative and cou ld not be induced to express l a  by treatment with PMA. The 
H LA- DR pos itive parent  U937 l i ne  became progressive ly more posit ive wit h i n  the 
succeeding two months dur ing wh ich the percentage of positive ce l ls rose from 20% to 
approx imately 80%. 
The HLA phenotype of the HLA-DR positive and HLA-DR negative U937 cell lines 
was determined by microcytotoxicity assay. 
To rule out the possibi l ity that a contaminat ing ce l l  from another sou rce was 
responsible for the apparent strong expression of H LA- D R  in a ce l l  l i ne  characterized 
as very negative for H LA-DR ,  both the la negative and the la positive cell l ines were 
tested by the Tissue Typing Laboratory at MCV us ing m icrocytotoxicity techn iques  
employing a panel  o f  specific antisera and low cytotoxicity , pretitered complement and 
we re fo und to  express the  repo rted H LA phenotype fo r U 937 : H LA-A(3 ) ,  
8 (5 1 , 1 8)(95) .  The l a  positive l ine was also found to b e  positive for H LA-DR2 .  The 
concurrence of  the  H LA  phenotype of  both the la  negative and la  positive U937 ce l l  l i nes  
ru les  out the  possibi l ity of  overgrowth by  a contaminat ing ce l l ;  thus  one  of the U937 
parent ce l l  l i nes had begun  to express MHC class I I  ant igens spontaneously and for 
unknown reasons. 
Sublines of U937 were isolated by cloning at Ijmiting dilution. 
80th la  pos itive and l a  negative parent l ines were plated in  96 wel l  plates at 
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ce l l u lar  concentrations  of 0 .5 ,  1 ,  2 ,  5 ,  and 1 0  ce l l s/we l l  for l i m it i ng  d i l u t ion  
techn iques (426) to  isolate clones of  U937 cel ls  for further  study. Approx imately a 
hundred clones were isolated and expanded in five separate clon ings from wel ls plated to 
conta i n  0 .5  or  1 ce l l/we l l .  Ce l l  su rface express ion of l a  was m e as u red by 
immunofluorescence using ei ther a fluorescence m icroscope or the Ortho Spectrum I I I  
flow cytometer with a monoclonal  antibody to a framework determinant of human  l a  
(mAb Ku la2) . Pre l iminary evaluation of the clon ing data (data not shown) suggests 
that the plating efficiency of the la positive cel ls was g reater than that of the la  negative 
cel ls ,  i .e .  in attempts to isolate clones from either parent ,  a larger number of c lones 
g rew from h igher  d i lut ions of the la  positive parent  l i ne  than from the  l a  n egative 
parent l ine .  A second finding was that of the c lones that were successfu l ly expanded 
fro m e i ther  parent ,  a d i sproport ionately large  n u mber were la posit ive m ak ing  
se lection of  clearly negative clones difficult .  For  example in the f inal clon ing of  the 2-
1 parent l ine which was approximately 50% l a+ at  the t ime of c lon ing ,  1 5/1 7 c lones 
isolated were strongly positive,  1 c lone was la± (2 1 % la+)  and 1 c lone was negative 
(5 .8% l a+ ) .  Th is negative clone was selected for fu rther  study and subsequently 
became la  positive (clone G1 1 ) . 
Several clones were chosen for further  study during the cou rse of the project. 
When or ig inal ly isolated , the cells designated as clones were probably derived from 
s ing le  cel ls as requ i red by the mathematics of l im it ing d i lut ion analys is  (426 , 427,  
428) , i .e .  these clonal  populations grew from wel ls  orig ina l ly plated at concentrations  
of 0 .5 or 1 celVwe l l  and were iso lated from plates i n  wh ich g reater than 37% of the 
p lated wel l s  were negative for g rowth .  The clones ut i l ized were kept i n  cont i nuous 
cu l ture for  more than two years d u ring the project and were not s ubsequent ly 
subcloned ;  therefore, both the possibi l ity of or ig inal ly plat ing more than one  cel Vwel l  
a n d  t h e  possibi l i ty o f  subsequent m utation with i n  a c lonal  popu l at ion c a n  n o t  be 
addressed and the clones used in this study wi l l  be referred to s imply as "subl i nes . "  
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The cel ls used in this study, both parent l ines and subl ines,  are l isted in  Table 1 .  Two 
parent  ce l l  l i nes and five subl ines were chosen for fu rther  study at var iou s  t imes 
throughout the  project. The 2-1  parent l i ne  was general ly used as the  representative 
parent or orig inal  U937 population .  
Morphologically the cells of the sublines are similar to the U937 parent line. 
Growth characteristics . U n l i ke monocytes from periphera l  b lood o r  
macrophages, these cel ls d o  not adhere to surfaces un less further treated with DMSO o r  
PMA.  They grow rapidly i n  s ing le  cel l  suspe nsion cu l tures i n  R P M I  1 640 t issue 
cu l ture medium if  1 0% feta l bov ine serum is added and requ i re reduction of the 
population and addition of  fresh media approximately every 4-5 days . The U937 ce l l  
l i ne  g rows we l l  i n  media h aving a s l ightly acidic p H  rang i ng from 6 .8 -7 .0 ,  u n l ike 
lymphocytes which survive more readi ly i n  more alka l ine  p H  of 7.2-7.4 .  After  fou r  
days , the cel ls reach a max imum concentration o f  1 - 1 .2 X 1 06 cel ls/ml .  a t  wh ich t ime 
the cel ls are qu ite healthy and the medium is usual ly clearly acidic. Without spl i tt ing 
and feeding , however, the med ium ,  which conta ins phenol  red as a pH ind icato r, 
becomes lemon yel low indicating a very low pH with in  24 hours and the cel ls beg in  to 
die .  
Morphology. The cel ls have a pleomorphic shape and vary with in  a population 
from nearly round to very asymmetrica l ,  as shown in  Figure 7 .  The cells of both 
parents and subl ines are characterized by the appearance of m any cel l  surface blebs 
and the development of long ,  sharply pointed or blunt c lub- l ike projections attached to 
the cell by a th inner stalk. All of the subl ines examined exh ibited the whole range of 
morpholog ical variations whi le in cultu re ,  usual ly at the same t im e ;  however,  when 
cel ls in  cu ltu re flasks were at their  peak concentration they tended to appear most 
homogeneously spherical .  The U937 cel ls are characterized by a n uclear to cytoplasm 
U 937 S U B L I N ES 
2 - 1  parent  
H-K 
Subl ine D1 0 
Subl ines G4 & E1 1 
Subl ine G1 1 
Subl ine E9 
TAB LE 1 .  U937 C E L LS AN D S U B LI N ES 
O R I G I N S  
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Parent ce l l  l i ne .  l a  negative U937 cel ls  orig ina l ly  frozen 
1 /5/8 1 i n  l iqu id n itrogen ; recovered and recu ltured 
4 / 5 / 8 4 . 
Parent cel l l ine .  la  negative U937 ce l l  l ine obtained from 
Dr. H i l le l  Koren ,  Duke Un iversity ,  Durham , N .C .  i n  May,  
1 985, to be used as a second la  negative parent l ine .  
la  positive subl ine .  Cloned 3/8/84 from an l a  positive 
parent from which 6 clones were derived out of 24 wel l s  
plated a t  1 ce l l/wel l .  Strong ly l a  positive .  
la  positive subl ines. C loned from an la  positive parent 
l ine referred to as "Grandma" because of the patchy 
fluorescent pattern apparent when stained for surface l a  
using mAb Ku la2 .  I solated from d i lutions o f  1 .0 a n d  0 .5 
cel ls/we l l ,  respectively ,  both of wh ich yie lded g rowth of 
ce l ls i n  8 of 24 wel ls plated. 
la negative subline wh ich converted to la  positive .  
I solated from the 2- 1 l a  negative parent l ine cloned 
3/1 8/85 (at a t ime when the 2-1  parent exh ibited up  to 
50% la positive cel ls) . G 1 1 may not have been clona l  
when isolated as it was obtained from wel ls  in  wh ich 
growth occurred i n 1 8 of 24 wel ls ,  thus not satisfy ing the 
requ irement for at  least 37% negative wel ls .  
la  negative subl ine. C loned from an la  negative parent  
ce l l  l i neby Dr.  Carl McCrady prior to Apri l ,  1 983 , and 
recovered from l iqu id n itrogen and recu l tured i n  Apri l ,  
1 986 ( in  desperation for an l a  negative subl i ne) . 
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FIG URE 7. Morphology of U937 cel l  l ine and subl ines in  culture . 
Parent ce l l  l i ne  and subl ines were photographed at 20X magn ificat ion us ing  
Nemarski optics . Pane ls  (A) and (8) i l l ustrate representative popu lat ion s  of  the  
U937 parent 2-1  ce l l  l i ne ,  pane l  (C)  sub l i ne  E1 1 ,  panel ( D) sub l i ne  G4,  pane l  ( E) 
subl ine G1 1 ,  and pane l  (F) subl ine E9 . 
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rat io approaching 1 .  The cytoplasm appears to have numerous g ranules and there is a 
s ing le ,  lobed, spherical or kidney shaped nucleus. 
The parent l ines and subl ines are s im i lar in  s ize and with i n  the popu lat ion 
there is  marked heterogeneity ; however,  the average cel l  s ize i n  the G 1 1 sub l ine is  
s l ightly larger than either  the parent or  other subl ines and the average cel l  s ize  i n  the  
E 1 1 subl ine is smal ler .  Th is  became apparent when cel ls  were examined us ing the 
Ortho Spectrum I I I  when gating parameters were be ing set .  The increased forward 
l ight  scatter seen with subl ine G1 1 was consistently seen throughout the project. A 
representat ive experiment ,  shown i n  Fig u re 8 ,  i l l ustrates that the popu lat ion s  a re 
overlapping both in size as demonstrated by forward scatter and by complexity which is 
reflected in  the right angle scatter. 
Nonspecific esterase activity. Nonspecific esterase act ivity i n  cytoplasm ic 
g ranu les wh ich is characteristic of monocytic ce l ls was a lso seen in  both parent  U 937 
and the subl ines. As seen from the results of alpha-naphthol acetate esterase stain i ng of 
smears of ficol l -hypaque isolated peripheral blood mononuclear cel ls and U 937 ce l ls  
shown i n  Table 2 ,  the black stain ing g ranu les were apparent in  1 9% of the PBMC 
wh ich represents t he  monocytes present i n  t he  preparation and v i rtual ly 1 00% of the 
U937 cel ls .  Although the percentage of positive cel ls did not reflect large differences 
i n  esterase pos itivity in d icat ing that  n e a rly al l  cel ls conta ined dark ly sta i n i ng  
cytoplasmic granu les ,  sta in ing was not  u n iform i n  the U937 cel ls  as the re was  
cons iderable variabi l ity i n  stain ing intensity with in  populations .  I t  was noted that the 
2-1  parent stained less darkly than the sub l ines tested , and the G4 subl i ne  gave the 
strongest, most homogeneously positive reaction . 
HLA determjnations by mjcrocytotoxjcity. The five subl i nes se lected for 
further study were tested by microcytotoxicity and fou nd to express the HLA phenotype, 
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FIGURE 8. COMPARISON OF CELL SIZE AND INTRACELLULAR COMPLEXITY AMONG U937 
PARENT CELL LINE AND SUBLINES. 
Size measured as forward scatter and complex ity measu red as r ig ht  ang le  
scatter were determined for the  U937 parent 2-1 ce l l  l i ne  and subl ines E1 1 ,  G4,  G 1 1 
and E9 us ing the O rtho Spectrum I I I  laser act ivated flow cyto meter .  Standard 
deviations indicate heterogene ity of al l  U937 populations examined . 
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TAB L E  2.  NONSPECIFIC EST E RAS E R EACTI VITY O F  U937 P A R ENT L I N E 
AN D S U B LI N ES M EAS U R E D  AS A L PHA-N APHTH O L  AC ETATE ESTERASE* 
CELLS 
PBMC 
2-1  PAR ENT 
SUBLINE  E1 1 
SUBLlNE G4 
SUBLINE G1 1 
SUBLINE E9 
% ESTERASE POSITIVE 
1 9 % 
9 6 %  
9 8 %  
1 00%-STRONGL Y POSITIVE 
1 0 0 %  
1 0 0 %  
* Alpha-naphthol acetate esterase reactivity was measured o n  fixed smears of ce l l s  
us ing S IGMA kit 90- 1 A .  
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H LA-A (3,X) , B(51 , 1 8) (95) .  The l a  positive subl ines were H LA- DR2.  Othe r  M H C  
class I I  specificit ies have not been clearly d istingu ishable .  The m icrocytotoxicity tests 
did not indicate a second H LA-DR antigen being expressed on these cel ls ,  therefore the 
phenotype is H LA-DR (2,X) . Confirmation of the H LA-A and B phenotype indicates that 
the subl ines are progeny of the orig inal parent U937 cel l  l ine and can not be attributed 
to the presence of a contaminating cel l .  Although the microcytotoxicity reactions of the 
subl ines for H LA-DR were occasional ly weak, they consistently i ndicated the presence 
of H LA-DR2 from the i r  first test ing i n  1 984.  When sub l ines were tested for H LA 
antigens by m icrocytotoxicity in  the fal l  of 1 987, however, H LA- DR antigens cou ld not 
be determ ined by microcytotoxicity .  Decreased expression of H LA-DR was ind icated as 
the probable cause and i ndeed th i s  was conf i rmed by data obta i n ed from 
immunofluorescence tests d iscussed be low. 
U937 parent and sublines were examined for expression of la using fluorescent 
antjbody techniQues. 
I ndirect immunofluorescence techn iques were used to exam ine the expression of 
l a  on the su rface of the U937 parent and subl ines many t imes during the course of the 
project . The cel ls were stained with mAb Ku la2 ,  incubated , washed and incubated with a 
second antibody labeled with FITC,  e ither F(ab')2 goat anti-mouse IgG or F(ab')2 sheep 
anti-mouse IgG. prior to examination by laser activated flow cytometry us ing the O rtho 
Spectrum I I I .  Controls consisted of cel ls preincubated with MOPC 1 1  supernate wh ich 
is an isotype matched i r re levant monoclona l  ant ibody prio r to i ncubation with the 
f luorescent second antibody.  Normal peripheral blood mononuclear ce l l s  ( PBMC) ,  or  
selected gated populations of PBMC such as lymphocytes or  monocytes, were a lso 
examined under the same conditions to ascertain the relevance of the U937 sta in ing on 
normal popu lations.  
A representative exper iment is shown i n  Figure 9 in  wh ich periphera l  b lood 
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FIGURE 9. CYTOFLUOROGRAPHS OF U937 2-1 PARENT, FOUR SUBUNES AND NORMAL 
HUMAN MONOCYTES ± Kula2 
Representative cytofluorographs of normal human monocytes (A) , parent  U937 
ce l ls  (B) and · fou r  sub l ines ,  E1 1 (C) , G4 ( D) ,  G 1 1 (E) and E9 (F) ,  isolated from 
U937 l a+ and la- parent ce l l  l i ne  by l im it ing d i l ut ion techn iques.  Cel ls  were tested 
with Ku la2 monoclonal antibody to a framework determinant of human la fo l lowed by 
F ITC conjugated F(ab')2 fragment of goat ant i -mouse im m u noglobu l i n .  Ce l l s  were 
evaluated by flow cytometry using the Ortho Spectrum I I I .  Abscissa = mean chan ne l  
f luorescence (MCF) ;  ordinate = cel l  number (Count) . 
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monocytes,  the U937 2-1  parent ce l l  l i ne and subl ines E 1 1 ,  G4 , G 1 1 and E9 were 
examined for the expression of M HC class I I  using Ku la2 .  The cytograms shown ind icate 
the sharp peak of the negative control region to the left of the g raph and the broad range 
of the positive region extending the fu l l  range of  the green fluorescence . This pattern is 
typical of MHC class I I  expression on both normal monocytes and on the l a+ U937 cel ls  
and indicates that within both cel l  populations there is a wide range of expression of the 
MHC class I I  antigens.  This positive reactivity is measured as fl uorescence i ntensity 
wh ich is expressed as percent positive ce l ls and also as mean channe l  fluorescence ± 
standard deviation (MC F±S D) wh ich provides a re lative measurement of degree of 
posit ivity. The large  standard deviat ions attached to mean channe l  f luoresce nce 
measurements shown for both normal monocytes and U937 cel ls are indicative of the 
heterogene ity with in each population .  The U937 2- 1 parent l ine was fou nd to be on ly  
5 .8% positive with a MCF±S D of1 49 .5±42 . 0  for the smal l  n u mber of pos it ive ce l ls  
measured. The E9 sub l ine tested in th is  exper iment was found to be 30 .2% posit ive 
with MCF±SD 1 93 .0±50 .6 .  Subl ines G4, E 1 1 and G 1 1 were found to be strong ly 
posit ive with 73 .9%, 80 .3% and 53 .4% positive , respective ly .  The i r  correspond ing 
M C F±S D va lues  we re 1 95 . 8±65 .0 ,  220 . 7±50 .6  and  1 69 .8±64 . 0 ,  respect ive ly , 
ind icat ing that the percent positive ce l ls  corre lated with the degree of posit iv i ty of 
those cel ls ,  i .e .  E1 1 >G4>G1 1 for both percent positive and MCF values. In general th is 
was found to be true throughout the study for ce l ls having g reater than fi fty percent 
positive cel ls .  In cel ls hav ing less than fifty percent positive ce l ls ,  such as the E9 cel ls 
in  th is case, the MCF was frequently fou nd to be h igh relative to the percent posit ive 
ce l ls .  There are two possible explanations for th is  phenomenon .  The smal l  percent 
positive may reflect dead cel ls or ce l ls which have taken up the F ITC labe led antibody in 
a non-specific manner  and although contro l led for i n  sett ing the negat ive contro l  
parameters are sti l l  available in the positive reg ion o f  the gated ce l l  popu lation where 
the i r  bright ,  but non-specific fl uorescence g ives an art ific ial ly h igh  M C F  val ue .  The 
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second explanation is the obvious possibi l ity that there may be a sma l l  but  very 
intensely positive popu lation of cel ls present. Although there are u ndoubtedly positive 
cel ls present in the E9 subl ine population tested, the h igh MCF value seen is bel ieved to 
reflect background non-specific stain i ng wh ich was found for the E9 subl i ne  i n  most 
experiments and not for e ither the 2- 1  parent l i ne  or for the other sub l ines .  The 
normal  h uman monocytes tested are clearly positive for Ku la2 (76 .4%) and h ave a 
MCF±SO value ( 1 85.9±70 . 1 ) comparable to subl ines E l l ,  G4, and Gl l .  
The 2-1 parent U937 and the sublines were tested with a battery of antibodies 
to establish a phenotypic characterization . U937 parent l i nes and primari l y  fou r  
subl ines,  El l ,  G4 , Gl l and E 9  were examined by flow cytometry us ing a variety of 
monoclonal and polyclonal antibodies to human cell surface antigens. The antibodies and 
the i r  respective specificit ies are l isted in Tables 3A and 3B. The ant ibod ies were 
chosen to represent a broad range of specificities typical of immunologica l ly re levant 
ce l l  types.  
Cells were tested with antibodies specific for MHC class II.  As previously noted 
the ce l ls were tested with monoclonal antibody Ku la2 wh ich is specific for a fram ework 
determinant of human HLA-OR.  Table 4 indicates the resu lts of mu ltiple test ings us ing 
several antibodies specific for MHC class I I  including Ku la2.  Although there was wide 
variabi l ity over the fou r  years involved in the project, the mean percent positive cel ls  
are l isted. Both the 2-1 parent U937 and the E9 subl ine were weakly posit ive i n  a l l  
exper iments , 1 6 .7% and 1 8 .3% posit ive,  respectively.  The 0 1 0 sub l ine  wh ich was 
invest igated early in the project was very strong ly  posit ive fo r K u l a2 (96 .9% 
positive) . Subl ines G4 and El l were found to  be positive for Ku la2 averag ing 62.6% 
and 61 .6% positive,  although somewhat less positive than the 0 1 0 sub l ine .  The G 1 1 
subl ine , or ig inal ly i so lated from the la  negative parent  l i ne ,  was marginally pos i tive 
when isolated (5.8% positive) ; however, the cell l i ne  became i ncreas ing ly  la posit ive 
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TA B L E  3A. S P ECIFICITI ES O F  ANTI B O DI ES U S E D  FOR FLOW CYTO M ET R I C  
ANALYSIS O F  U937 PARENT A N D  S U B L I N ES 
NAME 
ANTI-MHC CLASS II 
K u l a2 
K u l a3 
L2 2 7  
L2 0 3  
ANTI-HLAlA. B. C) 
W 6 / 3 2  
ANTI- 82M 
B B M . 1  
ANTI- M H C  & ANTI- M I2J  
SPECIFICITY 
H LA-OR 
HLA-OO? 
H LA-OR,OP (�O) 
HLA-OR 
HLA-A, B, C 
82 m icrog lobu l i n  
REFERENCE 
u npubl ished 
u npubl ished 
3 1 3 ,  453 
3 1 3 ,  453 
454 
439 
ANII-MONOCYTEIMACROPHAGE 
M 1  
MMA 
Mac 1 
6 3 0 3  
Mo 1 
Mo 2 
My 4 
My 7 
OKM5 
mature monocytes 
mo nocyte/g ran u locyte 
CR3, mature monocy1es, PMN , LGL 
mature monocytes 
C01 1 b; monocytes, g ranu locytes , nu l l  cells 
C01 4 ;  monocytes,  macrophages,  granulocytes 
myeloid cel ls  
myeloid cel ls  
human monocyte, platelet 
455 
456 
457 
458 
459 
460 
461  
462 
463 
1 2 8 
TA B L E  3 B .  S PECIFICITI ES O F  ANTI BODI ES US E D  FOR FLOW CYTO M ET R I C  
ANALYSIS O F  U937 PA R E NT AN D S U B L I N ES 
ANTI-EN DOTH ELIAL C E L L, T C E L L, B C E LL,  N K  C E L L  & OTH E RS 
NAME SPECIFICITY REFERENCE 
ENOOIHEUAL CELL 
2F1 1 endothel ia l  ce l l  464 
2 H 1 0 endothel ia l  ce l l  464 
3 A 1  endothel ia l  ce l l  464 
I, B, NK, ANP OTHERS 
I A - 1 activated I cel ls, monocytes 465 
OKT3 C 03;  I cel l  466 
OKT4 C04; he lper I cel l  467 
K I 6 9 - 7  C04;  he lper I cel l  440 
OKT8 C08;  cytotoxic I cel l  468 
3 a 1  I cel l  469 
Leu 4 C04;  I helper  cel l  470 
Leu 5 C02; S-RBC receptor 471 
slg B cel l  surface Ig 
Leu 1 1 a  NK ( natura l  k i l le r  ce l ls )  472 
K u Fc79 human Fc receptor 431 
OKT9 human transferrin recepto r 473 
I L - 2 R human i nterleuk in 2 receptor 474 
MOPC 1 1  f i b ro n e ct i  n -co n t ro I 
TABLE 4.  U937 SUBL I NES AND PARENT CELL L I NE EXPRESS 
SURFACE MOLECULES ENCODED BY THE MAJOR 
H I STOMPAT I B I L I TY COMPLEX 
Cel1s 
Antl body Norm a l  Pare n t  Sub] 10es 
SDeclf1c1ty peM" 2=l � Ell .GJ.l. E2 D..lQ 
aotl-Ia 
Ku l a2 7 6 . 4  1 6 .7  6 2 . 6  6 1 . 6  44.0 1 8 . 3  9 6 . 9  
Ku l a3 n . d .  2. 9 1 5 . 4  1 1 . 4  1 6 . 0  4. 8 n . d .  
L227  5 6 . 5  1 . 8 40 .3 38. 2 3 5 . 9  7 .0  n .d .  
L203 78 .7  2 .0  5 5 . 9  54. 2  5 3 . 3  1 2. 2  n .d .  
aot1-�LA 
(A,B,Cl 95 .4  69 .5  8 2 . 1 60.6 6 7 . 4  5 7 . 9 9 5 . 4  
an t1.:..Il2t::1 96 .3  65 .4  76 .4  42. 1 5 6 . 0  72. 5 n . d .  
-
N 
\0 
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over a period of several months and the average percent positive G 1 1 ce l ls was 44.0% 
t h roug hout  the project ,  a l thoug h as for oth e r  sub l i nes , the pe rcentag e s  var ied 
considerably . Normal human monocytes tested wi th  Ku l a2 were found to be 76 .4% 
pos i t ive .  
The  la  positive subl ines, G4  and E1 1 ,  appeared to  change during 1 987. H LA-DR 
cou ld no longer be  determ ined by m icrocytotox icity assay. When  immunofl uorescence 
data for K u l a2 was compi led as shown i n  Fig ure 1 0 , the variabi l i ty in assays is 
apparent from the standard deviations.  When the data was d iv ided betwee n  assays 
performed prior to May, 1 987, and assays performed after May, 1 987,  sub l ines G4 , 
E 1 1 and E9 were no longer reactive with Ku la2 to the same degree in  the later  t ime 
period . Although there was a s l ig ht change in  the reactivity of the G1 1 subl i ne ,  it was 
not markedly d ifferent from those values shown for either the composite results o r  for 
the earl ier  t ime period ; and the results shown for the 2-1  parent cel l  l i ne  ind icate no 
real change in reactiv ity . 
Reactivity to several other  antibodies specific for M H C  . class I I  was a lso tested 
as shown in Table 4.  The monoclonal antibodies L203,  which is reported to be specific 
for H LA-DR ,  and L227,  specific for determinants on H LA- D R ,  DP and also DO, g ave 
resu lts s im i lar  to K u l a2 in relative reactivity and i ntensity of sta in ing with normal  
h u m an monocytes, 2- 1 parent U937 cel ls and sub l ines G4 , E 1 1 ,  G 1 1 and E9 .  In  a l l  
cases , normal human monocytes were more reactive than subl ines G4,  E 1 1 and G 1 1 
wh ich were positive , and both parent 2-1  ce l ls  and subl ine E9 were negative . These 
values may indicate reactivity on ly  or  at least pr imar i ly with H LA- D R .  The K u l a3 
ant ibody tested has an unconfirmed specificity for H LA-DO and the  cel ls  tested gave 
weak reactions .  
U937 parent cell line and sublines were tested with antibodies specific for MHC 
class !. Two antibodies were employed for the purpose of confirming the cell surface 
expression of M HC class I molecu les by both parent U937 cel ls and by the sub l ines as 
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FIGURE 1 0. COMPARISON OF Kula2 REACTIVITY IN PARENT U937 AND SUBLINES OVER 
A FOUR YEAR PERIOD. 
Immunofluorescence data was compiled from experiments analyzed on the Ortho 
Spectrum I I I  us ing  Ku l a2 + F(ab')2 F ITC labe led goat (o r sheep) an t i - m o u se 
immunog lobu l in .  The fi rst column is a composite of a l l  the determinations performed. 
The second column i ncludes on ly those determinations done  between March , 1 984 , at 
t he  beg i nn ing  of the project ,  and M arch , 1 987.  The th i rd co l u m n  inc ludes  a l l  
dete rm inat ions done after  March , 1 987. Data is  expressed as m ean ± standard 
deviation for each of the ce l l  types examined. 
F I GU R E  1 0 . C O M P A R I S O N  O F  Ku l a 2 R E A CT I V I T V  I N  P A R E NT 
U937 A N D  S U B L  I N E S  O V E R  A F O U R  V E A R  P E R I O D 
2 - 1 
P A R E NT 
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s hown i n  Table 4 .  Although the U937 cel ls  gave somewhat lower percent  posit ive 
react ions than normal human monocytes,  they are a l l  clearly positive for M H C  class I 
as i nd icated by resu lts with both ant i  H LA-A , 8 , C  (W6/32) and  wi th  a n t i - B2 
m icrog lobu l in ,  which although not encoded by the MHC is he ld in  close association with 
the M HC class I molecule on the cel l surface . Normal human monocytes are v i rtual ly 
a l l  pos i t ive fo r ant i  H LA-A ,8 ,C  (95.4%) and fo r ant i - B2 m icrog lobu l i n  (96 .3%) . 
The  U937 parent  and sub l ines were not m arked ly d i fferent  from each other  i n  
reactivity , although t h e  G4 a n d  01 0 subl ines were 82 . 1 % a n d  95.4% posit ive with 
ant i  H LA-A ,8 ,C whereas the 2-1 parent and sub l i nes E 1 1 ,  G 1 1 and E9 were 
approximate ly 60% posit ive .  Th is  s l ight  h ierarchy of expression was not conf i rmed 
by the resu lts seen with the ant i- B2 m icrog lobu l i n  ant ibody resu lts a lso shown  i n  
Table 4 .  Although the G 4  subl ine showed a sl ightly h igher percent positive ce l l s  than 
the 2-1  parent,  the E 1 1 or G1 1 subl ines,  it was not h igher  than the find ings with the 
E9 subl ine.  The d ifferences seen in reactivity to anti MHC class I ,  therefore, probably 
are not s ign ificant  and no further i nvestigat ion was made of this po in t .  Th e 0 1 0 
subl ine was not tested with anti- B2 m icrog lobu l i n .  
The 2-1 parent U937 and the sublines were tested with nine monoclonal 
antibodies characterized as specific for monocytes and macrophages. Although  the 
ant ibod ies used were o rig i na l ly  character ized as specific fo r monocytes a n d  
macrophages,  they are genera l ly specific for m atu re monocyte-macrophage (M0) 
l ineage cells as  wel l  as  some other cel ls as indicated in  Table 3A.  The U937 cel ls ,  both 
parent l i ne  and subl ines,  were general ly found to be negative or  marg ina l ly posit ive 
with antibodies specific for mature monocytes and macrophages as s hown in Table 5 .  
The normal human monocytes tested were positive wi th a l l  M 0  specific antibodies with 
wh ich they were tested . The U937 cel ls  and subl i nes were very s l ig ht ly reactive with 
antibody M 1 , g iving a range of posit ive reactions from 6 .4% for subline E 1 1 to 1 0.5% 
for sub l i ne  E9  with values fo r a l l  others fa l l i ng between those values .  N o rma l  
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monocytes were 59.8% positive for M 1 . Antibody MMA which has a broader reactivity 
than M 1 , i .e .  monocytes and g ranu locytes rather than mature monocytes ,  was 64.0% 
reactive with normal human monocytes and 3 1 .2% and 30 .8% reactive with the 2- 1  
parent U937 and the E9 subl ine ,  respective ly.  Sub l ines  G4 and G 1 1 were weakly 
react ive, ind icated by 1 8 .2% and 1 5 .2% posit ive cel l s ,  respective ly ,  and the E 1 1 
subl ine was not reactive.  Both Mac 1 and 63D3 antibodies were negative for a l l  parent 
l i nes  and subl ines except the D 1 0 subl i ne  which was marg ina l ly  positive fo r both 
antibodies, 1 6.9% and 1 3 .3%, but which was tested only once . Antibodies Mo 1 ,  Mo 2 
and OKM5 were al l  negative for both parent and subl ine U937 cel ls .  Both My4 and My7 
monoclonal antibodies which are specific for cel ls of myeloid l i neage were positive for 
2-1  parent cel ls and for the subl ines.  Reactiv ity to My7 ranged from a m i n i m u m  of 
50 .6% positive fo r the E1 1 sub l ine to a maxim u m  of 6 9 .5% posit ive for the 2 - 1  
parent l i ne .  Normal h u man monocytes were found to  be  72 .4% posit ive for My7. 
There were more varied resul ts with My4 wh ich was 85.4% posit ive with norma l  
h uman monocytes. The G4,  G1 1 and E9 subl ines and the 2-1  parent l i ne  were  also 
clearly positive , although the re lative reactivity varied from 56.0% for the G4 sub l ine  
to  29 .3% for the 2-1 parent cel l  l ine .  The E1 1 subl ine  was weakly pos itive . 
Resu lts obtained by immunofluorescence techn iques us ing ant ibodies specific 
fo r su rface structu res characte ristic of matu re monocyte-macrophage l i neag e  ce l l s  
wh ich were positive for normal monocytes were general ly negative fo r both parent  
U 937 ce l l s  and sub l i ne  ce l l s .  H owever ,  a nt ibod ies  spec i f ic  fo r s t ructu re s  
characteristic of immature monocytic o r  myeloid ce l ls  were fou nd to b e  reactive with 
the U937 although reactivity was variable .  
Three monoclonal antibodies specific for endothelial cells were also tested. As 
seen in Table 5, there was variable reactivity with monoclona l  antibodies specific for 
endothe l ia l  ant igens .  Lowest reactivity was seen with mAb 3A 1 (8. 9%- 1 5 .9% 
posit ive) . Reactivity to 2F1 1 was 23. 1 - 29 .4% for the parent l i ne  and sub l i nes  E 1 1 ,  
TABLE 5. U931 SUBL I NES AND PARENT CELL L I NE EXPRESS 
SURFACE MOLECULES CHARACTER I S T I C OF I MMATURE 
MONOCVTES AND ENDOTHEL I AL CELLS 
Cel]s 
Ant 1 body Norm a l  Pare n t  Sub] loes 
Sgec1 f1cuy PBM" 2::.1 � Ell !ill E.9. Ill.Q 
aotl -monocyte 
M l  5 9 .8 9 . 9  8 . 5  6. 4 9 . 4  1 0 . 5  5 . 3  
MM A 64.0 3 1 . 2 1 8 . 2  4. 9 1 5 . 2  3 0 . 8  4. 4 
M a c  1 32 .0  5 .3  4.9 3 .0  3 . 3  4. 1 1 6 . 9  
6 3 D 3  n . d .  4. 7 0 . 8  3 . 2  2 . 6  1 .3 1 3 . 3  
M o l 5 9 .4  3 . 5  5 . 1 1 . 7 2 . 7  3 .7 n . d .  
M o  2 7 5 . 1 5 . 0  4.6 1 . 6 2 .8 3 . 9  n . d . 
My 4 8 5 . 4  2 9 . 3  5 6 . 0  1 3. 8  40 . 8  3 2 . 3  n . d .  
My 7 7 2 . 4  6 9 . 5  5 5 . 8  5 0 . 6  6 1 .0 57 .4  n .d .  
O KM5 n . d .  0 . 7  2 . 0  1 . 0 0 . 5  6 . 0  n . d .  
aotl -eodothe11a] ce11 
2F 1 1  n . d .  23 . 1 46 .4  27 .2  23 .2  29 . 4 n . d .  
2 H I O  n . d .  5 1 . 7 7 9 . 3  65. 6 43 . 5  72 .0  n . d .  ..... 
3 A l n . d .  8 . 9  1 5 . 9  1 3. 5  1 5 . 1  1 0 . 7  n . d . w 
VI 
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G 1 1 ,  and E9. Subl ine G4 was approximately twice as positive at 46 .4% positive ce l ls .  
Of the three antibodies tested, antibody 2 H 1 0 was found to be the most reactive with 
U937 cel ls (43 .5%-79 .3% positive) . Despite the var iable reactivity with the  three 
endothel ia l  antibodies,  the U937 parent ce l ls  and subl ines were clearly pos it ive with 
ant ibodies 2F1 1 and 2 H 1 0 ,  and therefore express surface structures in common with 
endothe l ial cel ls .  
U937 sublines and parent cell line were tested with a diverse panel of 
antibodies specific for T cells. B cells and other cell surface antigens. Table 6 i ndicates 
reactiv it ies of U937 parent cells and subl ines when examined by immunofl uorescence 
us ing flow cytometry with antibodies with d iverse specificities . As shown i n  Table 6 ,  
both 2 - 1  parent ce l ls and a l l  subl ines were found to b e  strongly positive for ant ibodies 
T A- 1 , wh ich is specific for both T lymphocytes and monocytes ;  OKT 4 and KT69-7,  
wh ich are specific for the CD4 molecu le found on  helper T cel ls and at low density on 
h uman monocytes ;  and KuFc79 , wh ich is specific for the h u man Fc receptor. U 937 
showed no reactivity with NK specific Leu 1 1 A ,  ant ibody to I L-2 receptor,  s u rface 
immunoglobul in (s lg ) ,  S-R BC receptor specific Leu 5, thymocyte specific OKT1 0 and 
MOPC 1 1  anti fibronectin contro l .  Several antibodies showed weakly positive reactions  
with some o f  t he  U937 cel ls  bu t  not with others .  OKT3 , 3a1  and Leu 4 which are T 
lymphocyte specific, OKT B which is  specific for the C OB molecule on  cytotox ic  T 
lymphocytes and OKT9 which is specific for the transferrin receptor were fou nd to be 
weakly reactive « 20% posit ive) with some but not a l l  U937 parent and sub l ines .  The 
G4 subl ine was the on ly subl ine found to be weakl� reactive with OKT3 , 3a1 , Leu 4, 
OKTB and OKT9. 
MHC class " antigens expressed by U937 sublines were demonstrated by SDS­
pAGE techniQues. Cel l  surface prote ins on the U937 parent l i ne  (2- 1 ) ,  a second /a 
negative U937 parent  l i ne  (H -K) and several sub l ines were radio iod inated by the 
TABLE 6. U937 SUB L I NES AND PARENT CELL L I NE WERE 
TESTED W I TH A D I VERSE PANEL OF ANT I BOD I ES SPEC I F I C  FOR 
T CELLS, B CELLS, NK CELLS AND OTHER SURFACE ANT I GENS 
Cel1s 
Ant 1 body Norm a l  Pare n t  Sub110es 
Spec1f1c1ty PBM" 2::l � ill 1il1 E.2 Dl.Q 
T a  1 n . d .  94. 9  7 9 . 1 80.3  8 7 . 1 8 5 . 8  8 6 . 5  
O KT 3  1 1 .  1 1 3 . 8  1 6 .0 2 .9 3 . 3  1 1 . 7  n . d .  
O KT 4  0 . 2  5 0 . 7  3 6 . 2  3 3 . 6  3 9 . 1 32 . 1 n . d .  
KT 6 9 - 7  46 .6  45 . 2  47 .4 4 1 .9 27 . 5  3 2 . 8  3 2 . 3  
O KT8 0 . 9  1 4. 6 1 3 . 1  6 . 2  2 . 0  8 . 7  n . d .  
O KT 1 0  n . d .  1 . 7 6 . 6  6 .8  n . d .  n . d .  1 0 . 8  
3 a l n . d .  5. 1 2 4. 0  1 3 . 0  4.3 1 0 . 2  n . d .  
L e u  4 3 . 4  7 . 8  1 2 . 4  5 . 3  1 6 . 4  1 8 . 5  n . d . 
Leu  5 2 3 . 0  3 . 2  3 . 8  1 . 7 2 . 4  3 . 0  n . d .  
5 1 g n . d .  6. 1 7 .9  4.6 6 . 6  8 . 5  n . d .  
L e u  1 1  A n . d .  0 . 3  0 .6 n .d .  n . d .  n . d .  n . d .  
KuFc79 8 6 . 9  6 0 . 7  8 7 . 1 76. 0 6 9 . 3  62 . 1 n . d .  
OKT 9  4. 5 8 . 6  1 3 .8  3 .9  25 .2  7.8  2 3 . 1 
I L-2R 0 . 1 0 . 1 0 . 5  0. 1 0 . 3  0 . 1 n . d .  
MO pe 1 1 1 .4 1 . 4 3 . 3  0 . 7  1 . 7 2 . 5  n . d .  
....... 
l.J.) 
-..J 
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lactoperoxidase method , extracted and immunoprecipitated with a monoclona l  ant ibody 
to a framework determinant of human H LA-OR ( Ku l a2) .  As seen i n  F ig u re 1 1 ,  the 
auto radiograph shows bands at molecu lar weights corresponding to 29 ,000 and 34,000 
for subl ines G4, E 1 1 ,  and 0 1 0 ,  with h ighest intens ity for the 01 0 subl i n e .  The 2- 1  
parent and the H-K parent U937 cel l  l ines are negative for these bands. The molecular 
weights of the proteins  immunoprecipitated by Ku la2 on  the subl ines are cons istent 
with molecu lar weights for the beta and alpha chains of the heterodimeric MHC class I I  
molecu les .  T h u s  h u man M H C  c lass I I  ant ige n s  are demonstrab le  both  by 
i m munoprecipitation of iod inated ce l l  surface molecu les and by immu nofluorescence 
techn iques. 
Cell surface expression of MHC class II molecules by U937 subl ines can be 
modulated by gamma interferon. The level of expression of M H C  class I I  molecules by 
the subl ines is increased by treatment with gamma interfero n .  Subl ines were g rown in  
the  presence of 1 00 U n its/m l .  of pu rified (natu ral) gamma i nterfe ron fo r var io u s  
t imes to examine t h e  kinetics o f  the effects o f  gamma interferon on t h e  express ion of 
both surface la and expression of Fc receptor. After incubation for the prescribed t ime 
periods ce l ls  we re stained with Ku la2 (ant i-human la) o r  wi th Ku Fc79 (ant i -h u m an 
Fc receptor) fo l lowed by incubation with F ITC coupled F(ab')2 fragment of ant ibody to 
mouse immunog lobu l in .  These cel ls were then examined by flow cytometry us ing the 
Ortho Spectrum I I I .  The resu lts can be seen in  Figure 1 2 . Time points examined were 
0 ,  1 ,  6 ,  1 2 , 24 , 36,  48,  and 72 hours .  By 24 hours, the expression of ce l l  su rface l a  
was maximal and only a s l ight increase was noted after 2 4  hours with sub l ine E9 .  I n  
al l cases the  leve ls  o f  l a  expressed was markedly increased . The  most  d ram atic 
i ncrease was with sub l ine E9 wh ich was 22% posit ive without  g a m m a  i nterferon 
treatment and reached 70% positive cel ls by 48 hours . Subl ines E 1 1 and G 1 1 showed 
an  increase from 45-55% posit ive to 75-80% posit ive ce l l s .  Sub l i ne  G 4  was 
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F IG U R E  1 1 .  CELL S U R FAC E EXP R ESSION O F  M H C  C LASS I I  M O LE C U LES 
DEMONSTRATED ON SUBLINES OF U937 CELL LINE. 
Cel ls from two U937 parent cel l  l ines ( lanes 1 and 5) and subl ines G4,  E 1 1 and 
0 1 0 ( lanes 2 ,  3 ,  & 4) were radioiod inated with 1 25 1 by the lactoperoxidase m ethod. 
Ce l l  surface prote ins were extracted and immunoprecipitated with Ku la2 ( mAb ant i ­
h uman la) .  Fo l lowing electrophoresis on a 1 0- 1 6% polyacry lamide ge l  u nder reducing 
condit ions ,  proteins having molecu lar weights characteristic of human M H C  class I I  
a lpha (34K) and beta (29K) were demonstrated by autoradiography. 
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FIGURE 1 2 . K INETICS OF INDUCTION OF EXPRESSION OF la  AND FcR ON T H E  CELL 
SURFACE OF U937 SUBLINES AFTER GAMMA INTERFERON TREATMENT 
Gamma interferon increases expression of l a  on U937 subl ines and reaches 
max imal  effect by 24-.48 hours .  Gamma interferon  ( 1 00 U/ml . )  was added to cu ltu re 
flasks containing U937 cel ls  and cel ls  were incubated for 0 ,  1 ,  6, 1 2 , 24 , 36,  48 ,  72 
hours.  Cel ls were harvested and stained with Ku la2 (mAb anti-human l a) or K u Fc79 
(mAb anti-Fc receptor) and examined by Ortho Spectrum I I I  to determine percent l a  
and FcR positive cel ls at each t ime point. 
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strong ly  posit ive without gam m a  interfe ron treatment ;  h owever it became n e a rly 
1 00% posit ive with in  24 hours .  In al l cases the density of l a  expression measured as 
mean channe l  fl uorescence a lso i ncreased with gamma i nterfe ron t re atment . Fc 
receptor expression was found to be s l ightly i ncreased by gamma interferon treatment 
with s im i lar kinetics . Several sub l ines al ready expressed Fc recepto r at max ima l  
levels (subl ines G4 and E9)  and  were not induced to increase the  percent o f  positive 
ce l ls ,  a lthough the mean channel  f luorescence, i .e .  FcR density, did increase s l ight ly.  
In more recent experiments using U937 subl ines having decreased leve ls  of 
constitu itive M HC class I I  expression ,  treatment with gamma interferon  i ncreased the 
level of expression i n  al l  subl ines except E 1 1 as shown in  Figu re 1 3 . Ce l l s  were 
treated as described above except that Fc receptor expression was not assayed.  T ime 
poi nts at  which l a  expression was measured were 0 ,  2 ,  1 2 , 24 , 48  and 72 hours .  
I n i t ia l  leve l s  o f  express ion  were  m uch lower  t han  i n  previo us l y  d escr ibed 
expe r iments ; however ,  the k inet ics of i nduct ion of  express ion  were s i m i l ar as  
ind icated by maximal levels of  expression obtained at  24 hours for subl i ne  G4 and at 
48  hours fo r subl i nes  G 1 1 and E9 . The E 1 1 subl i n e ,  which i n  t he  prev io u s  
experiments (F igure 1 2) appeared t o  decrease l a  expression a s  a primary res u lt of 
gamma interferon treatment prior to demonstration of an enhanced la expression by 1 2  
hours, again showed decreased la expression which was never succeeded by enhanced 
expression ; and indeed, in i tial levels of la expression were not reached u nti l 72 hours 
of gamma interferon treatment (Figure 1 3) .  Although not shown, treatment of the  2-1  
parent  l i ne  wi th  gamma in terferon i ncreased l a  expression with ki netics s i m i la r  to 
sub l ine E9 beg inn ing with an i n it ial leve l of 1 1  % and reach ing  24% positive cel ls by 
48 hours .  
Functional capacity of the U937 cell line and subljnes. The second aspect of the 
i nvest igat ion of the U937 sub l ines i nvo lved the dete rm inat ion of t he i r  fu nct io na l  
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F IGURE 1 3 . K INETICS OF EXPRESSION OF l a  FOLLOWING GAMMA INTER F E RON 
TREATMENT ON U937 SUBLINES-RECENT FINDINGS 
Gamma interferon increased expression of l a  on U937 subl ines and reached 
maximal  effect by 24-48 hours .  Gamma interferon  ( 1 00 U/ml . )  was added to cu l ture 
f lasks conta in i ng U937 ce l ls  at 0 ,  2 ,  1 2 , 24 , 48 and  72 hours and ce l l s  were 
harvested and stained with Ku la2 (mAb ant i- human l a) as described i n  F igure 1 2 . 
Cel ls examined i n  th is experiment were taken from cu lture i n  May,  1 987. 
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capabi l it ies .  The subl ines were shown to be able to mediate a response normal ly  
attributed to monocytes or  accessory cel ls  in a variety of  cel lu lar assays. 
The lat U937 cell line was able to stimulate a mixed lymphocyte response and 
to stimulate the generation of Cytotoxic T cells. Stimu lat ion of a m ixed lymphocyte 
react ion was measured as 3 H-thymidine incorporat ion by responder ce l l s  in cu l ture 
with U937 stimu lator ce l ls  i n  a six day assay i n  m icrot iter plates .  Generation of 
cytotox ic T cel ls was measured as ce l l  mediated Iympholysis and expressed as % 
Cytotox icity of radio labeled target cel ls ,  wh ich were ident ical to the st im u lato r ce l ls ,  
i n  a s ix  hour chromium release assay fo l lowing a s ix day cu ltu re of responder and 
stimu lator ce l ls .  Responder ce l ls i n  both m ixed lymphocyte reaction and cytotoxicity 
assays were comprised of peripheral blood mononuclear cel ls prepared from normal  
blood donors by fico I I  hypaque techn iques as previously described . U 937 stim u lator 
cel ls were treated with m itomycin C prior to addit ion to the assays un less othe rwise 
ind icated. 
The U937 cel ls were able to stimulate a m ixed lymphocyte response by several 
responders . l at and l a- parent U 937 cel ls  and several  subl i nes were u sed as  
stimu lators i n  mixed lymphocyte reactions to  determine whether  t he  express ion of l a  
wou ld corre late with a change i n  functional capacity. T h e  responders i ncl uded ce l ls  
from three different indiv iduals.  Responder ce l ls  1 and 2 were isolated as previous ly 
described. Responder 3 and responder 2 are the same individual ,  however, cel ls  used 
as responder 3 were kept in cu lture without stimu lators for th ree days pr ior to the 
assay. Cel ls  from responder 4 were isolated as previously described and subsequently 
monocytes were removed by counterflow e lutriation prior to addition to the assay . The 
resu lts are g iven in Figure 1 4 . In general , it became apparent that ce l ls  wh ich had 
been  e i ther cu ltu red o r  e l utr iated were less reactive to U 937 ce l l s  t han  fresh ly 
isolated ce l l s .  Stimu lator A, wh ich was the l at parent ce l l  l i ne  U937 ce l l  l ine from 
which subl ines G4 and E1 1 were isolated as indicated in  Table 1 ,  was found to be able to 
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F IGURE 1 4 . l a  POSITIVE U937 CELL LI N ES AND SUBLINES STI M U LATE A M I X E D  
LYMPHOCYTE REACTON 
Five U937 ce l l  l i nes  and sub l ines were tested as st i m u lators i n  m ixed 
lymphocyte reactions with four  responder cel l  popu lations.  Responder ce l ls  (R1 and 
R2) were isolated from normal  donor blood by ficoll-hypaque techn iques as previously 
described. Responder 3 cel ls were isolated from responder 2 and isolated ; however, the 
ce l ls were kept in cultu re for 3 days prior to addition to the assay. Responder 4 cel ls  
were isolated from a normal  individual as previously described ; however ,  ce l l s  were 
fu rther pu rified by counterflow e lutriation and on ly the lymphocyte fract ion was u sed 
in  the assay. Stimu lator U937 cel ls were treated with mitomycin C prior to addit ion to 
m icrotiter plates. The cel ls were i ncubated for s ix days,  pu lsed for the last 1 6  hours 
with 3 H-thymidine, harvested and counted . Resu lts are expressed as cpm .  Stimu lator  
populations were as  fol lows : 
(A) U937 la+ parent cel l  l ine 
(B)  U937 subl ine F7,  l a± 
(C) U937 subl ine G4, la+ 
(D) U937 parent l ine ,  recently converted to la+ 
(E) U937 parent l ine ,  la-
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stim u late a strong response rang ing from 40,000 cpm with responder 4 to 1 40 , 000 
cpm with responder 1 .  Stimu lato r B ,  which was a marg inal ly l a+ sub l ine ( F7) and 
which was not  used beyond th is experiment, gave strong stim u lation to responders 1 
and 2, but did not stimu late e ither  the previously cultu red cel ls  or  the e lutriated ce l l s .  
Stimu lator C,  the  la+ G4 subl ine ,  also stimu lated strongly with responders 1 and 2 but 
very l i tt le with responders 3 and 4. Stimu lator D ,  wh ich was an l a+ pare nt  U 937 
which had previously been an l a- parent and rapidly converted to become an la+ parent 
ce l l  l ine ,  was also a strong stimu lator of al l responders. St imu lator E, which was an 
l a- parent U937 which remained l a- , was found to lack the abi l ity to stim u late any of 
the responders. The normal m ixed lymphocyte reactions  are shown with stimu lators 
R 1 , R2 and R3. These pre l im inary resu lts suggested a corre lat ion betwee n  the 
expression of ce l l  su rface l a  on the U937 ce l l  l i ne  and the i r  abi l ity to stim u late a 
m ixed lymphocyte reaction .  
The U937 parent l ines and the subl ines tested were also found to be capable of 
generating specific cyto lytic T ce l ls .  As shown in Figu re 1 5 , U937 l a+ parent  ce l l  
l i ne  (A) and the G4 subl ine were able to  stimu late three d ifferent responders to g reater 
than 50% cytotoxicity after a six day incubation .  The other  l ines tested were capable of 
st imulating a smal ler cytotoxic response as shown with stimu lators B ,  D and E.  U n like 
the m ixed lymphocyte reaction where no stimu lation was noted, the la- parent l i ne  (E)  
was able to stimu late a smal l  cytotoxic reaction .  
From these resu lts we concluded that t h e  l a+ U937 cel l  l i n e  was capable of 
st imu lating a m ixed lymphocyte reaction and also stim u lat ing the generation of specific 
cyto lytic T ce l ls .  At this point in time,  the isolation and characterizat ion of subl ines or 
c lones of l a+ and l a- U937 ce l l s  was u ndertaken fo r the dua l  pu rpose of ( 1 ) 
characteriz ing phenotypical ly (described above) and functional ly the two types of ce l ls  
and (2) discerning the role of the expressed la  and the nature of  the la expressed. 
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F IGURE 1 5 . BOTH la  POSITIVE AN D la  N EGATIVE U937 C ELL LINES AND SUBLI N ES 
STIMULATE THE GENERATION OF CYTOLYTIC T CELLS 
Respo nder cel ls  from three normal  donors ( R 1 , R2 & R4) were iso lated as 
described in Figure 1 4 . Stimulator U937 cel ls  were also the same as those described 
in Fig u re 1 4 . Cel ls  were i ncubated together for six days fol lowed by a six hou r  
incubation with stimu lator- identical , 5 1  ch rom ium- labe led target cel l s .  Supernatants 
were counted for chrom ium released. Resu lts are expressed as % Cytotoxicity and 
calcu lated as previously described. 
8 0  
70 
6 0  
50  
Po Cytotox l c t ty 40 
30 
20 
1 0  
0 
A 
F I GURE 1 5. BOTH l a  POS I T I V E  AND NEGAT I VE 
. U 9 3 7 CELL L I NES AND SUBL I NES ST I MULATE 
THE  GENERAT ION  OF  CYTOLYT I C  T CELLS 
B C D E R l  R2 
St i mu l ator 
R3 
• R l  
1m R 2  
� R 4  
....... 
V1 
....... 
1 5 2 
The U93? sublines were capable of stimulating the generation of cytolytic T 
�. Figure 1 6  represents a compi lation of several CMl experiments i n  wh ich  the 
U93? parent l i ne  and sub l ines served as st i m u l ator ce l l s  w i th  e leven  no rma l  
responders .  U 93? st i m u lators were i ncubated w i t h  n o rma l  per iph e ra l  b lood 
mononuclear ce l l  responders for s ix days fol lowed by addit ion of  5 1 Cr- Iabeled target 
ce l l s  i n  a s ix  hour chrom ium re lease assay as previous ly described . The re was 
cons iderable variabi l ity in  % Cytotoxicity from one responder to another  as shown in 
Fig ure 1 6A;  however,  the CMl response stimu lated by U93? parent and subl ine  ce l ls  is  
comparable to the response seen when normal PBMC were used as stimu lators. To 
compare the different parent l ines and sub l ines shown in  Figu re 1 6A,  the mean and 
standard deviations were determined for the responses with each stim u lator as s hown 
i n  Figure 1 6B .  The standard deviations  indicate the high degree of variabi l i ty i n  CTl 
generation among responders ; however, a l l  parent and subl ine U93? cel ls  were capable 
of st imulating the generation of a CMl response comparable to the normal  response i n  
both magn itude and variabi l ity. Figure 1 6A indicates a more consistent C M l  response 
by both G4 and E1 1 subl ines than the other subl ines or parents and considerably more 
cons istant C M l  than normal  PBMC st imu lated CM l responses .  D i ffe re nces i n  
st imu latory capacity in the CMl response may correlate with the level o f  expression of 
M HC class I on the cel l  surface of the stimuating ce l ls ,  although as indicated in Table 4 ,  
t he  cel l  surface expression o f  M HC class I as  measured by anti-H LA-A,B ,C and  by  ant i -
132 m icrog lobu l in  antibodies is h igher  for the G4 subl ine than for the other  U93? cel l  
l i nes ,  that is  not found t o  be true for the E1 1 sub l ine wh ich was shown to b e  less 
positive for MHC class I than other subl ines. The D1 0 sub l ine wh ich was very strong ly 
positive for MHC class I as measured by anti-H LA- A,B,C appears to be a less efficient 
stimu lato r than either subl i ne  E 1 1 o r  the 2- 1  parent .  Th i s  fi nd ing  m ay actua l ly  
reflect an enhanced resistance of the D1 0 sub l ine targets to be lysed by the CTl's 
generated . In the experiments summarized in Figures 1 6A and 1 6B ,  the % Cytotoxicity 
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FIGURE 1 6. U937 PARENT AND SUBLINES STIMULATED THE GENERATION OF SPECI FIC 
CYTOLYTIC T CELLS IN CML ASSAYS. 
U937 parent ce l l  l i nes (2- 1 and HK) ,  subl ines (G4, 0 1 0 and E 1 1 )  and normal  
per ipheral  b lood monon uclear ce l l s  (PBMC) were added as sti m u l ato r ce l l s  to 
a l logene ic peripheral blood mononuclear ce l ls  i n  CML assays.  The res u lts we re 
var iable as ind icated .  St imu lato rs ( 1  X 1 05 ce l l s/we l l )  were i ncubated wi th  
responder ce l ls  ( 1  X 1 05 ce l ls/we l l) for  s ix days fol lowed by a s ix  hour  i ncubat ion  
w i th  st imu lato r- ident ical  5 1  Cr- Iabeled target ce l l s .  Resu lts are expressed as  % 
cytotox icity (% C).  I ndividual responses with e leven d ifferent responders (A) showed 
marked var iabi l ity fo r U937 st i m u lato rs as we l l  as normal  PBMC st i m u l ators .  
Responses shown in (A) were compiled (B)  and the data is presented as mean ± s .d .  
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i s  based on  cytotoxicity of stimu lator- identical targets rather  than a s ing le  type of 
labeled U937 target . In other experiments, the D 1 0 subl ine was found to be a potent 
s t i m u l ator .  
I n  order to  fu rther  exam ine the capacity of the U937 cel ls  to  mediate a C M L  
response, the effect o f  different doses o f  stimulators was exam ined . As shown i n  Figu re 
1 7, the magnitude of a CML response generated by the U937 subl ines and 2- 1  parent 
l ine was dose dependent. Also i l lustrated in  Figure 1 7  is the CML response generated 
when subl ines G1 1 and E9 were uti l ized as stimu lators . As indicated the G 1 1 sub l ine 
was found to be a strong stimu lator in CML assays even at ce l l  doses as low as 5 X 1 03 
ce l ls/we l l .  Routinely the stimu lator ce l l  dose was 1 X 1 05 ce l ls/wel l  and at that dose 
the G4 and G1 1 subl ines were somewhat stronger stimu lators than the other  sub l ines 
and parent 2-1  ce l l  l i ne ;  however, at  the h ighest ce l l  dose a l l  sub l ines st imu lated to 
approximately the same degree. 
U937 sublines were able to stimulate a mixed lymphocyte reaction .  As 
previously ind icated in  Figu re 1 4 , the l a+ U937 cel l  l i ne and the la+ G4 subl i ne  were 
capab le of stimu lat ing a m ixed lymphocyte reaction i n  early experiments .  The  
generation o f  a mixed lymphocyte reaction was deemed to be  an important f indi ng for 
the l a+ U937 cel ls because its generation is a function of the expression of M H C  class I I  
molecules .  Because t he  l a- U937 cel ls were not found to  be  capable o f  stim ulat ing an  
M LR ,  t he  l a+ U937 subl ines were seen as  a potential ly u sefu l too l  for t he  e lucidation of 
the role of MHC on monocyte- l ike ce l ls .  M ixed lymphocyte experiments were set up 
frequently ove r  the who le  cou rse of the project and the resu lts cont in ued to  be 
somewhat problematic in  that in repeated M LR assays u sing a relatively smal l  pool  of 
normal responders , the resu lts have been u npredicatable .  Stimu lation of an M LR by 
the la+ subl ines E1 1 and G4 were more frequent than by la negative subl ines G 1 1 and 
E9 and the 2-1 and H-K parent ce l l  l i nes ; however, us ing the same responders rarely 
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FIGURE 1 7. U937 PARENT AND SUBLINES STIMULATED THE GENERATION OF SPECIFIC 
CYTOLYTIC T CELLS IN CML ASSAYS IN A DOSE DEPENDENT MANNER. 
U937 parent 2-1 and subl ines E1 1 ,  G4, G 1 1 and E9 were added as stim ulator 
cel ls at four  ce l l  doses( 1  X 1 04 ce l ls/we l l ,  5 X 1 04 ce l l s/we l l ,  1 X 1 05 ce l l s/we l l ,  
a n d  2 X 1 05 cel ls/wel l) t o  normal PBMC ( 1  X 1 05 cel ls/wel l )  in  a s i x  day assay as 
previously described . Resu lts are expressed as average % cytotoxicity (%C) based on 
re lease of 5 1  Cr  from sti mu lator- iden tical target cel l s  i n  tr ip l icate we l ls  i n  t h ree 
experiments . 
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were the same resu lts obta ined i n  successive experiments and as the G 1 1 sub l i ne  
became strong ly la+ i t  too began to stimu late a strong MLR.  
As indicated in  Figure 1 8A in which normal responders ce l ls were stimu lated by 
normal  PBMC stim ulato r cel l s ,  there is  marked var iabi l ity in the response .  The  
resu lts a re  expressed s imply as cpm to  ind icate the degree of 3 H - t h y m i d i n e  
incorporation by the responder cel ls in a six day assay. The magn itude of the response 
is re lated to two factors : disparity of MHC class I I  molecu les expressed on responders 
and stimulators and inherent responsiveness of individuals used as responders. The 
most obvious responses are those g reater than 20,000 cpm ; however, there are many 
positive responses less than 20 ,000 cpm and i ndeed less than 1 0 ,000 cpm which were 
deemed to be positive responses because they were g reater than th ree standard 
deviations above the negative control values. 
A compi lation of MLR responses for the U937 parent cel l  l ines H-K and 2-1 and 
subl ines 0 1 0 ,  G 1 1  and E9 is i l l ustrated i n  Figu re 1 8B .  The H-K parent l ine never 
stimu lated a strong MLR response , although  with at least th ree individials a response in  
excess of  5000 cpm was obtained. The 2-1  parent  l i ne  proved to  be a var iable 
stimulator in MLR assays. In the earl iest assays the response was general ly very low. 
Recent M LR findings with parent 2-1 i ndicate two patterns :  strong stimu lat ion or no 
stimu lation with few values i n  between .  The 0 1 0 subl ine was used on ly in the first 
several M LR assays, and this subl ine showed a pattern s imi lar to that exhibited by the 
2-1 parent l i ne  in that there was either  strong stim u lat ion or no stimu lat io n ,  indeed , 
3H-thymidine incorporation measured as cpm fel l  below that of negative contro ls .  The 
G 1 1 subl ine also gave variable resu lts in  M LR assays. The E9 subl i ne  never g ave 
strong st imu lation ;  however, th is subl ine was ut i l ized as a stimu lator i n  re lative ly few 
M LR assays , thus it may be coincidental that it appears to be a poor stimu lator. The 
G 1 1 subl ine,  although orig inal ly isolated as an l a- subl ine ,  became rapidly la+ and was 
probably l a+ in al l  of the M LR assays in  which it was added as a stimulator. Therefore, 
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FIGURE 1 8. U937 SUBLINES STIMULATED A MIXED LYMPHOCYTE REACTION . 
Normal PBMC responders ( 1  X 1 05 ce l ls/wel l )  were incubated with al logene ic 
PBMC stimu lato rs (A)  or  U937 parent  o r  subl i ne  st imu lators ( B  & C)  ( 1  X 1 05 
cel l s/wel l )  as described.  I ndividual  responses are ind icated as the m ean of 3 H -
thymidine incorporation of tripl icate wel ls expressed as cpm . 
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lack of expression of MHC class " molecules does not explai n  the negat ive resu lts seen 
i n  approximately half of the M LR assays in  which G 1 1 subl ine ce l ls  were added as 
s t i m u l ators .  
Shown in  Figure 1 8C are the compiled M LR resu lts for subl ines G4 and E1 1 i n  
wh ich  there are many  strong responses .  Al ternat ing  with the strong pos i t ive 
responses,  however, are very negative responses in  wh ich the net cpm is  negative . 
Both subl ines express MHC class " molecu les constitu it ively and would therefore be 
expected to stimulate an MLR .  The negative resu lts can not be explained by co ncurrence 
of H LA-OR antigens on both responders and stimu lators and in many cases the  same 
responders were found to g ive strong responses in  some experiments and very negative 
responses in  other experiments. 
In general , if the MLR response was very low with one responder i n  a s ing le  
assay us ing a particu lar U937 stimu lator, a l l  responses were low us ing that same 
preparat ion of  stimu lator ce l ls .  Although the earl iest M LR responses were suggestive 
of M H C  class " restrict ion phenomena,  that notion was rapidly d ism issed by the 
inconsistancy in reaction with the same pool of responders . Although the l a+ sub l ines 
were genera l ly more stim u latory i n  M LR assays than the l a- sub l ines or  parent  ce l l  
l i ne ,  the resu lts were variable and did not corre late with l a  express ion on  t h e  U937 
subl ines or l a  d isparity between responders and U937 stimu lators . The generation of a 
pos itive response might wel l  requ i re that MHC class " molecu les be present ;  however, 
it did not insure that a response wou ld be generated. 
The effect of stimulator dose on the generation of an MLR was examined . The 
propens ity of macrophages to act i n  a stimu latory capacity at low co ncentrations and i n  
an i nh ib itory capacity a t  s l ightly h igher  concentrations  was wel l  known . I t  therefore 
became necessary to examine the effect of stimu lator ce l l  dose on the generation of a 
response.  The standard stimu lator cel l  dose used i n  the M LR assays was 1 X 1 05 
cel ls/we l l .  F igures 1 9A and 1 9B represent two patterns wh ich emerged from these 
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F I G U R E  1 9 . U 937 STI M U LATO R DOS E  RESPONSE WAS VAR IABLE I N  M I X E D  
LYMPHOCYTE REACTIONS. 
Representative exper iments (A & B)  exempl ify the  two types of response  
encountered in MLR in  which U937 parent and  subl ine cel ls were added as  stimu lators 
at several doses to normal PBMC (1 X 1 05 ce l ls/wel l )  in  a six day assay . Resu lts are 
expressed as the mean of tr ipl icate wel ls .  In panel  A, a maxi m u m  response  wi th 
normal al logeneic PBMC stim u lators was obtained at  the m ax imum stim u lator cel l  dose 
(2 X 1 05 cel ls/we l l ) ; however,  U937 sub l ine G4 stimu lated a M LR respo n se at the  
m in imum ce l l  dose examined (5  X 1 04 ce l ls/we l l )  and the  stimu lat ion decreased at 
increas ing cell doses .  In pane l  B, a positive dose response was noted for a l l  U937 
parent and subl ines tested at  increasing ce l l  doses. 
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experiments. Both h igher and lower doses of stimulators were added to the MLR assay 
to assess the effect of stimu lator dose. The first pattern as shown in  Figure 1 9A shows 
maximal stimu lation at low cel l  dose , in th is case on ly with the G4 subl i ne .  The E 1 1 
and G 1 1 sublines showed no capacity to stimulate in th is assay and with the G 1 1 sub l ine 
in  particular, as h igher doses of cel l s  were added to the assay , the net cpm decreased 
below the negative contro l .  The G4 subl ine stimu lated wel l  at a dose of 0.5 X 1 05 and 
the stimulation decreased with each successively h igher dose. Although there continued 
to be a positive M LR at 2 X 1 05 cel ls/wel l ,  it is s ign ificantly lower than seen with 0 .5 
X 1 05 cel ls/we l l .  The normal  PBMC generated M LR is shown for compariso n .  As 
indicated by the normal MLR in  this experiment ,  the responder ce l ls used were capable 
of exh ibiting a strong response. 
The second pattern seen in response to i ncreasing doses of stim u lator U937 
ce l ls  is shown in Figure 1 9B in  which 3 H-thymidine incorporation increases i n  a dose 
dependent fashion from the lowest stimu lator dose of 0 .1  X 1 05 cel ls/wel l  to the 
h ighest dose of  2 X 1 05 cel ls/wel l .  Although al l  U937 stim u lators e l l icit a response at 
doses of 0 .5 X 1 05 ce l ls/wel l  and above,  the 2- 1 parent ce l l  l ine and the G4 and G 1 1 
subl ines e l l icit a sl ightly h igher  response than e ither the E1 1 or  E9 subl ines.  
From the preceeding experimental data it seemed apparent that the 2- 1 parent 
U937 ce l l s  and sub l ines E 1 1 ,  G4 , G 1 1 and E9 were capable of stim u lat i ng  the  
generation of  an M LR to  some degree and that th is  stimu lato ry capacity m ight  be 
dependent on the  level o f  expression of  MHC class I I  molecules i f  some other  i nh ibito ry 
capacity cou ld be explained and e l iminated . 
Inconsistency in the MLR response was attributed to an inhibitory capacity 
inherent in the U937 cell line . I n  order to i nvestigate the natu re of  the  i nh ibitory 
capacity exhibited by these cel ls experiments were conducted i n  wh ich U 937 sub l ines 
we re treated wi th  m itomyc in  C as they were for use as st im u lator cel ls and 
subsequently added in  different doses to a normal M LR react ion between H LA- D R  
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m ismatched i nd ividuals in  an assay in which T cel l pro l iferation wou ld be stim u lated to 
ascertai n  whether the i nh ibitory effect cou ld  be med iated by the  ce l l s  (or  t he i r  
products wh i l e  i n  cu l tu re) o r  whether the addi t ion o f  U 937 sub l i ne  ce l l s  wou ld 
cost imu late producing an additive effect on 3 H-thymid ine incorporation .  T h e  resu lts 
are shown in Figure 20. When no U937 cel ls were added, the M LR reaction produced 
by one of the three combinat ions in which the same responder PBMC were used with 
three d ifferent H LA mismatched stimu lator PBMC populat ions was very weak (2200 
cpm) whereas the M LR reaction for the second and th i rd combinat ions were 1 3600 
cpm and 1 3900 cpm ,  respective ly. When E1 1 subl ine ce l ls  were added to th is  M LR 
there was augmented 3 H-thymid ine incorporation at low E 1 1 cel l  dose . When 5000 
E 1 1 ce l ls were added to the stimulated combinations (A X Cx and A X Dx) , there was 
s ig n ificant increase in the cpm . When 1 0 ,000 E1 1 ce l l s  were added, 3 H - t h y m id i n e  
incorporation for al l  three combinations was increased ; however, at h igh ce l l  dose the 
E 1 1 ce l ls  added were clear ly i nh ibitory and reduced 3 H-thym id ine inco rpo ration to 
or ig ina l  MLR levels for [A X Bx] and below base l i ne  M LR leve l s  fo r the  other  
combinations .  I n  F igu re 20B,  G4 sub l ine  cel ls were added to  these same M LR ce l l  
combinations. I n  th is case , addition to [A X Bx] and [A X Cx] caused a transient i ncrease 
in  3 H-thymidine i ncorporation when 5 X 1 03 U937 cel ls  were added fo l lowed by a 
dramatic inh ibition of the normal M LC at 1 X 1 04 and 5 X 1 04 added U937 ce l ls .  When 
G4 subl ine ce l ls were added t o  [A X Ox] , al l  doses of G4 cel ls  were markedly inh ibitory ,  
although the  1 X 1 04 dose was not more inh ibitory than 5 X 1 03 U937 ce l ls .  In  Figu re 
20C ,  the add ition of G 1 1 subl ine cel ls was stimu latory at al l  doses added. The f inding 
that the addit ion of G1 1 subl ine cel ls at al l concentrat ions was stimu latory appears to 
ru le out the possibi l ity that addition of moderate to high doses of U937 cel ls to we l l s  
already conta in ing reactive responder and stimu lator cel ls  i nh ibit  M LR by mechan ical 
means by sheer weight or  senescence due to crowding or  use of ava ilable n utrients .  
Thus the i nh ibitory effects are mediated e i ther  by the ce l l s  them se lves poss ib ly  
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FIGURE 20. SUPPRESSIVE ACTIVITY OF U937 CELLS WAS INVESTIGATED BY ADDITION 
OF U937 SUBLINE CELLS TO A NORMAL MIXED LYMPHOCYTE REACTION. 
MLR assays were set up  between three normal PBMC responders and th ree 
normal  PBMC stimu lato rs (1 X 1 05 cel ls/we l l  for each) . Several doses of  U 937 
sub l ine E1 1 ce l ls  (A) , sub l ine G4 cel ls  (B) , and subl ine G 1 1 cel ls (C)  were added to 
each combinat ion (5 X 1 03 , 1 X 1 04 , 5 X 1 04 U937 cel ls  added/we l l ) .  Resu lts are 
expressed as the mean of 3H-thymidine i ncorporation as cpm in  tr ipl icate we l ls .  
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through interaction with a cel l  surface receptor o r  by some product secreted by the 
U937 cel ls  i n  spite of  the i r  repl icative i nactivation by treatment with mitocycin C .  
To further study the ability of the U937 parent and sublines to mediate an MLR 
and discover the nature of the inhibition commonly seen. cells were treated in two ways 
prior to addition to MLR assays. Gentle fixation with 1 % paraformaldehyde has been 
shown to preserve the cel l su rface receptor arch itectu re wh i le  i nactivat i ng  any  
further metabolic function (98) . Subl ines G4 ,  E 1 1 ,  G 1 1 and  E9 were treated i n  t he  
normal manner with m itomycin C or by  overn ight f ixation with 1 % paraformaldehye 
fo l lowed in both cases by extensive washing.  When these cells were added to responder 
ce l l s  in a series of experiments i l l ustrated in F ig u re 2 1 , i t  was fou n d  that the  
paraformaldehyde fixed ce l ls were able to  stimu late the generation of  an M LR .  Although 
the leve l of stimu lation of the responders by fixed G4 subl ine cel ls  was less than that 
seen with m itomycin C treated G4 subl ine ce l ls except at the h ighest dose , stimu lation 
by f ixed E 1 1 ce l ls was v i rtua l ly  identical to m itomyci n C treated E 1 1 ce l l s  and  
st imulation by  fixed G 1 1 and  E9  subl ines exceeded that seen with m itomycin C t reated 
cel ls  at several concentrations. The normal M LR is shown for comparison to the U 937 
stim u lated M LR and to indicate that the responder cel ls were not maximal ly stimu lated 
by any of the U937 cel ls .  Thus paraformaldehyde fixed U937 cel ls  are capable of 
stimu lating an MLR to approximately the same degree as m itomycin C treated ce l ls  and 
in the case of the G1 1 subl ine, an M LR i s  produced at the usual  dosage of 1 X 1 05 
cel ls/we l l  with fixed cel ls  but not with m itomycin C treated cel ls .  Thus  it postu lated 
that the production of secreted i n h ibitory factors m igh t  be respons ib le  fo r the  
inconsistencies seen in generation o f  MLR. 
The effect of dose of normal peMC stimulators in MLR to which U937 cells were 
added was examined. To further i nvestigate the effect of addition of U937 cel ls to a 
normal M LR between two individuals known to have different M HC class II and to expand 
on  the information gained from the exper iments shown in  Figure 20,  responder ce l l s  
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FIGURE 21 . STIMULATORY CAPACITY OF PARA FORMALDEHYDE FIXED AND M ITOMYCIN 
C-TREATED U937 SUBLINE CELLS WAS COMPARED IN M IXED LYMPHOCYTE REACTION. 
U937 subl ine cel ls were treated with m itomycin C, as previously described , or 
gent ly f ixed with 1 % paraformaldehye prior to addit ion to normal PBMC responder  
ce l ls  ( 1  X 1 05 ce l ls/wel l ) . U937 subl ines E 1 1 and  G4 (A) and  subl ines G 1 1 and E9  
(B) were treated and added a t  fou r  doses : 1 X 1 04 , 5 X 1 04 , 1 X 1 05 , and  2 X 1 05 
ce l ls/we l l .  Normal al logene ic M LR react ion between responder and PBMC stim u lator 
ce l l s  is i l l ustrated for comparison .  Resu lts a re presented as the mean  o f  tr ip l icate 
wells in th ree assays.  
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( 1  X 1 05 ce l ls/wel l) were i ncubated with a series of doses of normal PBMC sti mu lator 
cel ls (5 X 1 03 , 2.5 X 1 04 , 5  X 1 04 and 1 X 1 05 ce l ls/we l l )  as shown in F igu re 22 .  
Addition of  1 X 1 05 normal PBMC st imu lator ce l ls  e l l icited the h ighest 3 H - th y m i d i n e  
incorporation by the responders and stim ulators alone, althoug h ,  at a l l  doses there was 
a strong M LR.  When various doses of mitomycin C treated E1 1 subline ce l ls  were added 
to this M LR,  a dose dependent increase in 3H-thymidine i ncorporation was noted when 
low doses of normal stimu lators were added. At normal M LR stimu lator concentration 
(1 X 1 05 ce l l s/we l l )  the add i t ion  of m i to myci n C -treated E 1 1 c e l l s  at a l l  
concentrations fai led to s ign ificantly i ncrease the M LR generated . When 5 X 1 04 
paraformaldehyde fixed E 1 1 subl ine ce l ls were added to the normal M LR ,  there was 
marked enhancement of stim ulation at al l  stimu lator ce l l  doses and even at the h ig hest 
normal stimu lator ce l l  dose,  the addition of paraformaldehyde fixed ce l ls  s ig n ificant ly 
e n hanced 3 H-thymidine incorporation .  Conversely ,  when U937 supernatant poo led 
from t issue cu lture flasks of 3-day cultures was added to the normal  M LR at a fi na l  
concentration of  1 :4 or  1 :40 ,  the  M LR was ablatted at  al l  ce l l  concentrations .  F indings 
in th is  series of  experiments that addition of  mitomycin C treated or paraformaldehyde 
fixed U937 E1 1 subl ine ce l ls  to a normal M LR was capable of st imu lating  enhanced 
3 H-thym idi ne incorporation indicated fu rther that the U937 cel ls  were capable of 
st i m u l at ing an M L R .  The f ind ing that add i t ion of paraformaldehyde t reated ,  
metabo l ica l ly inactive E 1 1 subl ine cel ls enhanced to  a marked degree even  a t  t he  
h ighest doses fu rther ind icated that there m igh t  be  someth ing secreted by  part ia l ly  
inactivated , m itomycin C treated cel ls .  Also the finding that d i rect addit ion of pooled 
fresh U937 supernatant in the form of spent cu lture medium caused loss of MLR at al l  
stimulato r doses conf i rmed t hat U937 ce l l s  const i tu i t ive ly  p rod uce i n h i b itory 
substances. 
Addition of U937 cell supernatant inhibited MLR assays. Figu re 23 iHustrates 
a representative experiment in  which supernatant from parent 2 - 1  and sub l i nes  E 1 1 ,  
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F IGURE 22. PARAFORMALDEHYDE-FIXED OR MITOMYCIN C-TREATED U937 SUBL INE 
E1 1 CELLS AUGMENT A NORMAL MIXED LYM PHOCYTE R EACTION WHEN N O R MAL 
STIMULATORS ARE ADDED AT SUBOPTIMAL DOSES. 
M LR assays were set up with normal PBMC responders (1 X 1 05 ce l l s/we l l )  
and fou r  doses of  normal PBMC stimu lator ce l ls :  5 X 1 03 , 2 .5 X 1 04 , 5 X 1 04 and 1 X 
1 0 5 cel ls/we l l .  U937 subl ine E 1 1 cel ls  were t reated with m itomycin C and added to 
M LR assay we l ls at three doses (5 X 1 03 , 1 X 1 04 , 5 X 1 04 , and 1 X 1 05 ce l ls/we l l ) ; 
fixed with 1 % paraformaldehyde and added to M LR assays at a s ing le dose of 5 X 1 04 
ce l ls/wel l ; or  supernatant from U937 subl ine E 1 1 was added to M LR assay wel l s  at a 
f inal  concentrat ion of 1 :4 or  1 :40 . Resu lts are expressed as the mean of 3 H- thym id i n e 
incorporation as cpm of tripl icate we l ls i n  two assays. 
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F IGURE 23. SUPERNATANT FROM U937 PARENT AN D SUBLI N ES IS  A POTENT 
INHIBITOR OF NORMAL MIXED LYMPHOCYTE REACTION. 
Supernatant from U937 parent 2-1 and subl ines E 1 1 ,  G4, G 1 1 ,  and E9 was 
added to M LR assay we l ls  contain i ng  normal PBMC responder cel ls (1 X 1 05 
ce l ls/wel l )  and normal a l logeneic PBMC stimu lator ce l ls  ( 1  X 1 05 ce l ls/we l l )  at fi na l  
concentrations of  1 :4 , 1 :40 and 1 :400.  Resu lts are expressed as % I nh ibit ion of the 
normal al logeneic MLR as measured by 3 H-thym id ine incorporation in  tr ipl icate wel ls 
in three assays. 
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G4, G 1 1 and E9 was added to normal MLR assays at f inal concentrations  of 1 :4 , 1 :40 
and 1 :400.  For al l  supernatants at a 1 :4 d i lut ion ,  g reater than 80% inh ibit ion was 
seen .  I n hibitory activity persisted a t  1 :40 and 1 :400 d i lut ions and  on ly with G 1 1 and 
G4 supernatants was there any d im in ution i n  i nh ibitory capacity at 1 :400  d i l u t io n .  
Thus  t h e  inh ibitory substances secreted b y  U937 cel l s  are secreted b y  a l l  of the 
subl ines and the parent l ine and are very potent. 
Addition of indomethacin to the MLR did not affect the response. Prostag landins ,  
particu larly PG E2,  have been shown to be smal l  molecular weight inh ibitory molecules 
produced by macrophages.  Because the U937 ce l l  l ine has macrophage - l i ke 
characteristics , it seemed probable that i nh ibition of the M LR m ight  be related to the 
product ion of PG E2 by the U937 cel ls .  To i nvestigate the role of PGE2 in  U937 
supernatant inhibition ,  indomethacin , a PGE2 inh ibitor, was added to the M LR at th ree 
concentrations as shown in Figure 24A and 24B. Addition of indomethacin to the assay 
had no sig n ificant effect on the generation of the MLR by the m itomycin C treated G4 
subl ine stimu lator ce l ls ,  Figure 24A, or  E 1 1 subl ine stim u lator ce l ls ,  Figu re 24B,  and 
the level of stimu lat ion was s im i lar to the l eve l  obtai ned with the addi t ion of  
paraformaldehyde fixed stimu lator cel ls .  Thus,  production of prostag landin which may 
occur  is  not  responsib le for the M LR inh ibit ion see n when supernatant i s  added.  
Addition of st imu lator U937 subl ine G4 or subl ine E 1 1 ce l ls  inactivated by i rradiation 
with 3000 rads in  a 1 3 7 Cs sou rce cel l i rrad iator,  abrog ated any M LR respo n se 
i ndicat ing that i rradiat ion of U937 with the standard dose used fo r i nactivat ion of 
PBMC stimu lators does not i nact ivate U937 production and secretion of i nh ib itory 
substances. 
pretreatment of stimulator U937 cells with immunomodulators did not affect 
the MLR. I t  was reasoned that if the la+ U937 subl ines G4 and E 1 1 are capable of 
mediat ing an MLR,  then treatment with gamma interferon ,  wh ich increases MHC class 
I I  expression ,  or PDBu,  which increases membrane I L- 1  expression {to be d iscussed 
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FIGURE 24. ADDITION OF INDOMETHACIN TO MIXED LYMPHOCYTE REACTION IN  WHICH 
U937 SUBLINE CELLS WERE ADDED AS STIMULATOR CELLS HAD NO EFFECT. 
U937 subl ine G4 (A) and subl ine E 1 1 (B) ce l ls  were m itomycin C-treated and 
added to normal PBMC responder ce l ls ( 1  X 1 05 cel ls/wel l)  at th ree doses : 5 X 1 04 , 1 
X 1 05 and 2 X 1 05 . I ndomethacin at th ree concentrat ions i nd icated was added at the 
in it iat ion of M LR assay to we l ls  contain ing  m itomycin C-treated U937 ce l ls  + normal 
PBMC.  I n  addit ion U 937 cel ls treated by  f ixatio n with 1 % paraformalde hyde o r  by 
i rrad iat ion with 3000 rads us ing a 1 37 Cs i rrad iator were also added as st im u lator 
ce l ls  to normal PBMC responders. Resu lts are expressed as the mean of 3 H-thym id i ne  
incorporation as  cpm o f  tr ipl icate wel ls i n  two assays . 
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below) , m ight enhance the abi l ity of these sublines to stimu late an MLR.  As shown in  
Fig u re 25, th is  was not found to be t rue with sub l ines G4 and E 1 1 .  U937 cel ls were 
treated with gamma interferon for 24 hours or treated with PDBu for 72 hours pr ior 
to addit ion to an M LR assay. As indicated there was no change i n  3 H - t h y m i d i n e  
incorporation after treatment with either gamma interferon o r  PDBu . The normal MLR 
in  shown to  emphasize the  fact that the  responder cel ls used in  these experiments were 
not maximal ly stimu lated by the U937 ce l ls ,  either treated or non-treated. 
U937 sublines haye been shown to mediate macrophage dependent functions in 
seyeral cellular assays. 
U937 sublines were able to replace monocytes in CD3lT3) induced mitogenesis. 
Monoclona l  ant ibody to the C D3 molecu les of the C D3-T ce l l  (T3-TcR) receptor 
complex on the surface of T cel ls has been shown to bind to the CD3 molecule and cause a 
m itogen ic pro l iferation of the T ce l ls (99) . Th is prol i ferat ion ,  however, i s  dependent 
on the presence of monocytes i n  the cul ture ( 1 03) . I t  h as been cla imed that  the 
requ i rement for monocytes may also be overcome by addition of exogenous I L- 1  ( 1 04) . 
F ig u re 26 represents a t i t rat ion experiment i n  wh ich d iffe rent concentratio ns  of 
normal human monocytes iso lated from PBMC by adherence fol lowed by scraping from 
plastic petri dishes were added to  nylon-wool purified lymphocytes to  reconstitute the 
m itogen ic response caused by the addition of C D3 specific ant ibody (OKT 3)  to 
per i phe ra l  b lood mononuc lear  ce l l s .  Ny lon -woo l pur i f ied lymphocytes a lone  
incorporated less than 1 0000 cpm 3H-thymidine during a 1 6- 1 8 hou r  pu lse ,  whereas 
addit ion of monocytes increased the 3H-thymidine incorporat ion i n  a dose dependent 
fashion for doses of 5 X 1 03 and 1 X 1 04 monocytes. The addition of 2 X 1 04 monocytes 
did not sign ificantly i ncrease the m itogenic response seen with 1 X 1 04 monocytes and 
5 X 1 04 monocytes i nhibited the response. Thus a dose of 1 X 1 04 monocytes/we l l  
appeared to mediate optimal m itogenic response. 
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F IGURE 25. PRETREATM ENT OF U937 SUBLI N E  STI M U LATOR CELLS WITH GAMMA 
INTERFERON OR PDBU DID NOT AUGMENT THEIR ABIUTY TO STIMULATE AN MLR. 
U937 subl i ne  G4 ce l l s  and sub l i ne  E 1 1 cel ls we re treated wi th  g a m m a  
in te rferon ( 1 00 u ni ts/m l . )  for 2 4  hours o r  P DBu  ( 1 0 -8 M)  fo r 7 2  hours pr ior  to 
m itomycin C treatment and addit ion to M LR assay we l ls  contain ing  normal  P B M C  
respo nder cel ls  ( 1  X 1 05 cel ls/wel l ) . Resu lts are expressed a s  the  m ean o f  3 H ­
thymid ine incorporation as cpm of tr ipl icate wel ls in two assays.  
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F I G U R E  26 .  MONOCYTES ADDED TO NYLON-WOOL P U R I F I E D  LYM P H OCYTES 
RECONSTITUTES THE CD3 MITOGENIC RESPONSE. 
Peripheral blood mononuclear cel ls isolated by fico l l - hypaque techn iques  were 
incubated in plastic petri d ishes for 1 -2 hours .  Non-adherent cel ls were removed by 
p ipet, concentrated by centrifuging and added to nylon woo l columns to remove residua l  
B ce l ls  and any remain ing monocytes . The petri d ishes were washed with media and 
adherent monocytes were removed with a rubber pol iceman.  Ce l ls  were cou nted and an 
appropriate number of monocytes was added to wel ls  contain ing  nylon-wool p u rif ied 
lymphocytes . OKT3 antibody (0 . 1  �g/wel l )  was added to wel ls contain ing  u n separated 
PBMC and Iymphocytes+monocytes .  M icrotiter p lates were incubated fo r 72 hours 
with a 1 6- 1 8 hour 3 H-thym id ine  pu lse .  
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Experiments were conducted to determine whether U 937 subl ines were capable 
of substitut ing for monocytes i n  the mediat ion of C 03 induced m itogenesis . Part ia l ly  
pu r if ied T ce l ls  were prepared by passag e ove r  ny lon -woo l co l u m n s ,  added to 
m icrot iter plates to which monoclonal ant i  C 03 (OKT3) was added at a concentration of 
0 . 1  �g/m l and U937 sub l ines were added at doses of e i ther  1 X 1 04 or  5 X 1 04 
ce l ls/we l l .  As seen in F igu re 27, the U937 subl ines were capable  of substitut ing for 
monocytes in  the m itogen ic response. Subl ine G4 was found to mediate leve ls of 3 H ­
thymidine uptake comparable to the level seen with monocytes at cel l doses of both 1 X 
1 04 and 5 X 1 04 . Subl ines G l l and E9 were effective accessory cel ls  at the h ig her  ce l l  
concentration but  much less able to mediate the m itogenic response at  the lower ce l l  
concentration . Sub l ine El l and 2- 1 parent U937 ce l l  l i nes m ediated strong responses 
at  both cel l doses but  i n  both cases the response was sl ightly less than that seen for 
ei ther added monocytes or added G4 subl ine ce l ls .  T cel ls incubated with U937's alone 
d id  not  take up 3 H-thymid ine (data not  shown)  and T ce l ls  incubated with ant ibody 
alone incorporated less than 1 0 ,000 cpm . 
pretreatment of U937 parent and subline cells with gamma interferon did not 
significantly alter their relative abilities to mediate the mitogenic response to C 0 3  
specific antibody. U937 parent and subl ines were pretreated with gamma in terferon at 
a concentration of 1 00 Un its/ml .  for 24 hours as shown i n  Figu re 28 at an accessory 
cel l  concentration of 5 X 1 04 cells/wel l ,  except for the  G l l subl ine  for which gamma 
in te rfe ro n  pretreatment decreased the  accessory ce l l  fun ctio n .  The 3 H - t hy m i d i n e  
incorporation exh ibited by nylon-wool purified lymphocytes i n  we l ls  where U937 2 - 1  
parent ce l ls ,  E l l sub l ine and G4 sub l ine ce l ls  were added as accessory cel ls was 
sl igh tly higher for pretreated ce l ls  than for non-treated cel ls ; and the 3 H - t h y m i d i n e  
incorporat ion i n  the presence o f  pretreated E 9  subl i ne  ce l ls  was s l igh t ly lower  than 
non-treated E9 sub l ine cel ls .  U937 cel ls were washed after incubat ion with gamma 
in terfe ron fo r 24 hours and gamma interfero n  was not  present d u ri ng  t h e  C 03 
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F IGURE 27. U937 SUBLINES AN D PARENT LIN E  ACT AS ACCESSORY C ELLS IN C D3 
MITOOENESIS. 
U937 subl ines were added to nylon wool purified peripheral blood mononuclear 
ce l ls  as accessory ce l ls in a C D3 m itogenesis assay. Mononuclear leukocytes prepared 
by standard ficol l  hypaque density g radient techn iques were i ncubated in p lastic petri 
d ishes for 1 -2 hours to a l low adherence of monocytes .  Non-adherent  ce l l s  we re 
removed and further purified by passage over nylon-wool co lumns .  These ny lon wool 
non-adherent  ce l ls  were then pipetted in to microtiter p lates ( 1  X 1 0S/we l l )  to w h ich 
mo noclona l  ant i-CD3 (OKT3) was added at a co ncentr�t io n of 0 . 1  Jlg/m l .  U937 
s u b l i n e s  wh ich were  pretreated w i th  m itomycin  C to preve nt  3 H - t h y  m i d i n e 
incorporation were added at doses of ei ther 1 X 1 04 or 5 X 1 04 cel ls/we l l .  Contro ls  
i ncluded T cel ls alone,  T cel ls  + OKT3 , T cel ls  + U937's ,  U 937's + OKT3, and  T ce l ls  + 
monocytes ( removed from the petri d ishes by scraping with a rubber pol iceman)  at 
concentrat ions of 5 X 1 03 ,  1 X 1 04 or 5 X 1 04 cel ls/we l l  ± OKT3 . The ce l l s  were 
i ncubated for 72 hours with a 3 H-thymid ine pu lse fo r the  f ina l  1 6- 1 8 hours .  Ce l l s  
were harvested and  cou nted i n  a l iquid scint i l lation cou nter to  measure 3 H - thy m id i n e  
u ptake . 
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F IG U R E  28 .  EFFECTS OF GAMMA I NTER FERON P R ET R EATM E NT O N  U 937 
RECONSTITUTION OF CD3 MITOGENESIS. 
U937 parent 2-1  ce l l  l i ne  and subl ines were incubated with gam m a  interferon  
a t  a concentration of  1 00 U/m l .  for 24  hours fol lowed by  wash ing to  remove any 
res idual  gamma i nterferon .  Ce l ls  were resuspended i n  media and treated wi th  
m itomycin C.  CD3 m itogenesis assay was set up in  the same manner as for Fig u re 23 ,  
except that on ly  one ce l l  dose was ut i l ized . Gamma interferon was not  present  dur ing 
the CD3 mitogenesis assay. 
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mitogenic assay. 
U93? parent and sublines were able to present antigen to nylon wool purified 
lymphocytes. The antigen chosen for presentation was tetanus toxoid because a l l  of the 
avai lable donors had been immun ized with tetanus toxoid with in  24 month s of th is  
study. Donors were tested fo r a cel l u lar response to tetanus toxoid by addit ion of 
d i l ut ions of tetanus toxoid to fico l l - hypaque iso lated PBMC (438) . Respo n se was 
measu red as 3 H-thym idine incorporation after a 1 6  hou r  pu lse at the end of a 96  hour  
incubat ion .  I n  a l l  cases where a response was noted , a 1 /200 di l ution of  ant igen was 
found to be optimal (data not shown) .  
Although the standard method for assay of tetanus reactivity s imply requ i red 
addit ion of the di lution of tetanus toxoid di rect ly to the m icrotiter we l l  contain ing  the T 
ce l ls and accessory cel ls ,  this method proved to be unsatisfactory for testing the antigen 
prese ntat ion capacity of U93? ce l l s .  A cont i n u i n g  prob lem wi th the an t i g e n  
presentat ion expe r iments was the  res idual teta n u s  reactivity of  t he  ny lo n -woo l  
pu rified lymphocytes,  which were probably contaminated with autologous accessory 
ce l ls  as ind icated in Figure 29.  When normal monocytes were added to the T ce l l s  + 
tetanus toxoid,  there was a dose dependent increase i n  3 H- thymid ine  i nco rporatio n 
(F igure 29A) ; however, when U93? subl ine G4 cel ls were added, there was an increase 
i n  3 H-thymidine incorpo ration at low G4 dose and suppression of 3 H - t h y m i d i n e  
incorporation at h igher G4 doses as shown i n  Figure 29B.  This phenomenon was even 
more striking when subline E1 1 cel ls were added as ind icated in Figure 29C. I n  o rder 
to ci rcumvent autologous ant igen processing and presentation by res idua l  accessory 
ce l ls as much as poss ible ,  ce l ls to be used as accessory cel ls  were incubated overnig ht 
with tetan us toxoid at a concentrat ion of 1 /200 pr ior to m itomycin C treatment 
fol lowed by extensive washing . Monocytes and U93? subl ines G4 and E 1 1 treated in  
th is  manner  were able to  present tetanus toxoid to  T ce l l s  as  shown in  F ig u re 29 .  
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F IGURE 29. U937 SUBLI NE G4 AND E1 1 CELLS CAN PRESENT ANTIGEN TO NYLON 
WOOL-PURI FI ED T CELLS. 
Nylon wool purified responder lymphocytes were prepared from normal  PBMC 
by adherence fo l lowed by passage of non-adherent ce l l s  over  a nylon woo l  co l u m n .  
Donors selected had been reimmunized to tetanus toxoid with in the previous 2 4  months.  
Monocytes were isolated by retrieval of adherent cel ls  from petri d ishes by scrap ing . 
Monocytes (A) and U937 subl ine G4 (B) and E 1 1 (C) ce l ls  were pu lsed with tetanus  
toxoid a t  a concentration o f  1 :200,  incubated overn ight ,  washed 4 -5  t imes ,  treated 
with m itomycin C and added to responder lymphocytes in m icrot iter p lates (2 X 1 05 
ce l l s/we l l )  at stated doses .  Alternative ly ,  U937 sub l i ne  G4 and E 1 1 ce l l s  and 
monocytes were added to wel ls contain ing responder lymphocytes and tetanus toxoid at  a 
f inal concentration of 1 :200 was added directly to the wel ls .  Assays were incubated for 
s ix days with 3 H-thymid ine pu lse for the  f ina l  1 6- 1 8 hou rs .  Resu lts as cpm are 
expressed as the mean of tripl icate wel ls  in two experiments. 
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Tritiated-thymidine i ncorporation increased in a dose dependent fash ion for monocytes 
and increased to a maximum leve l at 1 X 1 04-2 X 1 04 cel ls/wel l  for U937 sub l ines G4 
and E1 1 prior to becoming suppressive at 5 X 1 04 cel ls/we l l .  F ig u re 30 shows a 
compi lation of several exper iments i n  which antigen pu lsed monocytes and ant ige n  
pu lsed U937 subl ines G 4  a n d  E1 1 were added t o  ny lo n-wool purified T ce l l s .  A s  
ind icated , t h e  tetanus response mediated b y  both  the  sub l ines a n d  mo nocytes  i s  
comparable in magn itude of 3H-thymidine incorporation a n d  ce l l  dose response.  Non­
ant igen pu lsed U937 sub l i nes and monocytes fa i led to st i m u late 3 H - t h y m i d i n e  
i ncorpo ration .  
preliminary data indjcated that treatment of U937 sublines with tuftsin did not 
alter antigen presentation. Tuftsin , which is a smal l  molecu lar weight polypeptide ,  has 
been shown to stimulate phagocytic uptake by monocytes or macrophages (475) . It was 
reasoned that monocytes and U937 cel ls might be able to process and present antigen to 
a greater degree if more antigen could be endocytosed. This was tested with subl ine G4 
cel ls and normal monocytes .  Ce l ls were treated with tufts in  j ust prior to addit ion of 
ant igen .  Although a s l ight increase in  tetanus response by to tufts in-treated ant igen  
pu lsed monocytes,  no  comparable response was seen with subl ine G4  ce l l s  (data not 
shown ) .  
pretreatment of U937 parent cells and subljnes G4 and E1 1 with either gam ma 
interferon or POSu did not significantly alter their capacity to present tetanus toxoid. 
F u rther  attempts to augment the ant igen present ing capacity of the  U 937 ce l ls  by 
pretreatment of the U937 subl ines G4 and E1 1 and . the 2-1 parent ce l l  l i ne  with e i ther 
gamma interferon for 24 hou rs or POSu for 72 hours pr ior  to addit ion of these cel ls to 
ny lon wool  pu rified lymphocytes had no s ign ificant  effect on the  magn i tude of the 
response (data not shown) .  Thus pretreatment with either  gamma inte rfero n  or  P OSu 
ne ither enhances the ant igen present ing capacity of the U937 cel ls nor does it inhibit 
that capacity . 
1 9 3 
F IGURE 30.  ANTIGEN PULSED U937 SUBLI N E  G4 AN D E1 1 CELLS EFFECTI VELY 
PRESENT ANTIGEN TO NYLON-WOOL P U R I F I E D  T LYM PHOCYTES I N  A MAN N E R  
CO\1PARABlE TO AUTOLOGOUS M<:)\J(CYTES. 
Cel ls were isolated and ant igen pu lsed with tetanus toxoid and assays were 
conducted as described for Figure 29. Results as cpm are expressed as the m ean of 
trip l icate we l ls i n  th ree experiments . 
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The antigen presenting capacity of U937 is inhibited by antibody specific for 
MHC class II. Figure 31 i l l ustrates the response of th ree  donors to tetanus  toxoid 
pu lsed autologous monocytes and to tetanus toxoid pu lsed U937 subl ine G4 and E 1 1 
ce l ls and parent 2-1  ce l ls .  The levels of response were varied as i nd icated by the vast 
difference in ordinate sca le .  Responders CS and CJ , F ig u res 31 A and 3 1  B ,  were 
re latively low responders and responder CD,  Figu re 3 1 C ,  was a h igh responder.  In a l l  
cases, however, the response to antigen presentation by U937 cel ls  was comparable to 
ant igen presentation by autologous monocytes .  Ant ibodies specific for fra mework 
dete rm inants of human la (Ku l a2) , 62 microg lobu l i n  (BBM . 1 ) which associates with 
MHC c lass I molecu les, C D4 (KT69-7) wh ich is in association with the T cel l receptor 
and also present on U937 ce l ls and at a low concentration on normal human monocytes , 
and he tero logous ant ibod ies  specif ic fo r part icu la r  H LA- D R  specif ic i t i es  and  
presumably specific for t he  polymorphic reg ions o f  those MHC class " mo lecu les were 
added to the antigen presentation assay.  Tetanus toxoid antigen was added to the antigen 
presenting cel ls  and incubated overnight as previously described,  fol lowed by extensive 
wash ing prior to addition to the nylon-wool purified lymphocytes. Thus on ly antigen in 
association with the antigen presenting cel ls was added to the assay. As shown in  F ig u re 
32, antibody to human l a  (Ku l a2) effective ly i nh ibited the response in a l l  cases both at 
a 1 : 1 0  di lution and at 1 :25 in a dose dependent manner.  A second antibody wh ich was 
a lso broadly in h ib itory was the ant ibody specific fo r C D4 (KT69- 7) w h ich  has  
previous ly been shown to  inh ibit t he  autologous  M LR bu t  no t  t he  al logeneic M LR (440) . 
The 2 - 1  parent  U937 ant igen presentat ion reaction was not i nh ibited to the  same 
deg ree by th is  antibody for any of the three responders tested. As indicated in  Table 5 ,  
t he  2 - 1 pare n t  ce l l  l i n e  expresses  C D 4  as  m e a s u red by KT6 9 - 7  u s i n g  
immunofluorescence techniques t o  the same degree a s  the subl ines G4 a n d  E1 1 .  N o  
s ign ificant i nh ibit ion o f  the  tetanus response by  the antibody to  62  microg lobu l i n  was 
observed in antigen presentation by U937 ce l ls  or autologous monocytes .  Althou g h  
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F I G U R E  31 . ANTIGEN P U LSED U937 PARENT 2- 1  AN D SUBLI N ES G4 AN D E 1 1 
PR ESENTED TETAN US TOXOI D  TO THREE R ESPONDER NYLON-WOOL P U R I F I E D  T 
LYMPHOCYTE PREPARATIONS. 
Nylon wool purified T lymphocytes were prepared as previously described and 
added to assay wel ls at 2 X 1 05 cells/wel l .  Accessory cel ls (APC) were pulsed, washed 
and treated with m itomycin C prior to addition to the assay wel ls at a dose of 5 X 1 03 
ce l l s/we l l .  Responder 1 (A) and responder 2 (B)  were moderate ly respo nsive to 
ant igen presentation by al l  APC ;  however, responder 3 (C) gave a sign ificantly h igher  
response. Contro l  values included addition o f  non-pu lsed APC to responder ce l ls  and  
add it ion o f  tetanus toxoid d irect ly to  responder ce l l s .  A l l  values shown h ave been  
corrected for response to non-pu lsed APC at  the  same dose and  for response to  tetanus 
wi thout  addit ion of APC.  Va lues i l l ustrated are the  mean of cpm fo r i ndiv id u a l  
responders assayed in tripl icate wel ls. 
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F IGURE 32. ANTIGEN PRESENTATION BY MONOCYTES AND U937 2-1 PAR ENT AND 
SUBLINE G4 AND E1 1 CELLS IS ABROGATED BY ADDITION OF ANTIBODY TO MHC CLASS 
I I  OR CD4. 
Responder lymphocytes and ant igen prese nt ing ce l l s  were those previo us ly  
described in Figure 3 1 . Heteroantibodies specific for H LA-DR2,  H LA- D R3 ,  and H LA­
DR7 were added to wel ls  at a concentration of 1 : 1 0 . Monoclonal  antibody specific for 
framework determ inant of h uman la ,  K u l a2 was added at 1 :1 0  and 1 :25 ; monoclona l  
ant ibody specific for C D4 ,  KT69-7,  was added at a conce ntratio n of 1 : 1 0 ; and 
monoclonal antibody to  B2-microg lobu l i n ,  BBM,  was a lso added at  a concentration of  
1 : 1 0 .  Values i l l ustrated ind icate the % I n h ibit ion of the  max ima l  response seen in  
Figu re 3 1  for monocytes (M0) (A) , U937 parent 2- 1  (B ) ,  U937 sub l ine G4 (C)  and 
U937 subl ine E1 1 (D ) .  
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sl ig ht inhibition was seen , the responses were smal l and inconsistent. 
When heterologous H LA- O R  specificity specif ic antibodies were added to the  
assays , the  resu lts were very interesting .  As shown in  the chart of H LA specificit ies of 
the responders and the U937 ce l l  l i ne  shown in Fig u re 32,  on ly responder CS shares 
the  H LA-OR2 specificity wi th  the  U 937 ce l l  l i n e ;  h owever ,  a l l  of th e responders 
respond to the addition of antigen pu lsed U937 cel ls  to the assay. H LA-OR2 specific 
ant ibody was strongly i nh ibitory fo r responders CS and CJ and was s m a l l  with 
responder CO,  who it must be remembered from Figu re 3 1  C ,  was hyperresponsive to 
tetanus toxoid .  H LA- OR3 specific ant ibody d id not i nh ibit ant igen presentat ion by 
either G4 or E1 1 subl ine or parent 2-1  ce l ls .  The effect of H LA-OR7 specific ant ibody 
on U937 mediated antigen presentation was variable ,  strong ly inh ibit ing the response 
by CS but not the response by CJ . Unfortunately, the HLA-OR7 antibody was ut i l ized 
on ly on two of the three responders. When these same antibodies were added to antigen 
presentation assays i n  wh ich antigen pulsed autologous monocytes were added , ant i ­
H LA- OR2 antibody blocked a l l  responses somewhat with strongest i nh ibit ion of H LA­
OR(5 ,6) responder CJ . Although th is can not be explained at th is t ime, h etero logous  
ant ibodies used for typ ing reagents are  polyclonal  reagents which frequ e nt ly h ave 
specificity for Ow52 and Ow53 supertypic specificit ies which react with H LA- OQ.  I n  
spite of the i r  h ig h  corre latio n coefficients ( R  values) fo r a particu lar specificity , they 
are also reactive with these broader specificit ies, although in  a microcytotoxicity assay 
they wou ld not be strongly cytotoxic for the supertypic specificit ies.  Ant i - H LA- O R3 
was s l ight ly i nh ibitory of ant igen presentation by autologous monocytes o n ly from 
responde r CD ,  [HLA-O R (3,5)]  and anti -O R7 strong ly  i n h ibited responder C S ,  [H LA­
OR(2,7)] . I n h ibition of the antigen presentation by U937 cel l s  by the  addition of 
ant i - H LA- O R7 ind icates the  possib i l ity that i n  these assays t h e re a re su ffic ient  
residual antigen presenting cel ls  to  mediate a response by presenting antigen provided 
by the addition of the antigen pu lsed U937 ce l ls .  Although the response appears to 
2 0 1 
corre late with the H LA-DR7 specificity known to be expressed by the responder ,  the  
presence of  other specificity interactions can not  be ruled out .  Th is data,  particu lar ly 
with regard to HLA-DR specificity specific blocki ng , m ust be v iewed as pre l im i nary 
due  to the smal l  n u mber of responders exam ined and the i r  H LA  disparate n atu re ;  
howeve r,  there was strong i n h ib i t ion o f  ant igen-pu lsed U 937 st i m u l at ion o f  3 H ­
thymid ine incorporation ,  i . e .  antigen presentation , by monoclonal  ant ibod ies specif ic 
for h uman la and for CD4. 
The inhibitory capacity of U937 supernatant was investigated. 
Supernatant from U937 cells was found to inhibit the CML response. 
Previously it had been shown i n  F igure 23 that supernatants from the parent  and a l l  
subl ines tested were able to inh ibit a normal MLR when added at  concentrations as  h ig h  
a s  1 :400 .  Further investigation of the i nh ibitory propert ies of the supernatan t  were 
undertaken .  F igure 33 summarizes the inh ibitory effects of added supernatant in the 
generation of a CML response. As shown, the generation of a CML was re latively less 
sens itive to the supernatant effects than the MLR in  that the % i nh ibition was less than 
60% in a l l  cases in the CML rather than the 85% for the MLR. Because the C M L  is  
quantitated by measurement of chromium release and the M LR is quantitated as 3 H ­
thym id ine incorporation , the two values are not exactly comparable but g ive a genera l  
idea about relative sensit ivity .  Because a strong prol i fe rative respo n s e  i s  not  
n ecessary for the generation of the C M L, the relative insens itivity of the  C M L  m ay 
reside i n  reduction of cel l  n u mbers of cytolytic T cel l  precu rsors (CTLp) wh ich  can 
respond.  I n h ibit ion seen in the M LR in  which the incorporat ion of radion u cl ide is  
co rrelated wi th  ce l l u la r  p ro l i fe ration may ind icate e i the r  a cytostatic effect or  a 
cytotox ic effect and probably both .  Also seen in Figure 33 is the  m arkedly decreased 
inh ibition for subl ines E1 1 and G1 1 and enhancement with subl ines G4 and E9 and the 
parent 2-1 cel ls of the C M L  response with the add i t ion of s m a l l  a m o u nts  of 
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F IGURE 33 . ADDITION OF SU PERNATANT FROM U937 PARENT 2-1  AN D SUBLI N ES 
E1 1 ,  G4, G1 1 AND E9 INHIBITS THE CML RESPONSE. 
Cel l  mediated Iympholysis assays (CML) were set up  between normal PBMC 
responders and  stim u lators as  previously described . Supernatant from U 937 parent  
2 - 1  and subl ines E 1 1 ,  G4, G 1 1 and E9 were added to assay wel ls  at  concentrations of  
1 :4 , 1 :40 and 1 :400 at  the i n it iation of the assay. Resu lts are ind icated as the % 
I n h ibition of the % Cytotoxicity in the normal CM L in  the six hour 5 1 C r  re lease assay. 
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supernatant, 1 :400 d i lut ion .  Th is indicates that the supernatant probably conta ins  a 
complex m ixtu re of d ifferent secreted products some of wh ich are inh ibito ry and some 
stimu latory having specific activities wh ich are d i l uted out  at different rates .  
Supernatant from U937 also inhibits tritiated-thymidine incorporation in 
other assays and is partially heat labile . F ig u re 34 i l l u strates typical i n h ib ito ry 
patterns in three assays . The M LR as previously s hown in Figu re 23 is i nh ibited by 
addit ion of supernatant from pare nt 2- 1 U937 ce l ls and from a l l  sub l ines  tested.  
Supernatants added to assays shown in Figure 34 were pooled from equal  quantit ies of 
supernatant from parent 2-1  and subl ines E1 1 ,  G4 , G 1 1 ,  and E9.  Pooled supernatant 
added to both MLR and PHA responses, Figure 34 (A and B) inhibit those assays, both of 
which ut i l ize PBMC iso lated from normal donors .  When supernatants were subjected to 
d ig estion by tryps in  or  chymotrypsin  coated beads for 30-60 m in utes at 3 7°C no 
d im inut ion in  i nh ibitory capacity was noted . Also no loss of i nh ibitory capacity was 
noted after three cycles of freezing and thawing which i nvo lved 30 m inutes at -40°C 
fol lowed by 30 minutes at 37°C.  Sign ificant decrease in  i nh ibit ion of both assays was 
seen ,  however, fo l lowing either 30 minute incubation at 56°C or  1 0  m inutes at 80°C.  
In  the PHA response incubation at  80°C for 1 0  m inutes was clearly more effect ive than 
the 56°C incubation ,  but the differences are seen on ly at  the h ighest concentration i n  
the M LR assay. I n  contrast, t he  assay shown in  Fig u re 34C i l l ustrates 3 H - t h y m i d i n e  
i ncorporation b y  a lymphoid ce l l  l i n e ,  R E H ,  wh ich was d i l uted i n  norma l  cu l tu re  
med ium and plated i n  96 we l l  p lates a t  approximately 2 X 1 05 ce l ls/m l .  P lates were 
incubated for 72 hours and pulsed with 3H-thymidine for the f inal 1 6  hours .  The R E H  
cel l  l i n e  was fou nd t o  b e  very sensitive to t h e  effects o f  supernatant a n d  3 H -t hym id i ne  
incorporat ion was inh ibited by  non-treated supernatant,  enzyme digested supernatant 
and supernatant subjected to freezing and thawing . Un l ike the PHA and MLA assays , 
supernatant wh ich had been incubated at 56°C or  80°C acted as a g rowth factor and 
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FIGURE 34. INH IBITORY EFFECTS OF POOLED SUPERNATANT FROM U937 C ELLS ARE 
PARTIALLY ABROGATED BY HEAT. 
Supernatants were pooled from U937 parent 2- 1  and subl ines E 1 1 ,  G4 ,  G 1 1 
and E9 and al iquots were subjected to digestion with t rypsin or  chymotryps in  coated 
beads, three cycles of freezing and thawing,  heating at 56°C for 30 m in . ,  or h eat ing at 
80°C for 1 0  minutes. After treatment supernatants were added at stated d i l ut ions to a 
normal M LR (A) , PHA st imu lation (B) ,  o r  to REH cel ls ( human n u l l ce l l  leukemia ce l l  
l ine)  in  cultu re (C) . A l l  assays were dependent on  3 H-thymid ine i ncorporat ion d u ring  
the f inal 1 6  hours of  the assay. % I n h ibition was calcu lated based on the response in  
the various assays in the absence of  supernatant. Al l  assays were repeated three t imes 
and values expressed are the mean of tripl icate wells . 
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i ncreased the 3 H-thymidine incorporation showing maximal  effect at a 1 : 1 6 d i lut io n .  
A t  a 1 :4 d i lution t h e  supernatant treated a t  56°C was very s l ig htly i nh ibitory. These 
assays i l l u strate that t he  i n h ibitory factor i s  e i ther  not  d igested by t ryps in  or  
chymotryps in  o r  that d igestion does not d im in ish potency .  A lso i l l u strated is  the  
sensit ivity to  inactivation by heating but insensit ivity to short cycles of freezi ng  and 
thawing . 
Dialyzed samples of supernatant were more labile than non-dialyzed samples 
oyer a three month period of storage. Two potentia l ly i nh ibitory characteristics of the 
supernatants, i .e .  the low pH of the supernatants removed from U937 ce l l  cu l tures and 
the  possib i l ity that  the U937 ce l l s  were producing  prostag landins o r  othe r  sma l l  
molecu lar  weight i nh ibito ry factors such as  p latelet activat ing factor ( PAF-acethe r) , 
were investigated by subjecting samples of the supernatants to dialysis against R P M I  
1 640 cu lture medium contain ing HEPES buffer to mainta in  a neutral pH  dur ing  t h e  
pe riod o f  dialysis a t  4 ° C .  Althoug h ste ri l e  condit ions  were m ainta ined dur ing  t h e  
d ialys is ,  t h e  dia lyzed samples a n d  other supernatant samples were ste ri l ized b y  
fi ltration fol lowing 2 4  hou rs at 4°C a n d  a l iquoted in  smal l  samples prior t o  freez ing to 
obviate the necessicity for freezing and thawing samples repeatedly. The supernatants 
treated in this manner were added to various cel l u lar assays over a th ree month period. 
As shown in  Figure 35A, dialyzed supernatants from sub l ine E 1 1 and G4 ce l l s  were 
st i l l  strong ly i nh ib ito ry when  added to normal  M LR assays ;  however ,  d i a lyzed 
supernatants from subl ines G 1 1 and E9 and parent  2- 1 U937 were less i n h ibitory 
than non-dialyzed samples.  The supernatant concentrations  i n  a l l  cases were 25% of 
the total wel l  volume.  The resu lts with non-dialyzed supernatants from sub l ines G 1 1 
and E9 were surprising in that in previous assays usi ng fresh supernatants at th is h igh 
concentration ,  inh ibit ion had a lways bee n  g reater than 80%. Supe rnatants u sed i n  
these assays and tested on 7/1 4 had been in  storage a t  -20°C for several months.  Non 
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FIGURE 35. SUPPRESSIVE CAPACITY IN  DIALYZED SAMPLES OF SUPERNATANT WAS 
MORE lABILE OVER THREE MONTHS IN STORAGE THAN NON-DIAL VZED SAMPLES. 
Supernatant from U937 parent 2- 1 and subl ines E 1 1 ,  G4, G 1 1 and E9 were 
col lected and divided. Half of each supernatant sample was dialyzed against fresh R P M I  
1 640 cu lture medium overn ight .  After dialysis, samples o f  dia lyzed and non-dialyzed 
supernatants were a l iquoted and frozen . These samples were then removed fro m  
storage at two time points and added to normal assays for M LR (A) , REH cel ls  i n  cu ltu re 
(8)  and K562 (eryth rleu kemia ce l l  l ine)  ce l ls  i n  cu l ture at a 1 :4 conce ntrat io n .  3 H ­
thymid ine incorporation as cpm was measured and % I nh ibit ion was calcu lated us ing 
values in assays to wh ich no supernatant had been added. The M LR results are a 
composite of two assays for each date , each assay set up in  tr ipl icate we l ls .  R E H  and 
K562 ce l ls were set up as a single assay for each date , also set up in tripl icate we l ls .  
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d ialyzed supe rnatants from parent 2- 1 and sub l ine  E 1 1 removed from t h e  fre ezer 
th ree months later ( 1 0/1 3) and added to the same type of MLR assays were found to be 
as i n h ibitory as previously fou nd at the  same d i l ut ion ( 1  :4) ;  however ,  supernatant 
from the G4 subl ine was s l ig htly less i nh ibitory and supernatants from sub l ines G 1 1 
and E9 appeared to be sl ightly more inh ibitory, although the difference in  the response 
with G 1 1 and E9 s u pernatants was possib ly attr i bu tab l e  to d i ffe re nces i n  
responsiveness of the responding cel ls and therefore resistance t o  i nh ibit ion .  Resu lts 
shown for d ialyzed supernatants ind icate that in a l l  cases l i tt le i n h ibitory capacity 
remained. The somewhat h ig her i nh ibitions seen with dia lyzed 2-1 parent s upernatant 
may also reflect responder resistance rather than i nherent  supernatant change .  As 
shown in  F ig u re 358 in  wh ich supernatant was added to R E H · cel ls  in cu l tu re as 
previous ly described, al l supernatants , both non-dialyzed and d ialyzed,  except sub l ine 
E 1 1 were strongly i nh ibitory when tested on  7/1 4 ;  however, when retested o n  1 0/1 3 ,  
a l l  d ia lyzed supernatants h a d  lost most o f  the i r  abi l ity t o  i nh ibi t  t h e  g rowth o f  R E H  
ce l ls whereas t h e  non-dialyzed supernatants maintain ed in h ibitory capacity . U n l ike 
resu lts seen in F igu re 34C with heated supernatants, stored d ialyzed supernatants 
showed no capacity for enhanced 3H-thymidine incorporation . Resu lts obta ined when 
supernatants were added to the erythroleukemia cel l l i ne ,  K562, s hown in  Fig u re 35C 
indicate that supernatants whether  dialyzed or  not were n ever as i nh ibitory for K562 
ce l l s  as for R E H  cel l s ,  although  supe rnatant from G 1 1 sub l ine  ce l l s  i n h ibited 3 H ­
thymidine inco rporation by K562 ce l ls  by approx imately 80%. Except for sub l ine  G4 
supernatant where there were no diffe rences between d ialyzed and non-d ia lyzed 
supe rnatant  i n h ib i t ion , al l  d ia lyzed supernatants were less  i n h ib i tory t han  non­
dialyzed supernatants when tested on 7/1 4 . Most supernatants, both  d ia lyzed and  non­
d ialyzed , tested on  1 0/1 3 showed stimulatory capacity rather  than i n h ibit io n ,  except 
for the smal l  i nh ibit ion mediated by supernatant from the 2-1 parent and sub l ine G 1 1  . 
F ig u re 35C i l l ustrates that the  inh ibito ry capacity of the supernatants changes over  
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t ime in  cu l ture and,  as i l l ustrated in  F ig ure 35B , the i n h ibitory capacity in  d ia lyzed 
supernatants is more labi le than in  non-dialyzed supernatants . 
Effects of pH and possible prostaglandin production by U937 cells were 
examined . Parent 2-1  cel ls and subl ines G4 and E 1 1 ce l ls  were g rown i n  m edia 
contain ing e i ther  1 0m M  H EPES buffer (N-2-hyd roxyethy l p i pe raz i ne-N '-2-e t h a n e -s u l fo n i c  
a c i d )  (S igma)  wh ich has a n  e ff ic ien t  buffe ri ng  range  of 6 .8 -8 .2  o r  1 0- 5 M 
indomethac in  ( 1 - [p-c h l o r o be n z oy l] - 5 - me t h o xy - 2 - m e t h y l i nd o l e - 3 - ac e t i c  ac i d )  ( S ig m a )  
which i s  a n  inhibitor o f  prostaglandin synthesis. Cel ls  were washed and added t o  fresh 
media conta in ing e i ther addit ion and incubated for 72 hours .  Supernatants were 
removed from these flasks and added to assays at d i lut ions of 1 :4 , 1 :8 ,  1 : 1 6 and 1 :32. 
As shown in F igure 36 (A,  B,  C) the i nh ibition of MLR ,  PHA stimu lat ion and R E H  
prol ife ration was nearly 1 00% for a l l  supernatants at a l l  d i l ut ions and addit io n of 
H EPES and indomethacin to cu lture media had no effect . Although the concentration of 
indomethacin may not have been sufficient to prevent prostag landin production for the 
entire three days during which the cel ls were in  culture i f  the U937 ce l ls were capable 
of m etabo l iz ing the i ndomethacin ,  i t  appears that the profound i nh ibit ion seen with 
supernatants from U937 cel ls is not attributable to either production of an excessively 
acidic env i ronment o r  to production of prostag land ins .  As indicated i n  F ig u re 35 ,  
however,  some fraction of the  i n h ibitory capacity is  probably attr ibu tab le  to t he  
effects o f  pH and  dia lyzable , i . e .  smal l  molecu lar  weight ,  moieties which m ay o r  m ay 
not include prostag landins. I t  is suggested that the specific evaluation of prostag landin 
production wou ld requ ire the use of a radioimmunoassay.  
Inhibition of tritiated-thymidine incorporation was shown to paral lel a 
decrease in viable cells present. As shown in Figure 37, th ree of the assays in wh ich 
the mode of assessment is evaluation of incorporation of 3 H-thymid ine  m e asu red as 
cpm by l iqu id scinti l lation were set up in  dupl icate and eval uated in two ways: by 
standard methods of isotope count ing  and by ce l l  counts  of ce l l s/we l l  u s i ng a 
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FIG U R E  36 . PRODUCTION OF SUPPRESSIVE ACTIVITY WAS NOT DECREASE D  BY 
ADDITION OF HEPES BUFFER OR INDOMETHACIN TO U937 TISSUE CULTURE MEDIA. 
U937 parent 2-1 ce l ls  and sub l ine  G4 and E 1 1 ce l l s  were g rown in t he  
presence o f  1 0  m M  H EP ES buffe r or  1 0-5 M indomethacin for 72 h o u rs .  Ce l l s  
i ncubated i n  normal t issue cu l ture m edia were removed from cu l ture ,  washed with 
fresh media, and added to fresh normal media or media contain ing either  H EP ES (+ H)  
or  i ndomethacin (+ I M ) .  Cel ls  were i ncubated for an addit iona l  72  hours after wh ich 
supernatants were removed and tested at two di l utions ( 1 :4 and 1 :32) in  th ree types of 
assays :  (A) MLR ,  (B) PHA m itogen sti mu lat io n ,  and (C)  R E H  ce l ls  in cu l tu re . 
Suppressive activity was determined as % I nh ibit ion of 3 H-thymidine incorporat ion as 
previous ly described . 
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FIGURE 37. SUPPRESSIVE ACTIVITY AS ASSESSED BY 3H-THYMI DINE I NCORPORATION 
CORRELATED WITH CYTOSTASIS. 
Paral le l  assays were set up for M LR ,  REH cel l  cu l ture and K562 cel l  cu l ture .  
I n  o n e  set o f  assays % I n h ibit ion was assessed by 3 H- thymid ine  incorpo rat ion  a s  
described. I n  the second set of assays the % I nh ibition was assessed b y  cou nting cel ls i n  
a hemocytometer. Ce l l  v iabil ity was determined by t rypan b lue exclus ion .  
AS S AY 
F I GURE  37 .  S U P E R N AT E  S U P P R E S S I O N  OF 
P RO L I F E R AT I O N  AND 3 H -T HYM I D I N E 
I N CO R PO R AT I ON 
MLC 1 : 4  &-i��TTTTNti'YFu�,?Y£I 
1 : 8 � 
REH 1 : 4 ����»� 
1 : 8 -.J 
1 :  1 6  �iiiiiil'ii' 
K562 1 : 4 .. 
1 : 8  ".11"'.111111", 
1 :  1 6  
o 1 0  20 30 40 5 0  6 0  7 0  80 90 1 00 
� I NH I B I T I O N  
[IIJ C E L L  CO UNT 
� C PM 
tv ...... 
Ul 
2 1 6  
hemocytometer and determination of viable cel ls by t rypan b lue exclus ion . The resu lts 
i n  al l th ree assays , (MLR ,  R E H  pro l iferation and K562 pro l ife ration )  i nd icate that 
where strong inh ibition was seen using isotope cou nting , a marked decrease was a lso 
seen i n  viable ce l ls  present .  When the M LR was exam ined,  supernatant at a 1 :8 
di lu tion was found to i nh ibit 3H-thymidine incorporat ion with no concomitant decrease 
i n  viable ce l ls ; however,  because of the n ature of the M LR ,  i . e .  that t he re is  a 
popu lation of supposedly viable responder cel ls  and a senescent popu lation of i rrad iated 
sti m u l ator ce l l s ,  evaluation of viable ce l l  cou nts i nvo lves l arge errors in  cou n ting  
which on average were the  same as wel ls to  which no supernatant had been added . I n  
assays for prol i feration o f  ce l l  l ines ,  counting o f  ce l ls  was s impl ified by t h e  presence 
of only one cel l  type. I n  these assays, changes i n  ce l l  n umber appeared to be a more 
sens it ive measure of supernatant added than 3 H-thym id ine  i ncorpo rat io n as  the  
decrease in cel l  count was dose dependent. I t  must be noted that in a l l  assays except 
prol iferat ion of K562, a sign ificant increase in  the percentage of dead ce l ls present was 
noted when supernatants were added (data not shown) . The supernatants which were 
cytotoxic fo r both normal PBMC and R E H  ce l ls were not cytotoxic for K562 ce l ls ,  
although there was clearly a cytostatic effect on  K562 cel ls .  The supernatants added to 
a l l  assays were not complete ly cytotoxic to any cel l  population and although many cel l s  
appeared to  be more g ranu lar and vacuolated in  the presence of  supernatant ,  they 
continued to exclude trypan blue. The supernatants used in this series of  experiments 
exh ibited decreased inh ibitory capacity as shown by the marked decrease in  i n h ibit ion 
at 1 :8 d i l ut io n .  This decrease is  attr ibuted to the i r  long term storage as poo led 
supernatant kept for several months at  -20°C . 
Inhibition of cellular assays was not overcome by addition of recombi nant IL-2 . 
Using fresh supernatants from subl ines E1 1 ,  G4 , G 1 1 and E9 and from the 2- 1 parent 
U937 cel l s ,  3 H-thymid ine incorporation by norma l  PBMC in normal  M L R  ( Fig ure  
38A) , PHA stim u lat ions (F ig u re 38B)  and Con A sti m u lat ions (F ig u re 38C)  was  
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FIGURE 38. INHIBITION OF CELLULAR ASSAYS WAS NOT OVERCOME BY ADDITION OF 
RECOMBINANT I L-2. 
Ce l lu lar assays us ing normal PBMC were set up as described.  Supernatants 
from U937 2-1 parent and subl ines E 1 1 ,  G4,  G 1 1 and E9 were added to m icrotite r 
wel ls at two di l ut ions :  1 :4 and 1 :20. Recombinant I L-2 ( 1 00 u/wel l) was added at 
in it iation of the assays and 1 5  minutes prior to addit ion of supernatant .  Resu lts are 
presented as the mean of 3H-thymidine cpm from tripl icate wel ls  in two assays. 
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abrogated by supernatants from a l l  U937 cel l  sou rces at d i l ut ions of 1 :4 and 1 :20.  
Addition of recombinant I L-2 d id not overcome the effects of the added supernatants i n  
any  case, although addition of  I L-2 sign ificantly increased the weak M LR and the Con A 
response. The PHA response was not augmented by the addition of I L-2 ; however ,  the 
PBMC may have been maximal ly  stimu lated without I L-2 and u nable to mo u nt any 
increase in response. 
A partial fractionation of supernatant indicated that the primary inhibito ry 
factor eluted was a relatively high molecular weight. U937 ce l ls were transfered to 
media contai n ing 1 % fetal bovine serum after g rowing rout ine ly in 1 0% fetal bov ine  
serum .  Ce l l s  were i ncubated for 48 hours i n  reduced fetal bovine se rum after  which 
supernatant was col lected, pooled and concentrated 50 fo ld by vacuum dialysis as shown 
in Fig ure 39. Concentrated supernatant and a sample of pooled, neat supernatant were 
dia lyzed against PBS. Concentrated supernatant was appl ied to an 85 cm3 col u m n  of 
Sephacryl S-200 equi l ibrated in PBS and 1 m l .  fractions were col lected.  Absorbance 
was measured spectrophotometrical ly at 280 nm .  as shown in Figure 40A and fractions 
were poo led as shown in Figure 40B.  I t  is apparent from the e lution pattern shown in  
Fig ure 40 that fractions pooled wou ld contain a m ixture of components ;  however,  i t  was 
hoped that the inh ibito ry capacity wou ld be found to reside i n  one or perhaps two 
fract io n s .  
A s  i ndicated in Fig u re 4 1 , inh ibitory capacity was found t o  some deg ree i n  al l 
fract ions e lu ted from the co lu m n ;  however, t he  most potent fractions  eluted ear ly .  
I n h ibition of normal MLR was chosen as the assay system for assessing the distribution 
of i n h ibitory capacity i n  co l umn  fractions .  Co lumn fract ions i n it ia l ly  screened were 
added to assay wel ls  at a fi na l  d i l ut ion of 1 :4 . Maximal  i nh ibit ion was observed in  
fractions  I I  and I I I  as indicated i n  Figu re 4 1  A.  To confi rm th is  i n i t ia l  f ind ing and to 
examine the potency of the inh ibitory fractions, a second series of MLR assays were 
performed and fractions I - IV  were added at a ser ies of d i l ut ions,  1 :4 , 1 :8 ,  1 : 1 6 and 
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F I G U R E  39.  SCH EMATIC PROC E D U R E  FOR COLLECTION,  CONCENTRAT I O N  & 
FRACTI ONATION OF C E LL S U PERNATANT BY S E P HAC RYL S-200 C O LU M N  
C�TOORAPHY. 
U937 ce l l s  (parent  2- 1 and sub l ines E 1 1 ,  G4,  G 1 1 and E9) were g rown in 
media contain ing 1 % fetal bovine serum for 48 hours.  Supernatant was col lected by 
centrifug ing cel ls ,  and equal  amounts were pooled from each cel l  source . Pooled 
supernatant was concentrated by vacuum d ia lys is us ing  d ia lys is  tub ing  wi th  a 
mo lecu lar  weight exc lus ion of 1 2 ,000- 1 4 ,000 . Fol lowing SOX concentrat io n and 
d ialysis against PBS,  concentrated supernatant was added to  an 85 cm3 co l u m n  of  
Sephacryl S-200 and 1 m l .  fractions were co l lected. 
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FIGURE 40. SUPERNATANT FRACTIONS WERE ELUTED FROM SEPHACRYL S-200 AN D 
POOlED. 
Fractions ( 1  m l .  each)  col lected from the colum n  were e l uted as i l l ustrated in  
(A) . Absorbance was measu red by spectrophotometry at  280 nm.  Fract ions were 
poo led as indicated in (B) . 
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F IGU R E  4 1 . POOLED FRACTIONS WERE TESTED FOR SUPPRESSIVE ACTI VITY I N  
NORMAL MLR. 
Fractions of supe rnatant were added to normal  M LR set up as d escribed .  
Suppressive act ivity i ndicated as % I n h ib i t ion was determ ined by 3 H - t h y m i d i n e 
incorporation re lative to MLR to which no supernatant was added. Resu lts represent 
the mean of tr ipl icate wel ls  for each fraction in two assays.  As indicated i n  (A) al l  
fractions were tested at a d i lut ion of 1 :4 . I n  (8) fractions I ,  I I ,  I I I ,  and I V  which h ad 
appeared to contain the most potent activ ity i n  (A) were fu rther tested at d i l ut ions  of 
1 :8, 1 : 1 6 ,  and 1 :32 . 
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1 :32. As indicated in F igu re 4 1  B ,  maximal i nh ibit ion was again observed in  fract ions  
I I  and  I I I ,  although as  previous ly seen  a t  the h ighest concentration strong i nh ibit ion 
was also seen in fractions I and IV.  I nhibition in  fractions I and I V  was not as strong as 
that seen in  fractions I I  and I I I  and was rapidly lost at h ighe r  d i l u tions .  Th us  the 
inh ibitory component appears to have e luted in  early fractions (tubes 36-4 1 and tubes 
42-54) indicating from calculated Kav values based on  void vo lume determ inat ion and 
the separation capacity of Sephacryl  S-200 that it probably has a molecu lar  weig ht 
between 50 ,000- 1 00,000.  Fract ion I I  was a pool of s ix tubes contain ing  1 ml .  e ach . 
Although  not cleanly separated it was projected by calcu lated values to conta in  a 
m ixture of components with molecu lar weights rang ing from approx imately 1 20 ,000 
to 60,000.  Fraction I I I  contained the whole large  major peak and probably conta ined 
the  major portio ns of everyth ing h aving molecu lar  weigh ts from above 60,000 to 
approx im ate ly 20,000 inc lud ing as expected the h ighest prote in conte nt ,  probably 
inc lud ing albumin  from the fetal bov ine seru m .  U nfo rt unately ,  due  to the  arch aic 
nature of the chromatographic procedure ,the column was not cal ibrated pr ior to use 
and when retrieved for cal ibration after use ,  was fou nd i n  two pieces--perhaps for 
d isconti n uous separations .  Samples of the co lumn fractions were run under  reducing 
condit ions on Pharmacia- LKB Phastge l .  Fraction I had too l itt le prote in  content  to 
reveal any band . As assessed by molecular weight standards the major band seen in  
fraction I I  had a molecular weight of approx imaUy 90 ,000. Th is band appeared a lso in  
fraction I I I , although at  a lower concentration , and the major band in fract ion I I I  was a 
large band with molcu lar weight of approximately 66,000.  Th is  band is very probably 
albumin  attr ibutable to the fetal bovine serum present in  the mediu m .  The "a lbumin"  
band ,  but  not  the 90 ,000 kd band ,  pe rs isted throughout  the  next five fract io n s  at 
prog ress ively decreas ing concentration .  I t  i s  postu lated that t h e  i nh ibitory com ponent  
is the 90,000 kd band seen in both fractions I I  and I I I .  
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Interleukin 1 production by macrophages and other cell types constitutes an 
immunologically important product. both soluble and membrane bound. As monocyte­
l ike cel ls ,  it was expected that the U937 parent and subl ine cel ls wou ld produce I L- l  
as h ad been previous ly been reported (397) . I L- l  activi ty was m e as u red i n  a 
cost imu lator assay us ing the I L- l  dependent T ce l l  l i n e ,  0 1 0 .G4 . 1  developed by 
Janeway et. a l .  (444) with a submitogen ic dose of con A. This proved to be an 
unsu itable method for determ ination of so lub le  I L- l  because of  i ts  depende nce o n  
prol i feration a s  indicated b y  3 H -thymidine incorporat ion as seen i n  F ig u re 42 .  T h e  
assay was performed b y  addit ion o f  d i l ut ions o f  supernatant from t h e  U937 c e l l s  to 
01 0 .G4 . 1  ce l ls and incubation with a submitogen ic dose of con A for 72 hou rs with a 
3 H-thym idine pulse for the last 1 6- 1 8 hours .  When samples were cou nted for 3 H ­
thymid ine incorporat ion , i t  was fou nd that the supernatants from 2- 1 pare n t  and  
sub l ines E l l ,  G4 , G l l and  E9 had inh ibited the  backgrou nd incorporat ion to  s uch an 
extent that the  stimu lation ind ices were approximately 0 . 1 . The contro l  st im u l at ion of 
the 01 0 .G4 . 1  ce l l  l ine mediated by the addit ion of d i lut ions  of purif ied h u m an I L- l 
(0 .5 ,.tI . -0 . 1 25 ,.t. I . )  is a lso shown to indicate that indeed the ce l ls  were capable of 
mount ing a sign ificant response to h uman I L- l . Quant itation of the specific activ ity of 
the h uman I L- l  (Genzyme) used was prevented by the f inding that maximal stimu lat ion 
reached a plateau at low concentration wh ich was maintain ed th roughout  severa l  
d i fferent d i l ut ions and abruptly became inh ibitory o f  01 0 .G4 . 1  stimu lat ion a t  h ig her 
doses .  A dose response curve was not  run over  sufficient n umber of d ifferent  d i lut ions 
to warrant assignment of I L- l  un its,  although the orig ina l  preparation was assayed to 
conta in 1 u n it  of I L- l  activ itY/J.tI . 
Heat treatment of supernatant abrogated its inhibitory capacity in the I L-1 
assay. As ind icated i n  Figu re 43,  non-treated supernatant completely i n h ibited even 
the background 3 H-thymid ine i ncorporat ion by the 01 0 .G4 . 1  cel ls and th is i n h ib i t ion 
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FIGURE 42. U937 SUPERNATANT SUPPRESSED 3H-THYMID INE  INCORPO RATION BY 
I L- 1  I N DICATOR CELL LINE ,  D1 0 .G4 . 1 . 
Fresh supernatant from U937 parent 2- 1  and subl ines E 1 1 ,  G4 and G 1 1 was 
added at d i l ut ions of 1 :2, 1 :4, and 1 :8 to D 1 0 .G4 . 1  ce l l s  i n  the prese nce of  a 
submitogenic dose of con A (2.5 J.1g/ml .) i n  m icrotiter wel ls .  Plates were incubated for 
72 hours and pu lsed with 1 J.1Ci 3 H-thym id i n e  for the  fin a l  1 6  hou rs .  R e s u lts 
represent stimu lation indices determi ned by comparison  of cpm (the mean of tr ipl icate 
we l ls)  of contro l  wel ls to wh ich no addit ions were made to wel ls conta in ing e i ther  (a) 
0 .5  J.11 . (1 :2) , 0 .25 J.11 . (1 :4) , and 0 . 1 25 J.11 . ( 1  :8) of pu rified I L- 1  or  (b) d i l ut io ns  of 
supe rnatant.  
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F IGURE 43. H EAT TREATMENT OF SU PERNATANT ABROGATED ITS I N H I BITORY 
CAPACITY IN THE IL-1 ASSAY. 
Supernatant, at d i l ut ions of 1 :4 , 1 :8 ,  1 : 1 6 ,  and 1 :32 , was added to I L- 1  assay 
us ing  D 1 0 .G4 . 1  ind icato r ce l l  l i ne .  Supernatant h ad been pooled , a l iquoted and 
subjected to  two heat treatments :  56°C for 30 m inu tes (56°30") and 80°C for 1 0  
m i n utes (80°1 0") . Purified I L- 1  added to wel l s  was added as 1 ilL/wel l  of d i l ut ions 
stated. Resu lts are presented as stimu lation index (S . I . ) determined by comparison of 
the mean of contro l tripl icate wel ls to wh ich no additions  were made with the  mean of 
tripl icate wel ls contain ing stated additions in three assays . 
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was not overcome by addit ion of exogenous purif ied I L- 1 . However, supernatant  
treated by heat ing at 56°C fo r 30 m inutes or  80°C for 1 0  m inu tes was n o  longer  
i n h ib i tory and instead was found a t  h i ghest concentrat ion  ( 1  :4 )  to be  s l i g h t ly  
st i m u latory in the  I L- 1  assay . Addit ion of  pu rif ied I L- 1  to  the treated supe rnatants 
vastly augments the stim u lation of the 01 0 .G4 . 1  cel ls .  As prev ious ly described ,  the 
typical pattern of stimu lat ion seen after the addition of h uman I L- 1  is readi ly apparent 
in the plateau ach ieved after the addit ion of a 1 :8 d i l ut ion of 1 Jll . of pu rif ied I L- 1 . 
This plateau is clearly overcome or exceeded by the addition of heat treated pooled U 937 
supernatant. The impl ication from this data is  that there is some factor o r  component 
present in the U937 supernatant which is masked by the inh ibitory factor and which i s  
no t  the  same as  pu rified I L- 1  bu t  wh ich acts as a costimu lator or g rowth factor i n  the  
I L- 1  assay. 
Column fractions obtained by molecular sieving of concentrated pooled 
supernatant were also tested for IL-1  activity. As indicated from Figu re 4 1 , the major 
i n h ibitory capacity e l uted i n  the second and th i rd pooled fractio ns a l tho u g h  oth e r  
fract ions  exh ibited s ign ificant i nh ibit ion of MLR assays.  A s  indicated i n  F ig u re 43 ,  
heat treated supernatant showed abrogated inh ibit ion of the I L- 1  assay and a sma l l  
degree of i nherent I L- 1  activity. The column fractions tested showed an i nterest ing 
pattern of reactivity shown in Figure 44 . Fract ions  I I  and I I I  wh ich had exh ibi ted 
maximal M LR inh ibit ion a lso inh ibited the I L- 1  assay and background 3 H - t hy m id i n e  
incorporation to g ive a st imu lation i ndex of approximately 0 .2 .  Fract ions V I - IX  wh ich  
were proposed to  comprise the  sma l l  molecu lar weight components found in  the pooled 
supernatant a lso exh ib ited strong i nh ibitory capacity in  the I L- 1  assay to a s l ig ht ly 
higher degree even than fractions I I  and I I I  to g ive a stimu lat ion index close to 0.1 for 
fract ions VI I - IX .  Strong stim u lation of 3 H-thymid ine i nco rporat ion by 0 1 0 .G4 . 1  ce l l s  
m ediated by addit ion of  fract ion I ,  and to  a somewhat lesser degree ,  by addi t ion of 
fract ions IV  and V ,  ind icates that perhaps so l uble I L- 1  is  constitu it ively produced by 
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F IGURE 44 . I L- 1  ACTIVITY WAS DETECTED I N  SUPERNATANT SEPHAC RYL S-200 
COLUMN FRACTIONS. 
Column fractions of poo led supernatant obtained by fractionation on  Sephacry l  
S-200 were added at a 1 :4 d i l ut ion to  I L- 1  assays us ing D 1 0 .G4 . 1  ind icator ce l ls .  
Resu lts are expressed as Stimu lation I ndex determined by comparison of cpm of 3H­
thym idine incorporat ion ( the mean of tr ipl icate wel ls )  of contro l  we l l s  to  wh ich no 
additions were made with cpm of  wel ls contain ing supernatant in  th ree assays . P urified 
I L- 1  (1 Ill .!wel l )  was added to assess the capacity of the D1 0 .G4 . 1  cells to respond i n  
the  assay. 
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the  U937 ce l ls .  I f  the factor produced is not strictly synonymous with I L- l , t hen  it 
m ay h ave I L- l - l ike act iv ity and synergize with I L- l  as ind icated in F ig u re 43 .  
Clearly indicated from the  preceeding experiments i s  the finding that assessment of I L­
l presence and its quantitation can not be satisfactorily ach ieved in an assay dependent 
on pro l iferation as measured by 3 H-thymidine i ncorporation especial ly i n  supe rnatant 
samples in wh ich the i nh ibitor factor(s) is present i n  h igh concentration . 
Assessment of membrane IL-l  on U937 cells was facilitated by the use of 
parafo rmaldehyde-fixed cells . Fig u re 45 i l l u strates experi m e nts i n  w h ich 
constitu itively expressed membrane I L- l  was assessed on the 2- 1 parent and subl ines 
E l l ,  G4 and Gl l .  Paraformaldehyde fixed PBMC were used as contro ls  for normal  
constitu i tive membrane I L- l  expression .  Apparent  from Figu re 45 is  the f ind ing that  
at low doses of fixed U937 ce l ls ,  5 X 1 03 and 1 X 1 04 cel ls/wel l ,  there is sma l l  but  
consistent  stim u latio n of D l 0 .G4 . l  ce l l s .  M ax imal st i m u l at ion reach ed wi th  1 X 
1 04cel ls/wel l  decreases at h igher  cel l  concentrations  and becomes s l ig ht ly i nh ibitory 
at 1 X 1 05 cel ls/wel l  for subl ines E l l and G4.  The 2-1  parent ce l l  l i ne  reaches a 
maximal  st imu lation at 5 X 1 04 ce l ls/wel l  but  stim u lation with 2-1  parent ce l ls  a lso 
decreases at 1 X 1 05 cel ls/we l l .  Un l ike the U937 ce l ls ,  the  fixed PBMC cont i nue  to 
increase their stimu lation of Dl 0.G4. 1 in  a dose dependent manner throughout all doses 
of cel ls added . Thus a low level of membrane I L- l  is suggested for al l  the U937 cel ls 
tested. 
Treatments with immunomodulators generally were not effective inducers of 
increased membrane IL-l activity. As i l l ustrated i n  Figu re 46A, U937 ce l l s  were 
treated with 1 00 un its/m l .  purified gamma interferon for 24 hours ,  1 0  J.lg .lm l .  E. coli 
LPS for 24 hours ,  gamma interferon + LPS for 24 hours or P MA for 72 hours .  Only  
PMA augmented the detectable membrane  I L- l . I ncubat ion with PMA ( 1  0_9 M ) 
i ncreased the abi l i ty of E l l and G4 sub l ine cel l s  f ixed with paraformaldehyde to 
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FIGURE 45. UNTREATED U937 CELLS D ID  NOT DISPLAY SIGNI FICANT M EMBRANE I L-
1 . 
U937 2- 1 parent ,  subl ines E 1 1 ,  G4,  G 1 1 ,  and normal PBMC were f ixed with 
1 % paraformalde hyde and incubated in fresh m edia overn ight  befo re addit ion to 
D 1 0 .G4. 1 indicator ce l ls .  Fixed cel ls  were added at 5 X 1 03 , 1 X 1 04 , 5 X 1 04 , and 1 X 
1 05 ce l ls/we l l .  Resu lts are presented as Stim ulation I ndex (Stirn .  I ndex) determ ined 
by comparison of wel ls  to wh ich no fixed cel ls were added with wel ls  contai n i ng  
appropriate nu mbers o f  f ixed ce l l s ,  e i ther  U937 ce l ls  o r  PBMC,  as previous l y  
described. 
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F I G U R E  46.  PRETREATM ENT WITH PMA STI M U LATE D  MARKED I N C R EAS E I N  
M EMBRAN E I L- 1  IN  SUBLI NES E1 1 AND G4. 
U937 parent 2-1 and subl ines E1 1 and G4 were treated with gamma interferon 
(G- I FN)  at a concentration of 1 00 u/m l .  for 24 hou rs ;  E .  co l i  l ipopolysaccharide 
(LPS) at a concentration of 1 0  Jlg .lm l .  for 24 hours;  combined G- I FN and LPS fo r 24 
hours ;  or phorbol myristate acetate (PMA) at a concentration of 1 0-9 M for 72 hours 
prio r to fixation with 1 % paraformaldehyde . Fixed cel ls  ( 1  X 1 05 cel l s/we l l )  were 
added to D1 0.G4 . 1  indicator ce l ls .  Resu lts are presented as Stimu lation Index (S. I . )  as 
previous ly described .  * contro l  D 1 0 .G4 . 1  ce l l s  without  addit iona l  ce l l s ;  S . I .= 1 . 0 .  
** D 1 0 .G4 . 1  ce l ls  + 1 Jll . pu rif ied I L- 1 . 
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stimu late pro l i feration by 01 0 .G4 . 1  cel ls to a stimu lation index of approxim ately 20 .  
The  2-1  parent was i nduced by PMA to  stimu late to a very smal l  degee.  Cel ls i n  these 
experiments, except subl ine G4 cel ls ,  were found to be very i nh ibitory to background  
3 H-thym idine incorporation ,  thus ,  the st im u lations ind ices fo r E 1 1 sub l i ne  and 2 - 1  
parent l i ne  fe l l  be low 1 .0 .  I n hibit ion by  fixed cel ls i s  not explained.  Because PMA is 
known to be h igh ly l ipophi l ic and bypasses s ignal for activation in varied ce l l  systems ,  
i t  was poss ible that the dose of  PMA used to  treat the  U937 ce l ls had mere ly inserted 
into the U937 m embrane where it cou ld d i rectly st im u late the  0 1 0 . G4 . 1  ce l l s .  
Therefore, a dose response curve was set up for addition o f  PMA d i rect ly to  the  I L- 1  
assay. As shown in Figu re 4 7 ,  a t  1 0-9 M PMA i s  beg i nn i ng t o  d i rectly st imu late t h e  
0 1 0 .G4 . 1  cel ls to a very smal l  degree. At the next h ig her dose,  1 0-8M PMA, there is  
more clearly a stimu latory response.  Because the ce l l s  pretreated wi th  PMA were 
extensively washed prior to addit ion to the I L- 1  assay , it appears u n l ike ly  that a 
suffic ient ly h ig h  concentration of PMA was carried over to d i rectly stim u late t he  
0 1 0 .G4 . 1  cel ls .  I f  on the other  hand, PMA selective ly seeks to enter the m embrane 
from the aqueous medium , it seems possible but improbable that a h ig h  concentrat ion of 
PMA might be avai lable in  the membrane microenvironment and that th is concentration 
might  loca l ly exceed the  m in imum requ i rements for d i rect stimu lat ion of 0 1 0 .G 4 . 1  
ce l ls .  To circumvent this problem, t h e  more water sol uble and more easi ly washed o ut 
phorbol  este r ,  POBu ( 1 0 -8 M ) ,  was ut i l ized to pretreat U 937 cel l s  pr ior  to t he i r  
addit ion to  I L- 1  assays . As  indicated i n  Fig u re 48 ,  POBu proved to  be  a potent 
stim u lator of membrane I L- 1  express ion .  I t  must a lso be noted that i n  th is  series of 
I L- 1  assays, i t  appears that the fixed but non-pretreated sub l ine E 1 1 and G4 ce l l s  
expressed sign ificant membrane I L- 1  a s  shown b y  stimu lation ind ices g reater t h a n  5 .  
Gamma interferon pretreatment for 24  hours apparently abrogated any membran e  I L-
1 expression by subl i nes E1 1 and G4, however, it s l ig htly increased the membrane I L-
1 on  parent 2-1  ce l ls  wh i�h did not exhibit any membrane I L- 1  activity if not treated .  
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FIGURE 47. PMA HAS NO D IRECT EFFECT ON D1 0.G4 . 1  CELLS WHEN ADDED AT LOW 
CQ\JCENTRATla-J. 
Dose response curve was determined for response of D 1 0.G4. 1 ( I L- 1 ) ind icator 
cel ls to direct addition of PMA at concentrations stated . Assays were conducted as 
described and resu lts are presented as Stimu lation Index (S. I ) .  
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F IGURE 48. PRETREATM ENT WITH PDBu AUGM ENTS M EMBRAN E I L- 1  ON U 937 
CELLS. 
U937 2-1  parent and subl ines E1 1 and G4 were treated with gamma interferon 
(G- I FN )  for 24 hours with 1 00 u/m l . ;  d imethyl  su l foxide (DMSO) at 1 : 1 000 for 72 
hours ;  or  phorbo l dibutyrate ( P DBu)  at 1 0-8M for 72 hours prior to fixation with 1 % 
paraformaldehyde and addit ion to I L- 1  assay . Resu lts are presented as Sti m u l at ion 
I ndex (S . I . )  as previously described. 
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DMSO, wh ich was used as a d i luent  for d issolv ing PDBu in it ia l ly ,  was found  at low 
concentrat ion to have no effect on membrane I L- 1  expression by subl i n e  E 1 1 ,  to 
markedly increase membrane I L- 1  by subl ine G4 and to s l ight ly i ncrease membrane  
I L- 1  on 2 - 1  pare nt cel ls .  
Thus it appears that U937 ce l ls may constitu it ively express very low leve ls  of 
membrane I L- 1  and that th is level is  not increased sign ificantly by gamma interferon  
or E. coli LPS . Membrane I L- 1  expression is  markedly increased by  pretreatment with 
phorbol esters which change the membrane character istics and morphology of U937 
cel ls causing them to adhere to surfaces and to become more macrophage-l ike. DMSO at 
low concentrations also causes U937 ce l ls to become adherent and a concomitant effect 
was also seen on membrane I L- 1  express ion in the G4 subl ine .  The concentration of 
DMSO uti l ized (0 .001  �I ./m l . ) may represent a threshold amount in  U 937 activation 
thus causing a positive effect in the G4 subl ine and a negative effect in  the E 1 1 ce l l  l i ne .  
MHC class " specific mRNA was examined by Northern blot analysis using two 
cDNA probes specific for human HLA-DR alpha and HLA-DO alpha. As a final  aspect of 
the characterization of the U 937 parent and subl ines,  the Northern blot analysis was 
carried out us ing probe pDC H 1 , specific for H LA-DO alpha (446) , and probe T-33 , 
specific fo r H LA-D R  a lpha (u npubl ished) . Both probes were obta ined and were 
prepared as previously described.  
Autoradiograms were examined by scann ing densitometer and the results of the 
scan were normal ized for 28S rRNA present .  Normal ization using ribosomal  RNA was 
chosen as the preferred method for two reasons :  first, cell l i nes but not normal  ce l l s  
have been shown to  produce a re lative ly constant l evel of rRNA in  spite of treatment 
wi th activat ing agents (476) and second, it is unclear what effect activat ing agents m ay 
have on the leve ls of act in production in a monocytic ce l l  l ine being treated with agents 
wh ich clearly have profound effects on  morphology and adherence propert ies which in 
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al l  probabi l i ty involve increased production of cytoskeletal e lements .  A probe for 28S 
rRNA was obtained (pAD- 1 9 .IIa) (447) and prepared ;  however, when labeled and 
h ybr id ized with prev ious ly  hybr id ized-str ipped b lots , the res u l ts  were v e ry 
incons istent. It is bel ieved that the pattern of hybridization seen with the rRNA probe 
is consistent with compression of the blots du ring incubation with the labeled probe in  
a manner  which precluded probe from areas of the blots due to the cons iderable 
pressure exerted by large numbers of sealed pouches stacked on each other and weighted 
down to keep them submerged in the 42°C water bath . A few of the larg e  n u m ber  of 
blots hybridized at the same t ime with the rRNA probe gave hybridization patterns 
con s istent  wi th the 28S rRNA demonstrated by eth id i u m  brom ide sta in i ng  o n  the 
orig ina l  ge ls as photographed prior to transfer. These autoradiog rams were exam ined 
by scann ing  densitometer. Th us because the resu lts of the rRNA probing  were 
u nsuccessfu l in most cases, the photograph ic negatives taken of the orig inal  ge ls  served 
as an a lternative means for contro l l ing for the amount of rRNA in the part icu lar  lanes 
of the blots. The 28S rRNA band was measured by scann ing densitometer i n  the  same 
manner as the autoradiog rams.  Here again a di lemma presented itself i n  that the  fi l m  
backg round was found to vary i n  i ts density in a regu lar manner with t h e  l ig htest area 
appearing at the edges of the negative . Background readings were obtained across the 
base of each negative and these values were subtracted from the densitometer read ings 
for the rRNA bands measured. Because the densitometer had to be reset to m e asure 
these background areas, the values did not correlate with values obtained for the actual  
rRNA bands measured, but instead were relative amounts and varied accord ing to the 
darkness of the negative. Therefore, a th ird means of correcting for the amount of 28S 
rRNA present was developed as a modification of  the measurement of  the 28S rRNA on 
the photograph ic negative and was judged to be closer to the actual background observed. 
Because the f i lm background varied in  a regu lar manner, the background read ings and 
the rRNA readings cou ld be fitted to a normal curve and thus  adjusted . The  values  
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obta ined i n  th is way corre lated wel l  with visual  assessment of the relative s ize and 
i ntensity of  the rRNA bands on the photographic negatives and thus th is  method of 
background correction and rRNA normal ization was ut i l ized for most calcu lations i n  the 
absence of usable rRNA probe data. The values obta ined were further normal ized to 
either  a fraction of the total ,  the total being 1 ,  or fraction of the total ,  the  total be ing 
[0 . 1  X no.  of lanes] , to faci l i tate comparison of dupl icate or near dupl icate b lots . Thus  
the  n u m bers obtai ned for the  hybridization i n  any lane are re lative on l y  to  the  
hybridization seen in  a l l  other lanes on that particu lar blot and  are no t  co mparable to 
othe r  blots conta in ing that R NA sample un less a l l  othe r  samples a re also present .  
Therefore ,  the values obtained are qual i tative rather than quantitative . 
lat sublines of U93? produce detectable mRNA specific for HLA-OR and 00 . 
The in it ial hybridization is shown in  Figure 49 in  which RNA samples from parent  2 - 1  
U937 ce l ls  and subl ines G 1 1 ,  E9,  E 1 1 and G4 wh ich received no treatment o r  which 
were treated fo r 48 hours with purif ied gamma i nterferon ( 1 00 u n its/m l . )  were 
hybr id ized with probe T-33, specif ic for H LA- D R  a lpha .  Th is  i s  an  "ear ly" 
experiment as the RNA was extracted from these cel ls in  1 986 at a time when the  2- 1 
parent  and the E9 subl ine were sti l l  l a- , but  when subl ines G 1 1 ,  G4 and E 1 1 were 
strong ly l at as measured by immunofluorescence. The probe was nick trans lated and 
the membrane was hybridized for 24 hours,  stringently washed and autoradiog raphed 
for three days . The values shown for both the 2- 1  parent and the E9 subl ine  in Figure 
49B represent va lues for these samples wh ich are v is ib le  o n ly to t he  sca n n ing  
densitometer as  shown in  Figure 49A. Hybridization bands were apparent for the G 1 1 ,  
E1 1 and G4 subl ines, for both untreated samples and cel ls  pretreated for 48  hours with 
gamma interferon . There were smal l  changes in the amounts of m RNA produced after 
gamma interferon treatment ;  however, they were not consistent as there was a s l ight  
decrease with sub l ines G 1 1 and E 1 1 [(0 . 1 25->0 . 1 09)  and (0 . 1 5 0->0. 1 45) for G 1 1 
and E 1 1 ,  respective ly] and a s l ight  i ncrease for subl i ne  G4 (0 . 1 1 7-> 0 . 1 30) . Thus ,  
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F IGURE 49. U937 SUBLINES G1 1 ,  E1 1 AND G4 PRODUCE mRNA SPEC I FI C  FOR H LA­
ORa AN D THE LEVEL OF EXP R ESSION I S  NOT S I G N I F I CANTLY C HANG E D  BY 
PRETREATMENT WITH G- I FN FOR 48 HOURS. 
Scann ing  dens ito m eter  traci ng  of b lot hybr id izat ion auto rad iogram and  
autoradiogram show hybridization bands with n ick trans lated T-33 probe . 28S and  
1 8S rRNA are indicated. Hybridization I ndex ( H . I .) was calcu lated as  described (see 
Materials and Methods) by comparison between scann ing densitometer val ues for g e l  
photograph and hybridized probe autoradiogram. 
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although gamma interferon treatment maximal ly increases the expression of M HC class 
I I  molcu les on the cel l  su rface after 48  hours ,  no  concomitant increase in  specif ic 
m RNA is seen at that t ime . I t  was postu lated that there were several explanations  for 
th is fi nding . The most compel l ing explanation was that perhaps 48 hou rs is too late to 
observe an increase in m RNA as an increase in transcript ion wou ld temporal ly precede 
trans lation and subsequent transport and expression . Although there was no sig n ificant 
change after gamma i nterferon treatment for 48 hours ,  H LA-DR alpha and DO a lpha 
m RNA could be demonstrated for subl ines wh ich by other  means had been fou nd to be 
l a+ . 
A more extensive kinetic analysis was attempted to examine whether gam ma 
interferon treatment of U93? parent and subline cells could be shown to regulate the 
transcription of HLA-DR alpha or DO alpha mRNA. The 2- 1 parent U93? ce l l  l i ne  and 
subl ines were incubated with gamma interferon for 0 ,  2 ,  6 ,  1 2  and 24 hours pr ior  to 
RNA extraction . RNA samples obtained from the G4 and E1 1 subl ines were blotted and 
probed also with pDCH1  and T-33 probes and the resu lts are shown in  Figure 50. In 
F igure SOC , H LA-DR alpha specific hybridization gave bands of approximately 1 .2 kb 
just be low but distinctly separate from the posit ion of the 1 8  S rRNA bands v isua l ized 
by ethidi um bromide stain ing of blotted RNA. As i nd icated the E 1 1 subl ine hybridized 
with the probe to a somewhat higher degree than the G4 subl ine and showed opposite 
effects of g amma interfe ro n  treatment .  As shown i n  Fig u re SOA, t he  G4 sub l i ne  
hybr id izat ion decreased du ri ng the  whole cou rse of  gamma interfe ron t reatmen t ,  
reach ing a steady level o f  0 .069 a t  1 2  hours .  The E 1 1 subl ine showed an i n it ia l  level 
of 0 . 1 1 6  but  rapidly increased to 0 . 1 34 at 2 hours fo l lowed by an apparent  dec l i ne  
wh ich reached a m in imum level a t  1 2  hours before r is ing again a t  24 hours .  For both 
G4 and E 1 1 subl ines,  the H LA-DR specific mRNA demonstrated at 24 hours is c learly 
lower than the in it ial levels .  Although it i s  poss ible that at that time the ce l ls  h ave 
either metabol ized al l  of the avai lable gamma interferon via endocytosis through  the i r  
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FIGURE 50. HYBRIDIZATION OF HLA-DRa AND H LA-DQa SPECIFIC PROBES WITH TOTAL 
C E LLU LAR RNA FROM SUBL INES G4 AN D E 1 1 I N D I CATE K I N ET ICS OF m RNA 
EXPRESSION AFTER G-IFN TREATMENT. 
U937 sub l i nes  G4 and E 1 1 were treated with g a m m a  i nterfe ro n  ( 1 0 0  
u/m l , ) fo r  0 ,  2 ,  6 ,  1 2 , and 2 4  h o u rs and  total  ce l l u l a r  RNA w a s  ext racte d ,  
e lectrophoresed i n  agarose g e l ,  sta i ned with eth id i u m  brom ide ,  p hotog raphed ,  
e lectrica l ly transblotted to nylon membranes and  hybridized with probes (T  -33/H LA­
ORa and pDCH1 /H LA-DQa) labe led by random priming techniques. Measurements were 
made by scan n ing densitomete r from auto radiograms of probe hybr idizatio n s  and 
photog raphs of eth id i u m  brom ide sta ined ge ls .  Hybr id izatio n I ndex ( H . I . ) was 
calcu lated as described (see Materials and Methods) for hybridization with probe T-33 
(A) and pDC H 1  (B) . Scann ing densitometer tracings and autoradiog rams of p robe 
hybridizations  as wel l  as scann ing densitomete r traci ngs of gel photographs  and 
photographs are shown for T-33 probe (C)  and for pDC H 1  probe (D) . 
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g a m m a  interferon receptors or  that the  ce l ls  a re refractory to fu rthe r  st im u lat io n ,  
these possibil it ies are not supported b y  findings with t h e  H LA-OQ alpha probe, pDC H 1 . 
Fig u re SOB i l l ustrates the m RNA hybridizable with the H LA- OQ alpha probe i n  RNA 
samples also from subl ines G4 and E1 1 .  The G4 subl ine shows an in it ia l  hybridization 
with H LA-OQ a lpha (0 .082) wh ich rapid ly decreases at 2 hours d u ri ng  g a m m a  
interfero n  treatment (0 .063) but retu rns rapidly t o  a level  near that o f  t h e  u ntreated 
ce l l s  (0 .077) . The E1 1 sub l i ne ,  in contrast , s hows a h i ghe r  l ev e l  of  i n i t i a l  
hybrid ization (0 . 1 1 7) and increases to  a m uch h i ghe r  leve l (0 . 1 54) a t  6 ho u rs 
fol lowed by a decrease at 1 2  hours and return to h igh level after 24 hou rs of treatment .  
The re is no explanation from the avai lable data for the apparently b iphasic leve l  of 
H LA- OQ a lpha m R NA at 1 2  h o u rs .  F ig u re SOC i l l u strates a re pre s e n tat ive 
hybr idization of RNA samples from sub l ines G4 and E 1 1 with the T -33 ( H LA- O R  
a lpha) cONA probe . Th is probe was isolated from t h e  plasmid (pUC) by restr iction 
endonuclease digestion fol lowed by e lectroelution from a preparative ge l .  The purified 
probe was labeled by random prim ing techniques and is shown to g ive c lean , s ing le  
bands when hybridized. Figure 500 i l l ustrates a dupl icate blot hybridized wi th  pOC H 1  
( H LA- OQ alpha) probe wh ich was random pr imed d i rect ly i n  the p lasmid pr ior  to 
hybridization .  The results with th is probe were very m essy and difficu lt to in terpret 
by scanning densitometer because of the high background ;  however, after many scans 
and constant attention to  whether the  band intensity correlated with the  band o r  w i th  a 
random spot, resu lts were tabu lated. A second finding with th is probe is that t here are 
a lways two hybridization bands. This has been previously reported (477) and h as been 
attr ibuted to d ifferent transcript ional lengths seen with H LA-DQ alpha and a lso with 
the corresponding murine  MHC equivalent ,  I -A (478) . 
No HLA-OR alpha specific m RNA could be demonstrated in  RNA extracted from 
the  2 - 1  parent U937 ce l l  l i ne .  I n  contrast to  th is  fi nd ing ,  the  2- 1 pare n t  l i n e  
produced clearly d iscernable H LA-DQ alpha specific m RNA, a s  shown in  Fig u re 5 1 , 
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F IGURE 51 . m RNA SPECIF IC FOR H LA-DQa BUT NOT H LA-DRa WAS DETECTABLE I N  
TOTAL CELLULAR RNA ISOLATED FROM U937 PARENT 2-1 CELL LINE. 
U937 parent 2- 1 ce l l  l ine was treated with gamma inte rferon ( 1 00 u/m l . ) for 
0 ,  2 ,  6 ,  1 2 , and 24 hours and with 1 0-8M PDBu for 72 hours prior to extract ion of 
total ce l l u lar RNA. R NA was e lectrophoresed in ag arose ,  stai ned with eth id i um 
bro m ide,  photog raphed , transblotted to  nylon membranes and  hybridized with cDNA 
probes specific for H LA - D Ra (T-33) and  H LA- DQa (pDC H 1 ) labe led by random 
prim ing techniques. Hybridization was i ndicated by  autoradiog raphy. No hybridization 
was seen with probe T-33 (data not shown) : however,  hybrid ization indices ( H . I . )  are 
indicated for pDCH1  probe . H . 1 .  were determined as previously described.  
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which was decreased by gamma interferon treatment during the fi rst s ix hours fo l lowed 
by a s l ight increase at twe lve hours and again at 24 hours to reach a val u e  S l ig ht ly 
be low that seen i n  non-treated cel ls .  As indicated in  F ig u re 5 1 , treatment of the 2-1  
parent  ce l l  l i ne  with 1 a-8 M POBu for 72 hours caused a marked increase i n  the 
amount of HLA-OQ alpha specific mRNA produced. 
Subl ines G1 1 and E9 were also treated with gamma interferon us ing the  same 
protocol and total ce l lu lar RNA was extracted.  When hybridized with the T -33 probe as 
s hown i n  Figure 52A, the G 1 1 subl ine demonstrated the presence of H LA- O R  a lpha 
specific m RNA, although at low levels. Values indicated for the E9 subl ine indicate the 
presence of HLA-OR a lpha message also ; however,  there was very l i tt le hybridization 
apparent  and i l l ustrated values g ive an impression of g reater degree of hybridization 
for both G1 1 and E9 than was actual ly apparent. Hybridization with pOC H 1  ( H LA-OQ 
alpha)  gave more striking results for subl ine G 1 1 as i l l ustrated i n  Figu re 52B.  There 
was l itt le or no apparent hybridization with E9 subl ine RNA; however, the G 1 1 sub l ine 
s howed a pattern of hybridizat ion s imi lar  to the E 1 1 sub l ine i n  that  there was an 
i n i t ia l  leve l  of  H LA- OQ a lpha specific m R NA wh ich was clearly v is ib le and which 
rapidly rose to very h igh  leve l after 2 hours of gamma i nterferon treatment .  Th i s  
rapid rise was fo l lowed by a sharp decrease in H LA- OQ alpha specific mRNA present by 
1 2  hours of treatment  fol lowed by an i ncrease at 24 hou rs ,  ag ain i l l u st rat i ng  a 
biphas ic level of specific m RNA. 
Gamma interferon treatment of U937 cel ls has been  shown to markedly increase 
la expression as measured by immunofluorescence us ing K u l a2 monoclona l  ant ibody 
with specificity for a framework dete rminant  of  h u man  l a ,  probably H LA- O R ,  as 
i l l u strated in  Fig u res 1 2  and 1 3 . Al l  sub l ines except E 1 1 were found  to express 
increased l a  after 6 hours of incubation with gamma interfero n .  The E 1 1 sub l ine in  
early experiments showed a decrease in  express ion at  6 hou rs and a rise thereafter to 
reach a maximum expression after 24 hou rs of treatment (F ig u re 1 2) .  I n  more recent 
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F I G U R E  52.  RNA FROM U937 SUBLI N E  G 1 1 BUT NOT SUBLI N E  E9 HYB R I D I Z E D  
SIGNIFICANTLY WITH PROBES FOR HLA-DRa AND HLA-DQa. 
U937 subl ines G 1 1 and E9 were treated with gamma interferon ( 1 0 0  u/m l . )  
for 0 ,  2 ,  6 ,  1 2 , and 2 4  hou rs prior to extract ion o f  total ce l l u lar RNA.  RNA was 
e lectrophoresed , sta ined with eth id ium bromide,  photographed, transblotted to ny lon 
membranes and hybrid ized wi th  probes for H LA- DRa (T-33)  (A) and H LA- DQa 
(pDC H 1 ) (B) .  Hybrid ization I ndex (H . I . ) was calculated as previously described. 
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kinetic studies the E 1 1 cel l  l i ne  was found to decrease l a  expression as a resu l t  of 
gamma i nterferon treatment and the expression did not reach non-treated leve l s  u nt i l  
ce l ls were treated for 72 hours .  The findings with i m munofluorescence and Northe rn 
blott ing ,  therefore , are clearly contradictory for the expression of M HC c lass I I  as 
shown in  Fig ure 53 . Whereas the leve ls  of ce l l  su rface expressio n  of l a  i n i t ia l ly  
decreased slightly for sub l ine G4 as shown in  Fig u re 53A, then rose to maximum levels 
by 24-48 hours ,  the detectable m RNA for H LA- O R  alpha clearly decreased for the G4 
subl ine and continued to decrease to i ts lowest leve l by 1 2  hour of gamma interferon 
treatment. H LA-OQ alpha in it ial ly decreased but returned to a sustained leve l s l ightly  
lower than the init ial level found. These results seem to be contradictory if one expects 
a temporal relationsh ip between regu lation of transcription and trans latio n .  The E1 1 
sub l i ne  shown in  F ig u re 538 ,  wh ich exh ibited the  most profound decrease i n  l a  
expression at 6 hours of gamma interferon treatment ,  a lso exhibited the most profo u nd 
increase i n  H LA- OR alpha and H LA-OQ alpha m RNA at 2-6 hours .  Th is  pattern of 
expression lagg ing behind transcription of increased m RNA is the expected pattern .  The 
G 1 1 subl ine shown in  Figure 53C exhibited a long lag period in  MHC class I I  expression 
o n  the ce l l  surface with a very s l ig ht decrease i n  expression fo l lowing 2-6 hou r 
treatment with gamma interferon .  Also shown was a very sl ight decrease i n  H LA- O R  
alpha mRNA at 2 hours fol lowed by a very s l ight increase a t  6 hours and s ubseq uent 
larger decrease , but subl ine G 1 1 exh ibited a marked increase i n  H LA-OQ alpha at 2 
hours fol lowed by an equal ly marked decrease at 6 hours. It appears from these results 
that there is an apparent increase in H LA-OQ alpha , specific m RNA in the G 1 1 subl ine 
and concomitant decrease i n  H LA- OR alpha m RNA. The level of M HC class I I  
expression by the E9 subl ine,  shown i n  Figure 530 ,  as with subl ine G 1 1 ,  lagged for the 
fi rst 1 2  hours of gamma interferon treatment but i ncreased steadi ly thereafter .  The E9 
subl ine expressed levels of mRNA determined by probe hybridization for H LA-O R  alpha 
and HLA-OQ alpha wh ich were barely detectable . H LA-O R  alpha m R N A  decreased 
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FIGURE 53. COMPARISON OF la EXPRESSION ON THE CELL SURFACE AFTER GAMMA 
INTERFERON TREATMENT DID NOT NECESSARILY CORRELATE WITH MHC CLASS II mRNA 
HYBRIDIZATION. 
Data obta ined from kinetic study of l a  express ion on the ce l l  su rface as  
measured by  flow cytometry using monoclonal  antibody K u l a2 (% l a+) was com pared 
with hybridization index (mRNA) data obtained from H LA-D Ra (T-33) and H LA- DQa 
(pDC H 1 ) probe hybridizations for U 937 sub l ine  G4 (A) , sub l ine  E 1 1 (B ) ,  sub l i ne  
G 1 1 (C ) ,  subl ine E9 (D ) ,  and  parent 2- 1 (E ) .  
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stead i ly u nt i l  after 1 2  hours of gamma i nterferon treatment ;  however, H LA-D O  a lpha 
decreased i n it ial ly but by 6 hours appeared to be r is ing again ,  reaching n ear ly non­
treated leve ls by 24 hours. Also shown in  Figure 53E ,  the level of expression of M H C  
class I I  o n  the parent 2- 1 ce l l  l ine in itial ly decreased , b u t  b y  6 hou rs had beg u n  t o  rise 
qu ite substantial ly to reach a maximum at 1 2  hours fo l lowed by a steady decl i ne  to 
s l ig htly above non-treated levels at 48 hou rs .  As i nd icated , no H LA-D R  alpha m R NA 
was detected at any t ime point .  I n  a l l  hybridizations using RNA isolated from the 2- 1  
parent cel l  l i ne ,  H LA-DR alpha was never seen as more than a very weak smudge.  H LA­
DO alpha was seen however, qu ite clearly. As shown , H LA- DO alpha m R NA a lso 
decreased , however, with gamma interferon treatment and d id not appear to beg in  to 
increase again u nti l  6 hou rs after the observed rise in  ce l l  su rface la expression .  H ere 
again ,  the leve ls of expression and transcription do not appear to be temporal ly related 
i n  the expected manner. 
The effects of other immunomodulators on regulation of HLA-DR alpha and HLA­
DO alpha RNA transcription were also examined. Fig u re 54 i l l ustrates the  resul ts 
obtained from experiments in which ce l ls from subl ines G4 and E1 1 were treated with 
gamma interferon ,  LPS ( E. colt) , gamma i nterferon + LPS for 24 hours or P D B u  for 
72 hours prior to extraction of total cel lu lar RNA. When examined for H LA- D R  alpha 
us ing the T-33 probe , hybridization bands were apparent for the non-treated G4 and 
E 1 1 sub l ines .  Treatment with gamma interferon a lone increased the levels of m R N A  
very s l ig htly for subl ine G 4  and more substantial ly for subl ine E 1 1 .  Treatment o f  both 
sub l i nes  with LPS a lone decreased H LA- D R  a lpha specific m R NA transcr ipt io n ;  
however, treatment with a m ixtu re o f  gamma interferon and LPS caused a synerg istic 
response man ifested as an increase in HLA-DR alpha specific mRNA which exceeded that 
seen with gamma interferon alone .  Treatment with PDBu for 72 hours also decreased 
the H LA-DR alpha m RNA level markedly in the G4 subl ine and to about the same degree 
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F IGURE 54. IMM UNOMODULATOR PRETREATM ENT HAD VAR IABLE E FFECTS ON 
EXPR ESSION OF HLA-DRa AN D HLA-DQa mRNA BY U937 SUBLINE  G4 AN D SUBL INE 
E 1 1 .  
U937 subl ine G4 and subl ine E 1 1 were treated with gamma interferon (G I FN) 
( 1 00 u/m l . )  for 24 hours ; E .  co l i  l ipopo lysacchar ide ( LPS) ( 1 0 Jlg .lm l . )  fo r 24 
hours ;  a combination of G I FN and LPS (GI FN+LPS) for 24 hours ;  o r  phorbol dibutyrate 
( P D B u )  ( 1 0 - 8 M )  fo r 72 h o u rs p r io r  to tota l  ce l l u la r  R N A  e x t r act i o n , 
e lectrophoresis ,  eth id ium bromide stain ing ,  photography, and hybridization with H LA­
DRa (T-33) (A) or HLA-DQa (pDCH1 ) (B) probe hybridization and autoradiography.  
Resu lts are indicated as Hybridization I ndex (H . I . ) calcu lated as previously described . 
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as the decrease seen after LPS treatment in  the E1 1 subl ine .  When hybridization with 
pDCH1  ( H LA- DO alpha) was examined there was g reate r d isparity in response as  
ind icated in Figure 54B .  Both subl ines G4 and  E 1 1 in it ial ly hybridized with the H LA­
DO alpha probe . Treatment with gamma interferon decreased the H LA-DO alpha specific 
m RNA in the G4 subl ine ce l ls but strong ly increased the H LA-DO alpha specific m RNA 
in  the E 1 1 subl ine ce l ls ,  s imi lar to the increase seen in  Figure 50B. Treatment with of 
G4 subl ine cel ls with LPS i ncreased the HLA-DO alpha specific mRNA level s l ightly and 
treatment with a combination of LPS and gamma interferon  had a smal l  net negative 
effect. Treatment of the E1 1 subl ine with LPS a lone strong ly i ncreased the level of 
H LA-DO alpha specific m RNA present and treatment with a combination appeared to 
faci l i tate a hyperinduction of H LA-DO alpha m RNA transcription .  For both sub l ine G4 
and subl ine E 1 1 cel ls ,  treatment with PDBu for 72 hours caused a s ig n ificant loss of 
H LA-DO alpha specific m RNA to levels wh ich were on ly bare ly detectable .  
Normalization by the three methods described gave similar results. An 
experiment i l l ustrated in  Fig ure 55 in  wh ich the blot was probed with pDC H 1  ( H LA­
DO alpha) and successfu l ly  with pAD- 1 9 .IIa (28S rRNA) , the values obtained with 
three types of analys is  us ing ( 1 ) scann ing densitometer reading of the 3 2 P - r R N A  
hybridization autorad iogra m ,  (2) scann ing densitometer readi ng o f  rRNA o n  the  
photog raph ic negative of the or ig ina l  ge l  corrected by  subtraction of backgrou nd 
obta ined by d i rectly scan n ing the f i lm background and (3) scann i ng dens i to m eter 
reading of rRNA on the photographic negative of the orig ina l  ge l  corrected instead by 
subtract ion of background determ ined by normal  curve determ ined by curve fitt ing to 
rRNA readings, were comparable to each other. 
Although the Northern blott ing data is largely pre l im inary and requ i res fu rther  
confi rmation ,  the find ing that there was comparative s im i larity of the va lues ( Fig u re 
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F IGURE 55. HYBRI DIZATION INDEX (H . I .) CALCULATED FROM GEL PHOTOG RAPHS 
CORRELATED CLOSELY WITH H. I .  CALCULATED FROM 29S rRNA SPECI F IC P ROBE 
HYBRIDIZATION. 
U937 subl ines G4 and E 1 1 and parent 2- 1 cel l s  were treated with g a m m a  
in terfe ron  (G I FN)  ( 1 00 u/m l . )  for 2 4  hours o r  with phorbol  d ibuty rate ( PD B u )  
( 1 0 -8M)  fo r 7 2  hou rs pr ior  t o  extract ion of total  ce l l u la r  R N A .  R NA was 
subsequently electrophoresed in agarose , stained with ethid ium bromide , photographed, 
e lectrophoretical ly trans blotted onto nylon membranes and hybridized with probes  for 
H LA-DQa (pDC H 1 ) and 28S rRNA (pAD- 1 9 I 1a) labeled by random prim ing techn iques 
fo l lowed by autoradiography.  Hybridization I ndex calcu lated as previously described 
(see Materials and Methods) was used as a means of norm al iz ing data.  H . 1 .  as 
i l l ustrated in (A) was calcu lated us ing comparison of scann ing densitometer values for 
H LA-DQa specific hybrid ization with ( 1 ) scan n ing  densi tometer va lues from g e l  
photographs with fi l m  background subtracted, (2) scann ing densitometer va lues  from 
ge l  photographs with fi lm  background determined by curve fitting ,  and (3) scann ing 
densitometer values of rRNA probe specific hybridization . Resu lts are indicated as the 
m ean  ± s .d .  of these th ree values.  Scann i ng dens itometer t raci ng  and p robe 
hybridization autorad iogram for pDC H 1  hyrbid izat ion is  shown i n  (B) . Sca n n i ng 
densitometer tracings for gel  photograph and for fi lm  backgrou nd are shown in  (C) ,  and 
scann i ng densitometer tracing and probe hybridizat ion autoradiogram for pAD- 1 9 1 1 a  
are shown i n  (D) .  
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558) obta ined i n  spite of the difficu lt ies encountered i n  hybridizat ion with the rRNA 
probe al lowed the analysis of  mRNA specific for the H LA-OR alpha and H LA- OQ a lpha 
probes .  
Summary. Subl ines were derived from the U937 h uman monocyt ic ce l l  l i ne  by 
l im it ing di lution techniques . Several of the subl ines derived in this manner were fou nd 
to constituit ively express la ,  u n l ike most U937 cel l  l ines previously exam ined .  Thus  
the la+ and  la- sub l i nes  were examined and characte rized phenotypica l l y  and  
functional ly.  Morphologically the subl ines, both l a+ and la- , were fou nd to be s im i lar 
to the orig inal ly described U937 parent ce l l  l ine with smal l  differences in  size among 
the subl ines. They were positive for production of non-specific esterase and expressed 
the H LA phenotype A(3 ,X) , 8(51 , 1 8) , OR(2,X) . The sub l i nes were exam ined  by 
immu nofl uorescence tech n iques with a large nu mber of ant ibodies specific fo r ce l l  
surface structures and found to express MHC class I ,  M HC class I I  the major type be ing 
H LA-OR and perhaps H LA- OQ in smal l  amounts ,  Fc receptor, TA-1 structure typical of 
monocytes and T cel ls ,  endothel ial antigens and C04.  The subl ines and parent U 937 cel l  
l i n e  we re fo u n d  to e xpress few cel l s u rface an t ig e n s  typical  of  m a t u re 
monocytes/macrophages ; however, they expressed myeloid antigens typica l of e arly 
monocytic or promonocytic l ineage. Although low levels of expression of several  other 
ce l l  surface antigens were variably detected , no surface immunog lobul i n  was detected. 
Expression of MHC class I I  by the sublines was confirmed by immunoprecipitation with 
monoclona l  ant ibody to a framework determ i nant  of  h u m a n  la and S OS - PAG E  
autoradiog raphy wh ich g ave bands at p29 :34 for l a+ subl ines but not for la- parent  
U937 cel l  l ines.  Cel l  surface expression of l a  was increased to a s ign ificant deg ree by 
treatment  with gamma interferon wh ich peaked at 24-48 hou rs of  treatmen t .  
Functional ly t he  parent  U937 cel l  l i ne  and  several l a+ sub l ines were exam ined  i n  
several assays . The la- and la+ U937 cel ls were found to stimu late t h e  generation of 
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specific cyto lytic T cel ls i n  CML assays to approximately the same degree .  The l a+ 
subl ines were found to stimu late in M LR assay, although  variable resu lts were obta ined 
and i nd icated that the U937 parent and subl ine ce l ls produced factors which were fou nd 
to be inherently immunosuppressive . The subl ines were fou nd to be able to substitute 
for monocytes by reconstituting the C03 mediated T cel l m itogenic response.  The la+ 
subl ines and the parent U937 cel l  l ine (also weakly l a+ ) were fou nd to present tetanus  
toxoid antigen to nylon-wool purified T cel ls  fol lowing an overnight pu lse with ant igen ,  
and  th i s  response was found to  be  s ig n ificantly abrog ated by  addit ion of ant ibody 
specific for C04 and MHC class I I ,  but not MHC class I .  P re l iminary characterizat ion 
of the immunosuppressive factor produced by the U937 cel l  l ine and the sub l i nes  
revea led that i t  was strong ly antipro l ife rative and affected lymphoid ce l l s  som ewhat 
more than non- lymphoid cel l s ;  that it had a mo lecu lar  weight of approx i m ate ly  
90 ,000 ,  was not  i nactivated by treatment wi th  t ryps i n  or  chymotrypsi n ,  was not 
immediately inactivated by freezing although dialysis and long term storage d im in ished 
its activ ity , and was part ia l ly i nactivated by heat t reatment at both 56°C and 80°C .  
C lear  ind ication o f  so luble  I L- 1  product ion by t h e  U937 parent ce l l  l i ne  a n d  the 
sub l ines was problematic due to the strong i n h ib i t ion of pro l iferative assays by 
supernatants ; however ,  part ial inactivation of i nh ibitory activ ity by heat treatment  as 
wel l  as partial removal of the inh ibitor fraction by ge l  f i l tration indicated that I L- 1  or  
a cytokine with I L- 1  activity was constituit ively produced by the cel ls .  M embrane I L-
1 was detected i n  very low amou nts i n  u nst imu lated ce l l s  and was s ign if icant ly  
i ncreased by treatment  with phorbo l este rs but  not othe r  i m m u no modu l ators .  
Prel im inary exam ination of Northern blots of H LA-OR a lpha and H LA-OQ alpha m R NA 
production by the parent U937 cel ls  and the subl ines revealed that both HLA-OR alpha 
and H LA-OQ alpha m RNA were detectable for l a+ subl ines E1 1 ,  G4 and G 1 1 ,  that on ly 
trace amou nts were detectable for re latively l a- subl i ne  E9 and that su rp ri s i ng ly ,  
H LA-OQ alpha was detectable for the  2- 1 parent cel l  l i ne  but  no  H LA-OR alpha m R NA 
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was detectable. The results of mRNA analysis fol lowing gamma interferon treatment,  as 
we l l  as treatment with LPS and phorbol esters , were variable for the different sub l ines 
and i ndicate that in some subl ines gamma interferon treatment appears to augment la  
specific m RNA and in  others the levels  are decreased indicating that the expression of 
M HC class II specific m RNA may be differential ly regu lated in the different subl ines.  
DlSCUSSIQ\l 
Competent immune function is dependent on coordinated activity of a battery of 
ce l l  types, some of which act in re latively non-specific ways and some of which show 
exqu is ite discrim ination in  the i r  specificity . T ce l l s  and B ce l l s  wh ich co n fe r  
specificity to the immune response through interact ions mediated by the i r  respective 
receptors are extremely important regu lato rs of immune function and a lso are the 
repository ce l ls  for maintenance of an anamnestic capabi l ity . Macrophages ,  o n  the 
other hand,  mediate immune function in an apparently non-specific manner making u se 
a lso of  an array of cel l surface receptors which ,  though specific fo r c lasses of 
molecu les , are not specific for individual molecu les. In other words, T ce l ls and B ce l ls 
are imbued with the capabi l ity of recogn izing foreign molecules based on the somet imes 
infi n itesimal ly smal l  d ifferences which they display wh ich make these molecu les non­
self ,  and their  abi l ity to recognize these intruding molecules resides i n  a receptor 
which is clonal ly distributed and devised by a complex series of rearrangem e nts of 
genes which themse lves are s im i la r  in  o rgan ization us ing common mechan i sms .  
Macrophages make use  of receptors which recog nize mo lecules based o n  shared 
structural characteristics such as Fc port ions of ant ibody molecu les ,  m an nose and 
fucose residues and, of pr imary importance , M HC molecu les which m ake specific 
i m m u n e  respo nse med iated by T ce l l s  poss ib le .  Perh aps i t  wou ld be m o re 
accurate ,therefore ,  to describe the role  of macrophages i n  immune  function as semi­
specific rather than non-specific. Certa in ly other  ce l ls ,  from the ubiqu itous  epithe l ia l  
and endothel ial  ce l ls  to  the h igh ly special ized fo l l icular dendrit ic ce l l s ,  are a lso vita l ly 
important in protect ion of the organ ism from i nvas ion and i n  the induction of an  
immune response.  Their discussion is ,  however, beyond the scope of th is project .  
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I n  conjunction with the cel lu lar  components possessing their  respective arrays 
of membrane bou nd recogn it ion structu res , immune  funct ion is  regu l ated by the 
complex interaction of so luble mediators, many of  which are autocrine  products. Most 
of the exocrine products of immune cel ls are t ightly regu lated and induce feedback 
mechanisms wh ich modulate their production to del im it the immune response to the 
specif ic microenvi ronment where a response i s  requ i red . These " in ter le uk i ns , "  
ant ibodies and  other molecules are h ig h ly potent and  u n regu lated product ion wou ld 
cause general ized harm to the organism. 
Macrophages p lay a central ro le in m ed iat ing i m m u no logical ly i m po rtant  
functions.  As a ce l l  type they are found widely d istributed in t issues and o rgans as 
blood monocytes , h istiocytes,  a lveolar macrophages and Kuppfer ce l ls to catalogue  j ust 
a few. I n  a l l  tissues their function as mononuclear phagocytes is profoundly important 
for the removal and e l imination of foreign matter, organisms and autologous effete ce l ls 
and ce l l u lar debris .  Thei r  phagocytic activity is  important in  g rowth p rocesses for 
such jobs as restructuring bone arch itecture and wound repair  (24 1 ) .  Mononuclear 
phagocytes are important cytotoxic ce l ls  playing an essent ial  role  i n  e l im inat ion of  
bacte r ia l  invaders,  parasites and tumor ce l l s  th rough  processes of e n docytos is ,  
macrophage activation and subsequent release of  cytolytic proteases and reactive oxygen 
compounds.  In  some t issue macrophages,  particu larly alveolar macrophages ,  long 
term local ization in s i tu resu lts in  loss of capacity to re lease large amounts of cytotox ic 
substances as a resu lt of phagocytosis perhaps as a mechan ism of protect ing the 
relatively sens itive surround ing normal  t issues (24 1 ) .  M acrophages are extrem ely 
competent secretory cel ls and produce more than a hundred excreted products including 
enzymes ,  prostag land ins  and in terleuk ins  (350) . Macrophages are re lat ive ly  
impervious to physical and  chemical harm and can  withstand the  effects of the i r  own 
secretions as wel l  as the effects of gamma radiation part ia l ly at least through the i r  
complement of  enzymes capable of inactivat ing harmful peroxides and reactive oxygen 
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and perhaps a lso due in  part to the nature of their membrane phosphol ipids which have 
been found to contain a h igh proport ion of ether l inkages rather than ester l inkages 
(479) . Thus because of the i r  phagocytic funct ion mediated by membrane-bound  
recepto rs for immu nog lobu l in  Fc  and  for g lycosylat ion p roducts and the i r  va r ied 
secretory function , macrophages are important i n  a broad sense in  maintenance of 
o rgan ismic integ rity. Phagocytos is and endocytos is a lso a l low m acrophages to 
participate in the generation of a specific immune response through part ial digestion of 
antigen ic substances and their reexpression in conjunction with MHC class " molecules 
on the cel l  su rface where they become avai lable for i nteraction with T ce l l  receptors 
wh ich specifica l ly recogn ize the combination of a fore ign ant igen fragment with self­
M HC.  Although it may be argued that dendritic ce l ls and B cel ls  present large amounts 
of ant igen to potential ly reactive T cel ls  through the expression of large amounts of 
MHC class I I  molecules, the capacity of the M HC class " expressed on macrophages to be 
modu lated by immunological ly re levant soluble mediators such as gamma interferon  
make i t  l ike ly that macrophages serve an important antigen presenting function i n  v ivo 
in areas to which they have been attracted by chemotactic stimu l i ,  i . e .  a reas of 
i n fectio n .  
Study of monocytes and macrophages has been carried out for many years and 
there are vast tomes of information related to this ce l l  type.  As a cel l  type , however, 
they h ave been relat ively d ifficu l t  to study in depth for several reaso n s .  ( 1 ) 
Macrophages are characte rized by the i r  abi l ity to adhere to surfaces ;  th u s  when  
removed from the  peripheral circu lation as  cel ls i n  suspension ,  they rapidly marg i nate 
and adhere to any sol id surfaces provided. Macrophage adherence is tenacious  and 
'Iirtually irre'lersible requ i ring that macrophages once adhered be treated harsh ly  to 
remove them which i nvariably causes a loss of viabi l ity if scraping or  h ig h  pressu re 
l iqu id is used or change i n  cel l u lar  fu nction if e nzymes o r  xyloca ine  a re used .  
Laboratories wh ich have sought  to  remove m acrophages fo r study h ave devised 
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"favorite" methods for doing so and have found that they must accept losses incurred by 
isolation procedures. (2) Macrophages normal ly occur as a minor popu lation with i n  a 
large population of other  cel l s ;  thus ,  iso lation of macrophages requ i res e i ther  pr ior 
st i m u lat ion to attract m acrophages i n to a part ic i l a r  area by use of  s te r i l e  
inf lammatory agents for e l icit ing macrophages i n  the  peritoneum or complex methods 
for enrich ing the popu lation by such means as percol l  g radient centrifugation .  Each of 
these techniques has inherent difficult ies.  I njection of ster i le i nf lam matory agents 
and,  to an even greater degree , injection of  activating agents such as LPS or C .  parvum 
e l icit macrophages which are no t  i n  a resting state . Although these agents has been 
successfu l ly used in the study of murine macrophages,  they are not satisfactory for the 
study of human macrophages and obtain i ng macrophages by peritoneal  d ialys is of 
normal individuals is not general ly feasible. Macrophages obtained by perco l l  dens ity 
g radient centrifugation have also been found to ingest the s i l ica part icles of percol l  
wh ich  changes the i r  morphology and fu nctiona l  capacity to  som e  deg ree (358) . 
Monocytes isolated from h uman donors general ly come from peripheral blood samples 
u s i n g  e n r ich men t  o f  monon uc lear  ce l l s  by f ico l l - hypaque  d e n s i ty g rad ien t  
ce ntrifug ation fo l lowed by  adherence o r  fu rthe r  iso lat ion by  perco l l  g rad ient  o r  
centrifugal elutriation .  Just a s  i t  has been difficult t o  remove t h e  last monocyte from T 
ce l l  preparations,  it has been virtual ly impossible to remove the last T cel l ,  B cel l  and 
dendritic cel l  from monocyte populations. None of these methods is whol ly satisfactory 
m aking isolation of monocytes a troublesome aspect of their  study. (3) Monocytes 
leaving the bone marrow fol lowing their maturation from stem cel ls  do not general ly 
u n de rgo ce l l  d iv is ion in the  per iphery .  U n l ike T cel ls and B cel l s  fo r wh ich 
pro l iferative capacity is a function of act ivat io n ,  m acrophages do not i ncrease i n  
n umber when activated except in  the sense that increased numbers may b e  d rawn into 
an area by a chemotactic stimulus.  Thus, once isolated, macrophages do not make more 
of themselves, although whi le in  cu lture ,  they may develop i nto large ,  m u lti n ucleated 
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g iant cel ls and remain viable for long periods of t ime.  Attempts to establ ish long term 
cel l  l ines from human peripheral blood monocytes have been genera l ly u nsuccessfu l .  
Although there have been claims to  the effect that i t  has been  accomplished (364 , 365, 
366) , these cel l l ines have not been widely used and do not often appear i n  the human 
m acrophage l i te ratu re . Attempts to immorta l ize per ipheral  blood monocytes by 
transfection with an SV40 construct with a defective orig in  of repl ication were tr ied 
and for a period of t ime held promise ;  however, these cel ls g rew so slowly that they 
were not usefu l (personal  commun ication ) .  Attempts to use the same con st ruct in 
murine cells appeared to be more successfu l (363) , although i n  genera l  attem pts to 
establ ish macrophage cel l  l ines from murine cel ls has been  successfu l and numerous  
cel l  l i nes have been avai lable for several years ,  many o f  wh ich have been derived from 
tumor ce l ls (359, 360, 362) . Further attempts to produce h uman ce l l  l i nes i nvolved 
somatic ce l l  fusion  of human macrophages with other  cel l l i nes (367) , but these 
attempts have not yielded cel l  l ines which have found wide acceptabi l ity . The most 
successfu l methods for the establ ishment of human macrophage- l ike ce l l  l ines have 
been from macrophage tumors which are relatively rare . At the time when this p roject 
was begun  there were very few macrophage-l ike ce l l  l i nes of human orig in .  The H L-
60 cel l  l ine was described as being of value because it cou ld be differentiated i n  vitro 
along either g ranu locytic or monocytic pathways (369) . The U937 cel l  l i ne  wh ich was 
i so lated from the p leura l  effusion of a human h istiocytic lymphoma patien t  in 1 976 
was described as monocyte- l ike and appeared to have promonocytic character istics 
(95) . S ince the beg inn ing of th is project to characterize the la+ U937 cel l  l ine in  our  
laborato ry , severa l  other monocyte- l ike cel l  l i nes  have become more widely used 
i nc luding the KG- 1 (370) l ine and T H P- 1  l ine (371 ) ,  both of wh ich were derived 
from mal ignant cel ls .  
The U937 cel l  l ine did not express MHC class I I  molecules when isolated and 
a l though several g roups attempted to i nduce express ion ,  these atte m pts we re 
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unsuccessfu l .  I n  1 981 - 1 982,  several labo ratories repo rted find ing that t he  U937 
cel l  l i nes in their laboratories had begu n  to express MHC class I I  or could be induced to 
do so with gamma interfe ro n  t reatment (422 , 424) . The U 937 ce l l  l i n e  i n  o u r  
labo ratory was found to constitu it ively express MHC class I I  as m easu red b y  both 
immunofluorescence and by SOS-PAG E analysis us ing a monoclona l  ant ibody to a 
framework determinant of human l a. The U937 cel l  l i ne had previously been  shown to 
mediate several monocyte- l ike funct ions and to share monocyte specific cel l  su rface 
molecu les (452) ,  to produce lysozyme (95) , to bear FCE receptors (38 1 ) ,  to be 
positive for non-specific esterase (95) and to mediate AOCC (404) . F inding that the 
U937 ce l l  l ine also constituitively produced l a  for u nknown reasons made the cel l  l ine 
an attract ive tool for study of monocyte fu nct ions  which requ i red inte raction with T 
ce l ls by means of the T cel l  receptor-MHC class I I  interaction .  Thus th is study was 
u ndertaken .  
The U937 ce l l  l i ne  in  ou r  laboratory was fou nd to be  heterogeneous i n  both  MHC 
class I I  expression and ce l l  size. I t  was decided that if clones of the cel l  l i ne  cou ld be 
iso lated , a more homogeneous expression of MHC class I I  and homogeneity of ce l l  size 
wou ld a l low for evaluation and characterization of these ce l ls  and of the ro le  of M H C  
class I I  molecu les . I t  would al low for the selection o f  clones expressing a variety of 
levels of MHC class I I  molecu les , thus affording the opportun ity to look a t  M H C  class I I  
concentration effects o n  functiona l  capacity . C lones iso lated by l im it i ng  d i l ut ion 
techn iques were found instead to continue to express MHC class I I  in  a h igh ly  variable 
manner and cel l  size also remained h igh ly variable, although the G 1 1 subl ine averages 
s l ightly larger  than the parent l i ne  and the E 1 1 subl ine averages s l ight ly smal ler  as 
indicated i n  Figure 2 .  Several explanations for th is  observed behavior are possible . T 
cel l  l ines which express MHC class I I  molecules have been found to display a variable 
d istr ibution (480) and indeed normal monocytes,  although not a clona l  popu lat ion ,  
express M HC at widely d isparate leve ls  a s  ind icated i n  F ig u re 3 .  There i s  the  
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possibi l ity that expression of M H C  class I I  corresponds to posit ion i n  the cel l  cycle ; 
however, th is was not examined for the U937 ce l ls  and subl ines.  The pattern of l a  
expression exhibited by subl ines G 4  and E1 1 were found to remain constant over a 
period of time exceeding two years and ce l ls kept frozen and recu ltu red exh ibited the 
same pattern of expression .  Unfortunately, the parent cel l  l ines were not  completely 
l a- when clonings were done;  however, general ly more l a+ clones were derived from 
parent cell l ines than l a- clones. Also clones which were se lected for their low level of 
l a  expression in the search for an la- clone such as G1 1 and E9 , became progressively 
more l a+ , particularly the G 1 1 subl ine which rapidly became a strongly l a+ sub l i ne  
after its isolation a t  which t ime on ly 5.8% cel ls were l a+ . As previously stated the 
clones isolated by l im it ing d i lut ion techniques were not  subsequently subcloned and 
have therefore been referred to as subl ines. There is no readily apparent explanation 
for the wide variab i l ity in ce l l  s ize with in  popu lat ions  of U937 ce l l s  except the  
difference in ce l l  cycle which is  supported on ly  by  the  unquantified observat ion that 
U937 cel ls at near maximal ce l l  concentration approximately three days after spl itting 
of cu ltu res , and presumably at  a t ime when ce l l  density and depletion of avai lable 
nu tr ients might be retard ing entry in to m itosis thus  causing a cu l tural  synchrony,  
appeared to be more near ly  homogeneous i n  s ize and shape.  Recent ly repo rted 
karyotypic analysis of U937 cel ls obtained from three separate laboratories inc lud ing 
the laboratory i n  which the ce l l  l ine was o rig i nal ly  derived i nd icates the g e n et ic 
var iab i l i ty with in  the popu lations  (373 ) .  The i nvest igato rs stated that t he i r  f irst 
impress ion from the disparity in  ch romosome n umber and chromosomal  aberrations  
was that the ce l l s  were derived from entirely different ce l l  l i nes ;  and that  it was on ly  
after analysis revealed that concordance was present for fou r  chromosomal  aberrations 
including a change known to associate with monocytic mal ignancy that it was concluded 
that al l  three cel l  l i nes had indeed been monoclonal ly derived. Therefore , although the 
or ig i na l  ch romosomal aberrat ion leading to mal ignant transformation was preserved,  
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there was extensive genetic variabi l i ty among and withi n  U937 parent l i nes wh ich had 
arisen over the period of twelve years s ince the i n it ial cel l  l ine isolation .  
Morphological ly the U937 cel ls  examined were very s imi lar  to t h e  U937 ce l ls  
described by Sundstrom and N i lsson (95)  in  their  orig ina l  description of the ce l l  l ine .  
The l a+ and la- U937 cel ls  examined i n  th is project expressed the publ ished H LA 
phe notype,  except for the H LA-OR2 found o n  the l a+ ce l l s ,  thus  d ispe l l i ng  any  
possibi l ity that the la+ ce l l  might have arisen from a contaminating cel l .  A further  bit 
of evidence that these ce l ls are re lated to orig inal U937 cel ls was the f inding that they 
were posit ive for non-specific esterase .  
Phenotypic character izat io n was accomp l i shed by i m m u no-f l uo re scence 
techniques ut i l iz ing a battery of antibodies having specificities for monocyte,  T and B 
cel l  markers . As indicated i n  Table 4 ,  the 2-1  parent U937 cel l  l i ne and a l l  sub l ines 
expressed M HC class I mo lecu les at  levels  wh ich we re s l ightly lower than normal  
per ipheral blood monocytes ,  except sub l ine 0 1 0 .  The parent 2- 1 l i ne  was found  to 
express low but detectable levels of MHC class I I  molecules,  as was the E9 sub l ine .  
Subl ines characterized as l a+ , G4 , E1 1 and G 1 1 ,  were found to g ive positive react ions 
when incubated with antibodies specific for MHC class I I  as shown in Table 4 and there 
were no striking differences between subl ines in reactivity . The presence of M H C  class 
I I  mo lecules on the cel l surface of sub l ines G4, E 1 1 and 01 0 was confi rmed by 
immunoprecipitation and SOS-PAGE techn iques as shown in Figu re 1 1 ;  however, in 
this case there were clearly differences i n  amounts of l a  precipitated with no detectable 
la for parent ce l l  l i nes and p29 :34 detected in  a h ierarchy as fol lows : subl ine 0 1 0 > 
E 1 1 > G4. I n  a l l  cases,  the percent positive U937 cel ls  was lower than seen with 
normal human monocytes , except subl ine 01 0 ;  therefore, the U937 subl ines examined 
expressed less MHC class I I  than a comparable ,  normal popu lation and as i ndicated in  
Fig ure 1 0 , the level of expression was markedly d im in ished i n  the fina l  year  of  the 
project for unknown reasons.  The pattern of reactivity wi th ant ibodies specif ic for 
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monocyteslmacrophages i ndicated that these cel ls  lacked sign ificant levels of ant igens  
com mon to  matu re monocytic l ineage cel l s  i n  agreement with find ings prev ious ly  
described by others (374) .  Further evidence that these ce l ls  represented an  early 
monocytic stage was the finding that they were reactive with antibodies My4 and My7 
but not M01 and M02 (Table 5) . These cel ls also clearly shared surface antigens with 
endothelial ce l ls and expressed these antigens at somewhat different leve ls. As indicated 
further in Table 6, the U937 cel ls strongly expressed CD4,  Fc receptor and the TA- 1 
antigen reported on both T cel ls and monocytes.  The U937 cel ls appeared to express 
few of the other antigens for which they were tested , although low levels of transferr in 
receptor and CD3 were detected . The G4 subl ine appeared to be somewhat more positive 
than other subl ines for many of the antibodies tested. I t  is  d ifficu l t  to assess the 
s ign ificance of this fi nding without fu rther examination ; however ,  i t  is possib le that at  
least in some cases the increase in  reactivity may be re lated to the sl ightly h igher  level 
of Fc receptor expressed by this subl ine than the other  U937 cel ls exam ined, although 
steps were taken to contro l  for Fc binding of both directly conjugated reagents and 
reagents used in indirect assays. 
The level of expression of MHC class I I molecules on the cel l  su rface was fou nd 
to be modulated by treatment with gamma interferon as indicated in Figu res 1 2  and 1 3 . 
Although in  more recent experiments using cel ls which have d imin ished l a  expression 
the increases seen in la expression with original ly l a+ subl ines has been less , g a m ma 
i nterfe ron  treatment was found to cause a maximal  e nhancement after 24 hours of 
incubation .  There was an in it ial transient decrease in expression ,  seen most clearly in 
the E 1 1 subl ine .  In the recent studies shown in Figure 1 0 , the E1 1 sub l ine did not 
recover  from th is  i n it ia l  decrease u nt i l  72 hou rs of gamma i nterfero n  t reatm ent .  
When compared with data obtained from Northern blott ing experiments ,  no consistent 
corre lation of levels of expression with levels of detectable m RNA is seen .  Resu lts 
seem to be contradictory if one expects a temporal re lationsh ip between reg u lat ion of 
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transcription and translation . Although gamma inte rferon has been shown to affect a 
reg ion of MHC class I I  genes upstream from the coding reg ion i n  an area known to 
contain reg u latory e lements (329 , 330 ) ,  e ndocytos is of  gamma in te rferon v ia  its 
receptor m ight also be expected to cause an increased rate of endocytosis of exist ing 
M HC class I I  molecules on the cell surface which wou ld account for the in itial decrease 
in MHC class I I expression seen after short periods of gamma i nterferon treatment .  
Given the admittedly pre l im inary nature of the RNA data and the need for refinement of 
the questions being asked , it is postulated that gamma interferon affects M H C  class I I  
expression in  several ways . The first step appears to b e  engagement o f  t h e  gamma 
interferon receptor wh ich has been shown to be expressed on the  U937 cel l  l i ne  (384, 
385) . Engagement of th is receptor appears to induce receptor mediated endocytosis in  
ways described for many receptors. Whether l a  is endocytosed at  the same t ime by 
coincidence because i t  occupies the same area of the membrane and is  therefore 
passive ly engulfed with the gamma interferon ,  or whether  engagement of the gamma 
interferon receptor causes a coordinate clustering of  gamma interferon and l a  on  the  
surface in a manner simi lar to the  phenomenon of  capping or whether engagement of the 
gamma interferon receptor and the process of its endocytosis causes a coord inated 
stimu lation of la endocytosis can not be discriminated; however, they explain the i n it ia l  
decrease i n  la expression seen afte r incubat ion with gamma interfero n  of short 
du ration in some subl ines. I ncreased endocytosis of la  would al low for its clearing of 
bo u nd l igand,  wh ich is l ikely to be self-derived , i n  the acidic compartment  of the 
endocytic pathway and allow for attachment of avai lable antigen  fragments wh ich would 
perhaps be non-self and also the cause of gamma i nterferon product ion i n  the first 
place . Interaction of gamma interferon with DNA as a DNA binding prote in  may then 
cause the release from repression of MHC class I I  transcription o r  perhaps promotion 
of transcription .  This in turn leads to de novo transcription of m R NA for MHC class I I .  
There also may be a n  i ncrease i n  the rate of translation of M H C  class I I  wh ich wou ld 
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i ncrease the expression of l a  with l i tt le apparent increase i n  m RNA present. I t  is  a lso 
possible that inte raction with gamma i nterferon causes increased labi l ity of ex ist ing 
m RNA and perhaps of newly transcribed mRNA such that in  concert with the postu lated 
i ncrease in translational  activity, a marked increase in expression of la is ach ieved 
wh ich is of short se lf l im it ing duration .  Although it is not shown from the data, i t  is 
postu lated that ce l ls  previous ly stimu lated with gamma i nterferon ,  enter a refractory 
period of unknown duration .  Another  explanation for the plateau in la expression m ay 
also be the loss of gamma interferon act ivity by being metabolized by the ce l ls  thus  
progressively removing it from the environment.  Of  i nterest is the  find ing that  the 
d ifferent subl ines and the parent 2-1  l i ne  behave i n  d ifferent ways when treated with 
gamma interferon ,  although they appear s im i lar from la cel l  surface expression data . 
The subl ines al l  show increased l a  expressio n ;  however, the G4 subl ine accompl ishes 
th is without ind ication of s ign ificant net change i n  mRNA for e i ther H LA- D R  a lpha o r  
DO alpha and in fact there i s  a net decrease in  both .  I n  contrast, t he  E1 1 subl ine shows 
increased la expression and appears to exhibit profound increase in  both H LA-DR alpha 
and DO alpha mRNA levels. The G1 1 subl ine shows marked increase on ly in  the H LA-DO 
alpha mRNA avai lable with l ittle net change in  the HLA-DR alpha mRNA. Litt le can be 
said of the E9 subl ine behavior g iven the low levels of expression ,  but the impression 
is that there is a small net increase in  HLA-DR alpha and a decrease i n  DO alpha. The 
parent 2-1  cell l ine is also of interest because it is clearly stimu lated to i ncrease l a  
expression by gamma i nterferon treatment ;  however ,  H LA- D R  alpha m RNA was not 
seen at al l  and DO alpha m RNA was decreased. A possible compl icating problem in  the 
R NA hybrid izations  may be the fact that total  ce l l u lar RNA was iso lated and the 
quantitation was based on total RNA of which the overwhelming majority is  ribosomal .  
Al though there is evidence i n  cel l l i nes that r ibosomal  RNA t ra nscript ion is  not 
s ign if icantly increased after gamma i nterferon treatment u n l ike norma l  cel l s  (476 ) ,  
t h i s  particu lar cel l  l i ne  has not been examined. The  m RNA for part icu lar M H C  class I I  
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gene products would be expected to constitute an extremely small percentage of the total 
m RNA and therefore a van ish ingly smal l  percentage of total cel l u lar  RNA. I f  rRNA 
increased s l ightly with stimu lation ,  the d istort ion seen i n  in te rpretation of m R NA 
resu lts wou ld be magn ified giving the impress ion of decreased levels rather than what 
m ight in fact be sharply increased levels. Effects of other immunomodu lators were also 
examined. As seen in Figu re 54, subl ines G4 and E 1 1 exh ibited decreased H LA- O R  
alpha mRNA when treated with LPS for 2 4  hours.  H LA-OO alpha m R NA was a lso 
decreased in  the G4 sub l ine ,  but was sharply increased i n  the E 1 1 subl i n e  and 
combin ing LPS and gamma interferon was synerg istic for HLA-OR alpha for both G4 
and E1 1 sublines and HLA-OO alpha for subl ine E 1 1 .  Treatment of  these subl ines with 
POBu for 72 hours markedly decreased H LA-OO alpha m RNA and DR alpha mRNA to a 
smal ler  degree.  Converse ly,  treatment of the parent 2-1  cel l  l i ne  with POBu did not 
st imu lated H LA- O R  alpha m RNA transcription but DO a lpha m R NA was s h arply 
i ncreased. Thus la  was expressed and there were clearly differences seen in  the 
expression of la  and regu lation of transcription of la specific m RNA by the  various 
popu lations of  U937 cel ls in response to several substances previously shown to affect 
the immune response . 
Functional studies were u ndertaken to characterize the abi l ity of the U937 cel ls  
to mediate processes ascribed to macrophages. While a l l  of  these findings pointed to the 
monocytic l ineage for the orig ins  of the U 937 cel l  l i ne ,  the collateral finding that the 
ce l l  l i ne d id  not  express la  and apparently could not be induced to express l a  l imited its 
usefu lness as a monocyte analog . When it became apparent that the cel l l i ne  in ou r  
laborato ry expressed l a  and  that sub l ines iso lated from the re lat ively l a  neg ative 
parent U937 cel l  l ine also expressed la, it was postu lated that the U 937 cel l l i ne  cou ld 
be shown to mediate monocyte- l ike activation of T cel ls in  an l a  dependent manner. As 
indicated in Figu res 1 5  and 1 6 , the U937 cel l  l i ne  and derived sub l i nes  were fu l ly  
capable of  stimu lating the generation of specific cytolytic T ce l ls  in  a CML response 
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which was comparable to the response seen with normal PBMC. Generation of the C M L  
response was not. however, dependent on the presence o f  la  on  the surface o f  t h e  cel ls  
but  was instead dependent on MHC class I molecu les wh ich were detectable on  al l  U937 
cel ls .  Generation of a m ixed lymphocyte response ,  however, had been  shown to be 
dependent on the expression of la (48 1 ) .  but may also be dependent on the presence of 
cost imu lat ing moieties (482) or different ia l  g lycosylat ion (483) . St imu lation  of an  
MLR by the U937 cel l  l i ne  and subl ines has been problematic at least in  part because of 
the production of secreted products having strong ant ipro l iferative activity ; however ,  
in general the la+ U937 subl ines were fou nd to stimulate an M LR and the l a- ce l l  l ines 
were less capable as shown in  Figu res 1 4  and 1 8 . I nconsistencies i n  responses to 
U937 subl ines at varying cel l  doses in  the M LR response may also be at least part ia l ly 
attributable to the effects of so luble products . When stimu lator U937 cel ls remained 
able to secrete suppressive factors it would be expected that at a l l  ce l l  doses ,  the 
st imu latory function ,  la ,  would be intact ; however, at low ce l l  doses the suppre ssor 
factor production would be insufficient to suppress the response but at  h igh ce l l  doses 
sufficient suppressor factor wou ld be produced to completely depress the response.  In 
experiments where a positive dose response curve was noted , it is postu lated that the 
ce l l s  we re su ff icient ly  i n act ivated to preven t  facto r p roduct ion at i n h i b i tory 
concentrations.  Support for this view was provided by several f indings. Ev idence that 
in  some cases addition of cel ls to a known active normal M LR was suppressive and 
so met imes st imu latory as ind icated i n  F ig u re 20 and that f ixation , and therefore 
complete m etabol ic i nactivation ,  of U937 cel l s  aUowed the production of an M LR 
response of the same or h igher magn itude than m itomycin C treated cel l s  as shown in  
Fig u res 21 and 22 indicated that the capacity for stimu lat ion of the M LR was present.  
Although not quant itated, it was found dur ing the course of the project that use of 
recently purchased , fresh ly prepared m itomycin C at high dose relative to ce l l  n umber 
tended to correlate with production of an M LR response.  I nh ibit ion of ce l l u lar assays 
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by large numbers of normal monocytes or macrophages in  both the human and m u rine 
systems is  a wel l  known phenomenon wh ich m ay be caused by the production of  
suppressive levels of prostag land ins or combinations of other  suppressive products, 
although the exact nature of the i nhibit ion is not wel l  characterized. The i n h ib it ion in 
the assays with U937 subl i nes was not fou nd to be attr ibutable to prostag land in  
production as ind icated i n  exper iments i n  wh ich  indomethaci n ,  a prostag land in  
i nh ibitor,  was contained i n  the  cu ltures .  
U937 cel ls and subl ines were fou nd to be fu l ly  competent i n  a dose dependent 
manner  to reconstitute the T cel l  m itogen ic response to OKT3, monoclonal ant ibody to 
the C D3 cel l  surface molecu le,  wh ich has also been found to be monocyte dependent as 
shown in  Figures 27 and 28. Although this function was attributable to the presence of 
the Fc receptor on the surface of the U937 cel ls and was not dependent on the presence 
of l a ,  it is clearly a monocyte- l ike function which the U937 cel l s  had not prev ious ly 
been shown to mediate . 
The U937 subl ines G4 and E1 1 were shown to present tetanus toxoid antigen to 
normal T ce l ls  as ind icated in Figu res 29-31 . Because of the problem of res idua l  
reactivity in PBMC treated by adherence and nylon woo l  columns for the removal of  
monocytes and B cel ls ,  U937 cel l s  were pu lsed with tetanus toxoid,  incubated and 
carefu l ly washed prior to addition to the part ial ly purified T cel ls .  Therefore,  the on ly  
antigen present in the assay was added in  association with the U937 accessory cel ls .  As 
indicated, the stimu lation of 3H-thymidine incorporation by the T ce l ls was com parable 
to that seen with isolated human monocytes pulsed and added back i n  the same way. This 
stimu lation was also found to be sign ificantly abrogated by antibody both to human la 
( K u l a  2 monoclonal  ant ibody) and by ant ibody to the C D4 mo lecu le  (KT69-7 
monoclona l  antibody (440) which has been shown to interact i n  the b ind ing of T ce l l  
receptor-ant igen- I a  complex i n  t he  activat ion of T ce l ls . I rrelevant ant ibod ies and 
ant ibody to 82 m icrog lobu l i n  were not s ign ificant ly i nh ibitory .  H LA- D R  specif ic 
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ant ibody reactivity in inh ibit ion of ant igen presentation by U937 ce l ls  was found  to 
correlate to some degree with the reaction except for the anti DR2 reagent  wh ich was 
found to block all normal reactions to some degree and strong ly blocked the response by 
responders CS and CJ . Although this antiserum and the others used were found to have 
h igh  reactivity for the stated H LA-DR specificit ies ,  they a re heteroant isera with 
po lyclonal  react iv it ies which also inc lude the publ ic specificit ies Dw52 and Dw53 
w ;h ich include H LA-DO reactivity, and react iv ity wh ich would be predicted to block 
several other H LA-DR specif ici tes.  Thus  it is  not su rpris ing  that appare nt ly  
inappropriate responses were noted. I n  order to  de l ineate the H LA- D R  and DO 
specificity o f  the ant igen present i ng ce l l s ,  monoclona l  reagents to  t he  p rivate 
specificities found i n  the polymorphic port ions of the M H C  class I I  molecu les wou ld 
have to be employed . Unfortunate ly , these reagents are not currently avai lable .  I t  
wou ld a lso be advantageous to  uti l ize antigen specific T ce l l  clones to  exam ine  the 
capacity of  U937 ce l ls to  present antigen .  The use of  T ce l l  clones wou ld obv iate the 
necessity to purify the T cel ls and thus remove al l  auto logous accessory ce l ls .  The use 
of T cell c lones with known HLA phenotype also wou ld al low for investigation of the M HC 
restriction of antigen presentation by the U937 cel ls .  
I nvestigation of the suppressor activ ity fou nd in  the supernatants of the U937 
cel ls  i ncluded assessment of its effects on a number  of prol iferative assays i nc lud ing 
M LR and PHA and Con A mitogenesis, g rowth and 3H-thymidine incorporation by other  
cel l l ines and the  generation of  CM L reactivity. Pre l im inary characterizat ion i nd icated 
that the suppressive activ ity was very potent, that it was not prostag landin or a smal l  
mo lecu lar weight compound,  a lthough the product ion of  such products m ay h ave 
contr ibuted to the suppression seen , that it was not i nactivated by treatment  with 
either tryps in or chymotrypsin ,  but that part ial i nactivat ion cou ld be accompl ished by 
heat ing or  long term storage and that when part ia l ly fractionated the suppress ive 
activity correlated with e lution of a 90 kd protei n .  Suppressive factor product ion by 
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the U937 cel l  l i ne  has been previously reported by several g roups (393 , 394) and 
molecular weights for these factors have variously been found to be approximately 56 
kd (393) and 85 kd (394) .  The properties reported have been s im i lar  to  those wh ich 
were found  in  this study in that pro l ife rative assays were strong ly i n h ib ited by 
addition of the supernatants . Our findings closely paral le l  those of Fuj iwara and E l l ner  
(394 ,  395) in  s imi larity of  molecu lar weig ht and character of the suppression seen .  
Admittedly the results obtained in  investigation o f  the suppressive factors produced by 
these ce l ls is pre l iminary and warrants more extensive treatment. I t  is not apparent 
at present whether the potent inh ibitory activity , which seems to affect lymphoid ce l ls  
to  a g reater degree than non- lymphoid cel ls as shown by differential effects on PBMC 
and R E H  cel ls of  lymphoid orig in  as  opposed to  K562 cel ls of  erythroleukemia orig i n ,  i s  
characterist ic of monocytic ce l ls  or  whether  it is  a funct ion of  the  ma l i g n ant  
transformation which caused the  development of these cel ls  making i t  a tumor  ce l l  
characte r ist ic .  
P roduction of so lub le I L- 1  by U937 ce l l s  after st imu lation with bacter ia l  
extract from Staphylococcus aureus causing toxic shock syndrome has been  previously 
reported (397) . The I L- 1  derived from U937 cel ls  was found to be simi lar to but not 
exact ly synonymous with human I L- 1  B. I n  this study , measu rement of so l ub le  I L- 1  
act iv i ty us ing  t h e  sta ndard cost imu lator assay with measures 3 H - t h y m i d i n e  
Incorporat ion by the I L- 1  dependent  T ce l l  l i ne ,  0 1  0 .G4 . 1 , was fou n d  to be 
i n appropriate because of the ant ipro l iferative effect of othe r  com ponents of  the 
supernatants tested. A surpris ing f inding was the measurable I L- 1  activity in  col umn  
fractions  from the  Sephacry l  S200 fract ionat ion o f  concentrated supernatant  wh ich 
e luted either before or after the suppressive factor and a lso the synerg ist ic activ ity 
seen in  heat treated supernatants. It is unclear whether the stim ulatory co mponent in 
these supernatants or fractions of supernatants was normal human I L- 1  B . I n  rout ine 
I L- 1  assays, purified I L- 1  added to the assays at  h igh concentration was fou nd to be 
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i nh ibitory and stimu lation above a particu lar level could not be achieved . Add it ion of 
heated supernatant to these assays including optimal concentrations of purified h uman 
I L- 1  appeared to  synerg ize with the I L- 1  rather than inh ibit the  response as one wou ld 
expect with addition of h igher  concentrat io n  of purif ied human I L- 1 . I n  assays i n  
which column fraction I L- 1  activity was assessed , no purified I L- 1  was added to  the 
assay wel l s ,  thus the st imu lat ion seen was not a synerg i st ic response and the 
i mpl ication is  that I L- 1  activity was present.  Membrane I L- 1  wh ich has been shown 
to be important in T cel l  stimu lation was assessed by the method of Kurt-Jones et .  a l .  
(98) . Unstimulated U937 cel ls were found to display smal l  amounts of membrane  I L-
1 and treatment with immu nomodu lators i nc luding gamma i nterferon , LPS,  g a m m a  
interferon + LPS a n d  D M S O  were not s ign ificant ly stimu latory ; however,  phorbo l  
esters including both PMA and PDBu were very effective st imu lants o f  membrane I L- 1  
expression .  
I n  summarizing the data obtained du ring the cou rse of th i s  project,  i t  was 
apparent  that although there were i ndeed smal l  d ifferences i n  the sub l ines in some 
parameters, notably in  general cel l  s ize and  cel l  su rface phenotype , and  there were 
d ifferences noted in  their expression of MHC class I I  specific m RNA i n  response to 
treatment  with immunomodu lators, these differences d isappeared when functio na l  
capacity was investigated and  no  clear d istinction could be made between subl ines which 
could consistently be found. It became apparent early in the project that maintenance 
of an absolutely la negative U937 cel l  l ine was not possible over a long period of t ime.  
Although the impetus for expression of l a  by th is  ce l l  l i ne is not  known , several g roups 
have i nvestigated mechanisms causing expression including methylation of the DNA and 
h ave found that hypo methylation may be necessary but not sufficient for M HC class I I  
expression (424 , 484) . I t  appears that once negative regu lation o f  l a  expression i s  
re moved , its express ion is  posit ively regu l ated t o  a var iable deg ree b y  cu l t u re 
conditions.  I n  M LR assays there appeared to be a correlation between the degree of l a  
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expression and the frequency of M LR production .  This i s  particu larly apparent  with 
the H-K parent cel l  l ine which remained la  negative for the t ime that i t  was in cu l tu re 
and for sublines G4 and E1 1 which were isolated as l a  posit ive subl ines and remained la  
posit ive to  approximate ly the  same level  u nt i l  very recently. The  2-1  parent and the 
E9 subl ine wh ich were l a- when fi rst ut i l ized, became m easurably l a+ ove r t ime ,  
a lthough the  level o f  expression remained general ly lower than  other  sub l ines u sed.  
The G 1 1 subl ine became l a+ rapidly after isolation but also continued to show more 
variabi l ity in express ion than either the G4 or  E 1 1 subl ines .  
U937 ce l ls  have been invest igated by  n u mero u s  l aborator ies s i nce t he i r  
orig inal isolation and description . Other laboratories have described finding la  beari ng 
variants of the cel l  l ine, notably Gitter et. a l .  (425) who isolated their clone ,  1937, by 
se lection for a h igh level of la expression by cel l  sorting techn iques.  The i r  find ings 
with the 1937 cel l  l ine ,  that they wou ld stimu late an M LR and that phenotypical ly they 
resembled promonocytes i n  the i r  lack of  M01 and M02 expression ,  were s imi lar  to  our  
find ings  with the  la+ subl ines. A clear difference which has remained u n resolved is  
the i r  fi nd ing of HLA- O R3 positive ce l l s  rather than H LA- OR2 as we have found .  
Unfortunately the  H LA-OR phenotype o f  the patient from whom the  cel l l i ne  orig i nated 
is not known ; however, it is  possible that the H LA-OR genotype for the U937 cel l s  i s  
H LA-OR(2,3) and  that t he  ce l l  l i ne  i n  different laboratories selectively expresses one  
bu t  not both HLA-OR specificit ies. 
The U937 cel l  l i ne has been fou nd to be a usefu l too l  for numerous avenues of 
investigation .  Recent f indings that the  cel l  l ine can be chron ical ly i nfected with H I V- I  
(4 1 7, 4 1 8 , 4 1 9) has  made i t  a possible tool for t he  i nvestigation o f  t he  potent ia l ly 
letha l  role of monocytes as repositories and disseminators of virus in  AI  OS.  The U937 
cel l  l ine has also been shown to ingest cholesterol esters to become analogous  to foam 
cel ls making them potential ly usefu l for the i nvestigation of monocyte function i n  the 
establ ishment of atherosclerotic plaque format ion (379 , 380) . In  addit ion to these 
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studies,  the U937 cel l  l i ne  has been usefu l in  studies of the effects of m etabol ites of 
vitamin  D and of phorbol ester induced different iation in a large  n u mber of studies 
( 3 9 9 - 4 1 4 ) .  
The subl ines of U937 wh ich have been characterized in  th is project represent 
an important adjunct to the study of l a  beari ng cel ls in  the human system.  The re lative 
ease with wh ich they can be kept in culture makes them a readi ly avai lable reagent. 
Th is area of i nvestigation has previously been  dependent on  the iso lat ion of h uman  
monocytes which is  l im ited by  the  avai labi l ity o f  su itable un in fected donors of l arge 
volumes of blood fol lowed by tedious procedures wh ich yield relatively smal l  numbers 
of cel ls  general ly  contaminated by s ign if icant n u m bers of  T ce l l s ,  large g ranu la r  
lymphocytes, B ce l ls  and dendrit ic ce l ls .  There are  certa in ly d ifferences between 
U937 cel ls  and normal  human monocytes and the use of tumor derived ce l l s  for 
d iscovering "normal" functions poses many problems of extrapolation ; however ,  these 
problems once recogn ized may pose fewer problems than continuous isolations  of cel ls 
from a battery of donors. The f indings i n  th is study that the G4 and E 1 1 sub l ines 
appear to  be able to  process and present tetanus toxoid antigen to  part ial ly pu rified T 
ce l ls and that this function can be abrogated by addition of la  specific antibody m akes 
them a potential ly valuable tool for the i nvestigation of the mechanisms i nvolved in 
endocytosis and processing of antigens and of the reexpression of antigenic fragm e nts 
in association with MHC molecules which have been difficu lt areas to study. Other  
areas of interest and potential ly important investigation are the  ro le  o f  the Fc  receptor 
and the role of CD4 molecules on monocytes in faci l itation of l a  mediated function The 
find ing that the U937 subl ines were capable of reconstitut ing the mi togen ic effect of 
ant i-C D3 ant ibody in purified T cel l s  indicates that these cells can m im ic monocyte 
function in non- Ia dependent ways wh ich nevertheless lead to ful ly activated T cel ls .  
The expression of  CD4 by U937 cel ls and at  low levels by normal monocytes has been 
previously reported (387, 388) but its function on these cel ls and U937 ce l ls  i s  not 
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known.  The production of potent immunosuppressive factors partial ly described i n  th is  
project, and the regu lation of this factor production is a lso an area to wh ich the U937 
cel ls  can make a contribution .  F inal ly ,  pre l im inary find ings indicate that there may be 
differences in the regu lation of la expression among the subl ines of U 937 and the 
parent 2- 1 cel l  l i ne ;  therefore ,  investigation of regu lat ion of  l a  expression by addition 
of  i m m u nomod u l at i ng  d r u g s ,  i n te r l e u k i n s  a n d  oth e r  compo n e n ts  of  t h e  
m icroenvironment surround ing activated cel ls  may lead to further understanding o f  the 
differential regulation of the HLA-DR and DQ gene products as wel l  as H LA-DP ,  DO and 
DZ. 
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